<SEC-DOCUMENT>0001493152-23-014688.txt : 20230428
<SEC-HEADER>0001493152-23-014688.hdr.sgml : 20230428
<ACCEPTANCE-DATETIME>20230428160523
ACCESSION NUMBER:		0001493152-23-014688
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20230428
FILED AS OF DATE:		20230428
DATE AS OF CHANGE:		20230428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imunon, Inc.
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		23865874

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsion CORP
		DATE OF NAME CHANGE:	20071121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant to Section 14(a) of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Securities Exchange Act of 1934 (Amendment No. )</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by the Registrant &#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by a Party other than the Registrant &#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material under &sect;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(Name
of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N/A</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(Name
of Person(s) Filing Proxy Statement, if Other Than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
LENOX DRIVE, SUITE 100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
NJ 08648</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE HELD WEDNESDAY, JUNE 14, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
Our Stockholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
is hereby given that the annual meeting (the &ldquo;Annual Meeting&rdquo;) of the stockholders of IMUNON, INC., a Delaware corporation
(the &ldquo;Company&rdquo;), will be held at 10:00 a.m., local time, on Wednesday, June 14, 2023. You will be able to attend the Annual
Meeting, vote, and submit your questions during the meeting via live webcast through the link <B><I><U>www.virtualshareholdermeeting.com/IMNN2023
</U></I></B>and entering your 16-digit control number included on the notice of Internet availability of the proxy materials, on your
proxy card or in the instructions that accompanied your proxy materials. We have adopted a hybrid meeting format to expand access to
the meeting, improve communications and impose lower costs on our stockholders, the Company and the environment. We believe hybrid meetings
enable increased stockholder participation from locations around the world. This format allows us to continue to proceed with the meeting
while mitigating the potential health and safety risks to participants. The Annual Meeting shall be held for the following purposes,
all as more fully described in the accompanying Proxy Statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect two Class I Directors to serve until the Annual Meeting of Stockholders in 2026 and until a successor is duly elected and qualified;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the selection of WithumSmith+Brown PC (&ldquo;Withum&rdquo;) as the Company&rsquo;s independent registered public accounting
    firm for the fiscal year ending December 31, 2023;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, by a non-binding advisory vote, the 2022 executive compensation for the Company&rsquo;s executive officers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, by a non-binding advisory vote, the frequency by which future advisory votes on executive compensation will occur; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    consider and act upon an Amendment to the IMUNON, INC. 2018 Stock Incentive Plan to increase the aggregate number of shares of common
    stock that may be delivered pursuant to all awards granted under the Plan; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    consider and act upon any other matters that may properly come before the Annual Meeting and any adjournment or postponement thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
close of business on April 21, 2023 has been fixed as the record date for the determination of stockholders of the Company entitled to
notice of, and to vote at the Annual Meeting. Only stockholders of record at the close of business on April 21, 2023 are entitled to
notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
stockholders are cordially invited to attend the Annual Meeting. However, whether you expect to attend via the live webcast,
please complete, sign, date and return the enclosed Proxy Card as promptly as possible in the envelope provided for that purpose. Returning
your Proxy Card will ensure your representation and help to ensure the presence of a quorum at the Annual Meeting. Your proxy is revocable,
as set forth in the accompanying Proxy Statement. Therefore, you may attend the Annual Meeting and vote your shares via
the live webcast even if you send in your Proxy Card.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jeffrey W. Church</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
                                            28, 2023</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
    NJ</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
                                            W. Church</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Secretary</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YOUR
VOTE IS IMPORTANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PROXY STATEMENT IS FURNISHED IN CONNECTION WITH THE SOLICITATION OF PROXIES BY THE COMPANY, ON BEHALF OF THE BOARD OF DIRECTORS, FOR
THE 2023 ANNUAL MEETING OF STOCKHOLDERS. THE PROXY STATEMENT AND THE RELATED PROXY FORM ARE BEING DISTRIBUTED ON OR ABOUT MAY 5, 2023.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YOU
CAN VOTE YOUR SHARES USING ONE OF THE FOLLOWING METHODS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPLETE
    AND RETURN A WRITTEN PROXY CARD</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ATTEND
    THE COMPANY&rsquo;S 2023 ANNUAL MEETING OF STOCKHOLDERS VIA LIVE WEBCAST AND VOTE AT THE ANNUAL MEETING </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOTE
    VIA THE INTERNET AT <U>WWW.PROXYVOTE.COM </U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOTE
    BY PHONE BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING VOTING DOCUMENT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALL
STOCKHOLDERS ARE CORDIALLY INVITED TO ATTEND THE MEETING. HOWEVER, TO ENSURE YOUR REPRESENTATION AT THE MEETING, YOU ARE URGED TO COMPLETE,
SIGN, DATE AND RETURN THE ACCOMPANYING PROXY CARD AS PROMPTLY AS POSSIBLE IN THE POSTAGE-PREPAID ENVELOPE ENCLOSED FOR THAT PURPOSE OR
SUBMIT YOUR VOTE VIA THE INTERNET AT <I><U>WWW.PROXYVOTE.COM</U></I> OR VOTE BY PHONE BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING
VOTING DOCUMENT. ANY STOCKHOLDER ATTENDING THE MEETING VIA THE LIVE WEBCAST MAY VOTE EVEN IF YOU HAVE RETURNED A PROXY CARD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON WEDNESDAY, JUNE 14, 2023. THE PROXY STATEMENT
AND OUR 2022 ANNUAL REPORT ON FORM 10-K (AS DEFINED BELOW) TO SECURITY HOLDERS ON SECURITIES AND EXCHANGE COMMISSION FORM 10-K ARE AVAILABLE
AT <I><U>WWW.PROXYVOTE.COM</U>.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_001">Information
    Concerning Solicitation and Voting</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_002">Information
    About the Annual Meeting</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_003">Date,
    Time and Place of the Annual Meeting</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_004">Who
    May Attend the Annual Meeting</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_005">Who
    May Vote at the Annual Meeting</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_006">How
    to Vote</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_007">Voting
    by Proxy</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_008">Quorum
    Requirement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_009">Voting
    Requirements</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_010">Other
    Matters</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_011">Information
    about the Proxy Statement and the Solicitation of Proxies</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">4</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_012">Annual
    Report</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_013">Householding
    of Annual Meeting Materials</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_014">Beneficial
    Ownership of Common Stock</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">5</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_015">Code
    of Ethics</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_016">Certain
    Relationships and Related Party Transactions</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#kutty_017">Proposal
    No. 1: Election of Directors</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_018">General</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_019">Directors,
    Executive Officers and Corporate Governance</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">9</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_020">Legal
    Proceedings</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_021">Board
    Leadership Structure and Role in Risk Oversight</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">12</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_022">Committees
    of the Board of Directors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_023">Meetings
    of the Board and Its Committees</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">15</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_024">Director
    Nominations</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">15</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_025">Stockholder
    Communications</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_026">Board
    Attendance</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_027">Director
    Compensation</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_028">2022
    Director Compensation Table</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">18</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_029">Narrative
    Disclosure to Director Compensation Table</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_030">Compensation
    Committee Interlocks and Insider Participation</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_031">Stock
    Ownership Guidelines for Non-Employee and Executive Directors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">20</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_032">Report
    of the Audit Committee of the Board of Directors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_033">Executive
    Compensation</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">22</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_034">Compensation
    Discussion and Analysis</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">22</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_035">Compensation
    Committee Report on Executive Compensation</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">29</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_036">2022
    Executive Summary Compensation Table</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_037">Narrative
    Disclosure to Summary Compensation Table</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_038">2022
    Grants of Plan-Based Awards</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_039">2022
    Outstanding Equity Awards at Year-End</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">35</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_040">Pay
    Versus Performance</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_041">Equity
    Compensation Plan Information</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#kutty_042">Proposal
    No. 2: Ratification of Selection of Independent Registered Public Accounting Firm</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_043">Proposal
    No. 3: To approve, by a non-binding advisory vote, the 2022 executive compensation for the Company&rsquo;s executive officers</A>
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#kutty_044">Proposal No. 4: To approve, by a non-binding
    advisory vote, the frequency by which future advisory votes on executive compensation will occur</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">41</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#kutty_045">Proposal
    No. 5: Approval of Amendment to the IMUNON, INC. 2018 Stock Incentive Plan</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_046">Stockholder
    Nominations and Proposals for the 2024 Annual Meeting of Stockholders</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#kutty_047">Where
    You Can Find Additional Information</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: UpperRoman; Name: PageNo -->I<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_001"></A>INFORMATION
CONCERNING SOLICITATION AND VOTING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Proxy Statement is being furnished in connection with the solicitation of proxies by the Board of Directors of IMUNON, INC., a Delaware
corporation (sometimes referred to in this Proxy Statement as the &ldquo;Company&rdquo;, &ldquo;IMUNON&rdquo;, &ldquo;we&rdquo; or &ldquo;us&rdquo;),
for exercise in voting at the Company&rsquo;s 2023 Annual Meeting of Stockholders to be held on Wednesday, June 14, 2023 (the &ldquo;Annual
Meeting&rdquo;) for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. We are first sending this Proxy
Statement, accompanying Proxy Card, Notice of Annual Meeting of Stockholders and Annual Report on Securities and Exchange Commission
(&ldquo;SEC&rdquo;) Form 10-K for the fiscal year ended December 31, 2022 (our &ldquo;2022 Annual Report on Form 10-K&rdquo;) to our
stockholders on or about May 5, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be held on Wednesday, June 14, 2023. The Proxy Statement
and our 2022 Annual Report on Form 10-K are available at <I><U>www.proxyvote.com</U></I> or you may request a printed or electronic set
of the proxy materials at no charge.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instructions
on how to access the proxy materials over the Internet and how to request a printed copy may be found on the Notice. In addition, any
stockholder may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. Choosing to
receive future proxy materials by email will save us the cost of printing and mailing documents to stockholders and will reduce the impact
on our environment. A stockholder who chooses to receive future proxy materials by email will receive an email prior to next year&rsquo;s
Annual Meeting with instructions containing a link to those materials and a link to the proxy voting website. A stockholder&rsquo;s election
to receive proxy materials by email will remain in effect until such election is terminated by the stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2022, Celsion Corporation announced a corporate name change to IMUNON, INC., reflecting the evolution of the Company&rsquo;s
business focus and its commitment to developing cutting-edge immunotherapies and next-generation vaccines to treat cancer and infectious
diseases. The Company&rsquo;s common stock trades on the Nasdaq Stock Market under the ticker symbol &ldquo;IMNN.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMUNON,
INC. is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness
the body&rsquo;s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases, constituting
a differentiating approach from conventional therapies. Imunon has two platform technologies: Our TheraPlas platform for the development
of immunotherapies and other anti-cancer nucleic acid-based therapies, and our PLACCINE platform for the development of nucleic acid
vaccines for infectious diseases and cancer. The Company&rsquo;s lead clinical program, IMNN-001 (formerly GEN-1), is a DNA-based immunotherapy
for the localized treatment of advanced ovarian cancer currently in Phase II development. IMNN-001 works by instructing the body to produce
safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally,
the Company is conducting preclinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order
to validate its PLACCINE platform. IMUNON&rsquo;s platform technologies are based on the delivery of nucleic acids with novel synthetic
delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological
frontier of plasmid DNA to better serve patients with difficult to treat conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648 and our telephone number is (609) 896-9100.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_002"></A>INFORMATION
ABOUT THE ANNUAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_003"></A>Date,
Time and Place of the Annual Meeting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Annual Meeting will be held at 10:00 a.m., local time, on Wednesday, June 14, 2023. You will be able to attend the 2023 Annual Meeting,
vote, and submit your questions during the meeting via live webcast through the <B><I>www.virtualshareholdermeeting.com/IMNN202</I></B>3
and entering your 16-digit control number included on the notice of Internet availability of the proxy materials, on your proxy card
or in the instructions that accompanied your proxy materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Why
is the Annual Meeting a virtual, online meeting?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted this technology to expand access to the meeting, improve communications and impose lower costs on our stockholders,
the Company and the environment. The online format allows us to communicate more effectively via a pre-meeting forum that you can enter
by visiting the meeting via live webcast through the link <B><I><U>www.virtualshareholdermeeting.com/IMNN2023 </U></I></B>and entering
your 16-digit control number included on the notice of Internet availability of the proxy materials, on your proxy card or in the instructions
that accompanied your proxy materials. We believe that hosting a virtual meeting will facilitate shareholder attendance and participation
by enabling shareholders to participate from any location around the world and improve our ability to communicate more effectively with
our shareholders. We have designed the virtual meeting to provide substantially the same opportunities to participate as
you would have at an in-person meeting. You will be provided with the opportunity to submit questions via the live webcast during the
meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_004"></A>Who
May Attend the Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
stockholders who own our common stock, par value $0.01 per share, as of the close of business on April 21, 2023, the record date for
the Annual Meeting (the &ldquo;Record Date&rdquo;), will be entitled to attend the Annual Meeting. At the discretion of management, we
may also permit certain individuals to attend the Annual Meeting, including the media, professional service providers and our employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_005"></A>Who
May Vote at the Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of our common stock outstanding on the Record Date entitles the holder thereof to one vote on each matter submitted to the stockholders
at the Annual Meeting. Only stockholders who own common stock as of the close of business on the Record Date are entitled to notice of,
and to vote at, the Annual Meeting. As of the Record Date, there were 9,097,005 shares of our common stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_006"></A>How
to Vote</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you were a holder of our common stock as of the Record Date, you are entitled to vote at the Annual Meeting, and we encourage you to
vote your shares by attending the meeting via live webcast of the Annual Meeting<B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOWEVER,
WHETHER OR NOT YOU INTEND TO ATTEND THE ANNUAL MEETING, PLEASE COMPLETE, SIGN, DATE AND RETURN THE ACCOMPANYING PROXY CARD IN THE ENCLOSED
PRE-ADDRESSED AND POSTAGE-PAID ENVELOPE OR SUBMIT YOUR VOTE VIA THE INTERNET AT WWW.PROXYVOTE.COM OR BY CALLING THE NUMBER PRINTED ON
THE ACCOMPANYING PROXY CARD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in the name of a bank, broker, or other holder of record, you will receive instructions from the holder of record
that you must follow in order for your shares to be voted. If your shares are not registered in your own name and you plan to vote your
shares via the live webcast at the Annual Meeting, you should contact your broker or agent to obtain a proxy in order to
vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_007"></A>Voting
by Proxy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you vote by proxy, the individuals named on the proxy, or their substitutes, will vote your shares in the manner you indicate. If a beneficial
owner who holds shares in street name does not provide specific voting instructions to their brokerage firm, bank, broker dealer or other
nominee, under the rules of certain securities exchanges, including Nasdaq Marketplace Rules, the brokerage firm, bank, broker dealer
or other nominee holding those shares may generally vote as the nominee determines in its discretion on behalf of the beneficial owner
on routine matters but cannot vote on non-routine matters, the latter of which results in &ldquo;broker non-votes.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
No. 2 involves matters we believe to be routine in nature. Accordingly, if you do not give instructions to your broker, the broker may
vote your shares in its discretion on Proposal No. 2 and therefore no broker non-votes are expected in connection with Proposal No. 2.
Proposal Nos. 1, 3, 4 and 5 involve matters we consider non-routine under the applicable rules. If you do not give your broker specific
instructions, the broker will not vote your shares on Proposal Nos. 1, 3, 4 and 5 and your shares will constitute broker non-votes. If
you date, sign, and return the proxy card without indicating your instructions, your shares will be voted as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 1.</B> &ldquo;<B>FOR</B>&rdquo; (if authority to do so is not withheld) the election of the nominees for the Class I Directors
    to serve until the earlier of the Company&rsquo;s Annual Meeting of Stockholders in 2026 and until a successor is duly elected and
    qualified;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 2. &ldquo;FOR&rdquo;</B> the ratification of the appointment of WithumSmith+Brown PC as our independent registered public accounting
    firm for the year ending December 31, 2023; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 3. &ldquo;FOR&rdquo;</B> the approval of, by a non-binding advisory vote, the 2022 executive compensation for the Company&rsquo;s
    executive officers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 4. &ldquo;EVERY THREE YEARS&rdquo;</B> to approve, by a non-binding advisory vote, the frequency by which future advisory votes
    on executive compensation will occur; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 5. &ldquo;FOR&rdquo;</B> the approval of an amendment to the IMUNON, INC. 2018 Stock Incentive Plan; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
    Business.</B> In the discretion of your proxy holder (one of the individuals named on your proxy card), on any other matter properly
    presented at the Annual Meeting or any adjournment or postponement thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may revoke or change your proxy at any time before it is exercised by delivering to us a signed proxy with a date later than your previously
delivered proxy, by voting via the live webcast at the Annual Meeting, or by sending a written revocation of your proxy
addressed to our Corporate Secretary at our principal executive office. Your latest dated proxy card is the one that will be counted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_008"></A>Quorum
Requirement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum is necessary to hold a valid meeting. The presence of holders of our common stock entitled to cast one-third of all the votes
entitled to be cast at the Annual Meeting constitutes a quorum for the transaction of business. Abstentions and broker non-votes are
counted as present for purposes of establishing a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_009"></A>Voting
Requirements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 1.</B> The election of the Class I Directors at the Annual Meeting will be by a plurality of the votes cast. This means if the director
nominees receive the greatest number of votes cast by the holders of our common stock in the election of the Class I Directors, they
will be elected. Stockholders may not cumulate their votes in electing directors. Stockholders entitled to vote at the Annual Meeting
may either vote &ldquo;FOR&rdquo; the nominee for election as a director or may &ldquo;WITHHOLD&rdquo; authority for the nominee. Shares
represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the nominee named below in
Proposal No. 1. If a stockholder withholds authority to vote with respect to the nominees for director, the shares held by that stockholder
will be counted for purposes of establishing a quorum but will have no effect on the election of the nominees. Broker non-votes will
have no effect on the election of the nominees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 2.</B> Stockholders may vote &ldquo;FOR&rdquo; or &ldquo;AGAINST&rdquo; or may &ldquo;ABSTAIN&rdquo; on Proposal No. 2 regarding
the ratification of the selection of WithumSmith+Brown PC (&ldquo;Withum&rdquo;) as the Company&rsquo;s independent registered public
accounting firm for the year ending December 31, 2023. The affirmative vote of the holders of a majority of the shares of our common
stock present via live webcast or represented by proxy and entitled to vote on the proposal will be required to ratify the
selection of Withum. Abstentions will have the same effect as a vote against Proposal No. 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 3.</B> Stockholders may vote &ldquo;FOR&rdquo; or &ldquo;AGAINST&rdquo; or may &ldquo;ABSTAIN&rdquo; on Proposal No. 3 to approve,
by a non-binding advisory vote, the 2022 compensation for the Company&rsquo;s executive officers. The affirmative vote of the holders
of a majority of the shares of our Common Stock present via live webcast or represented by proxy and entitled to vote on
the proposal will be required to ratify the 2022 compensation for the Company&rsquo;s executive officers. Abstentions will have the same
effect as a vote against Proposal No. 3, but broker non-votes will have no effect on Proposal No. 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 4.</B> Stockholders may vote for &ldquo;EVERY YEAR,&rdquo; &ldquo;EVERY TWO YEARS,&rdquo; &ldquo;EVERY THREE YEARS&rdquo; or &ldquo;ABSTAIN&rdquo;
on Proposal No. 4 to approve, by a non-binding advisory vote, the frequency by which future advisory votes on executive compensation
will occur. Generally, approval of any matter presented to stockholders is determined by a majority of the votes cast affirmatively or
negatively on the matter, assuming a quorum is present. However, given that Proposal No. 4 is advisory and non-binding, if none of the
frequency options receive a majority of the votes cast, the option receiving the greatest number of votes will be considered the frequency
recommended by the stockholders. In such instance, while none of the three alternatives will have been approved, stockholders will still
have the ability to communicate their preference with respect to this vote. Abstentions and broker non-votes will have no effect on Proposal
No. 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 5.</B> Stockholders may vote &ldquo;FOR&rdquo; or &ldquo;AGAINST&rdquo; or may &ldquo;ABSTAIN&rdquo; on Proposal No. 5, to approve
an Amendment to the IMUNON, INC. 2018 Stock Incentive Plan. The affirmative vote of the holders of a majority of the shares of our common
stock present via the live webcast or represented by proxy and entitled to vote on the proposal will be required to approve
the Amendment. Abstentions will have the same effect as a vote against Proposal No. 5. Broker non-votes will have no effect on Proposal
No. 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_010"></A>Other
Matters</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors knows of no other matters that may be presented for stockholder action at the Annual Meeting. It is not anticipated
that other matters will be brought before the Annual Meeting. If other matters do properly come before the Annual Meeting, or any adjournments
or postponements thereof, however, persons named as proxies will vote upon them in their discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_011"></A>Information
about the Proxy Statement and the Solicitation of Proxies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
enclosed proxy is solicited by our Board of Directors, and we will bear the costs of preparing, assembling, printing and mailing this
Proxy Statement, accompanying Proxy Card, Notice of Annual Meeting of Stockholders and the Company&rsquo;s 2022 Annual Report on Form
10-K, as well as any additional materials that we may furnish to stockholders in connection with the Annual Meeting. Copies of our solicitation
materials will be furnished to brokerage houses, fiduciaries and custodians to forward to beneficial owners of stock held in the names
of such nominees. We will, upon request, reimburse those parties for their reasonable expenses in forwarding proxy materials to the beneficial
owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_012"></A>Annual
Report</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
2022 Annual Report on Form 10-K is being mailed to stockholders together with this Proxy Statement and contains financial and other information
about IMUNON, including audited financial statements for our fiscal year ended December 31, 2022. A copy of our 2022 Annual Report on
Form 10-K, as filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;), but excluding exhibits, is available on our website
and additional copies may be obtained without charge, upon written request directed to the Corporate Secretary, IMUNON, INC., 997 Lenox
Drive, Suite 100, Lawrenceville, New Jersey 08648.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><A NAME="kutty_013"></A>Householding
of Annual Meeting Materials</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
banks, brokers and other nominee record holders may be participating in the practice of &ldquo;householding&rdquo; proxy statements and
annual reports. This means that only one copy of our Proxy Statement or 2022 Annual Report on Form 10-K may have been sent to multiple
stockholders in your household. The Company will promptly deliver a separate copy of either document to you if you write or call the
Company at the following address or telephone number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
Lenox Drive</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suite
100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrenceville,
New Jersey 08648</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Attention:
Corporate Secretary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(609)
896-9100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you would like to receive separate copies of the proxy materials in the future, or if you are receiving multiple copies and would like
to receive only one copy for your household, you should contact your bank, broker, or other nominee record holder, or you may contact
the Company at the address and telephone number set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
COMPLETE, SIGN, DATE AND RETURN THE ACCOMPANYING WHITE PROXY CARD IN THE ENCLOSED PRE-ADDRESSED AND POSTAGE-PAID ENVELOPE AS PROMPTLY
AS POSSIBLE OR SUBMIT YOUR VOTE VIA THE INTERNET AT <I><U>WWW.PROXYVOTE.COM</U></I> OR BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING
PROXY CARD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NUMBER
OF SHARES OF COMMON STOCK BENEFICIALLY OWNED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_014"></A>BENEFICIAL
OWNERSHIP OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table is furnished by the Company and sets forth certain information known to the Company regarding the beneficial ownership
of the Company&rsquo;s common stock as of April 21, 2023 by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person or group known by us to own beneficially more than five percent of the outstanding common stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors and the director nominees, as well as each executive officer named in the Summary Compensation Table appearing under
    the heading &ldquo;Executive Compensation;&rdquo; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    directors and executive officers as a group.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine beneficial ownership in accordance with the rules of the SEC. Under SEC rules, beneficial ownership for purposes of this table
takes into account shares as to which the individual has voting or investment power as well as shares that may be acquired within 60
days. Shares of common stock subject to options that are currently exercisable or that become exercisable within 60 days of April 21,
2023, are treated as outstanding and beneficially owned by the holder of such options. However, these shares are not treated as outstanding
for purposes of computing the percentage ownership of any other person. Unless otherwise indicated or as to the interests of spouses,
the persons included in the table have sole voting and investment power with respect to all shares beneficially owned thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">NAME OF BENEFICIAL OWNER</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">NUMBER OF<BR> SHARES OF<BR> COMMON
    STOCK<BR> BENEFICIALLY<BR> OWNED</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">PERCENT OF<BR> SHARES OF<BR> COMMON<BR>
    STOCK<BR> OUTSTANDING</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Augustine Chow<B>*
    </B>(1)</FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">12,096</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James E. Dentzer<B>* </B>(2)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,556</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy R. Lindborg<B>* </B>(3)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,777</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick J. Fritz<B>* </B>(4)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,766</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Braun<B>* </B>(5)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,930</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine Pellizzari<B>*</B>
    (6)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,777</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael H. Tardugno<B>* </B>(7)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">142,513</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.57</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Corinne Le Goff* (8)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,700</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas Borys<B>* </B>(9)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,093</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed Anwer<B>* </B>(10)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,688</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey W. Church<B>* </B>(11)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,617</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Directors and Executive Officers as a group (11 persons) (12)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349,512</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.84</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    address of each of the individuals named is c/o IMUNON, INC., 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than one percent.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    12,000 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    1,566 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    5,777 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    12,000 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    10,333 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    5,777 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    126,000 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    29,700 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    15,666 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Includes
    42,833 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    49,000 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    310,652 shares of common stock underlying options currently exercisable or exercisable within 60 days of April 21, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_015"></A>CODE
OF ETHICS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted a Code of Ethics and Business Conduct (the &ldquo;Code of Ethics&rdquo;) applicable to its directors, officers, including
the Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer and other officers performing similar functions, and employees.
This Code of Ethics constitutes a code of ethics applicable to senior financial officers within the meaning of the Sarbanes-Oxley Act
of 2002 and SEC rules. A copy of the Code of Ethics is available on the Company&rsquo;s website at <I>http://www.imunon.com</I> and any
stockholder may obtain a copy by making a written request to the Company&rsquo;s Corporate Secretary, 997 Lenox Drive, Suite 100, Lawrenceville,
NJ 08648. In the event of any amendments to or waivers of the terms of the Code of Ethics, such matters will be posted promptly to the
Company&rsquo;s website in lieu of disclosure on Form 8-K in accordance with Item 5.05(c) of Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_016"></A>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Code of Ethics requires all of our directors, officers and employees to give their complete loyalty to the best interests of the Company
and to avoid any action that may involve, or that even may appear to involve, a conflict of interest with the Company. The Code of Ethics
also requires any of our directors, officers or employees who become aware of a conflict or potential conflict to bring it to the attention
of supervisor, manager or other appropriate personnel or consult the compliance procedures provided in the Code of Ethics. The Board
of Directors reviews and approves or ratifies all relationships and transactions between us and (i) any of our directors or executive
officers, (ii) any nominee for election as a director, (iii) any security holder who is known to us to own beneficially or of record
more than five percent of our common stock or (iv) any member of the immediate family of any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_017"></A>PROPOSAL
NO. 1:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ELECTION
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_018"></A>GENERAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation provides that the number of directors that constitutes the Board of Directors is to be fixed by, or in the
manner provided in, our Bylaws, as amended (the &ldquo;Bylaws&rdquo;). The Certificate of Incorporation also provides that the Board
of Directors is to be divided into three classes, designated as Class I, Class II and Class III, and it is our practice to have such
classes as even in size as possible. The Bylaws provide that the Board of Directors is to consist of between three and eight directors,
with the exact number to be fixed by action of the Board of Directors. The current number of directors has been fixed by the Board of
Directors at eight. Currently, no Board seats remain vacant, and the Board of Directors consists of eight directors, six of which are
independent under applicable SEC and NASDAQ rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has nominated Mr. Frederick Fritz and Ms. Christine Pellizzari to stand for re-election to the Board of Directors
as a Class I Director, with a term expiring at the Annual Meeting of Stockholders to be held in 2026 or with the election and qualification
of a successor. Dr. Augustine Chow, who is currently a Class I director, will not stand for re-election to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proxies named in the Proxy Card provided with this Proxy Statement intend to vote &ldquo;FOR&rdquo; the election of Mr. Frederick Fritz
and Ms. Christine Pellizzari unless otherwise instructed. If you do not wish your shares to be voted for Mr. Frederick Fritz and Ms.
Christine Pellizzari, you must so indicate by marking the &ldquo;WITHHOLD&rdquo; authority box on the Proxy Card next to Mr. Frederick
Fritz and Ms. Christine Pellizzari, in which event your shares will not be voted for Mr. Frederick Fritz and Ms. Christine Pellizzari.
In the event that Mr. Frederick Fritz and Ms. Christine Pellizzari become unavailable for election as a result of an unexpected occurrence,
the designated proxies will vote in their discretion for a substitute nominee, or our Board of Directors may reduce the number of directors
serving on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Class
I Director Nominees (If elected, term expires in 2026)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
Frederick J. Fritz.</B> Mr. Fritz was appointed to our Board of Directors in July 2011. Mr. Fritz has served as CEO and Founder of NeuroDx,
a development stage diagnostic device company focused on the neurosurgery market, since 2006. Mr. Fritz joined NeuroDx from Valeo Medical,
a biotechnology company he founded in 2003 to develop the world&rsquo;s first non-invasive diagnostic test for endometriosis. Prior to
that, Mr. Fritz was President and CEO of Songbird Hearing, Inc., a medical device company spun out of Sarnoff Corporation. Mr. Fritz
began his career in marketing management and new product development. He joined Schering Plough&rsquo;s Wesley Jessen in 1985 as VP Marketing
and Sales in 1986. He was promoted to general manager of Schering&rsquo;s Over the Counter pharmaceutical business in 1988 and of the
podiatric products business in 1990. He was President of Coleman North America from 1995 to 1997. Mr. Fritz holds a bachelor&rsquo;s
degree in engineering (summa cum laude) from University of Illinois and an MBA degree from Harvard University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ms.
Christine A. Pellizzari. </B>Ms. Pellizzari was appointed to our Board of Directors in June 2021. Ms. Pellizzari joined Insmed in 2013
as General Counsel and Corporate Secretary and was named Chief Legal Officer in 2018. She has global responsibility for legal and government
affairs including corporate governance, regulatory compliance, contracting, alliance management, clinical trial oversight, labor and
employment, litigation management and intellectual property strategy and portfolio management. From 2007 through 2012 Ms. Pellizzari
held various legal positions of increasing responsibility at Aegerion Pharmaceuticals, most recently as Executive Vice President, General
Counsel and Corporate Secretary. Prior to Aegerion, Ms. Pellizzari was Senior Vice President, General Counsel and Secretary at Dendrite
International, Inc., a publicly traded company that provided sales effectiveness, promotional and compliance solutions to the pharmaceutical
industry. Ms. Pellizzari received a J.D. from the University of Colorado School of Law and a B.A. from the University of Massachusetts
(Amherst). She is a member of Executive Women in Bio, Women Corporate Directors, National Association of Corporate Directors, Association
of Corporate Counsel, Society for Corporate Governance and National Association of Stock Plan Professionals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors concluded that Mr. Frederick Fritz and Ms. Christine Pellizzari have the requisite experience, qualifications, attributes
and skills necessary to serve as a member of our Board of Directors based on his respective leadership attributes, management experience
in the pharmaceutical industry and professional and educational background.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
election of Class I Directors at the Annual Meeting will be by a plurality of the votes cast. This means that the director nominee receiving
the greatest number of votes cast, via the live webcast or by proxy, by the holders of our common stock in the election
of the Class I Director, will be elected. Stockholders may not cumulate their votes in electing directors. Stockholders entitled to vote
at the Annual Meeting may either vote &ldquo;FOR&rdquo; the nominee for election as a director or may &ldquo;WITHHOLD&rdquo; authority
for the nominee. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the
nominee named above in Proposal No. 1. If a stockholder withholds authority to vote with respect to the nominee for director, the shares
held by that stockholder will be counted for purposes of establishing a quorum but will have no effect on the election of the nominee.
Broker non-votes will have no effect on the election of the nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OUR
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &ldquo;<I>FOR&rdquo;</I> THE ELECTION OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
DIRECTOR NOMINEES NAMED ABOVE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_019"></A>DIRECTORS,
EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors, or our Board, currently consists of eight members and is divided into three classes of directors serving staggered
three-year terms. Directors for each class are elected at the Annual Meeting of Stockholders held in the year in which the term for their
class expires and hold office for a three-year term and until their successors are duly elected and qualified, or their earlier death,
resignation or removal. In accordance with our amended and restated certificate of incorporation and bylaws, our Board may fill any vacancy
on the Board by appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is certain information regarding our Company&rsquo;s current directors, as well as our non-director executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NAME</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGE</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POSITION(S)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLASS</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Augustine
    Chow, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick
    J. Fritz</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine
    Pellizzari</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    E. Dentzer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    P. Braun, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne
    Le Goff, Pharm.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed
    Anwer, Ph.D. MBA</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President and Chief Scientific Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    W. Church</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President and Chief Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Continuing
Class II Directors (Term expires in 2024)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Corinne Le Goff</B>. Dr. Le Goff was appointed to our Board of Directors and as our President and Chief Executive Officer on July 18,
2022. Prior to joining the Company, Dr. Le Goff served as Chief Commercial Officer of Moderna, Inc. from January 2021 through January
2022. Dr. Le Goff served as Senior Vice President and General Manager of the U.S. Business Organization at Amgen, Inc. from March 2019
to January 2021. During her tenure at Amgen, she also served as Senior Vice President of Global Product Strategy from June 2018 to March
2019, and Senior Vice President of the Europe Region from June 2015 to May 2018. Dr. Le Goff held various positions within the Roche
Group, a publicly traded Swiss multinational healthcare company, including President of Roche&rsquo;s French affiliate from May 2012
to May 2015. Dr. Le Goff served on the board of directors of the Pacific Council on International Policy from October 2019 to December
2020. Dr. Le Goff also served on the board of directors of CFAO, a trading company, from October 2014 until October 2020, where she served
as a member of the Nomination and Compensation Committee, the Sustainable Development Committee and the Audit Committee. Dr. Le Goff
has served on the board of directors of Longboard Pharmaceuticals, Inc. since March 2021, where she serves as a member of the Compensation
Committee and the Audit Committee. Dr. Le Goff resigned from her director positions at Acticor Biotech and EuroAPI in December 2022,
as per her contractual obligations following her appointment as Imunon&rsquo;s President and CEO. Dr. Le Goff received a Pharm. D. from
the University Paris V and an M.B.A. in Marketing from La Sorbonne University, France</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Stacy R. Lindborg</B>. Dr. Lindborg was appointed to our Board of Directors in June 2021. Dr. Lindborg brings to Imunon more than 25
years of pharmaceutical industry experience with a particular focus on R&amp;D, executive management and strategy. She has worked with
biologics, small molecules and cell therapies to address a broad range of diseases and disorders, including multiple Orphan drug products,
along with extensive experience in early-stage development having taken molecules from first in man studies into the clinic through approval
and launch. Dr. Lindborg&rsquo;s holds the position of co-Chief Executive Officer at Brainstorm Cell Therapeutics, which she joined in
2020. From 2012 to 2020 she held positions of increasing responsibility at Biogen, where she worked in biostatistics and biometrics,
and served as Vice President for Global Analytics and Data Sciences. Dr. Lindborg joined Eli Lilly and Company in 1996 moving through
the organization to serve from 2010 to 2012 as Head of R&amp;D Strategy with responsibility for characterizing the productivity of the
portfolio and driving key R&amp;D strategy projects including the annual R&amp;D Long-Range Plan. Dr. Lindborg is a graduate of Baylor
University where she received a Ph.D. and M.A. in statistics and a B.A. in psychology with a minor in mathematics. She has authored more
than fifty abstracts, 200 presentations and 45 manuscripts that have been published in peer-reviewed journals. She serves on several
industry advisory boards related to statistics and biotechnology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
James E. Dentzer. </B>Mr. Dentzer was appointed to our Board of Directors in September 2022. He has been President and Chief Executive
Officer and a member of the Board of Directors of Curis, Inc. since September 2018. From March 2018 to September 2018, Mr. Dentzer served
as Curis&rsquo; Chief Operating Officer and Chief Financial Officer. From March 2016 to March 2018, Mr. Dentzer served as Curis&rsquo;
Chief Administrative Officer and Chief Financial Officer. Mr. Dentzer has also held the positions of secretary and treasurer from March
2016 to March 2019. Prior to joining Curis, Mr. Dentzer served as Chief Financial Officer of Dicerna Pharmaceuticals, Inc., a biotechnology
company, from December 2013 to December 2015. Prior to that, he was the Chief Financial Officer of Valeritas, Inc., a medical technology
company, from March 2010 to December 2013. Prior to joining Valeritas, Inc., he was the Chief Financial Officer of Amicus Therapeutics,
Inc., a biotechnology company, from October 2006 to October 2009. In prior positions, he spent six years as Corporate Controller of Biogen
Inc., a biotechnology company, and six years in various senior financial roles at E.I. du Pont de Nemours and Company, a chemical, petroleum
and biotechnology company, in the U.S. and Asia. Mr. Dentzer holds a B.A. degree in Philosophy from Boston College and an M.B.A. from
the University of Chicago.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Continuing
Class III Director (Term expires in 2025)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
Michael H. Tardugno.</B> Mr. Tardugno was appointed President and Chief Executive Officer of the Company on January 3, 2007, and was
elected to the Board of Directors on January 22, 2007. In October of 2014, Mr. Tardugno was appointed by our Board of Directors as our
Chairman. Effective July 18, 2022, Mr. Tardugno transitioned from the roles of President, Chief Executive Officer and Chairman to the
position of Executive Chairman of the Board. Prior to joining the Company and for the period from February 2005 to December 2006, Mr.
Tardugno served as Senior Vice President and General Manager of Mylan Technologies, Inc., a subsidiary of Mylan Inc. From 1998 to 2005,
Mr. Tardugno was Executive Vice President of Songbird Hearing, Inc., a medical device company spun out of Sarnoff Corporation. From 1996
to 1998, he was Senior Vice President of Technical Operations worldwide for a division of Bristol-Myers Squibb, and from 1977 to 1995,
he held increasingly senior executive positions including Senior Vice President of Worldwide Technology Development with Bausch &amp;
Lomb and Abbott Laboratories. Mr. Tardugno holds a B.S. degree from St. Bonaventure University and completed the Harvard Business School
Program for Management Development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Donald P. Braun.</B> Dr. Braun was appointed to our Board of Directors in December 2015. Dr. Braun has over 35 years of research experience
in oncology, cancer immunology, cancer immunotherapy, and inflammatory diseases. He is the author of more than 120 published peer-reviewed
manuscripts, twenty-five reviews and book chapters, and co-editor of a book on the role of prostaglandins and other COX 2 metabolites
in cancer patient immunity and immunotherapy. He served from 2006 to 2014 as Vice President Clinical Research, after which he served
as Vice President Translational Research and Chief Science Officer at the Cancer Treatment Centers of America until his retirement in
May 2016. Prior to this role, he was the Scientific Director of the Cancer Center and Professor of Medicine and Immunology at Rush Medical
College in Chicago from 1978 to 1999, and the Administrative Director of the Cancer Institute and a Professor of Surgery with tenure
at the Medical College of Ohio from 1999 to 2006. He received his Ph.D. in Immunology and Microbiology from the University of Illinois
at the Medical Center in Chicago. Dr. Braun has served as an advisor to numerous public agencies and private corporations concerned with
cancer therapeutics and diagnostics. At the National Cancer Institute, Dr. Braun served as a member of the Experimental Therapeutics
Study Section; the Small Business Innovation Grant Review Study Section; and the Experimental Therapy program for &ldquo;Molecular Targets
in Lung Cancer.&rdquo; He served as a member of the Immunology and Immunotherapy Study Section of the American Cancer Society-National
Division; as a Member of the Ohio Cancer Incidence Surveillance System; as a Member of the Biomedical Research Technology Transfer Commission
for the State of Ohio; and as an advisor to the State of Arizona&rsquo;s Disease Research Control Commission. Dr. Braun has also served
as a consultant to numerous pharmaceutical and biotechnology companies developing cancer treatments and diagnostics including Pfizer
Pharmaceuticals, Sterling Winthrop, Abbott Laboratories, Boehringer Mannheim, Serono Corporation, Biomira Inc., Centocor and Merck KGA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors concluded that all of the continuing directors have the requisite experience, qualifications, attributes and skill
necessary to serve as a member of the Board of Directors based on, among other things, their:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leadership
    attributes and experience;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    experience in the pharmaceutical industry and/or business experience in countries in which we are conducting clinical trials; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
    and educational background.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Executive
Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the biographical summaries for each of our executive officers. Each executive officer is elected by, and serves at the
pleasure of, our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corinne
Le Goff, Pharm.D.</B> Dr. Le Goff&rsquo;s biographical information appears above under the heading <B>&ldquo;<I>Directors</I>.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Khursheed
Anwer, Ph.D., M.B.A.</B> Dr. Anwer joined us in June 2014 as Executive Vice President and Chief Scientific Officer, in connection with
our acquisition of all the assets of EGWU, Inc. (formerly known as Egen, Inc.), an Alabama corporation (or &ldquo;EGEN&rdquo;). Before
joining Celsion, Dr. Anwer served as EGEN&rsquo;s President and Chief Scientific Officer, a position he held since 2009. He joined EGEN
in July 2002 as Vice President of Research and Development and directed EGEN&rsquo;s clinical and research and development functions.
Before joining EGEN, Dr. Anwer was Director of Pre-Clinical Development at Valentis, Inc. from July 2000 to June 2002. From 1993 to 1999,
he served in several positions at GeneMedicine, Inc., where he led several research projects in the area of non-viral gene therapy. He
has authored more than 40 publications in the area of non-viral gene therapy, resulting from his active career in research and development.
Dr. Anwer holds a Ph.D. in physiology/pharmacology from Ohio University and received post-doctoral training from the University of Texas
Health Science Center at Houston. Dr. Anwer also has a master&rsquo;s in business administration from the University of Alabama.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
Jeffrey W. Church. </B>Mr. Church joined us in July 2010 as Vice President, Chief Financial Officer and Corporate Secretary. Mr. Church
was appointed as our Senior Vice President, Corporate Strategy and Investor Relations in July 2011. In July 2013, Mr. Church was reappointed
as Senior Vice President and Chief Financial Officer. In December 2018, Mr. Church was promoted to Executive Vice President. Immediately
prior to joining us, Mr. Church served as Chief Financial Officer and Corporate Secretary of Alba Therapeutics Corporation, a privately
held life science company from 2007 until 2010. From 2006 until 2007, he served as Vice President, Chief Financial Officer and Corporate
Secretary for Novavax, Inc., a vaccine development company listed on The Nasdaq Global Select Market. From 1998 until 2006, he served
as Vice President, CFO and Corporate Secretary for GenVec, Inc., a biotechnology company listed on The Nasdaq Capital Market. Prior to
that, he held senior financial positions at BioSpherics Corporation and Meridian Medical Technologies, both publicly traded companies.
He started his career with Price Waterhouse from 1979 until 1986. Mr. Church holds a B.S. degree in accounting from the University of
Maryland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nicholas
Borys, M.D.</B> served as Executive Vice President and Chief Medical Officer of the Company until February 28, 2023, when he was terminated
from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_020"></A>LEGAL
PROCEEDINGS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 29, 2020, a putative securities class action was filed against the Company and certain of its officers and directors (the &ldquo;Spar
Individual Defendants&rdquo;) in the U.S. District Court for the District of New Jersey, captioned <I>Spar v. Celsion Corporation, et
al.</I>, Case No. 1:20-cv-15228. The plaintiff alleged that the Company and Individual Defendants made false and misleading statements
regarding one of the Company&rsquo;s product candidates, ThermoDox<SUP>&reg;</SUP>, and brings claims for damages under Section 10(b)
of the Exchange Act and Rule 10b-5 promulgated thereunder against all Defendants, and under Section 20(a) of the Exchange Act of 1934
against the Spar Individual Defendants. On February 6, 2023, the U.S. District Court granted a Motion to Dismiss filed by the Company
and Spar Individual Defendants and granted Plaintiff leave to file an amended complaint within 30 days. Plaintiff did not file an amended
complaint within the 30-day deadline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2021, a derivative shareholder lawsuit
was filed against the Company, as the nominal defendant, and certain of its directors and officers as defendants in the U.S. District
Court for the District of New Jersey, captioned <I>Fidler v. Michael H. Tardugno et al.</I>, Case No. 3:21-cv-02662. The plaintiff alleges
breach of fiduciary duty and other claims arising out of alleged statements made by certain of the Company&rsquo;s directors and/or officers
regarding ThermoDox<SUP>&reg;.</SUP> The Company believes it has meritorious defenses to these claims and intends to vigorously contest
this suit. Due to the early stage of the case neither the likelihood that a loss, if any, will be realized, nor an estimate of possible
loss or range of loss, if any, can be determined.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August of 2021, a complaint regarding a corporate books and records demand was filed against the Company in the Court of Chancery of
the State of Delaware, captioned <I>Pacheco v. Celsion Corporation</I>, Case No. 2021-0705. The plaintiff alleges he is entitled to inspect
the Company&rsquo;s books and records concerning the OPTIMA Study and other materials. The Company believes that the scope of the demand
is without merit and intends to defend it vigorously. Due to the early stage of the case neither the likelihood that a loss, if any,
will be realized, nor an estimate of possible loss or range of loss, if any, can be determined.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, an arbitration was commenced against the Company before the CPR Institute for Conflict Prevention &amp; Resolution, captioned
Curia New Mexico, LLC v. Celsion Corp., Case No. G-22-85-S. The claimant alleged that the Company failed to pay invoices for the manufacture
of two batches of ThermoDox&reg;. On April 19, 2023, the arbitral tribunal issued an interim award, upholding claimant&rsquo;s claim
with respect to one of the two batches of ThermoDox&reg; for an aggregate amount of approximately $260,000 including interest and denied
their claim with respect to the other batch of ThermoDox&reg;. The Tribunal has directed the parties to make submissions on the allocation
of the costs of the arbitration proceedings by May 12, 2023. The Company will vigorously contest any allocation of claimant&rsquo;s costs
to it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_021"></A>BOARD
LEADERSHIP STRUCTURE AND ROLE IN RISK OVERSIGHT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Leadership</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that it is important to select our Chairman of the Board and our Chief Executive Officer in the manner it
considers in our best interests. The members of our Board of Directors possess considerable business experience and in-depth knowledge
of the issues we face and are therefore in the best position to evaluate our needs and how best to organize and adopt our leadership
structure to meet those needs. Accordingly, our Chairman and the Chief Executive Officer may be filled by one individual or by two different
individuals, and our chairman may be a Company insider or an independent director. Mr. Tardugno currently serves as Executive Chairman
of our Board of Directors and Dr. Corinne Le Goff currently serves as the Company&rsquo;s President and Chief Executive Officer. Currently
all the other directors of our Board of Directors are independent under applicable SEC and NASDAQ rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Oversight of Risk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is responsible for oversight of the various risks we face. In this regard, the Board of Directors seeks to understand
and oversee the most critical risks relating to our business and operations, allocate responsibilities for the oversight of risks among
the full Board of Directors and its committees, and see that management has in place effective systems and processes for managing risks
we face. Overseeing risk is an ongoing process, and risk is inherently tied to our strategy and to strategic decisions. Accordingly,
our Board of Directors considers risk throughout the year and with respect to specific proposed actions. Our Board of Directors recognizes
that it is neither possible nor prudent to eliminate all risk. Indeed, purposeful and appropriate risk-taking is essential for us to
be competitive and to achieve our business objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
our Board of Directors oversees risk, management is charged with identifying and managing risk. We have robust internal processes and
a strong internal control environment to identify and manage risks and to communicate information about risk to the Board of Directors.
Management communicates routinely with our Board of Directors, Board Committees (as defined below) and individual directors on the significant
risks identified and how they are being managed. Our directors are free to, and indeed often do, communicate directly with senior management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors implements its risk oversight function both as a whole and through delegation to various committees (the &ldquo;Board
Committees&rdquo;). These Board Committees meet regularly and report back to our full Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Audit Committee oversees the management of financial, accounting, internal controls, disclosure
                                            controls and the engagement arrangement and regular oversight of the independent auditors.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Compensation Committee is responsible for the design and oversight of our compensation programs.
                                            Based on a review of our company-wide compensation programs, including the compensation programs
                                            for our executive officers, our Compensation Committee has concluded that these programs
                                            do not create risks that are likely to have a material adverse effect on us.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Nominating and Governance Committee periodically reviews our corporate governance practices,
                                            including the risks that those practices are intended to address. It also periodically reviews
                                            the composition of our Board of Directors to help ensure that a diversity of skills and experiences
                                            is represented by the members of our Board of Directors, taking into account the stage of
                                            our growth and strategic direction.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Science and Technology Committee assists our Board of Directors in monitoring the state of
                                            science and technology capabilities within the Company and associated risks and overseeing
                                            the development of key technologies and major science and medicine-driven innovation initiatives
                                            essential to our long-term success.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_022"></A>COMMITTEES
OF THE BOARD OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors presently maintains separately designated Audit, Compensation, Nominating and Governance, and Science and Technology
Committees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Good
Governance Practices</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has a commitment to strong and sustainable corporate governance. As such, we continuously review our practices to
ensure effective collaboration between management and our Board of Directors. Highlights of our Board of Directors&rsquo; best practices
are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six
    of the eight Board directors are independent;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Board of Directors has adopted and published committee charters (charters are available at <U>www.imunon.com</U>);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Board of Directors conducts an annual review of Board Independence;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Board Committees conduct annual self-evaluations that are reviewed by our Nominating and Governance Committee and our Board of Directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    directors participate in an orientation program and receive a current state briefing before their first Board meeting;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have stock ownership and stock retention guidelines for our directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have policies and practices to specifically align executive compensation with long-term stockholder interests;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have a policy prohibiting hedging and pledging, short sales, purchases or sales of puts or calls, and other derivative transactions
    of our stock (including any transaction that provides the economic equivalent of ownership) by our executive officers and directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    executive compensation claw back policy was adopted by our Board of Directors in 2014;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Board of Directors reviews management talent and succession annually with our chief executive officer; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    is no automatic enhancement of executive incentive compensation upon a change-in-control.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee consists of Mr. James A. Dentzer (Chairman), Mr. Frederick J. Fritz, Dr. Augustine Chow and Ms. Christine Pellizzari.
Our Audit Committee operates under a written charter as amended and restated effective January 24, 2023. A copy of that charter, as may
be amended from time to time, is available on our web site, located at <I><U>http://www.imunon.com</U></I>. Additional copies of the
charter are available upon written request to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee assists our Board of Directors in fulfilling its responsibility to oversee management&rsquo;s implementation of our financial
reporting process. In discharging its oversight role, the Audit Committee reviewed and discussed the audited financial statements contained
in our 2022 Annual Report on Form 10-K with our management and independent registered public accounting firm. Management is responsible
for the financial statements and the reporting process, including the system of internal controls. Our independent registered public
accounting firm is responsible for expressing an opinion on the conformity of those financial statements with accounting principles generally
accepted in the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has determined that all members of the Audit Committee meet the independence standards established by the SEC and Nasdaq. Our Board
has determined that Mr. Dentzer is qualified to serve as the &ldquo;audit committee financial expert&rdquo; as defined by Item 407(d)(5)
of Regulation S-K and that Mr. Fritz, Dr. Chow and Ms. Pellizzari meet the financial literacy requirements under applicable NASDAQ rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee is responsible for establishing and administering the compensation policies applicable to our directors, officers,
and key personnel, for determining the compensation arrangements to our President and Chief Executive Officer and for evaluating the
performance of senior management. Our Compensation Committee operates under a written charter as amended and restated effective January
24, 2023. A copy of that charter, as may be amended from time to time, is available on our web site, located at <I><U>www.imunon.com</U></I>.
Additional copies of the charter are available upon written request to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee does not delegate the authority to approve compensation policies and actions affecting our named executive officers
or directors. Our Compensation Committee applies discretion in determining compensation for our executives. Our Compensation Committee
has not established any equity or other security ownership requirements or guidelines in respect of its executive officers. Our Executive
Chairman and our President and Chief Executive Officer assist the Compensation Committee in evaluating the performance of other executive
officers and by providing information to directors as and when requested, such as salary surveys and compensation paid by our competitors,
to the extent such information is publicly available. Members of our Compensation Committee undertake to verify such information prior
to referring to it in determining executive compensation. The compensation of our President and Chief Executive Officer is determined
by the Compensation Committee based on their evaluation of her performance and with reference to such external or competitive data as
they consider necessary. The compensation of the other named executive officers is determined by our Compensation Committee based on
its evaluation of their individual performance and the recommendations of our Executive Chairman and our President and Chief Executive
Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Frederick J. Fritz (Chairman), Dr. Augustine Chow and Dr. Stacy R. Lindborg currently comprise our Compensation Committee. Our Board
has determined that all members of our Compensation Committee are independent under the applicable Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominating
and Governance Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee is responsible for identifying and recruiting new members of our Board of Directors when vacancies
arise, identifying and recruiting nominees for election as directors, reconsideration of incumbent directors in connection with nominations
for elections of directors and ensuring that our Board of Directors is properly constituted to meet its corporate governance obligations.
Our Nominating and Governance Committee operates under a written charter effective as of January 24, 2023. A copy of that charter, as
may be amended from time to time, is available on our web site, located at <I><U>www.imunon.com</U></I>. The current members of our Nominating
and Governance Committee are Mr. Frederick J. Fritz and Dr. Donald P. Braun. Our Board has determined that both Mr. Fritz and Dr. Braun
are deemed to be independent under applicable Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Science
and Technology Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary purpose of our Science and Technology Committee is to assist our Board of Directors in monitoring the state of science and technology
capabilities within our Company and associated risks and overseeing the development of key technologies and major science and medicine-driven
innovation initiatives essential to our long-term success. Our Science and Technology Committee&rsquo;s responsibilities includes reviewing
technologies and technology programs of significance to us, with special focus on major external initiatives, observing the evolution
of science and medicine outside the Company, participating in the development of metrics to assess the state of our science and technology
in subject areas including, but not limited to, patent estate, freedom to operate, productivity, capability and external benchmarks,
providing guidance for our external science and technology alliances, and providing guidance on the direction of our science and technology
activities, as appropriate. The current members of our Science and Technology Committee are Dr. Donald P. Braun and Dr. Stacy R. Lindborg.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_023"></A>MEETINGS
OF THE BOARD AND ITS COMMITTEES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, there were a total of four (4) regular meetings of our Board of Directors. All of our directors attended
all of the meetings of our Board of Directors and the Board committees on which they served that were held during the period for which
they were a director or committee member, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, our Audit Committee met four (4) times, our Compensation Committee met one (1) time and our Nominating
and Governance Committee met several times in connection with the recruitment of one new Board director in September 2022. Our Science
and Technology Committee did not meet during 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DELINQUENT
SECTION 16(A) REPORTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our executive officers, directors and persons who own more than 10% of our common stock to file reports
of ownership and reports of changes in ownership of common stock and other equity securities of the Company with the SEC. Executive officers,
directors and greater than 10% stockholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they
file.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our knowledge, based solely on a review of the copies of reports furnished to us, we believe that during the year ended December 31,
2022, our executive officers, directors and greater than 10% stockholders complied with all Section 16(a) filing requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_024"></A>DIRECTOR
NOMINATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Nominating and Governance Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
role of our Nominating and Governance Committee is to act on behalf of our Board of Directors to ensure that our Board of Directors and
its standing committees are appropriately constituted to meet their fiduciary and corporate governance obligations. In this role, our
Nominating and Governance Committee is responsible for identifying and recruiting new members of our Board of Directors when vacancies
arise, identifying and recruiting nominees for election as directors and reconsidering incumbent directors in connection with nominations
for elections of directors. Our Nominating and Governance Committee is also charged with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and recommending changes in the size and composition of our Board of Directors and Board
                                            committees;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
                                            and maintaining criteria and processes for selecting candidates for election as directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
                                            and recruiting candidates to stand for election as directors and determining whether incumbent
                                            directors should stand for reelection;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ensuring
                                            that we and our Board of Directors operate in accordance with current best practices;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                                            for ongoing director training and education;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting
                                            to our Board of Directors on Nominating and Governance Committee activities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually
                                            reviewing the Nominating and Governance Committee&rsquo;s performance of its responsibilities
                                            and duties; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually
                                            reviewing the Nominating and Governance Committee Charter, the structure and the processes
                                            and membership requirements of the Nominating and Governance Committee and recommending to
                                            our Board of Directors any improvements or amendments that our Nominating and Governance
                                            Committee considers appropriate or necessary.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Qualifications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is a policy of our Nominating and Governance Committee that candidates for director be determined to have unquestionable integrity and
the highest ethical character. Candidates must demonstrate the ability to exercise sound, mature and independent business judgment in
the best interests of the stockholders as a whole and may not have any interests that would, in the view of our Nominating and Governance
Committee, impair their ability to exercise independent judgment or otherwise discharge the fiduciary duties owed as a director. Candidates
must have experience and demonstrated achievement in one or more fields of business, professional, governmental, communal, scientific
or educational endeavors which will complement the talents of the other members of our Board of Directors and further our interests,
bearing in mind the composition of our Board of Directors and the current state of the Company and the state of the biotechnical/biopharmaceutical
industry generally. In particular, our Nominating and Governance Committee believes it is important for one or more members of our Board
of Directors to have in-depth experience in the biotechnical/biopharmaceutical industry. Our Nominating and Governance Committee has
determined that one or more of its members, including the incumbents nominated to stand for reelection at the Annual Meeting, have such
biotechnical/biopharmaceutical experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Candidates
are expected to have an appreciation of the major issues facing public companies of a size and operational scope similar to us, including
contemporary governance concerns, regulatory obligations of a public issuer, strategic business planning, competition in a global economy,
and basic concepts of corporate finance. Candidates must also have the willingness and capability to devote the time necessary to participate
actively in meetings of our Board of Directors and Board Committee meetings and related activities, the ability to work professionally
and effectively with other members of the Board of Directors and Company management, and the ability and intention to remain on our Board
of Directors long enough to make an effective contribution. Among candidates who meet the foregoing criteria, our Nominating and Governance
Committee also considers the Company&rsquo;s current and anticipated needs, including expertise, diversity and balance of inside, outside
and independent directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee, encouraging diversity, endeavors to comprise our Board of Directors of members with a broad mix
of professional and personal backgrounds. Thus, our Nominating and Governance Committee accords some weight to the individual professional
background and experience of each director. Further, in considering nominations, our Nominating and Governance Committee considers how
a candidate&rsquo;s professional background would fit into the mix of experiences represented by the then-current Board of Directors.
When evaluating a nominee&rsquo;s overall qualifications, our Nominating and Governance Committee does not assign specific weights to
particular criteria, and no particular criterion is necessarily required of all prospective nominees. In addition to the aforementioned
criteria, when evaluating a director for re-nomination to our Board of Directors, our Nominating and Governance Committee will also consider
the director&rsquo;s history of attendance at board and committee meetings, the director&rsquo;s preparation for and participation in
such meetings, and the director&rsquo;s tenure as a member of our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Diversity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="8" STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Board Diversity Matrix (As of March 30, 2023)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">Total Number of Directors: 8</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="5">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; color: black; font-weight: bold">Part I: Gender Identity</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; color: black; font-weight: bold; text-align: center">Female</TD><TD STYLE="padding-bottom: 1.5pt; color: black; font-weight: bold">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; color: black; font-weight: bold; text-align: center">Male</TD><TD STYLE="padding-bottom: 1.5pt; color: black; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 63%; padding-bottom: 1.5pt">Directors</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 16%; text-align: center">3</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 16%; text-align: center">5</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="8" STYLE="color: black; font-weight: bold">Part II: Demographic Background</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">African American or Black</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Alaskan Native or Native American</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Asian</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Hispanic or Latinx</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Native Hawaiian or Pacific Islander</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">White</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">4</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Two or More Races or Ethnicities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">LGBTQ+</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">0</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1.5pt">Did Not Disclose Demographic Background</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">0</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in accordance with the rules of the SEC and NASDAQ, the Company requires that at least a majority of the directors serving
at any time on the Board of Directors be independent, that at least three directors satisfy the financial literacy requirements for service
on the Audit Committee and that at least one member of the Audit Committee qualify as an &ldquo;audit committee financial expert&rdquo;
under those rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Dentzer acts as the chairman of our Audit Committee. The Board of Directors has determined that Mr. James E. Dentzer is qualified to
serve as the &ldquo;audit committee financial expert&rdquo; as defined by Item 407(d)(5) of Regulation S-K and that Mr. Fritz, Dr. Chow
and Ms. Pellizzari meet the financial literacy requirements under applicable SEC and NASDAQ rules. The Board of Directors determined
that of the eight currently serving directors, six directors (Drs. Chow, Braun and Lindborg, Messrs. Dentzer and Fritz and Ms. Pellizzari)
are independent under applicable SEC and NASDAQ rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominating
and Governance Committee Process</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
selecting candidates for our Board of Directors, the Nominating and Governance Committee begins by determining whether the incumbent
directors whose terms expire at the annual meeting of stockholders desire and are qualified to continue their service on our Board of
Directors. Under its charter, our Nominating and Governance Committee is charged with considering incumbent directors as if they were
new candidates. However, our Nominating and Governance Committee recognizes the significant value of the continuing service of qualified
incumbents in promoting stability and continuity, providing the benefit of the familiarity and insight into our affairs and enhancing
our Board of Directors&rsquo; ability to work as a collective body. Therefore, it is the policy of our Nominating and Governance Committee,
absent special circumstances, to nominate qualified incumbent directors who our Nominating and Governance Committee believes will continue
to make important contributions to our Board of Directors and who consent to stand for re-election. If any member of our Board of Directors
does not wish to continue in service or if our Nominating and Governance Committee or our Board of Directors decides not to re-nominate
a member, there is an existing vacancy on our Board of Directors, or our Board of Directors, upon the recommendation of the Nominating
and Governance Committee, elects to expand the size of our Board of Directors, the following process would be followed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nominating and Governance Committee develops a profile for candidates&rsquo; skills and experience, based on the criteria described
    above.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nominating and Governance Committee initiates a search, polling members of the Board of Directors and management, and retaining a
    search firm if the Nominating and Governance Committee deems this appropriate.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nominating and Governance Committee has a policy with respect to stockholders&rsquo; suggestions for nominees for directorships.
    Under this policy, stockholder nominees are given identical consideration as nominees identified by the Nominating and Governance
    Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    process by which stockholders may submit potential nominees is described below under &ldquo;Stockholder Recommendation Process.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nominating and Governance Committee then determines the eligibility and suitability of any candidate based on the criteria described
    above and the Nominating and Governance Committee&rsquo;s search profile.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Chairman of the Board of Directors and at least one member of the Nominating and Governance Committee interview prospective candidate(s)
    who satisfy the qualifications described above.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nominating and Governance Committee offers other members of the Board of Directors the opportunity to interview the candidate(s)
    and then meets to consider and approve the final candidate(s).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nominating and Governance Committee seeks endorsement of the final candidate(s) from the full Board of Directors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    final candidate(s) are nominated by the Board of Directors for submission to a stockholder vote or elected to fill a vacancy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
Recommendation Process</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee will consider for nomination any qualified director candidates recommended by our stockholders. Any
stockholder who wishes to recommend a director candidate is directed to submit in writing the candidate&rsquo;s name, biographical information
and relevant qualifications to our Corporate Secretary at our principal executive offices. All written submissions received from our
stockholders will be reviewed by the Nominating and Governance Committee at the next appropriate meeting. The Nominating and Governance
Committee will evaluate any suggested director candidates received from our stockholders in the same manner as recommendations received
from management, committee members or members of our board. The Company or the Nominating and Governance Committee may require a stockholder
who proposes a nominee to furnish such other information as may reasonably be required by the Company to determine the eligibility or
suitability of the proposed nominee to serve as director of the Company. See the section titled &ldquo;Stockholder Nominations and Proposals
for the 2023 Annual Meeting of Stockholders&rdquo; later in this Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revisions
to Nomination Process</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee and stockholder recommendation processes have been developed to provide a flexible framework to permit
the director nomination process to move forward effectively. Our Nominating and Governance Committee intends to review these processes
from time to time in light of our evolving needs and changing circumstances, as well as changes in legal requirements and stock exchange
listing standards. The Nominating and Governance Committee may revise these processes or adopt new ones based on such periodic reviews.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_025"></A>STOCKHOLDER
COMMUNICATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has adopted a process through which interested stockholders may communicate with our Board of Directors. Stockholders
who wish to send communications to our Board of Directors, or any particular director, should address such communications to the Corporate
Secretary, at the Company&rsquo;s headquarters at 997 Lenox Drive, Suite 100, Lawrenceville, New Jersey, 08648. The envelope containing
any such communication should be prominently marked &ldquo;To the Attention of the Board of Directors&rdquo; or to a particular committee
or director, and the communication should include a representation from the stockholder indicating the stockholder&rsquo;s address and
the number of shares of our common stock beneficially owned by the stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Corporate Secretary is primarily responsible for monitoring communications from stockholders. Depending upon the content of a particular
communication, as he deems appropriate, our Corporate Secretary will: (i) forward the communication to the director, directors or committee
to whom it is addressed; (ii) attempt to handle the inquiry directly, for example where the stockholder communication consists of a request
for information about the Company or is a stock-related matter; or (iii) not forward communications such as solicitations, junk mail
and obviously frivolous or inappropriate communications. At each meeting of our Board of Directors, the Corporate Secretary will present
a summary of all communications, whether or not forwarded, received since the last meeting and will make those communications available
to the directors on request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_026"></A>BOARD
ATTENDANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors strongly encourages, but does not require, all directors, to the extent reasonable and practicable, to attend the
Company&rsquo;s Annual Meetings of Stockholders in person. All of the current members of our Board of Directors were present at the Company&rsquo;s
2022 Annual Meeting of Stockholders held on June 13, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_027"></A>DIRECTOR
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_028"></A>2022
DIRECTOR COMPENSATION TABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the cash and noncash compensation paid to the Company&rsquo;s directors who are not employed by the Company
or any of its subsidiaries (&ldquo;Non-Employee Directors&rdquo;) for the year ended December 31, 2022. Other than as set forth in the
table, we did not pay any compensation, make any equity awards or non-equity awards to, or pay any other compensation to any of the Non-Employee
Directors in 2022. The compensation paid to any director who was also one of our employees during fiscal year 2022 is presented in the
&ldquo;2022 Summary Compensation Table&rdquo; and the information that follows that table. Such employee directors do not receive separate
compensation for their service on the Board of Directors or any of its Committees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name (1)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Fees Earned<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Option Awards <BR> ($) (2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Total<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Augustine Chow</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">45,300</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">44,357</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">89,657</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">James E. Dentzer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,825</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,972</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,797</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Frederick J. Fritz</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">149,957</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Donald P. Braun</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,300</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,964</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,264</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stacy R. Lindborg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,286</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Christine A. Pellizzari</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,886</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Robert W. Hooper (3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,175</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85,532</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    earned by Michael H. Tardugno and Corinne Le Goff for the year ended December 31, 2022 is presented in the Summary Compensation Table
    of the Proxy Statement. Employee directors do not receive separate compensation for their service on the Board of Directors or any
    of its Committees.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for Option Awards is the aggregate grant date fair value of stock options granted to each Director in 2022, determined
    in accordance with FASB ASC Topic 718. The assumptions for making the valuation determinations are set forth in Note 12 in the Financial
    Statements. As of December 31, 2022, Dr. Chow had 18,333 option awards outstanding; Mr. Dentzer had 4,667 option awards outstanding;
    Mr. Fritz had 18,333 option awards outstanding; Dr. Braun had 15,833 option awards outstanding; and Dr. Lindborg and Ms. Pellizzari
    each had 9,666 option awards outstanding.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Hooper resigned from the Board of Directors effective December 31, 2022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth stock option grants awarded to the Company&rsquo;s Non-Employee Directors for the year ended December 31,
2022. Stock option grants to any director who was also one of our employees during fiscal year 2022 are presented in the &ldquo;2022
Grants of Plan-Based Awards Table&rdquo; and the information that follows that table. Employee directors do not receive separate equity
awards for service on the Board of Directors or any of the Board committees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-Employee Director Stock Option
    and Grant Awards Table</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of<BR> Options<BR> Granted</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(#)
                                            (1)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Grant Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Expiration <BR> Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Grant Date<BR> &nbsp;Fair Value<BR>
    &nbsp;($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">Augustine Chow</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">7,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">4.60</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right">3/4/2022</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right">3/4/2032</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">4.16</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">James E. Dentzer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.65</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9/27/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/1/2033</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.49</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Frederick J. Fritz</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Donald P. Braun</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stacy R. Lindborg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Christine A. Pellizzari</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Robert W. Hooper (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3/4/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6/13/2032</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of these stock option grants vest in three equal installments, with one-third of the grant vesting on the date of grant and one third
    of the grant vesting on each of the first and second anniversary of the date of grant, subject to the applicable director&rsquo;s
    continued service as a member of our Board through each applicable vesting date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Hooper resigned from the Board of Directors effective December 31, 2022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_029"></A>NARRATIVE
DISCLOSURE TO DIRECTOR COMPENSATION TABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, each Non-Employee Director of the Company received annual cash compensation in the amount of $30,500
payable in quarterly installments, and an additional $2,200 for attendance at regular meetings of the Board of Directors and $1,200 for
each meeting of a committee of the Board of Directors that was not held in conjunction with a meeting of the Board of Directors. Each
Non-Employee director is reimbursed for the out-of-pocket costs of attending meetings of the Board of Directors and of committees of
the Board of Directors. In 2022, the Chairman of the Audit Committee received an additional annual cash fee of $13,500 and the Chairman
of the Compensation Committee received an additional annual cash fee of $10,500.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acting
on behalf of the Board of Directors, Mr. Fritz also received fees totaling $48,000 in 2022 for his role as a Board Liaison to our Board
of Directors. Mr. Fritz&rsquo;s responsibilities as Board Liaison include the following: (i) serve as an initial sounding board for our
management regarding issues, matters, or communications to be brought or potentially to be brought before the Board of Directors; (ii)
provide input and feedback to management regarding strategic matters, business matters, major scientific, clinical, collaboration, or
corporate development matters, key personnel matters, or other items of significance regarding which management would like to obtain
initial or further Board guidance, including, but not limited to, guidance regarding timing and content of communications regarding such
matters or items with the full Board or any of its committees; (iii) remain accessible to management to provide guidance on business
or strategy issues or other issues of significance on an as-needed basis; (iv) participate in meetings and relevant discussions as requested
by management; (v) conduct general advisory or liaison services to the Board, including relaying to management requests from other members
of the Board regarding desired additional information or clarification or suggestions or feedback regarding improvement in Board processes
or communications; (vi) serve as a conduit for informal communications between management and the Board; and (vii) any other such services
established by the Board from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acting
on behalf of our Board of Directors, Dr. Braun also received fees totaling $30,000 in 2022 for his role as a strategic advisor to our
Executive Chairman and our Chief Executive Officer. Dr. Braun&rsquo;s responsibilities as a strategic advisor include the following:
(i) provide strategic and tactical advice to our Chief Executive Officer; (ii) evaluate international subsidiary options; (iii) develop
strategies to secure business relationships other than in the U.S.; and (iv) having done both (ii) and (iii), develop high potential
ex-US market strategies that address the objectives for broad and profitable sales of its commercial products.</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_030"></A>COMPENSATION
COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Hooper, Dr. Chow and Dr. Lindborg each served on the Compensation Committee of our Board of Directors during 2022. Mr. Hooper retired
from our Board of Directors effective December 31, 2022. On January 24, 2023, Mr. Frederick J. Fritz was appointed as Chairman of the
Compensation Committee of our Board of Directors. No director who served on our Compensation Committee at any time during 2022 and 2023
is or was a current or former executive officer or employee of the Company or had any relationships requiring disclosure by the Company
under the SEC&rsquo;s rules requiring disclosure of certain relationships and related party transactions. None of the members of the
Compensation Committee during 2022 and 2023 was, or has ever been, an officer or employee of the Company, and, during 2022 and 2023,
no executive officer of the Company served on the board and/or compensation committee of any company that employed as an executive officer
any member of the Company&rsquo;s Board and/or Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_031"></A>STOCK
OWNERSHIP GUIDELINES FOR NON-EMPLOYEE AND EXECUTIVE DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that, as a matter of sound corporate governance, non-employee and executive directors should have a significant
personal financial stake in our performance. Consequently, in February 2011, our Board of Directors adopted stock ownership guidelines
for non-employee and executive directors. Our corporate governance guidelines require that each non-employee director acquire and hold
shares of our common stock having an aggregate value equal to two times the director&rsquo;s total compensation in the first year of
service and that our executive director acquire and hold shares of our common stock having an aggregate value equal to the executive
director&rsquo;s total compensation in the first year of service. Each director is expected to satisfy the applicable ownership guideline
within three years after his or her appointment to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock that count toward satisfaction of these ownership guidelines include, unless beneficial ownership therein is disclaimed:
(i) shares owned outright by the director or executive officer or their immediate family members residing in the same household, whether
held individually or jointly; (ii) shares held in a trust, family limited partnership or similar entity solely for the benefit of the
director or executive officer and/or their immediate family members; (iii) shares of restricted stock and restricted stock units awarded
under our equity incentive plans, including vested and unvested awards; and (iv) shares acquired upon stock option exercise, but not
shares underlying unexercised stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_032"></A>REPORT
OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is primarily responsible for our internal control and financial reporting process. Our independent registered public accounting
firm, WithumSmith+Brown, PC, is responsible for performing an independent audit of our consolidated financial statements and issuing
opinions on the conformity of those audited financial statements with United States generally accepted accounting principles and the
effectiveness of our internal control over financial reporting. Our Audit Committee monitors our financial reporting process and reports
to the Board on its findings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this context, the Audit Committee hereby reports as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Audit Committee has reviewed and discussed the audited financial statements with our management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Audit Committee has discussed with our independent registered public accounting firm the matters required to be discussed under the
rules adopted by the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;) and the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The Audit Committee has received from the independent registered public accounting firm the written disclosures and the letter required
by the applicable requirements of the PCAOB regarding the independent registered public accounting firm&rsquo;s communications with the
Audit Committee concerning independence and has discussed with the independent registered public accounting firm its independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Based on the review and discussions referred to in paragraphs (1) through (3) above, our Audit Committee recommended to the Board, and
the Board has approved, that the audited financial statements be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2022, for filing with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Members
of the Audit Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
James E, Dentzer (Chairman)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Frederick J. Fritz</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Augustine Chow</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Christine A. Pellizzari</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report does not constitute &ldquo;soliciting material&rdquo; and shall not be deemed filed or incorporated by reference into any filing
under the Securities Act of 1933 or under the Securities Exchange Act of 1934, except to the extent we specifically incorporate this
report by reference and shall not otherwise be deemed filed under such Acts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_033"></A>EXECUTIVE
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_034"></A>COMPENSATION
DISCUSSION AND ANALYSIS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section describes the material elements of compensation awarded to, earned by, or paid to the following Executive Officers of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno, our Executive Chairman and former President and Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne
    Le Goff, Pharm. D., our President and Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
    Borys, M.D., our former Executive Vice President and Chief Medical Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed
    Anwer, Ph.D., our Executive Vice President and Chief Science Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    W. Church, our Executive Vice President and Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
individuals are listed in the 2022 Summary Compensation Table below and are referred to in this discussion as the &ldquo;Named Executive
Officers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Le Goff was appointed to the positions of President and Chief Executive Officer of the Company effective as of July 18, 2022. Michael
H. Tardugno served as Chairman, President and Chief Executive Officer prior to such date and transitioned effective July 18, 2022, to
the position of Executive Chairman of the Board. Dr. Borys departed the Company as of February 28, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMUNON
is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the
body&rsquo;s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases, constituting
a differentiating approach from conventional therapies. Imunon has two platform technologies: Our TheraPlas&reg; platform for the development
of immunotherapies and other anti-cancer nucleic acid-based therapies, and our PLACCINE platform for the development of nucleic acid
vaccines for infectious diseases and cancer. The Company&rsquo;s lead clinical program, IMNN-001 (formerly GEN-1), is a DNA-based immunotherapy
for the localized treatment of advanced ovarian cancer currently in Phase II development. IMNN-001 works by instructing the body to produce
safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally,
the Company is conducting preclinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order
to validate its PLACCINE platform. Imunon&rsquo;s platform technologies are based on the delivery of nucleic acids with novel synthetic
delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological
frontier of plasmid DNA to better serve patients with difficult to treat conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of our drug development status, it is unlikely, in the short term, to generate revenues and income sufficient to cover product
development costs. As a result, our executive compensation philosophy is to align the interests of management and stockholders by emphasizing
rewards for Company performance, while remaining competitive with compensation paid by other clinical stage biotechnology companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation practices that we have outlined below have been implemented because we believe that they are consistent with our stockholders&rsquo;
interests:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
    we do: </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    significant portion of our executive compensation is based on actual Company performance compared to absolute and relative measures
    and is therefore &ldquo;at risk;&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
    performance metrics between the annual and long-term incentive plans discourage excessive risk-taking by removing any incentive to
    focus on a single performance goal to the detriment of the Company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    between annual and long-term compensation to discourage short-term risk taking at the expense of long-term results;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    executives are encouraged to acquire and maintain meaningful ownership positions in our Company&rsquo;s common stock; those executives
    who are also directors are subject to our stock ownership guidelines for directors discussed above. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    relevant competitive compensation information compiled from compensation surveys; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    reasonable, double trigger change in control arrangements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a list of compensation practices that we have not engaged in because we do not believe that they are consistent with our stockholders&rsquo;
interests:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
    we don&rsquo;t do:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re-pricing
    or backdating of stock options;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hedging
    or derivate transactions by our executive officers or directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excessive
    perquisites for executives;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Single
    trigger or modified single trigger cash severance benefits followed by a change in control; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
    for excise tax gross ups.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, we prohibit hedging or engaging in collars, short sales, or other derivative transactions by our executive officers or directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have had an executive compensation claw back policy since 2014. In the event of a material restatement of the Company&rsquo;s financial
results, the Board is authorized to take such actions as it deems necessary and appropriate, including the recoupment of all or part
of any bonus or other compensation paid to an executive officer. The Board will consider whether any executive officer received compensation
based on the original financial statements because it appeared that the executive achieved financial performance targets that in fact
were not achieved based on the restatement. The Board will also consider the accountability of any executive officer whose acts or omissions
were responsible in whole or in part for the events that led to the restatement and whether such actions or omissions constituted misconduct.
In the event of significant misconduct resulting in a violation of a significant company policy, law, or regulation that causes material
harm to the Company, the Board is authorized to recoup compensation from senior executives. The Company intends to revise and update
its claw back policy or adopt an additional policy as appropriate to comply with the Nasdaq listing standards to be issued in connection
with the SEC rules promulgated under the Dodd-Frank Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
Say-on-Pay Votes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide our stockholders with the opportunity to cast an advisory vote to approve our executive compensation program (referred to as
a &ldquo;say-on-pay proposal&rdquo;). In general, the Compensation Committee believes the program in place, as in prior years, includes
a number of features that further the goals of the Company&rsquo;s executive compensation program. The Compensation Committee will continue
to consider the outcome of the Company&rsquo;s say-on-pay proposals when making future compensation decisions for the Named Executive
Officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee has adopted the following executive compensation approaches, which the Company believes help to achieve the objectives
for the executive compensation program and are generally favored by stockholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    significant amount of the executives&rsquo; compensation is at risk. For fiscal year 2022, 42.6% of Mr. Tardugno&rsquo;s and 63.7%
    of Dr. Le Goff&rsquo;s target total direct compensation was performance-based (annual cash incentive awards) and/or linked to the
    value of our stock price (long-term equity incentive awards). </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&rsquo;
    bonuses under our annual incentive program are principally based on the achievement of specific performance objectives established
    at the beginning of the fiscal year by the Compensation Committee. Historically the Compensation Committee has awarded the annual
    incentive bonus for each year in the first quarter of the following year. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&rsquo;
    2022 annual equity awards were granted in the form of stock option awards. We believe the grant of stock option awards further aligns
    the executives&rsquo; interests with those of stockholders as the awards will not have value unless the Company&rsquo;s stock price
    appreciates after the award is granted. The stock option awards also provide a retention incentive as they vest over a multi-year
    period. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives
    are also granted stock options and restricted stock awards at the time they join the Company as these provide the same incentives
    as annual equity awards. These stock option grants and restricted stock awards generally vest over a three or four-year period beginning
    on the first-year anniversary of the date of grant.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides the components of Mr. Tardugno&rsquo;s compensation for the last two years, reflecting his transition to Executive
Chairman in mid-2022:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">(in 000&rsquo;s)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: right">2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: right">Change</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: right">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: right">Change</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Base Salary</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">574</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">2</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">561</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash Incentive Awards</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">383</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">381</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(5</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">956</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">942</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Option and Stock Awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">507</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(62</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,322</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">210</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">All Other Compensation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">623</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,197</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">48</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">6</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,086</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">(10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,312</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">64</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides the components of Dr. Le Goff&rsquo;s compensation for the last year, reflecting her partial year of service:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">(in 000&rsquo;s)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 72%; text-align: left">Base Salary</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 24%; text-align: right">264</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash Incentive Awards</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">157</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">421</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Option and Stock Awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">All Other Compensation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">56</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">883</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Compensation Philosophy and Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee attempts to design executive compensation programs to achieve three principal objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    program is intended to attract, motivate, and retain talented executives with total compensation that is competitive within the drug
    development and broader pharmaceutical and biotechnology industry;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    program is intended to create an alignment of interests between our executives and stockholders such that a significant portion of
    each executive&rsquo;s compensation varies with business performance and is dependent on stock price appreciation; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    program is designed to award behavior which results in optimizing the commercial potential of our development program.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee&rsquo;s philosophy is to pay competitive total compensation, comprised of annual salaries, annual cash incentives
and long-term equity awards (primarily stock options), with a significant percentage of total compensation directly linked with the Company&rsquo;s
performance. The Compensation Committee considers the elements of the compensation package to be reflective of compensation packages
given to executives of companies of similar size in our industry. Compensation packages generally are designed to pay competitive salaries
at the median of the industry compensation surveys as described below, reward superior annual performance through incentive compensation
awards and allow executives to participate in increases in stockholder value through stock option and other stock-based grants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining executives&rsquo; compensation levels, the Compensation Committee relies primarily on its experience and judgment to provide
a package that it believes appropriately balances the need to attract and retain key executive talent with the creation of incentives
that will (i) enhance the growth of the Company, (ii) align the interests of management and stockholders by emphasizing rewards for Company
performance, while remaining competitive with compensation paid by other clinical stage biotechnology companies and (iii) provide value
for stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of its decision-making process, the Compensation Committee takes into account the role and experience of each executive and reviews
industry surveys (specifically, the Radford Global Life Sciences Survey, which covers a broad cross-section of the biotechnology, pharmaceuticals
and life science industries and in which the Company participates) for information on the compensation paid to executive officers by
companies in our industry that are similar in size, breadth, stage of development or complexity to the Company. The Compensation Committee
also reviews custom surveys comparing executive compensation with that of specific peer groups (for example, pre-commercial biopharma
public companies, biopharma companies with under fifty employees, biopharma companies with a market cap above $100 million and biopharma
companies with a market cap below $100 million).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee utilized Mercer as its independent compensation advisor to compare the Company&rsquo;s executive and non-employee
director compensation levels, policies, practices and procedures to a set of peer companies selected by the Compensation Committee. Mercer
reported directly to the Compensation Committee and performed no work for management that was not under the Compensation Committee&rsquo;s
purview. The Compensation Committee assessed the independence of Mercer pursuant to the relevant SEC rules and the Nasdaq Listing Rules
and concluded that no conflicts of interest exist. The Compensation Committee and Mercer reviewed the compensation surveys as summarized
above as it relates to elements of yearly performance and compensation of all members of the executive management team. As part of their
engagement, Mercer prepared and submitted to the Compensation Committee a report on the audit of the Company&rsquo;s current compensation
benchmarking practices and its recommendations relating to executive and non-employee director compensation. Mercer concluded that the
Company uses appropriate market data sources to evaluate the competitive positioning of the top executives&rsquo; and the Board of Directors&rsquo;
compensation packages and market positioning relative to those data sources is reasonable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee believes that an appropriate level of input from our Executive Chairman and our Chief Executive Officer provides
a necessary and valuable perspective in helping the Compensation Committee formulate its own independent views on compensation. The Compensation
Committee takes measures to ensure its independence with respect to our Named Executive Officers&rsquo; compensation, excusing them from
portions of meetings to freely discuss their and the other Named Executive Officers performance and compensation. The Compensation Committee
made all final determinations on the compensation levels for all Named Executive Officers in 2022 and 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
discussion of each individual element of compensation and the compensation for each Named Executive Officer for 2022 follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
Salaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
participate in an ongoing industry survey, the Radford Global Life Sciences Survey, as described above. The Compensation Committee compares
base salary for our executives with the levels provided to similarly situated executives and generally targets base salaries at levels
in the median of the survey data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2022, the Compensation Committee reviewed each executive&rsquo;s job responsibilities, individual performance, our corporate performance,
competitive market data, our total compensation expense and the base salaries of Mr. Tardugno, Dr. Le Goff, Dr. Borys, Dr. Anwer and
Mr. Church and approved the following annualized salary adjustments for each Named Executive Officer:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Named Executive Officer</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid">Fiscal 2022 <BR> Salary</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid">Fiscal 2021<BR> Salary</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid">Change from<BR> Previous Year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Michael H. Tardugno</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">546,711</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">586,545</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">(6.8</TD><TD STYLE="width: 1%; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Corinne Le Goff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">624,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nicholas Borys</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">447,848</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">434,804</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Khursheed Anwer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">385,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">370,654</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jeffrey W. Church</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">412,130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">400,126</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.0</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incentive
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have an incentive compensation plan in which all members of our senior management participate. The plan is performance-driven based on
Company and individual personal operational objectives established at the beginning of the year by the Compensation Committee in consultation
with our Chief Executive Officer. These operational objectives include the completion of certain development projects, capital raising,
cost controls, business development and profit and loss goals, which we believe are ultimately linked to creating stockholder value.
These objectives are designed to achieve timely and efficient product development including completion of clinical studies and regulatory
approvals. Each member of senior management is individually evaluated based on the achievement of the Company&rsquo;s overall operational
objectives and each individual&rsquo;s personal performance against these objectives. This component of compensation is provided, among
other reasons, to create incentives for members of senior management to meet short-term and medium-term performance goals of the Company,
without regard to stock price. Objectives are weighted in terms of overall importance to meeting the Company&rsquo;s operating plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total annual incentive compensation a member of senior management can earn is based on his level within management, with more senior
members of management eligible to earn a higher percentage of their base salary as incentive compensation than less senior members. We
believe it is appropriate for executives to have a greater percentage of their compensation &ldquo;at-risk&rdquo; based on performance
as they generally have a greater role in the achievement of objectives that we believe promote the growth of the Company and the creation
of value for stockholders. The actual amount of incentive compensation paid to any member of senior management is determined on a sliding
scale dependent on how successful such member of senior management was in achieving the objectives upon which his or her incentive compensation
was targeted and the relative importance to the Company of the objectives achieved. The Compensation Committee retains complete discretion
to adjust any incentive compensation down and retains discretion as to whether to grant any incentive compensation to any individual
member of senior management at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the incentive compensation plan for 2022, the Compensation Committee established a number of annual corporate goals identified below
that include research and development, regulatory, manufacturing, organizational and financial goals which we believe are essential to
building stockholder value. The relative weighting of these corporate goals is based upon our assessment of the importance of each goal
in creating value for the Company and our stockholders. Each corporate goal was established so that significant levels of achievement
were required to meet the goal. Following the conclusion of the annual performance period, the level of achievement for each corporate
goal was assessed by the Compensation Committee. The Compensation Committee determined whether each corporate goal had been met, exceeded,
or not satisfied. In addition, in assessing corporate performance, the Compensation Committee had the discretion to factor in other significant
corporate events that occurred during the performance period, which could have resulted in an upward or downward adjustment in the determination
of corporate performance. After considering the level of attainment of each corporate goal and other appropriate corporate performance
factors, the Compensation Committee assigned the overall corporate performance rating, which could have ranged from 0% to 130%. A maximum
bonus pool is established by multiplying the overall corporate performance rating by the aggregate target bonuses for all individuals
in the incentive plan. Certain individual downward adjustments may be made at the discretion of the Compensation Committee. The aggregate
of all individual bonuses awarded under the policy cannot exceed the maximum bonus pool available such that the cost of bonuses ultimately
reflects our overall performance and is not inflated by any individual performance rating.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the corporate performance rating is determined by the Compensation Committee, the individual performance of each Named Executive Officer
is reviewed by the Compensation Committee in order to determine the appropriate annual performance percentage rating to be assigned to
the executive for the performance period. Each Named Executive Officer&rsquo;s actual annual performance-based incentive compensation
payment is based on a combination of our corporate performance rating and their individual performance rating. The actual annual performance
bonus compensation award for each Named Executive Officer is determined in the Compensation Committee&rsquo;s sole discretion, and the
maximum payout for each Named Executive Officer could be up to 130% of his target annual performance-based compensation target.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Named Executive Officers were each assigned a target annual incentive for 2022 ranging from 45% to 100% of base salary. The table below
shows the target annual incentive assigned to each Named Executive Officer for 2022 both as a dollar amount and as a percentage of base
salary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 93%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Target Annual<BR> Incentive <BR> for
    2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Target
                                            Annual<BR> Incentive for 2022</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(%
                                            of Base Salary)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Annual Incentive Awarded <BR> for
    2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
                                            Incentive<BR> Awarded for 2022</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(%
                                            of Base Salary)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Michael H. Tardugno</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">546,711</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">100</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">382,697</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">70.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Corinne Le Goff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">624,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.2</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nicholas Borys</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">447,848</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Khursheed Anwer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">385,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">139,737</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jeffrey W. Church</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">412,130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">139,094</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33.8</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
goals and targets are set at the beginning of the fiscal year and are approved by the Compensation Committee and Board. Executives&rsquo;
bonuses under the Company&rsquo;s annual incentive program are based on the achievement of specific performance measures established
at the beginning of the fiscal year. For 2022 the corporate objectives and relative weightings assigned to each objective include the
completion of certain development objectives, capital raising, cost controls, business development and profit and loss goals, which we
believe are ultimately linked to creating stockholder value. The following 2022 corporate goals and targets were heavily weighted toward
the clinical development of IMNN-001 for ovarian cancer, including targets for the timely completion of enrollment of the OVATION 2 Study,
initiation of a second clinical study with IMNN-001 in combination with Avastin&reg; and expansion of the Company&rsquo;s development
pipeline with a new product candidate (PlaCCine). The corporate goals also included targets for corporate development objectives related
to the transition of the Company to an immuno-oncology and vaccine focus including the successful rebranding of the Company, the addition
of key competencies to support vaccine clinical trials and the implementation of an executive succession plan to transition leadership
with immuno-oncology and vaccine experience. There were also a series of financial and business development goals to ensure strong cash
management and that sufficient levels of cash will be available to extend the Company&rsquo;s operating roadway for at least twenty-four
months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following 2022 objectives are designed to achieve timely and efficient product development including completion of clinical studies and
regulatory approvals and in total represent a potential payout at 130% of the executive&rsquo;s bonus target if all objectives are achieved.
The Board, upon the recommendation of the Compensation Committee, reviewed our achievement against our 2022 corporate goals and determined
the achievement level to have been 70% of target.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
    &amp; Development Objectives (35%)</B> &ndash; (i) Complete enrollment of the OVATION 2 Study by the third quarter of 2022 within
    budget while maintaining key quality metrics (15%), (ii) Initiate a second clinical study with IMNN-0011 in combination with Avastin&reg;
    which will be principally funded (~50%) by a research foundation (10%) and (iii) Add at least one new product technology to the company&rsquo;s
    development pipeline by the fourth quarter of 2022 (10%). <B>(THE FIRST AND THIRD R&amp;D OBJECTIVES WERE MET RESULTING IN 25% of
    35% OF OBJECTIVES MET)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
    Development Objectives (20%)</B> - Develop and implement a strategy to achieve 25% of common stock ownership by institutional investors<B>.
    (OBJECTIVES NOT MET)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
    Objectives (25%)</B> - Manage cash and operating expenses, ensure cash flows are within the operating budget and maintain sufficient
    levels of cash to extend operating roadway into 2025. <B>(ALL OBJECTIVES MET)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
    Development Objectives (20%)</B> - Successfully rebrand the Company, develop key competencies to support vaccine clinical trials,
    and implement the executive succession plan to effectively transition leadership with immuno-oncology and vaccine experience. <B>(ALL
    OBJECTIVES MET)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus
    Objective (30%)</B> - Monetize GEN-1 asset through an out-license or collaboration with pharma or through a major grant program.
    <B>(OBJECTIVE NOT MET)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Named Executive Officers participated in the annual incentive plan for 2022. The initial target bonus amount for each executive
was established pursuant to their employment agreement and is adjusted periodically by the Board. Historically the Compensation Committee
has awarded the annual incentive bonus for each year in the first quarter of the following year. In the first quarter of 2023, the Compensation
Committee approved the amount and the payment of the incentive bonus for 2022 for each of the Named Executive Officers. Please see the
&ldquo;Non-Equity Incentive Plan Compensation&rdquo; column in the 2022 Summary Compensation Table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock-Based
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
grant long-term equity awards to its executives and other employees that are designed to align the interests our Company employees and
stockholders, encouraging participants to maintain and increase their ownership our Company common stock with the opportunity to benefit
from our long-term performance. Our equity program has generally consisted of grants of stock options and occasional grants of stock
awards. Because the exercise price of the options is based on the market price of our common stock on the date of grant, the Compensation
Committee believes that options help to align the interests of our executives with those of its stockholders as the options will not
have value unless there is appreciation in our stock price. The options also serve as a retention tool since they generally vest over
a three to four-year period following the grant date. This approach is designed to focus key employees on sustainable growth of the Company
and the creation of stockholder value over the long term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
grants to the Named Executive Officers are generally made during the first half of the fiscal year. Annual grants are determined by the
Compensation Committee based on review of each individual&rsquo;s past performance as well as their potential impact on the Company&rsquo;s
future performance. Grants may also be made at other times during the fiscal year in certain circumstances (such as a grant in connection
with the hiring or promotion of an executive or other special circumstance as deemed appropriate by the Compensation Committee).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
officers are eligible to participate in our medical and other welfare benefit plans and for other benefits, in each case on generally
the same basis as other employees. We maintain a 401(k) plan for our employees. Other than the 401(k) plan, we do not offer any of our
employees a pension plan, retirement plan or other forms of compensation paid out upon retirement. The Company matches up to 50% of the
first 6% of employee contributions. Dr. Anwer received a $6,000 discretionary spending allowance. During 2022, in his capacity as President
and Chief Executive Officer Chief, Mr. Tardugno received a $23,000 discretionary spending allowance. Mr. Tardugno does not receive a
discretionary spending allowance as Executive Chairman.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Post-Employment
Obligations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that severance protections, particularly in the context of a change in control transaction, can play a valuable role in attracting
and retaining key executive officers. Under their employment agreements, each of the Named Executive Officers would be entitled to severance
benefits in the event of a termination of employment by the Company without cause. We have determined that it is appropriate to provide
the executives with severance benefits under these circumstances in light of their positions with us and as part of their overall compensation
package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the occurrence, or potential occurrence, of a change in control transaction will create uncertainty regarding the continued
employment of our executive officers as many change in control transactions result in significant organizational changes, particularly
at the senior executive level. In order to encourage the Company&rsquo;s executive officers to remain employed with us during an important
time when their prospects for continued employment following the transaction may be uncertain, we provide each of Mr. Tardugno, Dr. Le
Goff, Mr. Church and Dr. Borys with enhanced severance benefits if his employment is actually or constructively terminated by the Company
without cause in connection with a change in control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
Considerations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
162(m) of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), provides that annual compensation in excess of $1,000,000
paid to the Chief Executive Officer or certain of the Company&rsquo;s other executive officers will not be deductible by a publicly held
corporation for federal income tax purposes. Historically, there was an exception to this annual deduction limit for compensation meeting
the definition of &ldquo;performance-based compensation&rdquo; under Section 162(m) of the Code. With the enactment of tax reform in
December 2017, the performance-based compensation exception under Section 162(m) of the Code has been repealed, except with respect to
certain grandfathered arrangements. The Compensation Committee considers the anticipated tax treatment to the Company when determining
executive compensation and, historically, has sought to structure its executive compensation program in a way that preserved the deductibility
of compensation payments and benefits, subject to the satisfaction of other applicable regulatory requirements. It should be noted, however,
that tax deductibility is one of many factors considered by the Compensation Committee in determining executive compensation and the
Compensation Committee maintains the flexibility to compensate the Named Executive Officers in a manner it deems appropriate to attract,
retain, and motivate highly qualified executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_035"></A>COMPENSATION
COMMITTEE REPORT ON EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee has certain duties and powers as described in its charter. Our Compensation Committee is currently composed of
the three non-employee directors named at the end of this report, each of whom our Board of Directors has determined is independent under
the applicable Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee has reviewed and discussed with management the disclosures contained in the Compensation Discussion and Analysis
section of this Proxy Statement. Based upon this review and discussion, our Compensation Committee recommended to our Board of Directors
that the Compensation Discussion and Analysis section be included in this Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
    Committee of the Board of Directors</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Frederick J. Fritz (Chairman)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Augustine Chow</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Stacy Lindborg</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report does not constitute &ldquo;soliciting material&rdquo; and shall not be deemed filed or incorporated by reference into any filing
under the Securities Act of 1933 or under the Securities Exchange Act of 1934, except to the extent we specifically incorporate this
report by reference and shall not otherwise be deemed filed under such Acts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_036"></A>2022
SUMMARY COMPENSATION TABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the total compensation for services rendered in all capacities during the years ended
December 31, 2022 and 2021, awarded to, paid to, or earned by each named executive officers serving as of December 31, 2022. All compensation
awarded to, earned by, or paid to IMUNON&rsquo;s named executive officers are included in the table below for the years ended December
31, 2022 and 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name and Principal Position</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Salary</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Bonus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Stock<BR> Awards</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Option<BR> Awards<BR> (1)(2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Non-Equity<BR> Incentive <BR> Plan<BR>
    Compensation<BR> (2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">All Other<BR> Compensation<BR> (3)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Total<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-weight: bold; text-align: left">Michael H. Tardugno (4)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">2022</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">573,649</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">506,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">382,697</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">622,545</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">2,085,391</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Executive Chairman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">581,586</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,322,285</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">381,254</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">48,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,312,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Corinne Le Goff (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">264,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">97,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">308,564</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">157,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">56,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">883,794</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">President &amp; CEO</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Nicholas Borys (6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">445,340</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">118,286</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">130,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">707,122</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Executive VP &amp; CMO</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">432,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">203,410</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">127,180</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">27,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">789,947</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Khursheed Anwer (7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">382,629</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">118,286</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">139,737</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,506</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">678,658</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Executive VP &amp; CSO</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">362,878</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">508,555</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">120,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">28,583</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,020,478</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Jeffrey Church</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">409,822</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">87,715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">139,094</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">636,631</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Executive VP &amp; CFO</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">397,004</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">559,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">117,037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">14,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,087,963</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for option awards is the aggregate grant date fair value of stock options granted to the Named Executive Officers
    in the years shown, determined in accordance with FASB ASC Topic 718, disregarding adjustments for forfeiture assumptions. The assumptions
    for making the valuation determinations are set forth in Note 12 to the Financial Statements.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&rsquo;
    bonuses under our annual incentive program are based on the achievement of specific performance measures established at the beginning
    of the fiscal year by our Compensation Committee. Historically, our Compensation Committee has awarded the annual incentive bonus
    for each year in the first quarter of the following year. In the first quarter of 2023, our Compensation Committee approved the amount
    and the payment of the incentive bonus for 2022 for each of the Named Executive Officers in the form of stock awards and Non-Equity
    (Cash) Incentive Plan Compensation. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    column includes other compensation as indicated below and matching and discretionary contributions made by the Company for the Named
    Executive Officers under our 401(k) plan. Our matching contribution is equal to 50% of the employee&rsquo;s deferrals under the plan
    up to 6% of the employee&rsquo;s compensation, subject to applicable IRS limitations, and are made in shares of our common stock.
    The 2021 discretionary contribution is 5.0% of eligible salary of each employee which was contributed in January 2022. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Tardugno served as the Company&rsquo;s Chairman, President and Chief Executive Officer until July 18, 2022, when he transitioned
    to the position of Executive Chairman of the Board. For Mr. Tardugno, &ldquo;All Other Compensation&rdquo; for 2022 consists of $23,000
    for discretionary spending allowance for the period when he served as President and Chief Executive Officer, a 401(k)-plan matching
    contribution of $13,000 in our common stock and a $586,545 one-time payment made in July 2022 in connection with Mr. Tardugno&rsquo;s
    transition to his new role as Executive Chairman. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Le Goff joined the Company as President and Chief Executive Officer and as a director effective as of July 18, 2022. For Dr. Le Goff,
    &ldquo;All Other Compensation&rdquo; for 2022 consists of a 401(k)-plan matching contribution of $6,480 in our common stock and a
    $50,000 signing bonus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Dr. Borys, &ldquo;All Other Compensation&rdquo; for 2022 consists of a 401(k)-plan matching contribution of $12,500 in our common
    stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Dr. Anwer, &ldquo;All Other Compensation&rdquo; for 2022 consists of $6,006 for discretionary spending allowance and a 401(k)-plan
    matching contribution of $12,500 in our common stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_037"></A>NARRATIVE
DISCLOSURE TO EXECUTIVE SUMMARY COMPENSATION TABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employment
Agreement with Michael H. Tardugno</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2016, the Company and Mr. Tardugno entered into an employment agreement, effective March 30, 2016 (the &ldquo;March 2016 Agreement&rdquo;),
which superseded the previous employment agreement with Mr. Tardugno. Subject to earlier termination pursuant to the terms of the March
2016 Agreement, the initial term of the agreement ended on January 31, 2018, with automatic one-year renewals thereafter, unless either
party provides a notice of non-renewal. Mr. Tardugno&rsquo;s March 2016 Agreement provided for an annual base salary of $547,342 subject
to annual adjustment by the Board or the Compensation Committee. Mr. Tardugno was also eligible for an annual performance bonus from
the Company, pursuant to the Company&rsquo;s management incentive bonus program in effect from time to time. The Company agreed to reimburse
Mr. Tardugno for all reasonable business expenses and to provide a discretionary spending allowance. Under the March 2016 Agreement,
the Company agreed to grant to Mr. Tardugno, at the time of its usual annual grant to employees, annual stock options to purchase shares
of the Company&rsquo;s common stock as the Board of Directors or the Compensation Committee shall determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
July 18, 2022, Mr. Tardugno transitioned from his roles as Chairman, President and Chief Executive Officer to the position of Executive
Chairman of the Board. Mr. Tardugno and the Company entered into an employment agreement effective as of July 18, 202 that supersedes
the March 2016 Agreement. The agreement has a term ending on December 31, 2024, with the option for a one-year extension. Under the agreement,
Mr. Tardugno will receive a base salary of $500,000 (prorated to $240,000) for 2022 and a base salary of $350,000 for 2023 and 2024.
Mr. Tardugno will remain eligible for annual performance bonuses and equity awards and may participate in all compensation and benefit
programs generally made available to other senior executives. The Company will reimburse Mr. Tardugno for all reasonable business expenses
but he will no longer have a discretionary spending allowance. In the event of termination by the Company other than for cause, Mr. Tardugno
will receive an amount equal to one year&rsquo;s salary as a severance payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employment
Agreement with Corinne Le Goff</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Le Goff entered into an employment agreement effective as of July 18, 2022, in connection with her appointment as
President and Chief Executive Officer, Pursuant to the employment agreement, the Company will pay Dr. Le Goff an initial salary of
$624,000 and a signing bonus $50,000. Dr. Le Goff&rsquo;s targeted annual performance bonus is 72% of her annual base salary
(pro-rated for the year ended December 31, 2022). Dr. Le Goff also received (i) an option to purchase 177,000 shares of the
Company&rsquo;s common stock that will vest with respect to 25% of the subject shares on July 18, 2023 and the remaining 75% percent
will vest in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable as of the
fourth anniversary of July 18, 2022, and (ii) a restricted stock award of 53,000 restricted shares that will vest on July 18, 2023.
Dr. Le Goff will not receive any additional compensation for her service on the Board. The agreement has no set term of employment.
In the event of termination by the Company other than for cause, Dr. Le Goff will receive an amount equal to one year&rsquo;s salary
as a severance payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employment
Agreements with Other Named Executed Officers</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nicholas
Borys</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Borys entered into an employment offer letter on August 23, 2007, pursuant to which Dr. Borys agreed to serve as our
Vice President and Chief Medical Officer. Dr. Borys&rsquo; employment with us was &ldquo;at-will;&rdquo; however, subject to Dr. Borys&rsquo;
promotion to Executive Vice President in January 2019, if we terminated Dr. Borys&rsquo; employment for any reason other than just cause,
we would pay Dr. Borys a salary continuation and COBRA premiums for up to twelve months. The salary and COBRA premiums would cease at
the end of the twelve-month period or, if he found new employment prior to the end of the twelve-month period, the benefit would be reduced
by the amount of compensation which he would receive from any new employer. Dr. Borys&rsquo; right to receive these severance benefits
is subject to his providing a release of claims in favor of the Company. Dr. Borys&rsquo; separated from the Company effective as of
February 28, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Jeffrey
Church</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Mr. Church entered into an employment offer letter on June 15, 2010. Mr. Church&rsquo;s employment is &ldquo;at-will;&rdquo;
however, subject to Mr. Church&rsquo;s promotion to Executive Vice President in January 2019, if we terminate Mr. Church&rsquo;s employment
for any reason other than just cause, we will pay Mr. Church a salary continuation and COBRA premiums for up to twelve months. The salary
and COBRA premiums will cease at the end of the twelve-month period or if he finds new employment prior to the twelve-month period, the
benefit will be reduced by the amount of compensation which he will receive from any new employer. Mr. Church&rsquo;s right to receive
these severance benefits is subject to his providing a release of claims in favor of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Khursheed
Anwer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Anwer entered into an employment offer letter effective as of June 20, 2014. Dr. Anwer&rsquo;s employment with us is
&ldquo;at-will&rdquo;; however, subject to the retention and severance agreement between the Company and Dr. Anwer dated as of May 28,
2014, if we terminate Dr. Anwer&rsquo;s employment without cause (as such term is defined in the retention and severance agreement),
he will be entitled to receive cash severance equal to 12 months of his base salary and reimbursement of his COBRA premiums for up to
12 months. Dr. Anwer&rsquo;s right to receive these severance benefits is subject to his providing a release of claims in favor of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CIC
Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into amended and restated double-trigger change in control severance agreements (CIC Agreements) with each of the Named
Executive Officers (other than Dr. Anwer who is not subject to such an agreement) to provide severance benefits to these executives should
their employment terminate in certain circumstances in connection with a change in control of the Company (a &ldquo;CIC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the amended and restated CIC Agreements, in the event that, on or within two years after a CIC, we terminate the executive&rsquo;s employment
without cause or in the event that the executive terminates his employment for good reason, the executive would be entitled to receive
a cash lump sum payment equal to two (2) times the sum of (1) the executive&rsquo;s annual base salary and (2) the executive&rsquo;s
target annual bonus for the fiscal year in which the termination occurs. (For these purposes, the terms &ldquo;cause,&rdquo; &ldquo;good
reason&rdquo; and &ldquo;change in control&rdquo; are each defined in the CIC Agreement.) In addition, we will pay or reimburse the executive
for the cost of COBRA premiums and life insurance coverage for the executive and his eligible dependents, in each case for a period of
up to two years following the termination. The executive would also be entitled to full acceleration of his then-outstanding equity awards
granted to him by us. However, as to any equity award agreement that is subject to performance-based vesting requirements, the vesting
of such an award will continue to be governed by its terms. In the case of options or similar awards, the award would generally remain
exercisable for the remainder of the original term of the award (or, in the case of awards that vested after the date of the CIC, for
the lesser of 12 months following the last day such award would have been exercisable under the applicable award agreement and the remainder
of the original term). The benefits provided under the CIC Agreement are in addition to, and not in lieu of, any severance benefits the
executive may be entitled to receive in connection with the termination of his employment under any other agreement with the Company.
The executive&rsquo;s right to benefits under the CIC Agreement is subject to his execution of a release of claims in favor of the Company
upon the termination of his employment. The CIC Agreements do not provide for any tax gross ups.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Potential
Payments Upon Termination or Change In Control</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described above under &ldquo;Narrative Disclosure to Executive Compensation Tables,&rdquo; the Company has entered into agreements with
each of the Named Executive Officers currently employed by the Company that provide benefits that may become payable to the executives
in connection with a termination of their employment. The Company has also entered into agreements with Mr. Tardugno, Dr. Le Goff, Mr.
Church, and Dr. Borys that provide benefits that may become payable to the executives in connection with a termination of employment
following a CIC of the Company. If in the event the Named Executive Officer is entitled to receive severance benefits in connection with
a termination of employment under both their severance agreement and their CIC agreement, the executive shall be entitled to receive
the benefits from both agreements. The first table below indicates the benefits that would be payable to each executive if a termination
of employment in the circumstances described above had occurred on December 31, 2022 outside of a CIC. The second table below indicates
the benefits that would be payable to each executive if a change in control of the Company and such a termination of employment had occurred
on that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Severance Benefits (Outside of a Change in Control)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Severance</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Continuation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
                                            Health/Life</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Benefit</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Acceleration</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 42%; text-align: left">Michael H. Tardugno-</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">350,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">27,365</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">377,365</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Corinne Le Goff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">468,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">27,988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">495,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nicholas Borys</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">447,848</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">39,830</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">487,678</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Khursheed Anwer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">385,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">28,332</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">413,812</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jeffrey W. Church</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">412,130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">425,486</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Change of Control Severance Benefits</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Severance</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Continuation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
                                            Health/Life</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Benefit</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Acceleration</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 42%; text-align: left">Michael H. Tardugno</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">350,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">27,365</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">377,365</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Corinne Le Goff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">468,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">27,988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">495,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jeffrey W. Church</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,195,177</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">26,713</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,221,890</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Material
Terms of Option Grants During 202</I>2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the stock options awarded to the Named Executive Officers in 2022 and reported in the 2022 Grants of Plan-Based Awards Table below
was granted under, and is subject to, the terms of the IMUNON, INC. 2018 Stock Incentive Plan (the &ldquo;2018 Plan&rdquo;). The 2018
Plan is administered by the Compensation Committee, which has authority to interpret the plan provisions and make all required determinations
under the plan. This authority includes making required proportionate adjustments to outstanding awards upon the occurrence of certain
corporate events such as reorganizations, mergers, and stock splits, and making provision to ensure that any tax withholding obligations
incurred in respect of awards are satisfied. Awards granted under the plan are generally only transferable to a beneficiary of a Named
Executive Officer upon his death. Under the terms of the 2018 Plan, if there is a change in control of the Company, each Named Executive
Officer&rsquo;s outstanding awards granted under the plan will generally terminate, unless the Compensation Committee provides for the
substitution, assumption, exchange or other continuation or settlement (in cash, securities, or property) of the outstanding awards.
The Compensation Committee has the discretion to provide for outstanding awards to become vested in connection with a change in control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
option granted to the Named Executive Officers in 2022 was granted with a per-share exercise price equal to the closing price of our
common stock on the grant date. Each option is scheduled to vest in three installments, with one-third vesting on the date of grant and
the balance vesting in equal annual installments over each of the next two years, subject in each case to the executive&rsquo;s continued
employment through the applicable vesting date and has a maximum term of ten years. However, vested options may terminate earlier in
connection with a change in control transaction or a termination of the Named Executive Officer&rsquo;s employment. Subject to any accelerated
vesting that may apply in the circumstances, the unvested portion of the option will immediately terminate upon a termination of the
Named Executive Officer&rsquo;s -employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_038"></A>2022
GRANTS OF PLAN-BASED AWARDS TABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information regarding the incentive awards granted to the Named Executive Officers during 2022. Each of the
equity awards reported in the table below was granted under the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Grant Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Estimated<BR> Future<BR> Payouts<BR>
    Under Non- Equity<BR> Incentive<BR> Plan Awards<BR> Target<BR> ($) (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">All other<BR> Stock Awards:<BR> Number
    of<BR> Shares or<BR> Units of<BR> Stock<BR> (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">All Other<BR> Option Awards:<BR> Number
    of<BR> Securities<BR> Under- lying<BR> Options <BR> (#) (2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
                                            or<BR> Base Price<BR> of Option<BR> Awards<BR> ($/Share)</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(3)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant
                                            Date<BR> Fair Value<BR> of Stock<BR> and Option<BR> Awards<BR> ($/Share)</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(3)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 18%; text-align: left">Michael H. Tardugno</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center">N/A</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">350,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Corinne Le Goff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">N/A</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">449,280</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/18/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">177,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.95</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.74</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/18/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.95</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nicholas Borys</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">N/A</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Khursheed Anwer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">N/A</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">192,740</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/18/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.95</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jeffrey W. Church</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">N/A</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">185,459</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts reported in this column represent the target bonus opportunity under the Company&rsquo;s annual bonus program. See &ldquo;Compensation
    Discussion and Analysis &ndash; Incentive Compensation&rdquo; above for information on the terms of these bonuses.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts reported in this column represented stock option awards granted under the 2018 Plan. Each option granted to each Named Executive
    Officer is scheduled to vest in three installments, with one-third vesting on the date of grant and the balance vesting in annual
    installments over each of the next two years, subject in each case to the executive&rsquo;s continued employment through the applicable
    vesting date and has a maximum term of ten years. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for stock and option awards is the aggregate grant date fair value of stock options granted to the Named Executive
    Officers in 2022, determined in accordance with FASB ASC Topic 718, disregarding adjustments for forfeiture assumptions. The assumptions
    for making the valuation determinations are set forth in Note 12 to the Financial Statements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_039"></A>2022
OUTSTANDING EQUITY AWARDS AT YEAR-END</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the unexercised stock options held by each of the Named Executive Officers as of December 31, 2022. None of
the Named Executive Officers held any other outstanding stock awards as of December 31, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Grant Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">No. of Securities<BR> Underlying<BR>
    Unexercised<BR> Options (#)<BR> Exercisable</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">No. of Securities<BR> Underlying<BR>
    Unexercised<BR> Options (#)<BR> Unexercisable</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option<BR>
                                            Exercise<BR> Price</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Option <BR> Expiration <BR> Date</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; text-align: left">Michael H. Tardugno</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: center">10/3/2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">4,332</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">25.80</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: center">10/3/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,333</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Corinne Le Goff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/18/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">177,000</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.95</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/18/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nicholas Borys</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/3/2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25.80</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/3/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,333</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,333</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Khursheed Anwer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/3/2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,832</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25.80</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/3/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,333</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3/04/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,333</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jeffrey W. Church</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/3/2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25.80</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/3/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,333</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.93</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6/13/2032</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of these stock option grants vest in three equal installments, with one-third of the grant vesting each immediately, on the first
    anniversary, and on the second anniversary of the date of grant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of these stock option grants vest in four equal installments, with one-fourth of the grant vesting each on the first, second, third,
    and fourth anniversary of the date of grant.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>2022
Option Exercises and Stock Vested</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2022, none of the Named Executive Officers exercised any of their vested stock options. No officers were awarded shares of stock during
2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_040"></A>Pay
Versus Performance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reports the compensation of our principal executive officer (PEO) and the average compensation of the other named executive
officers (Other NEOs) as reported in the Summary Compensation Table for the past two fiscal years, as well as their &ldquo;compensation
actually paid&rdquo; as calculated pursuant to recently adopted SEC rules and certain performance measures required by the rules, including
total stockholder return (TSR).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Year
    (1)(2)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Summary
    Compensation Table (SCT) Total for First PEO</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Summary
    Compensation Table (SCT) Total for Second PEO</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Compensation
    Actually Paid to First PEO <BR>(3)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Compensation
    Actually Paid to Second PEO <BR>(3)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Average
    SCT Total for Other NEOs</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Average
    Compensation Actual Paid to Other NEOs (3)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Value
    of Initial Fixed $100 Investment Based on TSR (4)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    Loss (5)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2022</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,085,391</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">883,794</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,876,247</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">755,144</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">674,137</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">630,434</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.68</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(35,465,260</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2021</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,312,625</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">N/A</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,664,992</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">N/A</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">966,129</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">763,895</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">76.06</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(20,769,250</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are a smaller reporting company and, accordingly, we have not included any information in
                                            this table for 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            PEOs and Other NEOs for the applicable years were as follows:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022:
                                            Mr. Tardugno served as the &ldquo;First&rdquo; PEO until July 2022 and Dr. Le Goff joined
                                            in July 2022 as the &ldquo;Second&rdquo; PEO, and Dr. Anwer, Mr. Church and Dr. Borys as
                                            the Other NEO&rsquo;s. Although Mr. Tardugno was an executive officer but not the PEO for
                                            the latter part of 2022, since he served as the PEO for a portion of the year he is not included
                                            as an Other NEO for any portion of 2022.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021:
                                            Mr. Tardugno served as PEO and Dr Anwer, Mr. Church and Dr. Borys as the Other NEO&rsquo;s</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            2022 Summary Compensation Table totals reported for the PEOs and the average of the Other
                                            NEOs for each year were subject to the following adjustments per item 402(v)(2)(iii) of Regulations
                                            S-K to calculate &ldquo;compensation actually paid&rdquo;:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">First PEO</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Second PEO</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Average for Other NEOs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">PEO</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Average for Other NEOs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left; padding-bottom: 1.5pt">Summary Compensation Table Total</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">2,085,391</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">883,794</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">674,137</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">2,312,625</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">966,129</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">ADJUSTMENTS</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Deductions for amounts reported under the &ldquo;Stock Awards&rdquo; and &ldquo;Option
    Awards&rdquo; columns of the Summary Compensation Table(a)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(506,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(406,064</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(114,596</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,322,285</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(423,796</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Increase for the inclusion of Rule 402(v) Equity Value (a)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">297,356</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">277,414</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">70,893</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">674,652</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">221,561</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Compensation Actually Paid</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,876,247</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">755,144</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">630,434</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,664,992</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">763,895</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Compensation Actually Paid excludes the Stock Awards and Option Awards columns from the relevant fiscal year&rsquo;s Summary Compensation
Table total. The Rule 402(v) Equity Values instead reflect the aggregate of the following components, as applicable: (i) the fair value
as of the end of the listed fiscal year of unvested equity awards granted in that year; (ii) the change in fair value during the listed
fiscal year of equity awards granted in prior years that remained outstanding and unvested at the end of the listed fiscal year; and
(iii) the change in fair value during the listed fiscal year through the vesting date of equity awards granted in prior years that vested
during the listed fiscal year, less the fair value at the end of the prior year of awards granted prior to the listed fiscal year that
failed to meet applicable vesting conditions during the listed fiscal year. Equity values are calculated in accordance with FASB ASC
Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of
the grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Measured
                                            as the value of a $100 investment in Imunon common stock at market close on December 31,
                                            2020, the last trading day in 2020, through and including the end of the indicated year.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
                                            in accordance with U.S. GAAP</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
Performance Measures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently use financial performance measures to link executive compensation actually paid to our NEOs to our performance. However,
as discussed above under &ldquo;Executive Compensation,&rdquo; we do utilize non-financial measures such as clinical development progress
and timelines, manufacturing measures and progress towards commercialization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Analysis
of the Information Presented in the Pay Versus Performance Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in more detail above under &ldquo;Compensation Discussion and Analysis&rdquo; our executive compensation is designed to (1)
attract, motivate and retain talented executives with total compensation that is competitive in our industry; (2) align the interests
of our executives and our stockholders; and (3) award behavior which results in optimizing the commercial potential of our development
program. We use various performance measures to align executive compensation with our performance which are not presented in the Pay
Versus Performance table. In accordance with Item 402(v) of Regulation S-K, we are providing the following description of the relationships
between the information presented in the Pay Versus Performance table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Table
Compensation Actually Paid and Cumulative TSR</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of compensation actually paid to Mr. Tardugno and Dr. Le Goff is aligned with our TSR over the two years presented in the
table, reflecting the impact of the hiring of Dr. Le Goff as President and Chief Executive Officer and the transition of Mr.
Tardugno from those roles to the role of Executive Chairman during the year and cash payments made in connection with the
transition. Notwithstanding those payments, a substantial amount of Mr. Tardugno&rsquo;s compensation was in the form of stock
option awards that vest in three equal installments, with one-third immediately and one-third on each of the first and second
anniversary of the date of grant. A substantial amount of Dr. Le Goff&rsquo;s compensation was in the form of stock option awards
that vest in four equal installments, with one-fourth of the grant vesting each on the first, second, third and fourth anniversary
of the date of grant. As the trading price of our common stock fluctuates so does the value of the stock options and, accordingly,
the amount of the compensation actually paid to the PEO. The amount of compensation actually paid to Mr. Tardugno for 2021 is more
closely aligned to our TSR as a great portion of his compensation was in the form of stock option awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of compensation actually paid to the Other NEOs is aligned with our TSR over the two years presented in the table. Each of the
Other NEOs were NEOs for both 2022 and 2021. A significant portion of the compensation actually paid to the Other NEOs is composed of
stock option awards which vest in three installments, commencing one-third immediately and one-third on each of the first and second
anniversary of the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation
Actually Paid and Net Income</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of compensation actually paid to Mr. Tardugno and Dr. Le Goff and to the Other NEOs is not aligned with our net income over
the two years presented in the table. As a clinical stage biotechnology company, we have incurred substantial operating losses,
principally from expenses associated with the Company&rsquo;s research and development programs, clinical trials conducted in
connection with the Company&rsquo;s drug candidates, and applications and submissions to the U.S. Food and Drug Administration. We
have substantial future capital requirements to continue our research and development activities and advance our drug candidates
through various development stages. Accordingly, net income is not a performance measure we use in determining executive
compensation. As discussed above, under &ldquo;Compensation Discussion and Analysis&rdquo;, we use a number of corporate goals that
may include research and development, regulatory, manufacturing, organization and financial goals which we believe are important to
building stockholder value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
losses increased 2022 over 2021 largely due to a one-time impairment of in-process research and development. Excluding one-time
payments and equity grants to Mr. Tardugno and/or Dr. Le Goff, compensation actually paid to the PEOs, and the compensation actually
paid to the Other NEOs declined in 2022 from 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_041"></A>Equity
Compensation Plan Information as of December 31, 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Plan Category</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of securities<BR> to be issued upon<BR> exercise of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>outstanding<BR>
                                            options, warrants</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
                                            rights (a)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Weighted- <BR> average exercise price
    <BR> of outstanding <BR> options, <BR> warrants and <BR> rights (b)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">Number of <BR> Securities remaining
    <BR> available for <BR> future issuance<BR> under equity compensation <BR> plans (excluding securities reflected in<BR> column (a)
    (c)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Equity compensation plans approved by security holders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">555,719</TD><TD STYLE="width: 1%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">5.53</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">388,954</TD><TD STYLE="width: 1%; text-align: left"><SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Equity compensation plans not approved by security holders</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">204,501</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(3)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.89</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">760,220</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4.55</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">388,954</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    both vested and unvested options to purchase common stock and unvested stock grants under the 2018 Plan. These awards have a weighted
    average remaining term of 9.1 years. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    shares available for award grant purposes under the 2018 Plan. Subject to certain express limits of the plan, shares available under
    the plan generally may be used for any type of award authorized under that plan including options, stock appreciation rights, restricted
    stock and other forms of awards granted or denominated in shares of our common stock or units of our common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    both vested and unvested options to purchase common stock and unvested stock grants under inducement grants provided certain employees
    as an inducement to accept employment with the Company. These awards have a weighted average remaining term of 9.6 years. These grants
    are similar to those granted under the 2018 Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_042"></A>PROPOSAL
NO. 2:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RATIFICATION
OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has appointed WithumSmith+Brown, PC (&ldquo;Withum&rdquo;) as the independent registered public accounting firm of the
Company to audit our financial statements for the fiscal year ending December 31, 2023, and our Board requests stockholder ratification
of such selection. Withum, Brown + Smith PC (&ldquo;Withum&rdquo;) has served as our independent accountants since 2017 and has advised
us that neither Withum nor any of its members has, or has had in the past three years, any financial interest in the Company or any relation
to the Company other than as auditors and accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representatives
of Withum are expected to be present at the 2023 Annual Meeting and will be given the opportunity to make a statement if they so desire
and respond to appropriate questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FEES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fees as invoiced for professional audit services rendered for the audit of our annual financial statements included
in the Company&rsquo;s Form 10-K and review of quarterly financial statements included in the Company&rsquo;s Forms 10-Q for the fiscal
years ended December 31, 2022, and December 31, 2021, and fees for other services rendered during those periods:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">FEE CATEGORY</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">AMOUNT</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">% <BR> OF TOTAL</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">AMOUNT</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">%<BR> OF TOTAL</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; text-align: left">Audit Fees</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">158,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">81</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">124,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">75</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Audit Related Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,246</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,550</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tax Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">All Other Fees</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,850</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Fees</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">195,396</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">166,3840</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
fees consist of fees for professional services rendered by Withum for the audits of our annual financial statements in our Form 10-K
and for reviews of the quarterly financial statements included in the Company&rsquo;s Forms 10-Q. Audit related fees pertain to the work
performed during our equity offerings in 2022 and 2021. Tax fees consist of fees for preparation of the Company&rsquo;s federal and state
tax returns. All other fees consist of fees for attendance at the Company&rsquo;s annual meetings, review of registration statements
and similar matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERVICES
BY EMPLOYEES OF WITHUM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
part of Withum&rsquo;s engagement to audit the Company&rsquo;s financial statements for the years ended December 31, 2022 and 2021 was
attributable to work performed by persons other than Withum&rsquo;s full-time, permanent employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AUDIT
COMMITTEE POLICY ON APPROVAL OF AUDIT AND NON-AUDIT SERVICES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the policy of the Audit Committee to pre-approve all audit and permissible non-audit services provided by our independent accountants,
in accordance with rules prescribed by the SEC. These services may include audit services, audit-related services, tax services, and
other services. Pre-approval is based on a written proposal, accompanied by a cost estimate, and estimated budget. The Audit Committee
has delegated to its chairman the authority to pre-approve audit and non-audit services with an estimated cost of up to $25,000, provided
the exercise of such authority is reported to the Audit Committee at its next regular meeting. The Audit Committee reserves the right,
from time to time, to delegate pre-approval authority to other of its members, so long as such members are independent directors. All
audit and permissible non-audit services during 2022 and 2021 were approved by the Audit Committee in accordance with its pre-approval
policy and the approval requirements of the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
ratification of the selection of Withum as our independent registered public accounting firm is not required by our Bylaws or other applicable
legal or regulatory requirements. However, the Board, upon the recommendation of the Audit Committee, is submitting the selection of
Withum to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection
of Withum, the Audit Committee will reconsider whether or not to retain that firm, or whether to retain a different firm. Even if the
selection is ratified, the Audit Committee, in its discretion, may direct the appointment of a different independent accounting firm
at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
this vote is not required, there are no minimum stockholder approval requirements. However, in order for the resolution to pass, a majority
of the votes entitled to be cast for this vote must be received. Abstentions will have the same effect as a vote against Proposal No.
2. No broker non-votes are expected to exist in connection with this vote as ratification of the independent registered public accounting
firm is considered a routine matter under applicable rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &ldquo;FOR&rdquo; THE PROPOSAL TO<BR>
RATIFY THE SELECTION OF WITHUM AS THE INDEPENDENT REGISTERED<BR>
PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2023.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_043"></A>PROPOSAL
NO. 3:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADVISORY
VOTE TO APPROVE EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is providing its stockholders with the opportunity to cast a non-binding, advisory vote on the compensation of our Named Executive
Officers as disclosed pursuant to the SEC&rsquo;s executive compensation disclosure rules and set forth in this proxy statement (including
in the compensation tables and narratives accompanying those tables as well as in the Compensation Discussion and Analysis).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive compensation program is guided by the principle that the compensation of the Company&rsquo;s executive officers should encourage
the creation of stockholder value and achievement of strategic corporate objectives. In furtherance of this principle, the Company&rsquo;s
executive compensation program includes a number of features intended to reflect best practices in the market and help ensure that the
program reinforces stockholder interests. These features are described in more detail in the Compensation Discussion and Analysis and
include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            significant amount of the executives&rsquo; compensation is at risk. For fiscal year 2022,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">o</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">Approximately 72.5% of Mr. Tardugno&rsquo;s target total
    direct compensation was performance-based and/or linked to the value of the Company&rsquo;s stock price.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">o</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Approximately 70.1% of Dr. Le Goff&rsquo;s target total direct compensation
    was performance-based and/or linked to the value of the Company&rsquo;s stock price.</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&rsquo;
    bonuses under our annual incentive program are principally based on the achievement of specific performance objectives established
    at the beginning of the fiscal year by the Compensation Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&rsquo;
    equity awards are granted in the form of stock options that help to align the executives&rsquo; interests with those of our stockholders
    as the options will not have value unless there is appreciation in the Company&rsquo;s stock price after the option is granted.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the requirements of Section 14A of the Exchange Act (which was added by the Dodd-Frank Wall Street Reform and Consumer
Protection Act) and the related rules of the SEC, the Board of Directors will request your advisory vote on the following resolution
at the annual meeting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESOLVED,
</B>that the compensation paid to the Company&rsquo;s Named Executive Officers, as disclosed in this proxy statement pursuant to the
SEC&rsquo;s executive compensation disclosure rules (which disclosure includes the Compensation Discussion and Analysis, the compensation
tables and the narrative discussion that accompanies the compensation tables), is hereby approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
vote is an advisory vote only and is non-binding on the Company, the Board of Directors or the Compensation Committee, and will not be
construed as overruling a decision by, or creating or implying any additional fiduciary duty for, the Board of Directors or the Compensation
Committee. However, the Compensation Committee, which is responsible for designing and administering the Company&rsquo;s executive compensation
program, values the opinions expressed by stockholders in their vote on this proposal, and will consider the outcome of the vote when
making future compensation decisions for Named Executive Officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the shares of our Common Stock present via live webcast or represented
by proxy and entitled to vote on the proposal will be required to ratify the 2022 executive compensation for the Company&rsquo;s executive
officers. Abstentions will have the same effect as a vote against Proposal No. 3, but broker non-votes will have no effect on Proposal
No. 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;FOR&rdquo;
THE ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_044"></A>PROPOSAL
NO. 4:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADVISORY
VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Proposal 3 above, the Company&rsquo;s stockholders are being provided the opportunity to cast an advisory non-binding vote
on the Company&rsquo;s executive compensation program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Proposal 4 affords stockholders the opportunity to cast an advisory vote on how often the Company should include an advisory vote on
executive compensation in its proxy materials for future annual stockholder meetings (or special stockholder meetings for which the Company
must include executive compensation information in the proxy statement for that meeting). Under this Proposal 4, stockholders may vote
to have future advisory votes on executive compensation every year, every two years, or every three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that advisory votes on executive compensation should be conducted every three years, consistent with our long-term approach
to executive compensation. We believe the Company maintains a consistent compensation philosophy designed to align executives&rsquo;
interests with those of stockholders and that a triennial vote will provide stockholders sufficient time to evaluate the effectiveness
of our executive compensation program in relation to the Company&rsquo;s long-term business results. A triennial vote will also give
the Board of Directors sufficient time to engage with stockholders to understand advisory vote results, respond to stockholders&rsquo;
feedback about Company pay practices, and implement any necessary changes to our executive compensation program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proposal is advisory only and will not be binding on the Company, the Board of Directors, or the Compensation Committee. Although non-binding,
the Board of Directors and the Compensation Committee will carefully review the voting results. Notwithstanding the Board&rsquo;s recommendation
and the outcome of the stockholder vote, the Board may in the future decide to conduct advisory votes on executive compensation on a
more or less frequent basis and may vary its practice based on factors such as discussions with stockholders and the adoption of material
changes to the Company&rsquo;s executive compensation program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
voting on this proposal, stockholders will be able to indicate their preference regarding the frequency of future advisory votes on executive
compensation by specifying a choice of one year, two years or three years. Stockholders that do not have a preference regarding the frequency
of future advisory votes on executive compensation should abstain from voting on the proposal. Stockholders will not be voting to approve
or disapprove the recommendation of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOLD
FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION <U>EVERY THREE YEARS</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_045"></A>PROPOSAL
NO. 5:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
OF THE IMUNON, INC. 2018 STOCK INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BACKGROUND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the 2023 Annual Meeting, stockholders will be asked to approve the following amendment to the 2018 Plan, which amendment was approved
by our Board of Directors on March 17, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Increase
in Aggregate Share Limit. </B>The 2018 Plan currently limits the aggregate number of shares of common stock that may be delivered pursuant
to all awards granted under the 2018 Plan to 940,000 shares. Currently only 99,976 shares remain available for future grants. The proposed
amendment would increase this limit by an additional 1,030,000 shares so that the new aggregate share limit for the 2018 Plan would be
1,970,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 21, 2023, a total of 844,697 shares of common stock were subject to outstanding stock options and restricted stock awards granted
under the 2018 Plan. The outstanding stock options have a weighted average strike price of $3.55 per share with a weighted average term
of 8.94 years. A remainder of 99,976 shares of common stock were available for new award grants under the 2018 Plan. Our Board of Directors
recommends the increase in the number of shares available under the 2018 Plan to provide us the ability to provide eligible officers,
directors, key employees, and other individuals with additional incentives to contribute to our future success. In the judgment of the
Board of Directors, awards under the 2018 Plan are a valuable and critical incentive and will serve to the ultimate benefit of the stockholders
by aligning more closely the interests of the 2018 Plan participants with those of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that the proposed 2018 Plan amendment is essential for our ongoing success, the implementation of its product
and/or technology acquisition strategy and its ability to recruit, retain and reward key employees. The Board of Directors also believes
that if the proposed amendments are not approved, our ability to align the interests of key employees with stockholders through equity-based
compensation would be compromised, disrupting our compensation program, and impairing our ability to recruit and retain key employees.
The Board of Directors recommends approval of the proposed 2018 Plan amendment for the following reasons:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    align the interests of our stockholders and recipients of awards under the 2018 Plan by increasing the proprietary interest of such
    recipients in our growth and success; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    advance our interests of the Company by attracting and retaining non-employee directors, officers, other employees, consultants,
    independent contractors, and agents; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    motivate such persons to act in the long-term best interests of the Company and its stockholders. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above under &ldquo;<B>Executive Compensation &mdash; Compensation Discussion and Analysis</B>,&rdquo; we consider equity and
equity-based compensation to be a key component of our compensation program and believe that it is essential to attract, motivate, and
retain talented, experienced, and committed employees and to incentivize our employees to achieve our short- and long-term goals. On
February 12, 2018, the Board of Directors, upon the recommendation of the Compensation Committee, adopted the IMUNON, INC. 2018 Stock
Incentive Plan which later was approved by our stockholders at the 2018 Annual Meeting on May 15, 2018. The 2018 Plan replaced our 2007
Stock Incentive Plan (the &ldquo;2007 Plan&rdquo;). The 2018 Stock Incentive Plan constitutes the only plan we currently utilize to provide
equity and equity-based incentive compensation to eligible employees, consultants, and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Historical
Company Equity Usage. </I>We believe that our historic equity usage has been reasonable in light of competitive considerations and the
potential dilutive impact of equity award grants on our stockholders. Our average three-year &ldquo;run rate&rdquo; was 5.40% as a percentage
of weighted common shares outstanding which compares favorably to the non-Russell 3000 Index (Pharmaceuticals, Biotechnology &amp; Life
Science) mean run rate of 7.43% for that same three-year period (with the run rate in each case calculated the number of shares subject
to stock options and other equity awards granted during that period). We do not currently anticipate that our future annual long-term
incentive grants will significantly exceed this run rate. As noted above, the number of shares of common stock currently available for
future grants under the 2018 Plan is only 99,976 shares, demonstrating our need for additional shares to provide us greater flexibility
to structure future incentives and to better attract, retain and award key employees to execute our current business plans and strategies.
For more information on our past grants under the 2018 Plan, see &ldquo;Potential Dilution and Burn Rate&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
Need to Provide Competitive Compensation</I>. Similar to other companies in our industry, we believe equity compensation is integral
in providing a competitive total compensation package necessary to recruit, retain and reward key employees. Equity awards are commonly
used by companies our size, and the ability to provide competitive grants is essential to competing in our labor markets. Therefore,
we believe it is imperative to provide long-term incentive awards as a component of our compensation program. We will continue to seek
an appropriate balance between meeting employee hiring, retention, and compensation goals and avoiding excessive stockholder dilution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
Compensation Expense Increase</I>. If our ability to provide equity compensation is impaired, our cash compensation costs could increase
substantially to offset equity compensation typically provided in the marketplace. We believe it is important that we use our cash resources
to operate and expand our business, rather than unnecessarily diverting cash to pay compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
stockholders do not approve this 2018 Plan amendment, the current share limits under, and other terms and conditions of the 2018 Plan,
will continue in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Dilution and Burn Rate</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following paragraphs include additional information to help you assess the potential dilutive impact of the Company&rsquo;s outstanding
equity awards under the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the total number of shares of our common stock that were subject to outstanding restricted stock and restricted
stock unit awards granted under the 2018 Plan, that were subject to outstanding stock options granted under the 2018 Plan, and that were
then available for new award grants under the 2018 Plan as of December 31, 2022 and as of April 21, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">As of December 31, 2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">As of April 21, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%; text-align: left">Shares subject to outstanding stock options</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; text-align: right">555,719</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">844,697</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Shares subject to outstanding restricted stock and restricted stock unit awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">400</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shares available for new award grants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">388,954</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,976</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, a total of 555,719 shares of our common stock were subject to all outstanding awards granted under the 2018 Plan.
All outstanding stock option awards were subject to outstanding stock options having a weighted average strike price of $5.53 per share
with a remaining term of 9.12 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 21, 2023, a total of 844,679 shares of our common stock were subject to all outstanding awards granted under the 2018 Plan.
All outstanding stock option awards and restricted stock awards have a weighted average strike price of $3.69 per share with a remaining
term of 8.93 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average number of shares of our common stock issued and outstanding in each of the last three fiscal years is 2,112,750 shares
issued and outstanding in 2020; 5,426,953 shares issued and outstanding in 2021; and 7,142,970 shares issued and outstanding in 2022.
The number of shares of our common stock issued and outstanding as of December 31, 2022 and April 21, 2023 was 7,436,197 shares and 9,097,005
shares, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of shares of our common stock subject to awards that we granted under the 2018 Plan over the last two fiscal years and to
date as of April 21, 2023 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,482
    shares in 2021 (which was 2.8% of the weighted-average number of shares of our common stock issued and outstanding in 2021), of which
    148,016 shares were subject to stock option awards and 1,466 shares were subject to restricted stock grants; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">512,055
    shares in 2022 (which was 7.2% of the weighted-average number of shares of our common stock issued and outstanding in 2022), of which
    511,655 shares were subject to stock option awards and 400 shares were subject to restricted stock grants; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">331,100
    shares thus far in 2023 (which was 4.0% of the weighted-average number of shares of our common stock issued and outstanding in 2022
    through April 21, 2023), of which 331,100 shares were subject to stock option awards.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee anticipates that the aggregate share limit of 1,030,000 shares requested for the 2018 Plan and assuming usual
levels of shares becoming available for new awards as a result of forfeitures of outstanding awards, will provide us with flexibility
to continue to grant equity awards under the 2018 Plan for the next two years. However, this is only an estimate, in our judgment, based
on current circumstances. The total number of shares that are subject to the Company&rsquo;s award grants in any one year or from year-to-year
may change based on any number of variables, including, without limitation, the value of our common stock (since higher stock prices
generally require fewer shares to be issued to produce awards of the same grant date fair value), changes in competitors&rsquo; compensation
practices, changes in compensation practices in the market generally, changes in the number of employees, changes in the number of directors
and officers, whether and the extent to which vesting conditions applicable to equity-based awards are satisfied, acquisition activity
and the need to grant awards to new employees in connection with acquisitions, the need to attract, retain and incentivize key talent,
the type of awards we grant and how we choose to balance total compensation between cash and equity-based awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing market price for a share of our common stock as of April 21, 2023 was $1.25 per share. Based on this price and the maximum number
of shares that would have been available for awards as of such date under the 2018 Plan together with the 1,030,000 additional shares
requested in this proposed amendment, the maximum aggregate market value of the common stock that could potentially be issued under the
2018 Plan is approximately $2.47 million if this amendment is approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
DESCRIPTION OF THE 2018 PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary provides a description of the significant provisions of the 2018 Plan as amended to date and proposed to be amended
by this Proposal No. 5. However, the summary is qualified in its entirety by reference to the full text of the 2018 Plan as proposed
to be amended, which have been filed as an exhibit to the copy of this Proxy Statement that was filed electronically with the SEC and
can be reviewed on the SEC&rsquo;s website at <U>http://www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Plan
Highlights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the key features of the 2018 Plan include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan is administered by our Compensation Committee comprised entirely of independent directors; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    and SARs granted under the 2018 Plan may not be repriced without shareholder approval other than in connection with a Change in Control
    or adjustments described in the 2018 Plan; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the 2018 Plan as proposed to be amended by Proposal No. 5 the maximum number of shares our common stock available for awards, other
    than awards granted as substitute awards in connection with a corporate transaction, will be 1,970,000; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan prohibits liberal share recycling &ndash; meaning that shares tendered to pay the exercise price, or the withholding taxes
    related to an award may not be recycled back into the 2018 Plan;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    exercise price of options and the base price for SARs granted under the 2018 Plan may not be less than the fair market value of a
    share of our common stock on the date of grant, subject to certain exceptions for substitute awards granted in connection with a
    corporate transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan prohibits the grant of dividend equivalents with respect to options and SARs and subjects all dividends and dividend equivalents
    paid with respect to restricted stock awards, restricted stock unit awards or performance awards to the same vesting conditions as
    the underlying awards; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan does not contain a liberal change in control definition; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan provides that awards and any cash payment or shares our common stock delivered pursuant to an award are subject to forfeiture,
    recovery by us or other action pursuant to the applicable award agreement or any claw back or recoupment policy that we may adopt
    from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Administration</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan is administered by a committee designated by our Board of Directors (unless the Board elects to administer the plan), consisting
of two or more members of the Board, each of whom may be (i) a &ldquo;non-employee director&rdquo; within the meaning of Rule 16b-3 under
the Exchange Act and (ii) &ldquo;independent&rdquo; within the meaning of the rules of the NASDAQ Capital Market or, if Company common
stock is not listed on the NASDAQ Capital Market, within the meaning of the rules of the principal stock exchange on which Company common
stock is then traded. Our Compensation Committee currently administers the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the express provisions of the 2018 Plan, the Compensation Committee has the authority to select eligible persons to receive awards
and determine all of the terms and conditions of each award. All awards will be evidenced by an agreement containing such provisions
not inconsistent with the 2018 Plan as the Compensation Committee will approve. The Compensation Committee also has authority to establish
rules and regulations for administering the 2018 Plan and to decide questions of interpretation or application of any provision of the
2018 Plan. The Compensation Committee may, in its sole discretion and for any reason at any time, take action such that (i) any or all
outstanding options and SARs will become exercisable in part or in full, (ii) all or a portion of a restriction period on any award will
lapse, (iii) all or a portion of any performance period applicable to any award will lapse and (iv) any performance measures applicable
to any outstanding award will be deemed satisfied at target, maximum or any other level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may delegate some or all of its power and authority under the 2018 Plan to the Board of Directors (or any members
thereof) or, subject to applicable law, a subcommittee of the Board of Directors, a member of the Board of Directors, the Chief Executive
Officer or other executive officer of the Company as the Compensation Committee deems appropriate, except that it may not delegate its
power and authority to a member of the Board, the Chief Executive Officer or any executive officer with regard to awards to persons who
are subject to Section 16 of the Exchange Act. The Compensation Committee has not made such a delegation of authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Available
Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the adjustment provisions set forth in the 2018 Plan the number of shares of common stock available for awards under the 2018 Plan,
as proposed to be amended by Proposal No. 5, other than substitute awards granted in connection with a corporate transaction, will be
1,970,000. All of the available shares of common stock under the 2018 Plan may be issued in connection with incentive stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of available shares will be reduced by the sum of the aggregate number of shares of common stock which become subject to outstanding
options, free-standing SARs, stock awards and performance awards. To the extent that shares of common stock subject to an outstanding
option, free-standing SARs, stock award or performance award granted under the 2018 Plan or the 2007 Plan<SUP>1</SUP>, other than substitute
awards granted in connection with a corporate transaction, are not issued or delivered by reason of (i) the expiration, termination,
cancellation or forfeiture of such award (excluding shares of common stock subject to an option cancelled upon settlement of a related
tandem SAR or subject to a tandem SAR cancelled upon exercise of a related option), or (ii) the settlement of such award in cash, then
such shares of common stock will again be available under the 2018 Plan. Shares of common stock subject to an award under the 2018 Plan
or the 2007 Plan will not again be available for issuance under the 2018 Plan if such shares are (a) shares that were subject to an option
or stock-settled SAR and were not issued or delivered upon the net settlement or net exercise of such option or SAR, (b) shares delivered
to or withheld by the Company to pay the purchase price or the withholding taxes relating to an outstanding award or (c) shares repurchased
by the Company on the open market with the proceeds of an option exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Change
in Control</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of the applicable award agreement, in the event of a change in control, the Board, as constituted prior to the Change in
Control (as defined in the 2018 Plan), may, in its discretion take one of the following actions: (i) require that (a) some or all outstanding
options and SARs will become exercisable in full or in part, either immediately or upon a subsequent termination of employment, (b) the
restriction period applicable to some or all outstanding stock awards will lapse in full or in part, either immediately or upon a subsequent
termination of employment, (C) the performance period applicable to some or all outstanding awards will lapse in full or in part, and
(D) the performance measures applicable to some or all outstanding awards will be deemed satisfied at the target, maximum or any other
level; (ii) require that shares of stock of the company resulting from or succeeding to the business of the Company pursuant to such
change in control, or the parent thereof, be substituted for some or all of the shares of Company common stock subject to outstanding
awards as determined by the Board; and/or (iii) require outstanding awards to be surrendered to the Company in exchange for a payment
of cash, shares of common stock in the company resulting from the change in control, or the parent thereof, or a combination of cash
and shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Effective
Date, Termination and Amendment</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan became effective on May 15, 2018 and will terminate as of the first annual meeting to occur on or after the tenth anniversary
of the effective date, unless earlier terminated by the Board. If approved by the affirmative vote of a majority of the shares of common
stock present via the live webcast or represented by proxy at the Annual Meeting, the amendment to the 2018 Plan to increase
the aggregate number of shares reserved for issuance under the 2018 Plan will become effective as of June 14, 2023. The Board may amend
the 2018 Plan at any time, subject to stockholder approval if (i) required by applicable law, rule or regulation, including any rule
of the NASDAQ Capital Market or any other stock exchange on which the common stock is then traded, or (ii) such amendment modifies the
option and SAR repricing provisions in the 2018 Plan. No amendment may materially impair the rights of a holder of an outstanding award
without the consent of such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Eligibility</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participants
in the 2018 Plan will consist of such officers, other employees, non-employee directors, consultants, independent contractors and agents
and persons expected to become officers, other employees, non-employee directors, consultants, independent contractors and agents of
the Company and its affiliates and subsidiaries, as selected by the Compensation Committee. As of April 21, 2023, approximately 46 individuals
would have been eligible to participate in the 2018 Plan which includes approximately four officers, twenty-seven employees, six non-employee
directors and nine non-employee consultants would be eligible to participate in the 2018 Plan, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Options and SARs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan, as amended provides for the grant of non-qualified stock options, incentive stock options and SARs. The Compensation Committee
will determine the conditions to the exercisability of each option and SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
option will be exercisable for no more than ten years after its date of grant, unless the option is an incentive stock option and the
optionee owns greater than ten percent (10%) of the voting power of all shares of capital stock of the Company (a &ldquo;ten percent
holder&rdquo;), in which case the option will be exercisable for no more than five years after its date of grant. Except in the case
of substitute awards granted in connection with a corporate transaction, the exercise price of an option will not be less than 100% of
the fair market value of a share of common stock on the date of grant, unless the option is an incentive stock option and the optionee
is a ten percent holder, in which case the option exercise price will be the price required by the Code, currently 110% of fair market
value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
SAR will be exercisable for no more than ten years after its date of grant provided that no SAR granted in tandem with an option (a &ldquo;tandem
SAR&rdquo;) will be exercisable later than the expiration, termination, cancellation, forfeiture, or other termination of the related
option. The base price of an SAR will not be less than 100% of the fair market value of a share of common stock on the date of grant
(or, if earlier, the date of grant of the option for which the SAR is exchanged or substituted), provided that the base price of a tandem
SAR will be the exercise price of the related option. An SAR entitles the holder to receive upon exercise (subject to withholding taxes)
shares of common stock (which may be restricted stock), cash or a combination thereof with a value equal to the difference between the
fair market value of the common stock on the exercise date and the base price of the SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the terms relating to the exercise, cancellation or other disposition of options and SARs following the termination of employment
of a participant, whether by reason of disability, retirement, death, or any other reason, will be determined by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may not, without the approval of the stockholders of the Company, (i) reduce the purchase price or base price
of any previously granted option or SAR, (ii) cancel any previously granted option or SAR in exchange for another option or SAR with
a lower purchase price or base price or (iii) cancel any previously granted option or SAR in exchange for cash or another award if the
purchase price of such option or the base price of such SAR exceeds the fair market value of a share of common stock on the date of such
cancellation, in each case, other than in connection with a change in control or the adjustment provisions set forth in the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan provides for the grant of stock awards. The Compensation Committee may grant a stock award as a restricted stock award, a restricted
stock unit award or as another stock award. Except as otherwise determined by the Compensation Committee, stock awards will be non-transferable
and subject to forfeiture if the holder does not remain continuously in the employment of the Company during the restriction period or
if specified performance measures (if any) are not attained during the performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise set forth in a restricted stock award agreement, the holder of shares of restricted stock will have rights as a stockholder
of the Company, including the right to vote and receive dividends with respect to the shares of restricted stock. Distributions and dividends
with respect to shares of common stock, including regular cash dividends, will be deposited with the Company and will be subject to the
same restrictions as the restricted stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement awarding restricted stock units will specify (i) whether such award may be settled in shares of common stock, cash, or a combination
thereof, and (ii) whether the holder will be entitled to receive dividend equivalents, with respect to such award. Any dividend equivalents
with respect to restricted stock units will be subject to the same restrictions as such restricted stock units. Prior to settlement of
a restricted stock unit, the holder of a restricted stock unit will have no rights as a shareholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant other awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based
on, or related to, shares of common stock, including shares of common stock granted as a bonus and not subject to any vesting conditions,
dividend equivalents, deferred stock units, stock purchase rights and shares of common stock issued in lieu of obligations of the Company
to pay cash under any compensatory plan or arrangement, subject to such terms as shall be determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the terms relating to the satisfaction of performance measures and the termination of a restriction period, or the forfeiture and
cancellation of a stock award upon a termination of employment, whether by reason of disability, retirement, death, or any other reason
or during a paid or unpaid leave of absence, will be determined by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Performance
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan also provides for the grant of performance awards. The agreement relating to a performance award will specify whether such
award may be settled in shares of common stock (including shares of restricted stock), cash or a combination thereof. The agreement relating
to a performance award will provide, in the manner determined by the Compensation Committee, for the vesting of such performance award
if the specified performance measures established by the Compensation Committee are satisfied or met during the specified performance
period and such performance goals will be determined by the Compensation Committee at the time of grant. Any dividend or dividend equivalents
with respect to a performance award will be subject to the same restrictions as such performance award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the settlement of a performance award in shares of common stock, the holder of such award will have no rights as a stockholder of
the Company with respect to such shares. All of the terms relating to the satisfaction of performance measures and the termination of
a performance period, or the forfeiture and cancellation of a performance award upon a termination of employment with or service to,
whether by reason of disability, retirement, death or any other reason or during a paid or unpaid leave of absence, will be determined
by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.S.
Federal Income Tax Consequences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief summary of certain United States federal income tax consequences generally arising with respect to awards under
the 2018 Plan. This discussion does not address all aspects of the United States federal income tax consequences of participating in
the 2018 Plan that may be relevant to participants in light of their personal investment or tax circumstances and does not discuss any
state, local or non-United States tax consequences of participating in the 2018 Plan. Each participant is advised to consult his or her
personal tax advisor concerning the application of the United States federal income tax laws to such participant&rsquo;s particular situation,
as well as the applicability and effect of any state, local or non-United States tax laws before taking any actions with respect to any
awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time an option is granted, and the Company will not be entitled to a tax deduction
at that time. A participant will recognize compensation taxable as ordinary income (and if the participant is an employee, will be subject
to income tax withholding) upon exercise of a non-qualified stock option equal to the excess of the fair market value of the shares purchased
on such date over their exercise price, and the Company will be entitled to a corresponding deduction, except to the extent the deduction
limits of Section 162(m) of the Code apply. A participant will not recognize income (except for purposes of the alternative minimum tax)
upon exercise of an incentive stock option. If the shares acquired by exercise of an incentive stock option are held for at least two
years from the date the option was granted and one year from the date it was exercised, any gain or loss arising from a subsequent disposition
of those shares will be taxed as long-term capital gain or loss, and the Company will not be entitled to any deduction. If, however,
those shares are disposed of within the above-described period, then in the year of that disposition the participant will recognize compensation
taxable as ordinary income equal to the excess of the lesser of (i) the amount realized upon that disposition and (ii) the fair market
value of those shares on the date of exercise over the exercise price, and the Company will be entitled to a corresponding deduction,
except to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>SARs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time SARs are granted, and the Company will not be entitled to a tax deduction at
that time. Upon exercise, the participant will recognize compensation taxable as ordinary income (and if the participant is an employee,
will be subject to income tax withholding) in an amount equal to the fair market value of any shares delivered and the amount of cash
paid by the Company. This amount is deductible by the Company as compensation expense, except to the extent the deduction limits of Section
162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time stock subject to a substantial risk of forfeiture (&ldquo;restricted stock&rdquo;)
is granted, and the Company will not be entitled to a tax deduction at that time, unless the participant makes an election to be taxed
at that time. If such election is made, the participant will recognize compensation taxable as ordinary income (and if the participant
is an employee, will be subject to income tax withholding) at the time of the grant in an amount equal to the excess of the fair market
value of the shares at such time over the amount, if any, paid for those shares. If such election is not made, the participant will recognize
compensation taxable as ordinary income (and if the participant is an employee, will be subject to income tax withholding) at the time
the restrictions constituting a substantial risk of forfeiture lapse in an amount equal to the excess of the fair market value of the
shares at such time over the amount, if any, paid for those shares. The amount of ordinary income recognized by making the above-described
election or upon the lapse of restrictions constituting a substantial risk of forfeiture is deductible by the Company as compensation
expense, except to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time a restricted stock unit is granted, and the Company will not be entitled to
a tax deduction at that time. Upon settlement of restricted stock units, the participant will recognize compensation taxable as ordinary
income (and if the participant is an employee, will be subject to income tax withholding) in an amount equal to the fair market value
of any shares delivered and the amount of any cash paid by the Company. The amount of ordinary income recognized is deductible by the
Company as compensation expense, except to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax treatment, including the timing of taxation, of any other type of stock award will depend on the terms of such award at the time
of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Performance
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time performance awards are granted, and the Company will not be entitled to a tax
deduction at that time. Upon settlement of performance awards, the participant will recognize compensation taxable as ordinary income
(and if the participant is an employee, will be subject to income tax withholding) in an amount equal to the fair market value of any
shares delivered and the amount of cash paid by the Company. This amount is deductible by the Company as compensation expense, except
to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Plan Benefits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee has the discretion to grant awards under the 2018 Plan and, therefore, it is not possible as of the date of this proxy statement
to determine future awards that will be received by the Company&rsquo;s named executive officers or others under the 2018 Plan. Accordingly,
in lieu of providing information regarding benefits that will be received under the 2018 Plan the following table provides information
concerning the benefits that were received by the following persons and groups during 2022 under the 2018 Plan: each named executive
officer; all current executive officers, as a group; all current directors who are not executive officers, as a group; and all current
employees who are not executive officers, as a group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name and Position</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Average Exercise<BR> Price ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <BR> Awards (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael H. Tardugno
    <BR> <I>Executive Chairman</I></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1.32</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">25,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Corinne Le Goff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left">President and Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas Borys <BR> <I>Executive
    Vice President</I> a<I>nd CMO</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed Anwer <BR> <I>Executive
    Vice President and CSO</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey W. Church <BR> <I>Executive
    Vice President and CFO</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All current executive officers, as a group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">195,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">All current directors who are not executive officers, as a group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All current employees who are not executive officers, as a group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">117,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the weighted-average exercise price for the group.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors believes that the adoption of the increase in the number of shares available for issuance under the 2018 Plan will
promote the interests of the Company and its stockholders and will help us continue to be able to attract, retain and reward persons
important to our success. All members of the Board and all of our executive officers are eligible for awards under the 2018 Plan and
thus have a personal interest in the approval of the proposal to increase the number of shares available for issuance under the 2018
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the shares of our Common Stock present via the live webcast or represented
by proxy and entitled to vote on the proposal will be required to approve the amendment to the 2018 Plan. Abstentions will have the same
effect as a vote against Proposal No. 5, but broker non-votes will have no effect on Proposal No. 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &ldquo;FOR&rdquo; THE PROPOSAL TO<BR>
APPROVE THE AMENDMENT OF THE IMUNON, INC. 2018 STOCK INCENTIVE PLAN AS<BR>
DESCRIBED ABOVE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_046"></A>STOCKHOLDER
NOMINATIONS AND PROPOSALS FOR</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
2024 ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a stockholder wants us to include a proposal in our proxy statement for presentation at our 2024 Annual Meeting of Stockholders in accordance
with Rule 14a-8 promulgated by the SEC under the Exchange Act, the proposal must be received by us no later than December 31, 2023. Such
proposals should be directed to IMUNON, INC., 997 Lenox Drive, Lawrenceville, NJ 08648, Attention: Corporate Secretary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
stockholder may also nominate directors or have other business brought before the 2024 Annual Meeting of Stockholders by submitting the
nomination or proposal to the Company, not later than the close of business on the 90th calendar day, nor earlier than the close of business
on the 120th calendar day, in advance of the anniversary of the 2024 Annual Meeting of Stockholders; provided, however, in the event
that the date of the 2024 Annual Meeting of Stockholders is more than thirty calendar days before or more than thirty calendar days after
such anniversary date, notice by the stockholder to be timely must be so received no earlier than the close of business on the 120th
calendar day in advance of such date of annual meeting and not later than the close of business on the later of the 90th calendar day
in advance of such date of annual meeting or the 10th calendar day following the date on which public announcement of the date of the
meeting is first made. The nomination or proposal must be delivered to the Company&rsquo;s executive offices at 997 Lenox Drive, Suite
100, Lawrenceville, NJ 08648, Attention: Corporate Secretary no earlier than February 14, 2024, and no later than March 14, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if a stockholder intends to utilize Rule 14a-19 under the Exchange act in connection with a nomination must give the requisite
notice to the Company as indicated in the previous above sentence not later than the 60<SUP>th</SUP> calendar day in advance of the anniversary
of the 2024 Annual Meeting, or April 14, 2024. Any stockholder considering submitting a nominee or proposal for action at our 2024 Annual
Meeting of Stockholders is directed to the Company&rsquo;s Bylaws, which contain additional requirements as to submission of nominations
for directors or proposals for stockholder action. Copies of the Bylaws may be obtained upon request to the Company&rsquo;s Corporate
Secretary. Stockholder proposals or nominations must include the specified information concerning the stockholder and the proposal or
nominee as described in our Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="kutty_047"></A>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
website is located at imunon.com. You can view additional information on our website, such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charters
                                            of our Board Committees;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
                                            of Conduct; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            governance materials and reports that we file with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of those documents may also be obtained free of charge by written or telephonic request directed to the Corporate Secretary, IMUNON,
INC., 997 Lenox Drive, Suite 100, Lawrenceville, New Jersey 08648.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    28, 2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jeffrey W. Church </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    W Church</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Appendix A<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
2018 STOCK INCENTIVE PLAN AS AMENDED AS OF JUNE 14, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.
INTRODUCTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1
</B><U>Purposes</U>. The purposes of the IMUNON, INC. 2018 Stock Incentive Plan (this &ldquo;<U>Plan</U>&rdquo;) are (i) to align the
interests of the Company&rsquo;s stockholders and the recipients of awards under this Plan by increasing the proprietary interest of
such recipients in the Company&rsquo;s growth and success, (ii) to advance the interests of the Company by attracting and retaining Non-Employee
Directors, officers, other employees, consultants, independent contractors and agents and (iii) to motivate such persons to act in the
long-term best interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.2
</B><U>Certain Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
shall mean any entity other than a Subsidiary, if the Company and/or one or more Subsidiaries own directly or indirectly not less than
fifty percent (50%) of such entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agreement</U>&rdquo;
shall mean the written or electronic agreement evidencing an award hereunder between the Company and the recipient of such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board</U>&rdquo;
shall mean the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Change
in Control</U>&rdquo; shall have the meaning set forth in <U>Section 5.8(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
shall mean the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Committee</U>&rdquo;
shall mean the Compensation Committee of the Board, or a subcommittee thereof, or such other committee designated by the Board, in each
case, consisting of two or more members of the Board, each of whom is intended to be (i) a &ldquo;Non-Employee Director&rdquo; within
the meaning of Rule 16b-3 under the Exchange Act and (ii) &ldquo;independent&rdquo; within the meaning of the rules of the Nasdaq Capital
Market or, if the Common Stock is not listed on the Nasdaq Capital Market, within the meaning of the rules of the principal stock exchange
on which the Common Stock is then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; shall mean the common stock, par value $0.01 per share, of the Company, and all rights appurtenant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company</U>&rdquo;
shall mean IMUNON, Inc., a corporation organized under the laws of the State of Delaware, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; shall have the meaning set forth in <U>Section 5.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; shall mean the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fair
Market Value</U>&rdquo; shall mean the closing transaction price of a share of Common Stock as reported on the Nasdaq Capital Market
on the date as of which such value is being determined or, if the Common Stock is not listed on the Nasdaq Capital Market, the closing
transaction price of a share of Common Stock on the principal national stock exchange on which the Common Stock is traded on the date
as of which such value is being determined or, if there shall be no reported transactions for such date, on the next preceding date for
which transactions were reported; <U>provided</U>, <U>however</U>, that if the Common Stock is not listed on a national stock exchange
or if Fair Market Value for any date cannot be so determined, Fair Market Value shall be determined by the Committee by whatever means
or method as the Committee, in the good faith exercise of its discretion, shall at such time deem appropriate and in compliance with
Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Free-Standing
SAR</U>&rdquo; shall mean an SAR which is not granted in tandem with, or by reference to, an option, which entitles the holder thereof
to receive, upon exercise, shares of Common Stock (which may be Restricted Stock) or, to the extent set forth in the applicable Agreement,
cash or a combination thereof, with an aggregate value equal to the excess of the Fair Market Value of one share of Common Stock on the
date of exercise over the base price of such SAR, multiplied by the number of such SARs which are exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Incentive
Stock Option</U>&rdquo; shall mean an option to purchase shares of Common Stock that meets the requirements of Section 422 of the Code,
or any successor provision, which is intended by the Committee to constitute an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Incumbent
Board</U>&rdquo; shall have the meaning set forth in <U>Section 5.8(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Non-Employee
Director</U>&rdquo; shall mean any director of the Company who is not an officer or employee of the Company or any Affiliate or Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Nonqualified
Stock Option</U>&rdquo; shall mean an option to purchase shares of Common Stock which is not an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Other
Stock Award</U>&rdquo; shall mean an award granted pursuant to <U>Section 3.4</U> of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Performance
Award</U>&rdquo; shall mean a right to receive an amount of cash, Common Stock, or a combination of both, contingent upon the attainment
of specified Performance Measures within a specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Performance
Measures</U>&rdquo; shall mean the criteria and objectives, established by the Committee, which shall be satisfied or met (i) as a condition
to the grant or exercisability of all or a portion of an option or SAR or (ii) during the applicable Restriction Period or Performance
Period as a condition to the vesting of the holder&rsquo;s interest, in the case of a Restricted Stock Award, of the shares of Common
Stock subject to such award, or, in the case of a Restricted Stock Unit Award, Other Stock Award or Performance Award, to the holder&rsquo;s
receipt of the shares of Common Stock subject to such award or of payment with respect to such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Performance
Period</U>&rdquo; shall mean any period designated by the Committee during which (i) the Performance Measures applicable to an award
shall be measured and (ii) the conditions to vesting applicable to an award shall remain in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prior
Plan</U>&rdquo; shall mean the Celsion Corporation 2007 Stock Incentive Plan and each other equity plan maintained by the Company under
which awards are outstanding as of the effective date of this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Restricted
Stock</U>&rdquo; shall mean shares of Common Stock which are subject to a Restriction Period and which may, in addition thereto, be subject
to the attainment of specified Performance Measures within a specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Restricted
Stock Award</U>&rdquo; shall mean an award of Restricted Stock under this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Restricted
Stock Unit</U>&rdquo; shall mean a right to receive one share of Common Stock or, in lieu thereof and to the extent set forth in the
applicable Agreement, the Fair Market Value of such share of Common Stock in cash, which shall be contingent upon the expiration of a
specified Restriction Period and which may, in addition thereto, be contingent upon the attainment of specified Performance Measures
within a specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Restricted
Stock Unit Award</U>&rdquo; shall mean an award of Restricted Stock Units under this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Restriction
Period</U>&rdquo; shall mean any period designated by the Committee during which (i) the Common Stock subject to a Restricted Stock Award
may not be sold, transferred, assigned, pledged, hypothecated or otherwise encumbered or disposed of, except as provided in this Plan
or the Agreement relating to such award, or (ii) the conditions to vesting applicable to a Restricted Stock Unit Award or Other Stock
Award shall remain in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SAR</U>&rdquo;
shall mean a stock appreciation right which may be a Free-Standing SAR or a Tandem SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stock
Award</U>&rdquo; shall mean a Restricted Stock Award, Restricted Stock Unit Award or Other Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
and &ldquo;<U>Subsidiaries</U>&rdquo; shall mean only a company or companies, whether now or hereafter existing, within the meaning of
the definition of &ldquo;subsidiary company&rdquo; provided in Section 424(f) of the Code, or any successor thereto of similar import.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Substitute
Award</U>&rdquo; shall mean an award granted under this Plan upon the assumption of, or in substitution for, outstanding equity awards
previously granted by a company or other entity in connection with a corporate transaction, including a merger, combination, consolidation
or acquisition of property or stock; <U>provided</U>, <U>however</U>, that in no event shall the term &ldquo;Substitute Award&rdquo;
be construed to refer to an award made in connection with the cancellation and repricing of an option or SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Tandem
SAR</U>&rdquo; shall mean an SAR which is granted in tandem with, or by reference to, an option (including a Nonqualified Stock Option
granted prior to the date of grant of the SAR), which entitles the holder thereof to receive, upon exercise of such SAR and surrender
for cancellation of all or a portion of such option, shares of Common Stock (which may be Restricted Stock) or, to the extent set forth
in the applicable Agreement, cash or a combination thereof, with an aggregate value equal to the excess of the Fair Market Value of one
share of Common Stock on the date of exercise over the base price of such SAR, multiplied by the number of shares of Common Stock subject
to such option, or portion thereof, which is surrendered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Tax
Date</U>&rdquo; shall have the meaning set forth in <U>Section 5.5</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Ten
Percent Holder</U>&rdquo; shall have the meaning set forth in <U>Section 2.1(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.3
</B><U>Administration</U>. This Plan shall be administered by the Committee except to the extent the Board elects to administer the Plan,
in which case references herein to the &ldquo;Committee&rdquo; shall be deemed to include references to the &ldquo;Board.&rdquo; Any
one or a combination of the following awards may be made under this Plan to eligible persons: (i) options to purchase shares of Common
Stock in the form of Incentive Stock Options or Nonqualified Stock Options; (ii) SARs in the form of Tandem SARs or Free-Standing SARs;
(iii) Stock Awards in the form of Restricted Stock, Restricted Stock Units or Other Stock Awards; and (iv) Performance Awards. The Committee
shall, subject to the terms of this Plan, select eligible persons for participation in this Plan and determine the form, amount and timing
of each award to such persons and, if applicable, the number of shares of Common Stock subject to an award, the number of SARs, the number
of Restricted Stock Units, the dollar value subject to a Performance Award, the purchase price or base price associated with the award,
the time and conditions of exercise or settlement of the award and all other terms and conditions of the award, including, without limitation,
the form of the Agreement evidencing the award. The Committee may, in its sole discretion and for any reason at any time, take action
such that (i) any or all outstanding options and SARs shall become exercisable in part or in full, (ii) all or a portion of the Restriction
Period applicable to any outstanding awards shall lapse, (iii) all or a portion of the Performance Period applicable to any outstanding
awards shall lapse and (iv) the Performance Measures (if any) applicable to any outstanding awards shall be deemed to be satisfied at
the target, maximum or any other level. The Committee shall, subject to the terms of this Plan, interpret this Plan and the application
thereof, establish rules and regulations it deems necessary or desirable for the administration of this Plan and may impose, incidental
to the grant of an award, conditions with respect to the award, such as limiting competitive employment or other activities. All such
interpretations, rules, regulations and conditions shall be conclusive and binding on all parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may delegate some or all of its power and authority hereunder to the Board (or any members thereof) or, subject to applicable
law, to a subcommittee of the Board, a member of the Board, the Chief Executive Officer or other executive officer of the Company as
the Committee deems appropriate; <U>provided</U>, <U>however</U>, that the Committee may not delegate its power and authority to a member
of the Board, the Chief Executive Officer or other executive officer of the Company with regard to the selection for participation in
this Plan of an officer, director or other person subject to Section 16 of the Exchange Act or decisions concerning the timing, pricing
or amount of an award to such an officer, director or other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
member of the Board or Committee, and neither the Chief Executive Officer nor any other executive officer to whom the Committee delegates
any of its power and authority hereunder, shall be liable for any act, omission, interpretation, construction or determination made in
connection with this Plan in good faith, and the members of the Board and the Committee and the Chief Executive Officer or other executive
officer shall be entitled to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including
attorneys&rsquo; fees) arising therefrom to the full extent permitted by law (except as otherwise may be provided in the Company&rsquo;s
Certificate of Incorporation and/or By-laws) and under any directors&rsquo; and officers&rsquo; liability insurance that may be in effect
from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.4
</B><U>Eligibility</U>. Participants in this Plan shall consist of such officers, other employees, Non-Employee Directors, consultants,
independent contractors, agents, and persons expected to become officers, other employees, Non-Employee Directors, consultants, independent
contractors and agents of the Company and its Affiliates and Subsidiaries as the Committee in its sole discretion may select from time
to time. The Committee&rsquo;s selection of a person to participate in this Plan at any time shall not require the Committee to select
such person to participate in this Plan at any other time. Except as otherwise provided for in an Agreement, for purposes of this Plan,
references to employment by the Company shall also mean employment by an Affiliate or Subsidiary, and references to employment shall
include service as a Non-Employee Director, consultant, independent contractor or agent. The Committee shall determine, in its sole discretion,
the extent to which a participant shall be considered employed during an approved leave of absence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.5
</B><U>Shares Available</U>. Subject to adjustment as provided in <U>Section 5.7</U> and to all other limits set forth in this Plan,
the number of shares of Common Stock available for all awards under this Plan, other than Substitute Awards, shall be 1,970,000. All
of the shares available under the Plan may be issued under the Plan in connection with Incentive Stock Options. To the extent the Company
grants an award under the Plan, the number of shares of Common Stock that remain available for future grants under the Plan shall be
reduced by an amount equal to the number of shares subject to such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that shares of Common Stock subject to an outstanding option, SAR, Stock Award or Performance Award granted under the Plan
or a similar type of award granted under the Prior Plan, other than Substitute Awards, are not issued or delivered by reason of (i) the
expiration, termination, cancellation or forfeiture of such award (excluding shares subject to an option cancelled upon settlement in
shares of a related Tandem SAR or shares subject to a Tandem SAR cancelled upon exercise of a related option) or (ii) the settlement
of such award in cash, then such shares of Common Stock shall again be available under this Plan; <U>provided</U>, <U>however</U>, that
shares of Common Stock subject to an award under this Plan or a Prior Plan shall not again be available for issuance under this Plan
if such shares are (x) shares that were subject to an option or stock-settled SAR and were not issued or delivered upon the net settlement
or net exercise of such option or SAR, (y) shares delivered to or withheld by the Company to pay the purchase price or the withholding
taxes related to an outstanding award or (z) shares repurchased by the Company on the open market with the proceeds of an option exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of Common Stock available for awards under this Plan shall not be reduced by (i) the number of shares of Common Stock
subject to Substitute Awards or (ii) available shares under a stockholder approved plan of a company or other entity which was a party
to a corporate transaction with the Company (as appropriately adjusted to reflect such corporate transaction) which become subject to
awards granted under this Plan (subject to applicable stock exchange requirements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock to be delivered under this Plan shall be made available from authorized and unissued shares of Common Stock, or authorized
and issued shares of Common Stock reacquired and held as treasury shares or otherwise or a combination thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.
STOCK OPTIONS AND STOCK APPRECIATION RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1
</B><U>Stock Options</U>. The Committee may, in its discretion, grant options to purchase shares of Common Stock to such eligible persons
as may be selected by the Committee. Each option, or portion thereof, that is not an Incentive Stock Option, shall be a Nonqualified
Stock Option. To the extent that the aggregate Fair Market Value (determined as of the date of grant) of shares of Common Stock with
respect to which options designated as Incentive Stock Options are exercisable for the first time by a participant during any calendar
year (under this Plan or any other plan of the Company, or any parent or Subsidiary) exceeds the amount (currently $100,000) established
by the Code, such options shall constitute Nonqualified Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with
the terms of this Plan, as the Committee shall deem advisable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Number of Shares and Purchase Price</U>. The number of shares of Common Stock subject to an option and the purchase price per share
of Common Stock purchasable upon exercise of the option shall be determined by the Committee; <U>provided</U>, <U>however</U>, that the
purchase price per share of Common Stock purchasable upon exercise of an option shall not be less than 100% of the Fair Market Value
of a share of Common Stock on the date of grant of such option; <U>provided further</U>, that if an Incentive Stock Option shall be granted
to any person who, at the time such option is granted, owns capital stock possessing more than 10 percent of the total combined voting
power of all classes of capital stock of the Company (or of any parent or Subsidiary) (a &ldquo;<U>Ten Percent Holder</U>&rdquo;), the
purchase price per share of Common Stock shall not be less than the price (currently 110% of Fair Market Value) required by the Code
in order to constitute an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, in the case of an option that is a Substitute Award, the purchase price per share of the shares subject to such option
may be less than 100% of the Fair Market Value per share on the date of grant, provided, that the excess of: (a) the aggregate Fair Market
Value (as of the date such Substitute Award is granted) of the shares subject to the Substitute Award, over (b) the aggregate purchase
price thereof does not exceed the excess of: (x) the aggregate fair market value (as of the time immediately preceding the transaction
giving rise to the Substitute Award, such fair market value to be determined by the Committee) of the shares of the predecessor company
or other entity that were subject to the grant assumed or substituted for by the Company, over (y) the aggregate purchase price of such
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Option Period and Exercisability</U>. The period during which an option may be exercised shall be determined by the Committee; <U>provided</U>,
<U>however</U>, that no option shall be exercised later than ten years after its date of grant; <U>provided further</U>, that if an Incentive
Stock Option shall be granted to a Ten Percent Holder, such option shall not be exercised later than five years after its date of grant.
The Committee may, in its discretion, establish Performance Measures which shall be satisfied or met as a condition to the grant of an
option or to the exercisability of all or a portion of an option. The Committee shall determine whether an option shall become exercisable
in cumulative or non-cumulative installments and in part or in full at any time. An exercisable option, or portion thereof, may be exercised
only with respect to whole shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Method of Exercise</U>. An option may be exercised (i) by giving written notice to the Company specifying the number of whole shares
of Common Stock to be purchased and accompanying such notice with payment therefor in full (or arrangement made for such payment to the
Company&rsquo;s satisfaction) either (A) in cash, (B) by delivery (either actual delivery or by attestation procedures established by
the Company) of shares of Common Stock having a Fair Market Value, determined as of the date of exercise, equal to the aggregate purchase
price payable by reason of such exercise, (C) authorizing the Company to withhold whole shares of Common Stock which would otherwise
be delivered having an aggregate Fair Market Value, determined as of the date of exercise, equal to the amount necessary to satisfy such
obligation, (D) in cash by a broker-dealer acceptable to the Company to whom the participant has submitted an irrevocable notice of exercise
or (E) a combination of (A), (B) and (C), in each case to the extent set forth in the Agreement relating to the option, (ii) if applicable,
by surrendering to the Company any Tandem SARs which are cancelled by reason of the exercise of the option and (iii) by executing such
documents as the Company may reasonably request. Any fraction of a share of Common Stock which would be required to pay such purchase
price shall be disregarded and the remaining amount due shall be paid in cash by the participant. No shares of Common Stock shall be
issued and no certificate representing Common Stock shall be delivered until the full purchase price therefor and any withholding taxes
thereon, as described in <U>Section 5.5</U>, have been paid (or arrangement made for such payment to the Company&rsquo;s satisfaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2
</B><U>Stock Appreciation Rights</U>. The Committee may, in its discretion, grant SARs to such eligible persons as may be selected by
the Committee. The Agreement relating to an SAR shall specify whether the SAR is a Tandem SAR or a Free-Standing SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with
the terms of this Plan, as the Committee shall deem advisable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Number of SARs and Base Price</U>. The number of SARs subject to an award shall be determined by the Committee. Any Tandem SAR related
to an Incentive Stock Option shall be granted at the same time that such Incentive Stock Option is granted. The base price of a Tandem
SAR shall be the purchase price per share of Common Stock of the related option. The base price of a Free-Standing SAR shall be determined
by the Committee; <U>provided</U>, <U>however</U>, that such base price shall not be less than 100% of the Fair Market Value of a share
of Common Stock on the date of grant of such SAR (or, if earlier, the date of grant of the option for which the SAR is exchanged or substituted).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, in the case of an SAR that is a Substitute Award, the base price per share of the shares subject to such SAR may be less
than 100% of the Fair Market Value per share on the date of grant, provided, that the excess of: (a) the aggregate Fair Market Value
(as of the date such Substitute Award is granted) of the shares subject to the Substitute Award, over (b) the aggregate base price thereof
does not exceed the excess of: (x) the aggregate fair market value (as of the time immediately preceding the transaction giving rise
to the Substitute Award, such fair market value to be determined by the Committee) of the shares of the predecessor company or other
entity that were subject to the grant assumed or substituted for by the Company, over (y) the aggregate base price of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Period and Exercisability</U>. The period for the exercise of an SAR shall be determined by the Committee; <U>provided</U>,
<U>however</U>, that (i) no Tandem SAR shall be exercised later than the expiration, cancellation, forfeiture or other termination of
the related option and (ii) no Free-Standing SAR shall be exercised later than ten years after its date of grant. The Committee may,
in its discretion, establish Performance Measures which shall be satisfied or met as a condition to the grant of an SAR or to the exercisability
of all or a portion of an SAR. The Committee shall determine whether an SAR may be exercised in cumulative or non-cumulative installments
and in part or in full at any time. An exercisable SAR, or portion thereof, may be exercised, in the case of a Tandem SAR, only with
respect to whole shares of Common Stock and, in the case of a Free-Standing SAR, only with respect to a whole number of SARs. If an SAR
is exercised for shares of Restricted Stock, a certificate or certificates representing such Restricted Stock shall be issued in accordance
with <U>Section 3.2(c)</U>, or such shares shall be transferred to the holder in book entry form with restrictions on the shares duly
noted, and the holder of such Restricted Stock shall have such rights of a stockholder of the Company as determined pursuant to <U>Section
3.2(d)</U>. Prior to the exercise of a stock-settled SAR, the holder of such SAR shall have no rights as a stockholder of the Company
with respect to the shares of Common Stock subject to such SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Method of Exercise</U>. A Tandem SAR may be exercised (i) by giving written notice to the Company specifying the number of whole SARs
which are being exercised, (ii) by surrendering to the Company any options which are cancelled by reason of the exercise of the Tandem
SAR and (iii) by executing such documents as the Company may reasonably request. A Free-Standing SAR may be exercised (A) by giving written
notice to the Company specifying the whole number of SARs which are being exercised and (B) by executing such documents as the Company
may reasonably request. No shares of Common Stock shall be issued and no certificate representing Common Stock shall be delivered until
any withholding taxes thereon, as described in <U>Section 5.5</U>, have been paid (or arrangement made for such payment to the Company&rsquo;s
satisfaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3
</B><U>Termination of Employment or Service</U>. All of the terms relating to the exercise, cancellation or other disposition of an option
or SAR (i) upon a termination of employment with or service to the Company of the holder of such option or SAR, as the case may be, whether
by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, shall be determined
by the Committee and set forth in the applicable award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.4
</B><U>No Repricing</U>. The Committee shall not, without the approval of the stockholders of the Company, (i) reduce the purchase price
or base price of any previously granted option or SAR, (ii) cancel any previously granted option or SAR in exchange for another option
or SAR with a lower purchase price or base price or (iii) cancel any previously granted option or SAR in exchange for cash or another
award if the purchase price of such option or the base price of such SAR exceeds the Fair Market Value of a share of Common Stock on
the date of such cancellation, in each case, other than in connection with a Change in Control or the adjustment provisions set forth
in <U>Section 5.7</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.5
</B><U>No Dividend Equivalents.</U> Notwithstanding anything in an Agreement to the contrary, the holder of an option or SAR shall not
be entitled to receive dividend equivalents with respect to the number of shares of Common Stock subject to such option or SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III.
STOCK AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1
</B><U>Stock Awards</U>. The Committee may, in its discretion, grant Stock Awards to such eligible persons as may be selected by the
Committee. The Agreement relating to a Stock Award shall specify whether the Stock Award is a Restricted Stock Award, a Restricted Stock
Unit Award or, in the case of an Other Stock Award, the type of award being granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2
</B><U>Terms of Restricted Stock Awards</U>. Restricted Stock Awards shall be subject to the following terms and conditions and shall
contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Number of Shares and Other Terms</U>. The number of shares of Common Stock subject to a Restricted Stock Award and the Restriction
Period, Performance Period (if any) and Performance Measures (if any) applicable to a Restricted Stock Award shall be determined by the
Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Vesting and Forfeiture</U>. The Agreement relating to a Restricted Stock Award shall provide, in the manner determined by the Committee,
in its discretion, and subject to the provisions of this Plan, for the vesting of the shares of Common Stock subject to such award (i)
if the holder of such award remains continuously in the employment of the Company during the specified Restriction Period and (ii) if
specified Performance Measures (if any) are satisfied or met during a specified Performance Period, and for the forfeiture of the shares
of Common Stock subject to such award (x) if the holder of such award does not remain continuously in the employment of the Company during
the specified Restriction Period or (y) if specified Performance Measures (if any) are not satisfied or met during a specified Performance
Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Stock Issuance</U>. During the Restriction Period, the shares of Restricted Stock shall be held by a custodian in book entry form
with restrictions on such shares duly noted or, alternatively, a certificate or certificates representing a Restricted Stock Award shall
be registered in the holder&rsquo;s name and may bear a legend, in addition to any legend which may be required pursuant to <U>Section
5.6</U>, indicating that the ownership of the shares of Common Stock represented by such certificate is subject to the restrictions,
terms and conditions of this Plan and the Agreement relating to the Restricted Stock Award. All such certificates shall be deposited
with the Company, together with stock powers or other instruments of assignment (including a power of attorney), each endorsed in blank
with a guarantee of signature if deemed necessary or appropriate, which would permit transfer to the Company of all or a portion of the
shares of Common Stock subject to the Restricted Stock Award in the event such award is forfeited in whole or in part. Upon termination
of any applicable Restriction Period (and the satisfaction or attainment of applicable Performance Measures), subject to the Company&rsquo;s
right to require payment of any taxes in accordance with <U>Section 5.5</U>, the restrictions shall be removed from the requisite number
of any shares of Common Stock that are held in book entry form, and all certificates evidencing ownership of the requisite number of
shares of Common Stock shall be delivered to the holder of such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Rights with Respect to Restricted Stock Awards</U>. Unless otherwise set forth in the Agreement relating to a Restricted Stock Award,
and subject to the terms and conditions of a Restricted Stock Award, the holder of such award shall have all rights as a stockholder
of the Company, including, but not limited to, voting rights, the right to receive dividends and the right to participate in any capital
adjustment applicable to all holders of Common Stock; <U>provided</U>, <U>however</U>, that a distribution or dividend with respect to
shares of Common Stock, including a regular cash dividend, shall be deposited with the Company and shall be subject to the same restrictions
as the shares of Common Stock with respect to which such distribution or dividend was made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3
</B><U>Terms of Restricted Stock Unit Awards</U>. Restricted Stock Unit Awards shall be subject to the following terms and conditions
and shall contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Number of Shares and Other Terms</U>. The number of shares of Common Stock subject to a Restricted Stock Unit Award, including the
number of shares that are earned upon the attainment of any specified Performance Measures, and the Restriction Period, Performance Period
(if any) and Performance Measures (if any) applicable to a Restricted Stock Unit Award shall be determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Vesting and Forfeiture</U>. The Agreement relating to a Restricted Stock Unit Award shall provide, in the manner determined by the
Committee, in its discretion, and subject to the provisions of this Plan, for the vesting of such Restricted Stock Unit Award (i) if
the holder of such award remains continuously in the employment of the Company during the specified Restriction Period and (ii) if specified
Performance Measures (if any) are satisfied or met during a specified Performance Period, and for the forfeiture of the shares of Common
Stock subject to such award (x) if the holder of such award does not remain continuously in the employment of the Company during the
specified Restriction Period or (y) if specified Performance Measures (if any) are not satisfied or met during a specified Performance
Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Settlement of Vested Restricted Stock Unit Awards</U>. The Agreement relating to a Restricted Stock Unit Award shall specify (i) whether
such award may be settled in shares of Common Stock or cash or a combination thereof and (ii) whether the holder thereof shall be entitled
to receive, on a deferred basis, dividend equivalents, and, if determined by the Committee, interest on, or the deemed reinvestment of,
any deferred dividend equivalents, with respect to the number of shares of Common Stock subject to such award. Any dividend equivalents
with respect to Restricted Stock Units that are subject to vesting conditions shall be subject to the same restrictions as such Restricted
Stock Units. Prior to the settlement of a Restricted Stock Unit Award, the holder of such award shall have no rights as a stockholder
of the Company with respect to the shares of Common Stock subject to such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4
</B><U>Other Stock Awards</U>. Subject to the limitations set forth in the Plan, the Committee is authorized to grant other awards that
may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, shares of Common
Stock, including without limitation shares of Common Stock granted as a bonus and not subject to any vesting conditions, dividend equivalents,
deferred stock units, stock purchase rights and shares of Common Stock issued in lieu of obligations of the Company to pay cash under
any compensatory plan or arrangement, subject to such terms as shall be determined by the Committee. The Committee shall determine the
terms and conditions of such awards, which may include the right to elective deferral thereof, subject to such terms and conditions as
the Committee may specify in its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5
</B><U>Termination of Employment or Service.</U> All of the terms relating to the satisfaction of Performance Measures and the termination
of the Restriction Period or Performance Period relating to a Stock Award, or any forfeiture and cancellation of such award (i) upon
a termination of employment with or service to the Company of the holder of such award, whether by reason of disability, retirement,
death or any other reason, or (ii) during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the
applicable award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IV.
PERFORMANCE AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1
</B><U>Performance Awards</U>. The Committee may, in its discretion, grant Performance Awards to such eligible persons as may be selected
by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2
</B><U>Terms of Performance Awards</U>. Performance Awards shall be subject to the following terms and conditions and shall contain such
additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Value of Performance Awards and Performance Measures</U>. The method of determining the value of the Performance Award and the Performance
Measures and Performance Period applicable to a Performance Award shall be determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Vesting and Forfeiture</U>. The Agreement relating to a Performance Award shall provide, in the manner determined by the Committee,
in its discretion, and subject to the provisions of this Plan, for the vesting of such Performance Award if the specified Performance
Measures are satisfied or met during the specified Performance Period and for the forfeiture of such award if the specified Performance
Measures are not satisfied or met during the specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Settlement of Vested Performance Awards</U>. The Agreement relating to a Performance Award shall specify whether such award may be
settled in shares of Common Stock (including shares of Restricted Stock) or cash or a combination thereof. If a Performance Award is
settled in shares of Restricted Stock, such shares of Restricted Stock shall be issued to the holder in book entry form or a certificate
or certificates representing such Restricted Stock shall be issued in accordance with <U>Section 3.2(c)</U> and the holder of such Restricted
Stock shall have such rights as a stockholder of the Company as determined pursuant to <U>Section 3.2(d)</U>. Any dividends or dividend
equivalents with respect to a Performance Award shall be subject to the same restrictions as such Performance Award. Prior to the settlement
of a Performance Award in shares of Common Stock, including Restricted Stock, the holder of such award shall have no rights as a stockholder
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3
</B><U>Termination of Employment or Service</U>. All of the terms relating to the satisfaction of Performance Measures and the termination
of the Performance Period relating to a Performance Award, or any forfeiture and cancellation of such award (i) upon a termination of
employment with or service to the Company of the holder of such award, whether by reason of disability, retirement, death or any other
reason, or (ii) during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the applicable award
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>V.
GENERAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1
</B><U>Effective Date and Term of Plan</U>. This Plan shall be submitted to the stockholders of the Company for approval at the Company&rsquo;s
2018 annual meeting of stockholders and, if approved by the affirmative vote of a majority of the shares of Common Stock present in person
or represented by proxy at such annual meeting of stockholders, shall become effective as of the date on which the Plan was approved
by stockholders (the &ldquo;<U>Effective Date</U>&rdquo;). This Plan shall terminate as of the first annual meeting of the Company&rsquo;s
stockholders to occur on or after the tenth anniversary of its Effective Date, unless terminated earlier by the Board. Termination of
this Plan shall not affect the terms or conditions of any award granted prior to termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
hereunder may be made at any time prior to the termination of this Plan, provided that no Incentive Stock Option may be granted later
than ten years after the date on which the Plan was approved by the Board. In the event that this Plan is not approved by the stockholders
of the Company, this Plan and any awards hereunder shall be void and of no force or effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2
</B><U>Amendments</U>. The Board may amend this Plan as it shall deem advisable; <U>provided</U>, <U>however</U>, that no amendment to
the Plan shall be effective without the approval of the Company&rsquo;s stockholders if (i) stockholder approval is required by applicable
law, rule or regulation, including any rule of the Nasdaq Capital Market or any other stock exchange on which the Common Stock is then
traded, or (ii) such amendment seeks to modify <U>Section 2.4</U> hereof; <U>provided further</U>, that no amendment may materially impair
the rights of a holder of an outstanding award without the consent of such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.3
</B><U>Agreement</U>. Each award under this Plan shall be evidenced by an Agreement setting forth the terms and conditions applicable
to such award. No award shall be valid until an Agreement is executed by the Company and, to the extent required by the Company, executed
or electronically accepted by the recipient of such award. Upon such execution or acceptance and delivery of the Agreement to the Company
within the time period specified by the Company, such award shall be effective as of the effective date set forth in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.4
</B><U>Non-Transferability</U>. No award shall be transferable other than by will, the laws of descent and distribution or pursuant to
beneficiary designation procedures approved by the Company or, to the extent expressly permitted in the Agreement relating to such award,
to the holder&rsquo;s family members, a trust or entity established by the holder for estate planning purposes, a charitable organization
designated by the holder or pursuant to a domestic relations order, in each case, without consideration. Except to the extent permitted
by the foregoing sentence or the Agreement relating to an award, each award may be exercised or settled during the holder&rsquo;s lifetime
only by the holder or the holder&rsquo;s legal representative or similar person. Except as permitted by the second preceding sentence,
no award may be sold, transferred, assigned, pledged, hypothecated, encumbered or otherwise disposed of (whether by operation of law
or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer, assign, pledge, hypothecate,
encumber or otherwise dispose of any award, such award and all rights thereunder shall immediately become null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.5
</B><U>Tax Withholding</U>. The Company shall have the right to require, prior to the issuance or delivery of any shares of Common Stock
or the payment of any cash pursuant to an award made hereunder, payment by the holder of such award of any federal, state, local or other
taxes which may be required to be withheld or paid in connection with such award. An Agreement may provide that (i) the Company shall
withhold whole shares of Common Stock which would otherwise be delivered to a holder, having an aggregate Fair Market Value determined
as of the date the obligation to withhold or pay taxes arises in connection with an award (the &ldquo;<U>Tax Date</U>&rdquo;), or withhold
an amount of cash which would otherwise be payable to a holder, in the amount necessary to satisfy any such obligation or (ii) the holder
may satisfy any such obligation by any of the following means (or by other means that the Committee deems appropriate): (A) a cash payment
or delivery of cash equivalents to the Company; (B) delivery (either actual delivery or by attestation procedures established by the
Company) to the Company of previously owned whole shares of Common Stock having an aggregate Fair Market Value, determined as of the
Tax Date, equal to the amount necessary to satisfy any such obligation; (C) authorizing the Company to withhold whole shares of Common
Stock which would otherwise be delivered having an aggregate Fair Market Value, determined as of the Tax Date, or withhold an amount
of cash which would otherwise be payable to a holder, in either case equal to the amount necessary to satisfy any such obligation; (D)
in the case of the exercise of an option, a cash payment by a broker-dealer acceptable to the Company to whom the participant has submitted
an irrevocable notice of exercise or (E) any combination of (A), (B) and (C), in each case to the extent set forth in the Agreement relating
to the award. Shares of Common Stock to be delivered or withheld may not have an aggregate Fair Market Value in excess of the amount
determined by applying the minimum statutory withholding rate (or, if permitted by the Company, such other rate as will not cause adverse
accounting consequences under the accounting rules then in effect, and is permitted under applicable IRS withholding rules). Any fraction
of a share of Common Stock which would be required to satisfy such an obligation shall be disregarded and the remaining amount due shall
be paid in cash by the holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.6
</B><U>Restrictions on Shares</U>. Each award made hereunder shall be subject to the requirement that if at any time the Company determines
that the listing, registration or qualification of the shares of Common Stock subject to such award upon any securities exchange or under
any law, or the consent or approval of any governmental body, or the taking of any other action is necessary or desirable as a condition
of, or in connection with, the delivery of shares thereunder, such shares shall not be delivered unless such listing, registration, qualification,
consent, approval or other action shall have been effected or obtained, free of any conditions not acceptable to the Company. The Company
may require that certificates evidencing shares of Common Stock delivered pursuant to any award made hereunder bear a legend indicating
that the sale, transfer or other disposition thereof by the holder is prohibited except in compliance with the Securities Act of 1933,
as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.7
</B><U>Adjustment</U>. In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting
Standards Codification Topic 718, Compensation&mdash;Stock Compensation or any successor or replacement accounting standard) that causes
the per share value of shares of Common Stock to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization
through an extraordinary cash dividend, the number and class of securities available under this Plan, the terms of each outstanding option
and SAR (including the number and class of securities subject to each outstanding option or SAR and the purchase price or base price
per share), the terms of each outstanding Stock Award (including the number and class of securities subject thereto), the terms of each
outstanding Performance Award (including the number and class of securities subject thereto, if applicable) shall be appropriately adjusted
by the Committee, such adjustments to be made in the case of outstanding options and SARs in accordance with Section 409A of the Code.
In the event of any other change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete
liquidation of the Company, such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate
and equitable by the Committee to prevent dilution or enlargement of rights of participants. In either case, the decision of the Committee
regarding any such adjustment shall be final, binding and conclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.8
</B><U>Change in Control</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to the terms of the applicable award Agreements, in the event of a &ldquo;Change in Control,&rdquo; the Board, as constituted
prior to the Change in Control, may, in its discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that (i) some or all outstanding options and SARs shall become exercisable in full or in part, either immediately or upon a subsequent
    termination of employment, (ii) the Restriction Period applicable to some or all outstanding Stock Awards shall lapse in full or
    in part, either immediately or upon a subsequent termination of employment, (iii) the Performance Period applicable to some or all
    outstanding awards shall lapse in full or in part, and (iv) the Performance Measures applicable to some or all outstanding awards
    shall be deemed to be satisfied at the target, maximum or any other level;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that shares of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change
    in Control, or a parent corporation thereof, be substituted for some or all of the shares of Common Stock subject to an outstanding
    award, with an appropriate and equitable adjustment to such award as determined by the Board in accordance with <U>Section 5.7</U>;
    and/or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    outstanding awards, in whole or in part, to be surrendered to the Company by the holder, and to be immediately cancelled by the Company,
    and to provide for the holder to receive (i) a cash payment in an amount equal to (A) in the case of an option or an SAR, the aggregate
    number of shares of Common Stock then subject to the portion of such option or SAR surrendered, whether or not vested or exercisable,
    multiplied by the excess, if any, of the Fair Market Value of a share of Common Stock as of the date of the Change in Control, over
    the purchase price or base price per share of Common Stock subject to such option or SAR, (B) in the case of a Stock Award or a Performance
    Award denominated in shares of Common Stock, the number of shares of Common Stock then subject to the portion of such award surrendered
    to the extent the Performance Measures applicable to such award have been satisfied or are deemed satisfied pursuant to <U>Section
    5.8(a)(i)</U>, whether or not vested, multiplied by the Fair Market Value of a share of Common Stock as of the date of the Change
    in Control, and (C) in the case of a Performance Award denominated in cash, the value of the Performance Award then subject to the
    portion of such award surrendered to the extent the Performance Measures applicable to such award have been satisfied or are deemed
    satisfied pursuant to <U>Section 5.8(a)(i)</U>; (ii) shares of capital stock of the corporation resulting from or succeeding to the
    business of the Company pursuant to such Change in Control, or a parent corporation thereof, having a fair market value not less
    than the amount determined under clause (i) above; or (iii) a combination of the payment of cash pursuant to clause (i) above and
    the issuance of shares pursuant to clause (ii) above.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
For purposes of this Plan, a &ldquo;<U>Change in Control</U>&rdquo; shall mean:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consummation of an amalgamation, merger or consolidation of the Company with or into another entity or any other corporate reorganization
    of the Company, if more than fifty percent (50%) of the combined voting power of the continuing or surviving entity&rsquo;s securities
    outstanding immediately after such amalgamation, merger, consolidation or other reorganization (or, if applicable, more than fifty
    percent (50%) of the combined voting power of the ultimate parent company that directly or indirectly has beneficial ownership of
    the securities of such continuing or surviving entity) is not owned directly or indirectly by persons who were holders of the Company&rsquo;s
    then-outstanding voting securities immediately prior to such amalgamation, merger, consolidation or other reorganization;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    sale, transfer or other disposition of all or substantially all of the Company&rsquo;s assets to an entity that is not a parent,
    a Subsidiary or an Affiliate of the Company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    transaction as a result of which any person becomes the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange
    Act), directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented
    by the Company&rsquo;s then-outstanding voting securities. For purposes of this subsection, the term &ldquo;person&rdquo; shall have
    the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude: (i) any parent, Subsidiary or Affiliate
    of the Company; (ii) any employee benefit plan (or related trust) sponsored or maintained by the Company, a parent, or any Subsidiary
    or Affiliate; and (iii) any underwriter temporarily holding securities pursuant to an offering of such securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    change in the composition of the Board over a period of twenty four (24) consecutive months or less as a result of which individuals
    who, at the beginning of such period, constitute the Board (the &ldquo;<U>Incumbent Board</U>&rdquo;) cease for any reason to constitute
    at least a majority of the Board; <U>provided</U>, <U>however</U>, that any individual subsequently becoming a director whose election,
    or nomination for election by the Company&rsquo;s stockholders, was approved by a vote of at least a majority of the directors then
    comprising the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named
    as a nominee for director, without written objection to such nomination) shall be considered as though such individual were a member
    of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result
    of either an actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stockholders of the Company approve a complete liquidation or dissolution of the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>provided</U>,
that with respect to any nonqualified deferred compensation that becomes payable on account of the Change in Control, the transaction
or event described in clause (1), (2), (3) or (4) also constitutes a &ldquo;change in control event,&rdquo; as defined in Treasury Regulation
&sect;1.409A-3(i)(5) if required in order for the payment not to violate Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.9
</B><U>Deferrals</U>. The Committee may determine that the delivery of shares of Common Stock or the payment of cash, or a combination
thereof, upon the settlement of all or a portion of any award made hereunder shall be deferred, or the Committee may, in its sole discretion,
approve deferral elections made by holders of awards. Deferrals shall be for such periods and upon such terms as the Committee may determine
in its sole discretion, subject to the requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.10
</B><U>No Right of Participation, Employment or Service</U>. Unless otherwise set forth in an employment agreement, no person shall have
any right to participate in this Plan. Neither this Plan nor any award made hereunder shall confer upon any person any right to continued
employment by or service with the Company, any Subsidiary or any Affiliate or affect in any manner the right of the Company, any Subsidiary
or any Affiliate to terminate the employment or service of any person at any time without liability hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.11
</B><U>Non-Uniform Determinations</U>. The Committee&rsquo;s determinations under the Plan (including without limitation determinations
of the persons to receive awards, the form, amount and time of such awards, the terms and provisions of such awards and the Agreements
evidencing awards) need not be uniform and may be made by it selectively among persons who receive, or are eligible to receive, awards
under the Plan, whether or not such persons are similarly situated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.12
</B><U>Rights as Stockholder</U>. No person shall have any right as a stockholder of the Company with respect to any shares of Common
Stock or other equity security of the Company which is subject to an award hereunder unless and until such person becomes a stockholder
of record with respect to such shares of Common Stock or equity security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.13
</B><U>Designation of Beneficiary</U>. To the extent permitted by the Company, a holder of an award may file with the Company a written
designation of one or more persons as such holder&rsquo;s beneficiary or beneficiaries (both primary and contingent) in the event of
the holder&rsquo;s death or incapacity. To the extent an outstanding option or SAR granted hereunder is exercisable, such beneficiary
or beneficiaries shall be entitled to exercise such option or SAR pursuant to procedures prescribed by the Company. Each beneficiary
designation shall become effective only when filed in writing with the Company during the holder&rsquo;s lifetime on a form prescribed
by the Company. The spouse of a married holder domiciled in a community property jurisdiction shall join in any designation of a beneficiary
other than such spouse. The filing with the Company of a new beneficiary designation shall cancel all previously filed beneficiary designations.
If a holder fails to designate a beneficiary, or if all designated beneficiaries of a holder predecease the holder, then each outstanding
award held by such holder, to the extent vested or exercisable, shall be payable to or may be exercised by such holder&rsquo;s executor,
administrator, legal representative or similar person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.14
</B><U>Awards Subject to Clawback</U>. The awards granted under this Plan and any cash payment or shares of Common Stock delivered pursuant
to such an award are subject to forfeiture, recovery by the Company or other action pursuant to the applicable award Agreement or any
clawback or recoupment policy which the Company may adopt from time to time, including without limitation any such policy which the Company
may be required to adopt under the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations thereunder,
or as otherwise required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.15
</B><U>Governing Law</U>. This Plan, each award hereunder and the related Agreement, and all determinations made and actions taken pursuant
thereto, to the extent not otherwise governed by the Code or the laws of the United States, shall be governed by the laws of the State
of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.16
</B><U>Foreign Employees</U>. Without amending this Plan, the Committee may grant awards to eligible persons who are foreign nationals
and/or reside outside of the United States on such terms and conditions different from those specified in this Plan as may in the judgment
of the Committee be necessary or desirable to foster and promote achievement of the purposes of this Plan and, in furtherance of such
purposes the Committee may make such modifications, amendments, procedures, subplans and the like as may be necessary or advisable to
comply with provisions of laws in other countries or jurisdictions in which the Company or its Subsidiaries or Affiliates operates or
has employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.17
</B><U>Severability and Reformation</U>. If any provision of the Plan or any award is, becomes or is deemed to be invalid, illegal or
unenforceable in any jurisdiction or as to any person or award, or would disqualify the Plan or any award under any law deemed applicable
by the Committee, such provision shall be construed or deemed amended to conform to the applicable law or, if it cannot be construed
or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the award, such provision
shall be stricken as to such jurisdiction, person or award and the remainder of the Plan and any such award shall remain in full force
and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.18
</B><U>Unfunded Status of Awards; No Trust of Fund Created</U>. The Plan is intended to constitute an &ldquo;unfunded&rdquo; plan. Neither
the Plan nor any award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between
the Company or any Subsidiary or Affiliate and a participant or any other person. To the extent that any person acquires a right to receive
payments from the Company or any Subsidiary or Affiliate pursuant to an award, such right shall be no greater than the right of any general
unsecured creditors of the Company or such Subsidiary or Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.19
</B><U>No Limit on Other Compensation Arrangements</U>. Nothing contained in the Plan shall prevent the Company or any parent, Subsidiary
or Affiliate from adopting or continuing in effect other compensation arrangements (whether such arrangements be generally applicable
or applicable only in specific cases).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.20
</B><U>No Restriction of Corporate Action</U>. Nothing contained in the Plan shall be construed to limit or impair the power of the Company
or any parent, Subsidiary or Affiliate to make adjustments, reclassifications, reorganizations, or changes in its capital or business
structure, or to amalgamate, merge or consolidate, liquidate, sell or transfer all or any part of its business or assets or to take other
actions which it deems to be necessary or appropriate. No employee, beneficiary or other person shall have any claim against the Company
or any parent, Subsidiary or Affiliate as a result of such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="proxy_001.jpg" ALT="" STYLE="height: 866px; width: 670px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="proxy_002.jpg" ALT="" STYLE="height: 866px; width: 670px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 69; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxy_001.jpg
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" A^!I(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***"0 23@#J: "BN!
MN?C3\/[6YD@?7U=HV*EHK:5U)'HP4@CW!Q4?_"\/A[_T'6_\ Y__ (B@#T*B
MO/?^%X?#W_H.M_X!S_\ Q%'_  O#X>_]!UO_  #G_P#B* /0J*\]_P"%X?#W
M_H.M_P" <_\ \11_PO#X>_\ 0=;_ , Y_P#XB@#T*BO/?^%X?#W_ *#K?^ <
M_P#\171>&?&_ASQ@LQT+4TNF@QYB;&C=0>^U@#CWZ4 =!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M02>$_'=O]J#PP3M]EN4<8*@G@D'I@X_6E3]\<_<5SZJHHKQG]H/_ )!>B?\
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MKS&7LYL+(/7']X>X_'%=30(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/^//^2>>)?\
ML%77_HIJZ"N?\>?\D\\2_P#8*NO_ $4U 'C?[,W_ !\^)?\ <MOYR5]"5\]_
MLS?\?/B7_<MOYR5]"4 %%%% !1110 5\U_!S_DN6M_[EW_Z-6OI2OFOX.?\
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M;J*M)+W.VWRT>OF)MOW_ .K/_(X;X>^"_#^N>-_$VG:EI_GVEE(ZV\?G2+L
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MN*]BTS2K#1K%++3K2*UMD^['$N!]3ZGW/-7**!!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!
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MS$JASPV0,'GMFKBE"2MTBOO7*OOT)E>46G_,_N=[_(^>_$'_  A/_">^*/\
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M)<0OO?RU5G5@&.W(. >@->AV=EY6C06%QM;;;K#)MZ'"X.*5VX.V^GW\NO\
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MO3GD<]\'VJK:\O45U:_0Z:BN2F^(NB1:LMELO7A-T+)K](,VR3GCRR^>N>.
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M!IFD:4Q1A2Y#L 6QU. !S0M6_P"NMB>;9?UM<[*BBB@H**** "BBB@ HHHH
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M\XQBE%:6>O1_*[M^-WY:"EH[K3M\[*_X67F;.GV%MI>GV]C9Q+%;0((XT4<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=QVT2W$RJLDHC =P.@8]3C)QGIFN-M;^7Q3-H>G3K\]GFZU- >DL+&-4/L9
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M QU-);I?UYO^M]@EM?\ KR7]>I:U/4_!UWJ4=MJ=M;7,UK*L:S3Z>TD4$A.
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M>V<58\>R70_X1VWM=0N;'[3J\4,LEO)M8H4?*^A!QW]J?;N[?C_PX:6?E?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8]IZC:!C!R:CMM#TFRAFBM-+LH(YT"2I%;HHD4#: P Y '&#VI)<JT_I^?\
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MWK^G^5@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)I+_ .I9,$HZ^8^003ALC..@IK6R7];_ /!!NUV_ZV_X!U7]F6G]K?VIY/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOL0<6T<-KY"Y9=I=_F;<VTD<;1R>*NZEX@2QOUT^VL+S4;XQ^<UO:>6&2/.
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M7EL;D,$+'>QWJQ;YNN?7.<U9M/%UM<7UK;3V%]9)>1F2TGNE14G 7<<88LI
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MAJL^F2V-Y8WD<0G6.Z5/WD1. ZE&;C(Z'!'<5LTWK9_UV'IJOZ[_ -?(Y/\
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M3S/<3S2  R2.<L<#@#L!V K4HH_K]?S$DE_7R_(****!A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6/"Y.X# SR:]6K+M-&T'3]3DFL]-TVVU"52[O# B2N,\DD#)&3UJK^]?SO\
MC<GD7+9=K?A8H>-]+O-7\.?9+&'S9_M=O)MW!?E2568Y) X )K,LM U.'3?&
MT+VV)-2NIY+0>8O[Q6B50>O'((YQ7;45#BFFN_ZV_P C2^J?;_ASSRXT&[6P
MLHCX;OS?QV4,:7^F:DD#JZIC$OSID*2>GF C/':GMH7B"'4OM%U"VHSW>@#3
MY[B%HT59UW,68,P.&+8&T'GKBO0**<USWOUO^-_\_P B8+EM;I;\+?Y' 'PY
MJL'A3P:RV;2WVAO#+/9K*@9\1%&56)VY&>Y ..M4M0\*ZWXAOO$MS+8?8!>P
MV3V:S3HQ9X6+;7V%MO. <9'/!->F453=Y.7FW]]O\D)125O3\+_YLXC7X?$W
MB?0]2L5TA=/@:U*K'<R1M+--N!&UD<JJ8!&6P22.!5#6/"VK>(]1U.Y-D]DM
MQIELL(N)4R)XIFDV/L9N/NY(R.:]&HJ;=1V[G%7]AK'B75-,N+C29=-BTWSI
M&\Z>-C-(T90!-C'Y?F)RVT\#Y:I0>&=73X:^&=(:TQ?65S:/<1>8GR*D@9CG
M.#@#L37=07]G=7-Q;6]W!-/;$+/%'(&:(D9 8 Y4D>M237$-LJM/-'$K,$4N
MP4%B< #/<GM36FWD_P ;B<;_ (K\+&!XWTN\U?PY]DL8?-G^UV\FW<%^5)59
MCDD#@ FJ45GJWA[7=;GL])EU.WU69;B-HIXT,,FP(5<.P^7Y0<KN/)XXY["B
ME;?S_P DOT*>O]>=S@/"'A'4_#_B.VDN562"/1Q;O.CC:9C,TC* 3NP-W7&*
M@?PMK!^'=_I2V7^G3:L]RL?F)\T9NA(&SG'W.<9SVZUWUY?V>G1++>W<%M&S
MB-7GD" L>B@D]3Z58IK^OOYOZ\A6_KY-?K]YS4]C?0^.I=92SDGM5TDPJ(W0
M,\GF;M@#,.<=S@>]='&Q>-69&C+ $HV,K['!(_(U!_:%D-1&GF\M_MIC\T6W
MFKYFS.-VW.<9XSTJS0E96_K=A;4****!A15>]OK/3;1[N_NX+6V3&Z:>0(BY
M.!DG@<U.K!E#*001D$=Z %HHJM#J%E<7D]G#>6\EU;[3- DJEXL\C<H.1GMF
M@"S15>YO[.SE@BNKN""2X?RX$ED"F5O[J@GD^PJQ0 4444 %%%% !115:?4;
M&VCN))[RWB2V4/.TDJJ(E]6)/RC@]: +-%,AFBN(4FAD22*10R.C JP/0@CJ
M*?0 4444 %%%% !1137=8T9W8*BC+,QP /4T .HK-B\0Z+,LC1:QI\@BA%Q(
M4N4.R(\B0\\+[]*EMM9TN\TY]1M=2LY[% Q:YBG5HE ZY8' QWH NT5E)XFT
M"2UANDUS36MYY?)AE6[C*22?W%.<%O8<U<GU&QM;NWM;B\MX;FY)$$,DJJ\I
M'7:"<MCVH LT54L]4T_41.;&_M;H0.8YC!,K^6PZJV#P?8U$FNZ0^F-J::K8
MMIZYW70N$,0QUR^<<?6@#0HJI;ZII]Y8?;[:^MI[/!/VB*96CP.IW XHT_5=
M.U:V-SIM_:WL .#+;3+(N?3*DB@+ENBJ%CKFDZG<36]AJEE=SPG$L<%PDC1_
M[P!R/QI8=:TJXU&33H-3LY;Z(9DMDG5I4^J@Y% %ZBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV:SG%E]HN()%*F-@F6!!Y&#ZUYQ\.[O_ (171]4GNHW>XN[.VU,Q@8,LT[2
M(/<L%'XUZAK&C6^LZ!=:-*\L%M<PF!C;D*RH1C"Y! XXZ52_X1*P&MV6IAY@
M;2W2!8<C8P3.PD8ZC<WMT/84W9S;VOI\M7^=OSZ"L^5+MK\_^&N>4Z9K&H:%
MK6I-'NEU74]16QENX;62Y*")/,G=8T!+89]H'0 #/ KHKOQSK&@6NKGR]4U.
M!(X!I]UJ&ER6SO/(^PQE1&F_'#?*H...374Q> ]-M[&.&"[OHKF&\EOHKU73
MSDED)W'E=I!!(P5(QBI_^$+TN33+RTNGN;J6\D26>[FD'G-(F"C J %VD#
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M$O,D!A\O=Y:Y.2?FVC)P>F>*W_#7VBZ\?^(M3-A>V]G<6UJL$ES;M%YFT/G
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M#36T]O!;V]MY>#GSA;CS!Q@!').<$CDTL.DZB/@Y=6+:?=?;#>2.L!A;S/\
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M)V@<<CG%6M7_ %YZ?@OO]"+M1O\ UT_S9UC^.?#T;7 -[*?LTGEW!2TF80'
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M[[_UU_+\66[K;^OZ?X&EK?CRQL-,LKRP$ETL]_':2*MK,SQ9(W!D"[E?'12
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M0V\TDZ,TEM+;E790LI4E@#PPVL1@]1GGU JIKFLVV@:5)J%VLKQHRH$B4%G9
MF"JHR0,DD#D@>IKRC2+&VU'Q5HUM>0K- ^IZSOB?[KC>.&'1A['@T[7M-L?[
M+\2Z8;*V:RL=<LA:0-$I2 2>3O5!C"@Y;@>II1]Y+SM^<5_[<)NS?E_]M_\
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MI8[M?*D;"RMM3",/X@?[IX.*YG7;>*-K[2[2-5T2'Q!I\<$<;$)&S8\V-,=
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M#9L9BH&<YSD'M5]V*HS!2Y R%7&3[#/%</HVFZ1I?Q4OK;28+>V4:/&9+>W
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M_8ENWX?C_6OR[GJ=%,E_U+_[IKQG2]"TZ/X>>$M02V"7UQJ$$<ETC%9C&\K
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MFG)/_97B9K/[,\GA[54N[2&Q3$2;8U,D4:Y. 077MR3P.E).^_\ 6J3_ #_
M;TV_JZ=OR_$]?J.XD>&WDDC@DG=%)$494,Y]!N(&?J0*\MN]0AUFTNO$,://
M'JU_!IU@OG&&)X8R<>8^TD1L^_.!EA@=ZS]2C_LJ?Q?I$46F6L?_  CCS26F
MF1F.&-\L,E<XW$'K@<8Z]:3=M_ZTO^3'%IM6\OQ=OS/5K36(;O5KO35BFCN+
M6**63>%QB3. "">1M.?ZU8O[R/3M.N;Z96:*WB:5P@R2%&3C/?BO,+Z]2PCU
MV1_/P]AI<0$$PB)+EE +D':ISACC(!..:IZA;OH?B"?3D@T>R^TZ#>R7%KI2
M%%)"KM=\XW'J =H/7DYP%4;47;S^]*3_ $)I/FLWY?<^5?\ MQZ[:7*7ME!=
MQAA'-&LBANH!&1G\ZK:/JT&MZ<M[;)(D1DDCQ( #E'*GH3W4UP-G8Z9IMAX+
MO- 6(7UY-"DTT3;I+J'RCYGF-U<+UY^Z0.G2LBW^VW*^&M.^R6=YIUQ/J)>U
MOKAH8)YA,VU6(1]Q +$(5P<$]JTE\;BN]OQ_R_$B,VXQ;[7_  _S/9**X_P.
MEQ;W6MVC?8(;6&X18K.RGDFCM6V#<@=HT&.AVJ"%R1Q5WQU>I8>$KJ1_/P[Q
M1 03"(DNZJ 7(.U3G#'&0"<<U+>B:ZV_$T6M_G^!T=%>+:W;MHFJWFFI;Z/9
M?:?#UZ]Q::4A120J[7?.-QZ@':#UY.<#:CTZUT:'P)J&FVT<-[=RQ0W,ZCY[
MA6MV.)&ZL,@$9)QBB_7^NO\ E^(-V_/\G^IT7B#2O#>AVL^LWME=/"9T:6WA
MN9/*DD=PNYH=XC8[F!)(]^:ZVO&[VQTJY^&*ZQJ4< U][R-;BX9LS"<7(S$6
MZX'39T '3O7LE$=FOZV3_K_(&_>_KNT9$WB")/$::'#9W5Q<^4L\SQ! D$9)
M 9BS G)!X4,>.E:Y. 37EGB*P2T\:^*=1TO3K;^UH= 6>WE6!?,64M("X.,[
ML #/4X JS-9:5I<?A*^\.B);V^NHDDF@?+WD)0F0R-R9,==S9P>XI7]V_P#6
MO-;Y:!)V;_K9)_J=9IOBRPU2?3(H(;E6U&"6>(NJ@*L;!6#8)P<L,8S6]7CV
MGRWL&G^'YM.3?>IH6I- OJX=-OZUH2V>EV7A_P +:IH@B.K7MU:H]PCYEO V
M/.$C=9 %W$[LXQVQ5+6W];NR_P"")NW]=KGJ-%>+W8F5&T&W=PWA&>;4=J@C
M**RO"O/4&-Y!W^[7H'@LKJ$.I>(0Q9=5NC) Q_YX(-D>/8A2W_ J47S*_P#7
M2WZ_<#=G;^NOZ6?S-G5]7M=$LEN[POY;31PJ$7)+.P51^9%)9ZQ;WNKZCID:
M2B:P\OS68#:=Z[AMYST]0*YKXH6-K?>&;5;FUAN%74[3 EC#X!F53U]02#['
M%4+;P[HVI>,/%BWFFVUQ';Q6JP)(@*1 1'!1>BD=B.1ZU+E9-OI?\$G^I3W2
M76WYM'HE%>+Z'+JGB&YT6WU"PT[5[?\ L.*6&WU6[:..1]Y#R >7()' " DC
M*YXZUZ!X":X.@2K/<6\T<=W,D'D2R2I'&&X02.BEPIR,XQ@=>*T:LVOZWL3S
M?U\KG44444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]XC\26T^M6&I1PJE_);Q:?+$HA:*.4HQ9PIDWD D$$ ''%6XZN/;3\E^MO\
M@"YE9/O_ ,'_ "_IF_;V'AC14\RVM-(L$MY=FZ..*(12/@8R,88[@,=3D>M6
M[;1-)LG5[32[*!T=Y%:*W12&;AF&!U/<]Z\VAN=2T'3?%-]::M<M*?$,<.)8
MX2H#/$&/"#DJV/3@8 /-=!%J.M:Y;ZWJEEJ[V$6GW,]O;6HMHW20Q<$R[@6.
M2#C:RX'K4<RY>9]K_@G^H[:V7?\ 6QU4.BZ5;ZC)J,.F64=])]^Y2W42M]6
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M;/D,8P3%D8.T_P /''%3T4 !&1@]*J+I>GI:P6JV%JMO P>&$0J$C8'(*C&
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M3O"\UO;36U_?W]PI:*QTZW,TSJ.K;>  /<TY>[HP6JNCI**X]OB9X<'A2+Q
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MO;?:;-V5FC\QDR5.1RI!Z^]5:R^:?W6_R&OB3?1-?><-\9/^2-W>#C_CV_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\P&1@@Y'!S5+;[_NT_JY/7[OU(-8FU6*WA32+:*6XEE"-+,?W<"X.79<@MC
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M9ID7&2@122>1P.?;@UQ=G#?P721ZC%K=M&=.MDMTTRT8?:&$0#":54W*X.5
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MSZ@KC4$9[3R8WE,X4 D*$!R>>G4]A5W2]7LM9MWGL96=4<QR*\;1O&PZJR,
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MWA0"W.,# (ZXKSWQ9I>H>,I-1O-*LKV.!-'EMD^U6[6[7$K2*X4)( W 0\D
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MYM-??5HKVV>XLDM&AM+4+*I/EA55'0 <8+]<GID"UDEZ?B[?@5+2-_7\K_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9438IW84DC<P& &YYSP< \9U*\;O--L+/0O%$MM8V\$K>)($+1PJC%/-A('
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M3TFSUBW6WODDD@#;C&LKHK^SA2 Z_P"RV0?2KM% "    # '0"EHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH IZGI=IJ]H;2]61X"<
MLB3/&']FVD;E/=3D'N*MHBQHJ(H55&  , "EHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHH.<<=: *<6DZ;#,DT6GVD<L;.Z.L
M*AE9_OD''!;N>_>B72=-GCNHYM/M)$NR#<J\*D3$# W@CYN !S7,>!_%][KB
M:[;:W';6]_I%Z\$H@5E4Q@95\,2>0#WKG+?XL7R>"9?$-SIL5Q)>ZB]GHUI;
M*RM.H)"ER2?0]!VZ<TKJWR3^^UOO[>7D'7YM?=>__#^?F>C6^A:1::=)IUMI
M5C#8R@B2VCMT6-P>N5 P:EL=*T[3 PL+"UM X56\B%8\A1A0<#L.!Z5Y4/B3
MX]\.S0WOC7PA;VNB32JAN+20%X QX+C>WMU"_P!*=X_\>?$/PI<7FH6.AZ1)
MX;1HQ!>3'<SA@.JK*#]XD?=%._7OI_P']^@EKI_7R/2U\.:&MS)<KHVG">5U
MDDE%JFYV4Y5B<9)!Y![5+)HVE2ZFFIR:;9O?H,+=- IE4>@?&1^=>8W?CGXB
MZ'X%U?7?$&A:39W$#0?8E0ETD#MAMP65CP",<C\:ETKQ#\9;G4;(7WA/1HK"
M25/.E25=RQDC<0///.,]C]*:6MET_P O\A-JU^_XGI$NAZ1/<S7,NEV4D\VW
MS97MT+/M(*[CC)P0",],4MUHNE7U[#>W>F65Q=0_ZJ>6!7>/_=8C(_"J'C/6
MKGP[X.U76+1(GN+2 RQK,"4)'J 0<?C7ES_$CXI:5I4.OZUX4TD:&0DDDD$H
M#E&Q@C]\Q!Y'5:E-7MVM^.Q37XGM"6=K'=2W26T*W$RJLLJH [@= QZD#)QG
MUJG<^'M$O+*.RNM'T^>TB):."6V1HT)ZD*1@5R^N>-=1\/\ BC1#>6UN/#.J
MJL0N=C"6WG894.=V-I^GKSQ4V@^+=2\2>.-5L]/AM3X=TP>3)=LK&2:X[JAW
M8VCOP>GO32OIZ_*W]:>N@N9;^GX_U^!U0TS3P+4"QM@+0YMAY*_N3C&4X^7@
MD<>M6J\Y^*OCS6O!*Z3_ &-9V=TUT93*MPC'"QJ&)7:P[9]:J?$;XGZAX:TK
M1[G0+6TNI;Z W<GVE694A 7GAE[L.]*]U?SM\_ZZCM9V\KGJ-%<EXQ\6S^&_
M!"ZM;PQ3:C<"**U@8$K),^,#&0<=3U[4> _%L_BKPL]Y>P16^J6LLEO>6\>=
ML<J'I@DG&,=S0W;F_N[_ -?UT$FFHOOL=;17E%E\3M:N?AQ8^(GM=/%Y/JRV
M3((W\L(7VY WYW8]\>U>KU5OZ^2?Y,+ZV_K=K\T%%%%(84444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 >$?%&:^\)>,[^7387=?%>G?8P(^HN 0H;_ +Y(
M_.M_Q?X6O_#WA+PC=:+8M?2>&IDEEMHQEI5V_.0!U.>?QKTVSU33]1EN([*_
MM;F2V?RYU@F5S$W]U@#\IX/!IR:C8RZA+I\=[;O>Q*'DMEE4R(IZ$KG('O4I
M6BDM[W7RNU\M7]XI).3;VV?SLG^2/$?$OQ*'Q-T9_"/AKP_J9O;R1([A[F-0
MEN P))(8_P!T]<?TKI_C/;_8_@]);;MWDO;1Y]<,H_I7J%13W5O:^7]HGBA\
MUQ''YCA=[GHHSU)]*K2WS3^ZW^0UO=]$SSGXRX_X4U=YZ8M__0UKR'PE?_"[
M2_$^DWEFOC!K^.X3RQ,+8Q;R<<X(.,GZU]4T4XNTW+N[DN-Z:AV5CD?BC_R3
M#Q#_ ->;?TKYFM_^$'^Q6YT2+Q5+XF"H8$DBMY(#.,?P@%BN<XXS7V*[K&C.
M[!4499F. !ZFFV]Q#=V\=Q;S1S02*&22-@RNIZ$$<$5$5:3EZ?@5+56]3B_&
M]M)J7P=U+^V;=/M8TSSI4[),J;LCZ,*L?"NSM[+X9:"MO$L8DMEE?'\3MR2:
M["BKOK)][?A?_/\  GETBNU_T_R/-OB+;1WOCOP-:RC,<T]U&P]08L&O)X[2
M_N/!?BZ34E&= LXM&@//.+C<3STX"C\J^H:*A*WX_FG^C7S+OJGVM^%_SNON
M/#_&,>O^-/%^B>'O"]U:P3Z'9QW\LUR<QI*0H4$;6^8#D C^(TO@V+Q%X&^(
MUUI?BJ[M+A_$D#SI-:\1M.F<\;% 8C.>/2O;ZA%W;&\-F+B(W2H)##O&\(3@
M-MZXR",TVMUWO?YW_P"!]Q"CHEVM;Y6_X/WGSG;726/[/]A=RAC'!KZR,%ZD
M"3)Q^5>D>&OC=X:\5>(;31;&QU:.YNB0C3Q1A!A2W)$A/0>E>E5##=VUQ+-%
M!<12R0-LE5'#&-L X8#H<$'!]:I/5WV_X"7Z#:ZK?7\6W^I-139)$AC:25U2
M- 69F. !ZDTJLKJ&4AE(R"#D$4ABT444 %%%% !1110 4444 %%%% !1110
M4444 %%%0PW=M<2S107$4LD#;)51PQC; .& Z'!!P?6@":BBB@ HHJ%;NV>[
MDM%N(FN8T#O"'!=5.<$KU .#S[&@":BBB@ HI@FB,Y@$B>:%W&/<-P'3./2G
MT %%%% !144EU;Q7$5O)/$DTV?*C9P&? R=HZG ZXIT4T4\8DAD21"2 R,"#
M@X/(]Z 'T5%'=6\MQ-;QSQ/-#CS8U<%H\C(W#J,CUJ6@ HICS11/&DDJ(\IV
MQJS %SC.!ZG )_"F6]W;7B,]M<13HCM&S1.&"LIP5..X/!% $U%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'DG@?RM&\1WNIN5C@U'4;^TG8G WQR&2
M,G_@/FC\J;#<S:1XNU363);VMY=:%]L:2Z4[4+SG8&"@DE5V+@<G:!7<'P/I
M3:/<Z6\ERT%Q?-?LQ==P=GW$ X^Z>1CK@GFI-5\&Z7K.H7-Y=F<O/9K9LBN
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MY8Y+C4U"!M@C_=M$<]#YIZCGY#5_Q=K%WIL6EVEA(L-SJ=\EFL[('\H$%F8
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M@(PP^92K @#(8$< ]0*;H?AVWT&2_DANKNYEOIA//)<N&)<*%R, 8X4<=/3
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MKS_X'];K6ZO_ %M_P3SRVUCQ*_A+6/$LFN,S:=<W9BLQ;1".6**1AMD.W=G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P\'CS
M4)M*OM8/A\+I5A<30W,IO,R%8W*EXTV888&2"RGJ!GO:MO&DUUJ6L+'IUNNE
MZ3(!<WLEY@E#$)-RH$.>#T+#ZGI7-^'-,UO6O".K:1";!--O=1O8I+AW?SHD
M,S!@J;2K$\X)88ST.*Z/3/!?V=?%%I=-$;#5V58EC8EDC$*QX;(&#QVS4Z\M
MUV_&T?U;M_D+[5NE]?2[_0?'XOO8XK"]O]%%KINH2)';S"Z#R(S_ '/-3: H
M)P/E9\9YQ4D?C$2Z!8WT=CF]NKQ;$V7G<I+O*N-V.=H#-TY JG_PC>N:A9Z7
MI.JOIPT_3IH93<0.YEN?*Y0&,J!'R!GYGZ=LU-:^$;FW\?3ZRUU&VED-/#:\
M[DN754=^F,;5XYZLU7IS>7Z+_/8GWK>?Z^7DMR#3_%V^%;:PTYY=0N=1N[>&
M">^9E/E,=\C.P)5.GRJIQD "J&G^*;_3=:\2'5;>9KAKZUM;.P2Y\Q/,>(<1
MLV %)RQ.!T/&>*LV7@S4M->'4;=[*34[;4+R>))'<1R0SL24+!<JWW3G:V".
MAS4%WX$U'6WU.ZUC^RWGGO+>\M[?:TT"^6FTQR!E&X$$C..^<#&*S5]/37_R
M7;\?ZM>GUMW_ /DO^!_6VQ-XQ.D_;8O$%BEG<6UH;Q5MKCSTFC!P0A*H=P)4
M8*C[PP35"YU;7I/%WAB.\L?[/MKB2<E8+TRK(/*)"R#:N&'7 W#CK44?P^CO
M;?48[C2]#T5+JT-ND6DVZ,5;(;S&E,:,<$+A< <<YXQH#2?$E]KVB7FHC2HK
M?37D+BWFD=IBT90, 4 7K]W)Z_>XYM;J_P#6_P#P/ZVF5[.W];?\'^M]S7=9
MBT+3A=21/,[RI!##'C=)([!549Z<GKV&37/:IXXN] M[Q=8T>.&\BL9;VWCM
M[OS8IUCQN7>44JPR.JXYX)K:\2Z(VNZ;%%#,L-U;7$=U;R.NY1(C9&1Z'D'Z
MUS7B#PAK?BJ&[GU Z=:W8TZ>SM(8)GE3=+C<[R%%.,*  %XYY-3KK_6EO\S3
MJOZZ_P"1UFBWVH:A9BYOK"&S$@5X5CN3*2I&?F^5=I]AD>]9,WBJ\_X2?4-(
MMM,@:'3XX9[FZFN_+ C?.2%"-D@*3C(!]1706,#6NGVUNY!>*)48KTR !Q6%
M!X;F_P"$I\0:A<O$;+4[6&W5$8[QM#AL\8'WN,$U4[\SY?/_ (!$+\JYM]+_
M *E:#QI.UG9:O<:4L.A7LD<<%U]IW2J)#A'DBV@*I)'1F(R,@<XQM/\ %^L:
M=-J\NI6D-Q"VOI80[+QB8@^Q< &,#: <]>23TZE=-^'7V(6-G_8WAF.*S="=
M42T1[J94((!1HMJL<<ON/<@ ]+5]X,U2<:K%#)9!)=4CU6TD>5\F12A\MU"\
M+\I^8$GGIQ1HI7Z?I>/XVO\ UNGS->?ZVE^&W];:'B'QK_8-]JEM_9_G_8=)
M.I;O.V[\,5V8VG'3KS]*@;QCK,>H:39-X>M_.U:.22VVZCD(JHK?O#Y?'WL'
M;NQCC-4-9\'^(->NM9O+EM,MY+_16TZ*&.:1Q&^XG)<H,CGJ%!'H>M;<OAR\
M?7_#-^)(/*TJWEBG!8[F+HJC;QR,@]<4HWTO_7Q?_:C;=W;^OA_X)>T#77U=
MK^VN;5;6^T^?R+B))?,3)4,"K%5)!##J!6%XQUZYT^768-/B<7T&AR7<<[7;
MJBX8CB/!7<.H;&3C' YK9T31;G3==\07TSQ-%J-S'+"$)+*%B5#NR.#D'IFJ
M6M^%;C5]9U"X\^*.VN]&DT[J=ZNS$[L8QC!]:BI=Q5NWXV_S-(64M=KK[KK]
M+FKX:FO+CPUITU^D:W+VZ%]DQE!^48)8JI)/4\=>YZUR6G^+-3L-5\4OJD"S
MP0ZE%:6<,-R7<NZ($C52B@ [MQ;/!)X(&:['08+VUT.TMM0CMX[B")8B+>5I
M$(48!R54\XSC''O7+WG@O4+C4M7DCEM4CN;Z'4[6=F8O'/&J+L9-N"I"GY@V
M?FZ=ZUG;VC:VU_-?I<QBI*FEUT_)_K8V;#Q!=_VW'HVL:='97D\#3VY@N?/B
MD52 PW%$(8;AP5QSP31XLFN;"RM=8MYI533YUEN8D?"R0'Y9-PZ':#N'^[4-
MIHVJ7OB:UUS6ELK=[*WD@M[>TE:8$N1N=G95[* %"\<\FNCFBCGADAE4-'(I
M5E/0@\$5+O9-;_\ !T_#<O=M/;^K_P# .?UB[DNM>TK3;:Y>*),W]Y)$Y7]R
MG"J2.S,1]0C513QO<'3(==DT?9X?F=52Z^TYF"LVU9#%MP$.0?OEL'[M6_#/
MAF;2K2\CU*X2[FF MD<9R+9!MC4DCK@DGW8UE+X0UE_#<'A*66P_L:$HGVQ7
M?SWA1PP3RBNT'  +;SZ[::WM_6KU^Y6^=]Q.]K_UMI][_"Q#I/BS4=/7Q'=:
MQ$DL<>K?9+2.&Y,CL[;%2)044!>0<Y[GCC)Z.PU^[.M1Z/K&GQ65[- T\!@N
M3/'(JD!AN*(0PW+QC'/!.#6#?>!;G4(=9L9A8O:76H+J5L\N9,R#;^[DB*X*
M?*1G<<@]!BKOAWPH=.UK^TGT7P_I 2$Q+#I4",9"2,LTIB1@.,;0,<\D\4H;
M*_9?E^=_ZZ@[Z_UU_*W]="#XDWJV5GH7G:C-86<NK11W4T=VUM^Z*MD,ZLI
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M\Q\_+[[/\+_H-W_/[M/TO\_QTM.\?S:I#;06^C;=7N;FYA2SEN0JHL+8=Y)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB:BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2+^^U.SMKU'N-,8+>(59?*R,\Y R,=QD56@\9^'[GPO+XEBU%6T>(,7N?*<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS_X7DKI/B1AU&N7A
M'_?5>@5@>%?#7_",VVHP_:_M/VR_FO,^7LV>8<[>ISCU_2ILW?S5OQ0GT]?T
M9R'P\M+>_P#@]=O=HDK:@;R6[+#[[%W!S^0K?^%D\UQ\,= DG+%_LH7+')(!
M('Z 5F2?#[6;6._TO1O$HLM OY)))+9K0/+#O^^L;Y& >>HXS7;Z9IUMI&EV
MNG6:;+:VB6*-?10,5:>[VO;3T_JR$U[R]9/[V<3>LGAGXOP7KD1V6O6+12L>
M )X?F!/N4R/PKBKR)[_PQ8:O=#">)_%$,DP;O;!B(E/MA ?QKT[QWX-3QKHD
M=@+Y[">*82Q7*)O9."",9'521UJ;6O!]EK'A.'01(]LELL9M9HP-T+QXV,![
M8Z5$?=LWT:^Z_-_P/D.2NVNZ?WV<5_F8/CY%M_%O@6[@3%R-4-ON7@^6R'<O
MTX%/\1_\E@\&?]>U[_Z"M6M,\(:Q-KUEJ_B?7(M3ET\.+.*"U$"*S#!D;DY;
M''H*U-1\-?VAXPT;7_M?E_V;'-'Y'EY\SS !G=GC&/0YJHJW+ZM_>G_7S)DF
M^;T2^Y_U]QR/CV[U*R^)OA&?2=,74KQ;>\V6S7 @W#"Y^<@@8%=EX=U+7M1C
MG;7/#RZ.R$")5ODN?,'<Y4#&*R_%?@_4M=UW2M8TG7ETF\TZ.5$9K(7&X28!
MX+ #@>_6KWAW2/$NG7,SZYXH36(F0".-=.2VV-GKE6.?I1#2-GY_F5+XKKR_
M(Z&BN=T:'5T\5^();NZGETUVA%G')'M6,A/G"?WATY]<CM714=$Q]6>&2>%]
M7U7QCXFN=%D*"]U5M-U,[L;;9HXV+CGJ,,./[]9:ZKHVF>"="\.:E<):Z7<:
MY<O=;@6'V>&5CMP 2<MM%>VZ'H']BWVM7/VGSO[3O#=;?+V^7\BKMSDY^[G/
M'6N?\'_#D^%_$%WJL^K?;S(LB6\?V?R_(5Y#(W.XY))'/'2E!6M'I9?>M;??
M^I,E>[\W^*M?[OT.$L-<L;[X+>,M(L;M;J#2C+';2+D;K=CNCZ\\9(_"K5QJ
M6L>-O['\%7FAQ:)(JV]X+JYNUD:2*/!S"%7!8XY^;C/-=KXE^'QU[4]5NX-5
M^QKJFF_8;B/[/Y@8ALK)G<.1R,=_6K?B#P4NM:7I,<%^;+4])>-[2_6+<5*@
M @KN&58#D9HCNF^\?P35_P GYZBE%NZ7G^-G;\UY:'E&J:M>VOBKQ7ITL-S;
M^';C68EU;4H3S%&4 ">H#'JPZ ^]>]6%M:6>GV]M81QQVD<86%(ONA<<8KG]
M,\&06TGB/[?.E]#KDPDFA,.Q5&P*5^\<],]L5:\(^'[KPQHHTJ?5&U""%R+5
MGBV/'%_"C'<=V.F>/I3AI!1?9?Y6^73ROU';WN;U_P [_/K\NARWQ0GO+76O
M!D^GV0OKM-38Q6QF$0D/EGC>00/K531+N_G^+37?B32O[%U"XTMH;*WBF6=+
MA%;<Y:1>K+QQ@<5U/C+PG>>)9-)N-/U@:7=Z;<&XBF-J)P25*_=+ =_>J^C^
M"K^'Q!%KGB'Q#)K-];PM#:XM$MXX0WWCM4G)..N:A)V?_;WXJV@Y7Z>7X.^I
M3^#G_).+3_KYN?\ T:U,\._Z5\8?&$\^&EM;>T@@R.5C*ECCV)JMI'P^\7:!
MIXT_2?'T=O9J[ND9T6-R"S%CRSY/)K3OO!NM)JL6MZ-X@BMM8DM4MKZ2:S#Q
M76WH^P,-C=>A/!Q6C?O*7E;\$OTM\QRZKSO_ .3-_J>:6@S\=#H1CQI*ZU)>
M+'QL,WV<-T]<G/XU[+X@T?3YX;C5I+93?VUE/%%-D@JK+R.#@].]<\?AE&-(
M0)J\RZ\E\=1&K>4"QG/!RF<;,<;<].]6;+P9J=S?2ZEXDUM-0OQ;26UJ(+;R
MHK=7&&8+DEF/')/M64HOV7LUND_RZ?EZ!%^_S][?G_3]3S?X=7S:S=>%=+\2
MVLMIIEO9^9H\4F/*O9U)W.WJ1_"I^OI7H&M:1XCTOQM/XF\/6MCJ?VFTCM[B
MRN9C#(H4D@QO@@9]ZFF^'5O<> -.\-/?L+K3E5K344BVO%*IR'"Y_,9Y]:CN
M_!6O0ZI_;6B>)([35)X(XK_S+(/!=%!@/LW91OH36LW>5UW?SOU_1_*VAG"-
MHZ]E\K/^FO.]RUX$U#2[XZP+72)](U-;O?J=G,^XK,RCY@<E2" .1@'TK/\
MC$TB>"H'AC$LJZE:E(RVW<?,&!GMGUK>\*^&)= -_=WVHMJ.J:C*);JY,0C4
MD#:JJHS@ <=:/&GAB3Q;H(TZ&_%C*MQ'<).8?-P4;</EW#/YU,OL^7+MY-;?
M<4E=27>_XI[G$SZAJ]W\2?"][XJT$:#%&TL-F\-RESYTSK@1NZXVC )'')JI
MX)UGQ5IZ^((=&\(QZM:G6[LF<ZFEN0V_E=K*3^-=7:^!M7NM9T^_\3>*GUA-
M/D\^VMX[%+9!)@@,VTDMC/'2J5IX \5:3/?_ -C>.8[*UN[R6[,)T=)2K.V2
M-S/D^G:B.GX_BT_\_P  =V[^GY-?K^8OBF2:7Q_\.Y+B 03M+<F2(/OV-Y(R
MNX=<'O4OQ7)ETS0+)S_HUWK=K%< ]&3).#[9 J?7/!.MZP/#]TOBE8-7T@RM
M]M_LY6$S.-N?+W@+Q]:AN? ?B#6+&>S\0^,OM\1"R6QBTR.W>WG5@RR ACG&
M",=\TUI;R=_Q3_KT&]?G&WX27ZE;XEVJ-K_@V2*,"XDOWM,KP?*>)@R_3@5S
MOA'X@/HNC^$-&:%6M%A:'49V_P"7=B[QQ GMED-=MIOA#6)M>LM7\3ZY%J<N
MGAQ9PP6H@1688,C<G+8X]!5"T^%&GV_A?Q%HSWAD;6;AY_/\G!@R<H ,\[3S
MU&?:HLTG;S?X[?BW]PK7:?HOPU_1?>:'PMC/_" 65P?O7<DUT<_[<K-_6KOQ
M#_Y)SXB_[!\W_H)K3\/:0N@>'=/TA)?-6S@2'S-NW?@8SC)QGZUG>,_#VI>)
M]$?2[#6ETR*=6CN2;03^;&RXV\L-OKD&JK*Z<8^GY+]"Z3LTY>OXM_J<YXDY
M^ ,W_8&C_P#0%KB)99-#TW3O!MU(S?9=8L+S3W<\O;2/G'_ 6R*])C\%:G+X
M O?"VI>(5NS-#Y$%RMB(_)C   V!OFZ=2>]'B?X>6WB2X\.W1N_L]UHLT<BR
MB'=YJ+@E",C&2HYYQ6C:]JY=')?=J_P?YLQ47[-1ZI/[[6_%?H=I7CNF:EXF
ML_%?CF'0?#$.KQRWX\R26^2$(?*'RE&'S9^HKV*N ?P)XCM=>U?4=$\9+IT.
MIW'GR0'2DF*G:%^\S^WH*Q:N_DU]]C7HO5?J<2OV6/X7^$+:WDE:2V\1P17*
M2IM:*;S&+IC)P 3@<]*]'^*'_),?$/\ UZ-_2LV\^&(?PG9Z/8:S);W<&HC4
MGOYK<3-+."26*Y4<D_I5A?!WB>^CGL_$'C--3TNYA>&>U728X"X92,APQ(()
M!Z=JJ=Y1DNM[_A']4U]P0T:;_KWF_P F9/CH@^#_  41R/[5T_\ E5'3]4\1
M:=\2O&HT/PTFL*]Q;^:6U!+;RSY0Q]Y3G-;>G?#[5S<Z3#KOB-=1TO1Y%EL[
M=+01N[*,(9&R<[1Z=:DN? OB*+Q-J^L:'XP33%U.1'EA;2TGP40*/F9_Z#K5
M-^\WW<G]_+;\F9J+Y(Q[)+[KG8:3<WUWID$^I6 L+QQF2V$XF\LYZ;P #7&^
M-?\ 2?B+X%L9L&U-Q<3E6'#2)'\OXC)KK-"LM5L--$&L:NNJW>\G[2MJMO\
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M#)?-6[OP9K=IK5_?^&O$,>G1ZFP>\AFM!,/,Q@R1_,,$CL>,UK4:E.4EUO\
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M+#=;!E;:?G4GC(IA<]!HKE-7\?Z;IMY!9VEEJ6LW4T(N!%I5N)BD3?==B2
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M\L;R/S4:(.YBW;3N0[3^(KT+P3K,FH7.M6-_I%IIVLV5PHOOLF#'.S+E9 V
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MJW]N_8/)M%MO*^R>;G#NV[.]?[^,8[5Q_P#PS+_U-W_E-_\ MM?0%% 'S_\
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M=N-R_P!_.<]J["B@#Y__ .&9?^IN_P#*;_\ ;:/^&9?^IN_\IO\ ]MKZ HH
M^?\ _AF7_J;O_*;_ /;:]PT+3/[$\/:9I/G>=]AM(K;S=NW?L0+NQDXSC.,F
MM"B@#P_7?V>/[;\0ZGJW_"4^3]NNY;GRO[/W;-[EMN?,&<9QG K/_P"&9?\
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M_P#^&9?^IN_\IO\ ]MH_X9E_ZF[_ ,IO_P!MKZ HH \?\$_ O_A#O%]CK_\
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MIN_\IO\ ]MKZ HH *^?_ /AF7_J;O_*;_P#;:^@** /G_P#X9E_ZF[_RF_\
MVVC_ (9E_P"IN_\ *;_]MKZ HH \_P#AE\,O^%<_VI_Q-_[0^W^5_P NWE;-
MF_\ VVSG?[=*/B;\,O\ A8W]E_\ $W_L_P"P>;_R[>;OW[/]M<8V>_6O0**
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MC&[/3M7L%% '/^-O#'_"8^$+[0/MGV/[5Y?[_P KS-NV17^[D9SMQU[UX_\
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M_-.3Y;WZ*_\ G\]_N8DT]N]OZ\MOO1S'_#,O_4W?^4W_ .VT?\,R_P#4W?\
ME-_^VUN:#K'CCQ;J]O;67BM-/$>BVMY('TZ*99I) =V>A7GT_*NW\$^)-0U=
MM5TK6HH4UC2)Q!<-!D1RJ1E'4'D9':K:L[==?P=B5-/7^NYYYH7[/']B>(=,
MU;_A*?.^PW<5SY7]G[=^QPVW/F'&<8S@UZAXV\,?\)CX0OM ^V?8_M7E_O\
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MNMK#4Y+26V_LF >>L;8/S#!7=[9Q6UX5\57=]9>*&U'4(C-9:G=06H8(A6-
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M^QPVW/F'&<8S@UZAXV\,?\)CX0OM ^V?8_M7E_O_ "O,V[9%?[N1G.W'7O7
M:CXU\30^$]2LGOX[?7M-UB#3Y;V&!"LD<C##[&! )4]*U+J^\6>$O$.B6.H^
M)HM;@U><VNU["."6!MI(D79PP'<$5*=]OEYW5T#E;?IO]]CBO^&9?^IN_P#*
M;_\ ;:/^&9?^IN_\IO\ ]MKHM2M_B'I_C#1M _X6)YG]I1S2>?\ V+;CR_+
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MZA=:MX+T;4+V3S;JYLXY97VA=S%02<# 'X4+57\D_O'?6WFU]QXW_P ,R_\
M4W?^4W_[;6AH7[/']B>(=,U;_A*?.^PW<5SY7]G[=^QPVW/F'&<8S@UVFI:G
MKWB'QO>^'=!U==(@TRWCENKH6R3R/))DJ@#\  #)/6N8UGQWXJL/!6KP+/$?
M$6D:K%9-/%"NVY5R"IV'(!8'! _"IYE:_P#5KVO_ %TU&]';^MKGH?C;PQ_P
MF/A"^T#[9]C^U>7^_P#*\S;MD5_NY&<[<=>]>/\ _#,O_4W?^4W_ .VUZ"/&
MMQJEWX&N-.F\JTU>25;N$HI.5B)*$D9!##MCI6AX'UO4-8O/$\=_<>:MCJ\M
MM;C8J[(P%PO &>IY.35V=VNU_P &E^HKZ7]/QO\ Y,\N_P"&9?\ J;O_ "F_
M_;:/^&9?^IN_\IO_ -MKTH^(K[P_X]FTO7;L/I.HQ&?3;AT5!"R#+PL0!GCY
M@3S4_@C5]6\2M?Z]<RM'H]Q)LTRU,:@^4O'FDXW$L>@S@"E'7;^NEO6_]6!N
MSM_7<3X<>!?^%?\ AZXTG^T?M_G7;7/F^1Y6,HB[<;F_N9SGO78444#"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BN6F6UE:W17F"$
MQJQP"V. ?QKQ;6_B/\3_  [=:;;:GX;T.&;49O(ME$C-N;(')$AQ]X=:]NKR
M#XS?\C3X!_["@_\ 0XZ25YQ7=I?F-_#)]DW]R+>K>./'GAGP-J>M^(-"TNUN
MX)H4MHXY"Z.K-ABVUR>.,<BM'QIX_P!1\->'?#6HVMK:RRZK/#'*LH;:@=-Q
MVX(_7-0?'C_DE5__ -=X?_0Q7E_C+PSKFC:%X2O=2\67.K6MS=V_E6DL&Q8,
MKD8.XYP..@HB[RL_YHK_ ('S,JEXIM/[,G_7H>Y>.]7\1:)X?.H>';"TO)82
MTEPMTV%2)5)+###)X'%8WPO\7^*/&=A)J>L:986VFR+_ *++;,=SL&(8$%B1
MC'I73^+_ /D2]<_Z\)__ $ UR?P/(7X3:8QZ!YB?^_C4X?;OTM^-_P#(TEM&
MW5_DKF3)\1/''B#4]6_X0O0--N--TN9H))+QSYDK+G.T!UQTXZ]17=>"?$EQ
MXJ\-0ZC>:9/IUUN,<MO*A7##NN0"0:\UA\%VNOWVI^(_AEXTN-/=YV%S;A'6
M(R]2"#@@<YY5ASQ77?";QCJ/B_PS<2:L(S?6-RUM++& %EP 0W''?MQ13^&S
MWLG_ ,%>3_R%/XK]+M?\!^9WU%%% SR/4?B#XZNO'FM^'?#&AZ7?#3=K'SW*
M.5*@]2ZCJ<59TKXK7U[X8\3O>Z0ECX@T&%I);5R6C;&<=\]1SSZ<UREM#XLG
M^.'C%?"5UIEO<A8_.:_#%2FU<;=JGG-;%SX$U#PSX \<:SKNHQ7VMZI:.T[P
M@B-0 3@9 S^0Z"LKM4N9_P OXWZ!O.R[_A;6Y6C^*_CZS\/VOBC4_"VG2>'Y
M=I::VF*N%+8S@N2.>.17:^,OB/!X>\,:9J.G6IOKW5RBZ?;DXWE@""WL,C\2
M*\1ABUS_ (1CPIIWB?7IHO!.I@!/LT"?NF#'".V >O.23].*[_XEVUMI7CCX
M;! J:9;SB).ZJ T8'/TQ6[5VH]Y6\[6UOY]O)F:DTG+M%OR\K?J:5A\1?%VB
M>*-+TGQWHEA9PZHVRVN;)R0K\##99NY [=>]:UM\0+O3?'^H^&_%$5I:0K";
MFPNX]RK-&,D[MQ/( /3N#[5A?&TB?4_!=G%\UW)JBLBCKC*@_J163\=-GB?5
MM-\,:/8?;=;MT>[E=#S%$%SM_'&<>P]:RYM$_-KY6O?Y=?(TM[S5^B?XVM\S
M>L?B#XPUSPEKGB;2=)T_[#:2G[#%-'(9+B)3\['##D#T'7(K6O/BC8P_"Z+Q
M=;HDD\Z".&VR>;@\;/7@Y/T%:/PTUK2]=\!:<^FP)!%!$+>6V'_+)U&&!^O7
MWS7ENC>$+1/CU<^'C+(VCV#'58+,_P"K65@G&/0%A^0K1Q]_V?3OZ;_>M5YD
M*3Y/:=NGKHE\GIZ7/;O#T^J76@6=QK4,$.H2QAYHH 0L9/.WDDY Z\]:TZ**
M&[NY25E9D-W=0V-G/=W#A(8(VDD8]E R37D$7Q+^(&MZ?=>(?#WA6PD\/0,V
MW[1(?/E5?O$88?R/XUZ%X_BEG^'OB". $R-838 &2?E-<]\([^R@^#VFW,DL
M:06T4OGL>BX=BV:S_F=]DOQOO]Q3^RK;M_@O^"=+X1\5VGB[PM;ZY;HT$<BG
MS(W/,;+]X9[CWKB?A]\7)?&7C74=%GMK:&V57>QDCW;I%5L?-DXSCGC'>K7C
M/XA:9+\(+_7=$G9H[I39V[&-HR';Y3@$#H,]..*\6TSQ?X?TC4/ UWI N$N]
M+S#J+2QA5D5VRQ!!.<;G'/M6D=:K5M-%;S?7Y:?>9NZI7ZZO[NGSU^X]C\7>
M/?%MC\1(_"GAG2M-O97M%N!]I9E)ZYYW@=!5KP=\1M3UB_UC0]?TB/3=>TR$
MS-%&^Z-UP/<^H[G@]:XOQO#K]Y\=XO\ A%K^*TU/^Q]\,KHKA@ Y*_,".>F<
M5H_":"SU"Q\2:]?7US=>*71X-06X0(8< \ #M\HYXZ8P*R3?LI/RD_/=I6]+
M:E-^^DN\?R3=_7H5](^+/Q OM ;Q(/"FG7>B0LPG>VE*2*%QN."Q/3_9->N^
M&_$%EXI\/VFL:>Q-O<+D*W5"."I]P<BO,?@Y/!:_!&^GNG5($>Y+L_0#:*T_
M@%!/#\,HFF!"2W4KQ9_N\#/Y@UM]J4>R3^\S4FU&7=M?<>H4445)J>2^/?B!
MXW\*>*+>PM-&TJ6QOYQ!I\DS,7E;"YW8<8^9L<@5W4FO7>C>!GUSQ%:I#=VU
MJ9KJWMVW ,/X5.3[=S7 ?&;_ )&GP#_V%!_Z''7HOBRXT6W\+:@WB%PFDO$8
M[EBK-A6XZ*">_:HU]BVM[M?=;_/\BFOWB72R?XO_ "_,\RC^(_Q(_LFV\2MX
M2T^;09V5EBMV=[G83@'AC_Z#WKV&SN1>64%RJ/&)HUD"2+M9<C.".QKPB]\/
M:_\ #[PJ/%/@WQK+=Z!&JSI97:_*T;$8QGCOZ*?QKVGPWJ_]O^&M-U8Q>4;R
MW28Q_P!TD9(K72SMT?S6GXF6MU?K]S_R-2LCQ3?W^E>%]2U#2X8IKRV@::..
M4$J^WDC (/0&M>FNBR1LC@%6!!![BLYIN+Y=S2+2>IROA?QK#KGP[B\4W(CB
M"V[R7*I]U&3.X#/T_6J'@SQQ?ZQ\/;KQ9KEM;6L*>;+&D(8 Q(.IR3DD@UXS
M>ZK<>%M$\6?#B(M]IN=32*R7UBD//Z!?^^J[OXM7,7@OX0:=X9MWVO<K':?+
MUV* 7/XD?^/43E>+G'K9+U>K^[;Y"BFI*#Z7;]%M]^YM_"CXFW/C\ZE#J%K;
M6UU:E7C2#=AHVSR<D\@C]:TY?&M]'\7X/!XM[?[%)8FY,Q#>9N^;CKC''I7D
M/A3QCX?M?BWH,^@^?%8W%E'IETMQ&(\N!M5N"<Y(2NYN?^3GK/\ [!!_D]:.
MW-"VSYOP3_X#,G)\LN^C^]K\M4>NUXWKGQ$^(FF>.(_#4&@:,\]VTCV*O(V9
M(@6P2?,P"0O?%>R5Y!XL_P"3B_!__7F_\I:F*O4BN]_R;_0V>D)/LO\ +_,W
MOB1XWUGP9H6CW%E96<U]?7"V\D<^XHK%2>,,._'6L_2_B5XATOQ-9:'X[\/P
MZ6VH-LM;NVE#1,V< 'EO4=\C(XJG\>O^0;X8_P"PO'_(TSX[$7 \)V%N0U_+
MJBM$@^]C&,_3)%*#N]>LK?)VV]+F<[I-+I&_S5]_N/8**09P,]:6F6<[XW\7
M6W@GPQ<:Q<1F9E(CAA!P9)#T&>P[GV%>?/\ $WQQX=;3M1\7^&["VT.^D5!+
M:N?-AW<C<"YYQSC Z'I4W[02L/"NCS$$P1ZHAEXR,;6ZU/\ ':XMW^%T2JRL
MUQ=0>0!SN[\?A4Q=O>W]Y*WEI^+O^ VKM1VT;O\ ?^5BUX\^*,G@OQ?H5@UO
M;R:5?('N)FSO12V,KSC Z\BMG5/&-U9_$G0/#D$-O)9:E;23/,<EQM!(VD'&
M./2O/_&OAZ'Q!\1/!^AWZ\3Z-+$Q/5'$;8;Z@@'\*P/!6JW]U\5_"VC:JK#4
M-#BN;"5F_C"J^T_EQ^ JH*\E%]Y?-+F7X-+[S*4GR\WDODW9_CJCUKX>^-;[
MQ==^(H;RWMX5TR^-M$80V64%AELD\\=JL?$7Q+K/A+0$UG2[*WN[>"5?ML<H
M8LL1.-RX(Z>^>OM7)?!+_D)>./\ L+M_-Z]7N[2"^LYK2YC62"9#'(C#(92,
M$5.OLXM;V3]=$_Q+BUS23VNU^/Z'$>+OB,FE>&-)OM!BBO\ 4-9=$T^!\D/N
MQDD @\9Q]37;V?VG[%!]L\K[5L'F^4"$W8YQDDXS7A7PF\-1#XE:W!=7,MU#
MX:=[?3XY>1&'=N1Z'@_G7O=7IRW777T71?YBUYK/IIZOJ_R_$*XWXF^+=0\%
M>%!K&GV]O.ZW"1NDX;&UL\C!'.<5V5<%\9[,WGPJUD <Q+',/^ NI/Z9K.<N
M57[6_-&L%=V.LO=4^R^&[C5@JGRK1K@ ].$W5YE<_%;7+;P!X9U]K"P^TZM?
M&WDCVOL5,L 5^;.>.Y->?7WCW4Y=/OM39)/[ O-(_L2%\'!G2(-G'NS,,_X5
MK^.[&2W^#_P]M$<PRM/#A\9*,R$YQ[$UI;WK]+Q7XO\ -6^31S\SY$NMF[_]
MNK\G?[CU#Q5XUOM!\=^%]!M[>WDM]7=EFDD#;TP0/EP<=^X-<WJ'Q!\=77CW
M6O#GAC0]*O5TTJ29W*-M('))< \GM7,:KX<UGP[\6_ \>L>)[C76FN&:-YH?
M+,0!&0/F;.>/RIT7A[5_$7QO\8P:/XDN-"DC$;O+!%O,@P@V_>7'K41UM_V]
M^%K?<7)V;_[=_&_YG=2>*_'&C>!]>UKQ)HFFVEW9(KVL<4F]).<'=AR?3N*B
MT_XHR:I\(KWQ9;06W]I62%9[8YV+(".V<X(((YJKXI\/ZMX>^#WB>WU?Q'<:
M[+)'O2:>+88URHVCYF^M>7:_;R^!_#2&WC;^R/%.BP[T4<1W*JI)_'K_ ,"/
MI2D_B2\K>MK_ (V:]2DM8^KOZ:+\+W^\^E?#NI2ZQX;TS4ID1);NUCF=4SM!
M902!GMS6E6!X'_Y$/0/^P?!_Z *WZWJI*<DN[_,BFVX)LCN)TMK:6>0XCB0N
MQ]@,FO'(?B9\0M:TNY\1Z!X8TZ;0(78*LKLUQ(JGD@!QS[;3WZUZ]J-Q:VFF
MW-Q?,%M(XF:8E20$ YX')XKQ"+P;<Z;H%UXK^&GC>>+20)+@64ZL(CLR6'S?
M0CYE_&L&[-M[)?=KU^1I9M)+=O[_ $/6;36]0U?P2-7TW36CU*:V,D-E=@IB
M7!PK9QQD=>.*X'P9\0?'?B/QE<:-=Z)I,<&GSB+47A=@T0Y&5RY#<KV!KM/A
MUXGG\8>"+#6+J)8[B0,DH484LI()'L<9KB?A9_R5'XB?]?B_^AR5M:U5I]F_
MNM_G^1FG>E?K=+[[_P"1L^+O'^LVWBV+PEX0TJWU#6/*\Z=[I\10K[X(YQCN
M.HZYJ/PY\0]=N)M=TCQ%HD=EK6EVSW :#<UO* N1SDXZ@]3D>E8WATM;_M%^
M*XY2!<3V2M;[QU&V/I^7Z51TWQEXSG\5>(/"?B::Q?[/I4\K"UCP-WE@C#?1
MJY[OV=^KBW]U]O2QI:\WV3BOOMOZW.E\ ?%&3QAX0U>^G@MH=5TU'D>"/.QE
MVDJV"2<<$'GM4-S\3=5A^"\/C1;.S-_(X4PD-Y7^M*?WL]!ZUY5IMO+X/\%:
M#XQLHV-IJ-M<:=J:(.NYG".??I_WR/6MZ^_Y-2M/^NR_^E!K2IHI-=.5?.^O
MWJQ$'K%/K?[K?HTSL[#Q+\7[U+:X'A31#:S!'#BXP=AP<X,N>A]*D\6^/O%U
MC\0D\*^&=)TZ]F>S%R!<L58]<C.]1VJOX;^'WBX6ND7Y^)%^;79#-]D^RG;L
MP#Y>?,Z8XZ?A3+G_ ).>L_\ L$'^3U<E[ZCYO\$_\B%)\G/Y+TU:_P SH? _
MQ"G\0ZM>^']=THZ3K]DN^2WW[E=>/F4_B/7KG-=Y7CQ/VO\ :=5K-@ZVNF;;
MHK_"<'@^_P RU[#4I\T(R[_YM?C8O:4H]OU285@^-/$:>$_".HZTRH[V\>8D
M?H[DX4'\2*WJ\4^/OB&UM_[!T"YD<6T]R+J\$8RWE*<8Q[Y/Y5$ND4[7:7]?
M*YHNK[:G9?"[QW-X\\-SWMW#!!>V\YBEBA!"@8RIY)/(_E69\./BC)XQUO5]
M'U&"VM[RT=F@$.0)(P2#G)/(X_.N+^&?C#2)OC#K$.C^;%I>M1>9%%,@0I*H
MR1@$C^_7.Z-87&CZ'-X]TQ";O2-=F2Z5?^6MNVT$'Z9/_?1JV_>N]$X_<[VO
M]]ODS+7E:6Z?WZ7M^:]4>L:/\1M3U'X>>)?$4EI:+<Z5-/'#&H;8X0 C=SGO
MV(KGK3XL^-[/1;3Q)K7A2SD\.SA2;FREPZ G&2I9CU]0![UE>#YUNO@-XYN$
MSLEGNG7/7!136[%/!;_LO W#JJOIC(N[NQ8A0/?.*F3<%)]E#\5J4O>DH]&Y
M?@]#UK3[^VU33K:_LY!);7$:RQN.ZD9%6:X_X5P3V_PPT".Y!$GV;< >H4DE
M?T(KL*UFN632)IR<HILANYFM[*>90"T<;. >A(&:\3TCXL_$"^T!O$@\*:==
MZ)"S"=[:4I(H7&XX+$]/]DU[1J?_ ""KS_K@_P#Z":\F^#D\%K\$;Z>Z=4@1
M[DNS] -HK"4G'GEV5_Q9INXQ[NWX'H5AXRTS4O!!\50.18BW>=@W5-H.Y3[@
MC%<K\*/B;<^/SJ4.H6MM;75J5>-(-V&C;/)R3R"/UKR9=9FT/]G6*P=F1]8U
M"1(_7R007/TR,?C5[PIXQ\/VOQ;T&?0?/BL;BRCTRZ6XC$>7 VJW!.<D)6R2
M=5KIM\[7_/0R<G[-/Y_).WY7?R/0_&_C'XB^%Y-3U"WT#27T&U(,=S+*2[*<
M#)429SD^E3>$O%?Q"UA(-2U70=*@T2:U:X6X@E^<_)N3Y2Y/)QVK4^,7_)*=
M=_ZYI_Z,6K7@_P#Y))I/_8)3_P!%UBVU3F^J_P#D6S9J\H+O?\&C@_#OQ"^*
M?BO2AJ>C>&=$GM"[1[S*4.X=1AI :W?&/CSQ5X2\'Z'>7&EZ>NM7US]GGMV9
MFC0D'&"K>P[FN!^%7@OQ+KW@M;S2_'5YHUM]HD06L-N77(QEL[UZ_2NB^,-E
M<Z=X5\&V=Y?/?7,.IQ))=.NUI6"GYB,G&?J:VDK-+NX_CN8<SY7+LI?A?_(V
M=+^)7B'2_$UEH?COP_#I;:@VRUN[:4-$S9P >6]1WR,CBO4:\?\ CL1<#PG8
M6Y#7\NJ*T2#[V,8S],D5Z^,X&>M3%WC?LVOR_P RWI.WDG^8M%%%!04444 %
M%%% 'G_QBFCMO!4$\SA(H]2M7=CV D!)K.U/6[+XD>(O#MGX<:6[L-.OEO[R
M]$+)$FP':@+ 98D]!7J-%*.COYW_  L*2O\ =;\3YVTC_A5GV[7O^$S\C^T_
M[8NMN_S\^7OX_P!7QZUWGQ#N],O?@]'/HTBOIK2V@MV4,!L$R ?>Y[=Z]-HH
M2M%1[6_"W^7X@U=M][_C?_,X/XH237GAVQ\-V<OEW>NW4=HK8W;(_O2,1W 4
M?K7.WNDZYX,\7Z!K>KZ_%J=K<'^R)3'8+;>5&X^3.UCD!@.O2O7J*+?G^%K6
M^YO[P:NK>5OUO]Z7W'DW@SQ?I'@3PU-X;\07!M=3TV>94MVC8O<HSED:, ?-
MNSVJNVE6?C?XJV?_  D^A+&9/#RSFRED+&%O..,L,<X/ZUZ\\,4DB2/&C.GW
M6*@E?H>U/IIW:E+5_P# M_P?R&^J77_.YYQ\---L]'\4^-]/T^W2WM(+Z%8X
MDZ*/*!_K5SXIR37F@6?ANSE\N[UV[2T5L;MD>=TC$=P%'ZUW=%*UU%/I;YV$
MM+M=;_B>1W>EZYX)\9>'M>U?7XM3M9F_LF4I8+;"*-^4SM8Y 8#KTK ETRZ7
MX8R^(],3=?:7?Z@'4?\ +6WDD=9%/T!#?A7O=%*4;IK^M[_Y_>"233_K:W^7
MW'@G@CQ7HGA3Q!!-K5\+5)_#EBD68V<NP!. %!-=_P##^VN;W6/$GBJ>VFM8
M=7N(_LL4Z;',,:[0Y7J-W7FN\HK1RO+F]?Q=_P#@$J%E;Y_<CS_XQ0QW/@J"
M"4$QR:E:HP!(R#( >1R*P[/0-*^&/Q&MI?L<9T?5QY%M>3$O)93_ ///>Q)V
M,.F>?>O7**B/NN_G^%K6*DN;[OQO>Y\[:1_PJS[=KW_"9^1_:?\ ;%UMW^?G
MR]_'^KX]:[SXAW>F7OP>CGT:17TUI;06[*& V"9 /O<]N]>FT4)6BH]K?A;_
M "_$&KMOO?\ &_\ F<-\5;6XG\!M/;0O,UG<V]TZ(,L41P6P/89/X5CS:]IO
MCCXB^$Y?#UR+V#35N+F[E13MB#(%522/O$]J]1ID<,4(811H@8[CM4#)]:%H
M[^=_G:PFM-.UOE>Y\_6'@"WUCP;?>(K&S%SJ]GJMS(UM*[-%=QI(<QLA.,XS
M@C'-;.E)I?Q'UGQ(FF,D,4^CV?D!  ;69"Y48'0JP'%>UT4DK*WE^-DK_@GZ
MC:N[^?ZMV_&WH>8?!>\O;^P\1W&I1>5?-JS"X3T<1H&_45Z?115MWM\OR!*U
MS@OA7_R#?$/_ &'KS_T(5ROAGP5X<\01>,M1U728+J[AUB\6.5R<@#! X/J:
M]GHK-QO&W]VWY:_@4G;[[_GI^)\_ZGK^EV/[/_A_2KF[6.]N4AEBB*G+(DX+
M'.,<"O3M9\8:=-X*CUNPL1KNC2RB*Z"H3MASM=]A7+8QTX]:[*BKEKS>;O\
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MI\*!8Y69?.4@Y# [<9Y]*;J/PZT?5_!MKX:U&:\NH+0 6]U+(OGQD< A@H'
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M$"1QH,!5'058HIW=K!97N%%%%(9YWXE^#>A^*=>FUB^U76XYY'#B."X01QD
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MGXL^'^E^,=&L-,U"[OXHK%U>*2WD57)"[1DE3^@'-4?#7PG\.^&=775DDO\
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MV[>_WD_[YH_MV]_O)_WS73;$_N+^5&Q/[B_E0!S/]NWO]Y/^^:/[=O?[R?\
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MTH6-@"%4@\@@4NQ/[B_E0!S/]NWO]Y/^^:/[=O?[R?\ ?-=$LELTSPJ\1E0
ML@(W*#T)':AY+:.6.*1XEDDR$5B 6QUP.] '._V[>_WD_P"^:/[=O?[R?]\U
MTVQ/[B_E1L3^XOY4 <S_ &[>_P!Y/^^:/[=O?[R?]\UTVQ/[B_E1L3^XOY4
M<S_;M[_>3_OFC^W;W^\G_?-=-L3^XOY4;$_N+^5 ',_V[>_WD_[YH_MV]_O)
M_P!\UTVQ/[B_E4#7-D@F+3VZB'B4EU'E_P"]Z?C0!@?V[>_WD_[YH_MV]_O)
M_P!\UTH6-@"%4@\@@4NQ/[B_E0!S/]NWO]Y/^^:/[=O?[R?]\UTVQ/[B_E1L
M3^XOY4 <S_;M[_>3_OFC^W;W^\G_ 'S73;$_N+^5&Q/[B_E0!S/]NWO]Y/\
MOFC^W;W^\G_?-=-L3^XOY4;$_N+^5 ',_P!NWO\ >3_OFC^W;W^\G_?-=-L3
M^XOY4;$_N+^5 ',_V[>_WD_[YH_MV]_O)_WS73;$_N+^5&Q/[B_E0!S/]NWO
M]Y/^^:/[=O?[R?\ ?-=-L3^XOY4;$_N+^5 ',_V[>_WD_P"^:/[=O?[R?]\U
MTVQ/[B_E1L3^XOY4 <S_ &[>_P!Y/^^:/[=O?[R?]\UTVQ/[B_E1L3^XOY4
M<S_;M[_>3_OFC^W;W^\G_?-=-L3^XOY4;$_N+^5 ',_V[>_WD_[YH_MV]_O)
M_P!\UTVQ/[B_E1L3^XOY4 <S_;M[_>3_ +YH_MV]_O)_WS73;$_N+^5&Q/[B
M_E0!S/\ ;M[_ 'D_[YH_MV]_O)_WS73;$_N+^5&Q/[B_E0!S/]NWO]Y/^^:/
M[=O?[R?]\UTVQ/[B_E1L3^XOY4 <S_;M[_>3_OFC^W;W^\G_ 'S73;$_N+^5
M&Q/[B_E0!S/]NWO]Y/\ OFC^W;W^\G_?-=-L3^XOY4;$_N+^5 ',_P!NWO\
M>3_OFC^W;W^\G_?-=-L3^XOY4;$_N+^5 ',_V[>_WD_[YH_MV]_O)_WS73;$
M_N+^5&Q/[B_E0!S/]NWO]Y/^^:/[=O?[R?\ ?-=-L3^XOY4;$_N+^5 ',_V[
M>_WD_P"^:/[=O?[R?]\UTVQ/[B_E1L3^XOY4 <S_ &[>_P!Y/^^:/[=O?[R?
M]\UTVQ/[B_E1L3^XOY4 <S_;M[_>3_OFC^W;W^\G_?-=-L3^XOY4;$_N+^5
M',_V[>_WD_[YH_MV]_O)_P!\UTVQ/[B_E1L3^XOY4 <S_;M[_>3_ +YH_MV]
M_O)_WS73;$_N+^5&Q/[B_E0!S/\ ;M[_ 'D_[YH_MV]_O)_WS73;$_N+^5&Q
M/[B_E0!S/]NWO]Y/^^:/[=O?[R?]\UTVQ/[B_E1L3^XOY4 <S_;M[_>3_OFC
M^W;W^\G_ 'S73;$_N+^5&Q/[B_E0!S/]NWO]Y/\ OFC^W;W^\G_?-=-L3^XO
MY4;$_N+^5 ',_P!NWO\ >3_OFC^W;W^\G_?-=-L3^XOY4;$_N+^5 ',_V[>_
MWD_[YH_MV]_O)_WS73;$_N+^5&Q/[B_E0!S/]NWO]Y/^^:/[=O?[R?\ ?-=-
ML3^XOY4;$_N+^5 ',_V[>_WD_P"^:/[=O?[R?]\UTVQ/[B_E1L3^XOY4 <S_
M &[>_P!Y/^^:/[=O?[R?]\UTVQ/[B_E1L3^XOY4 <S_;M[_>3_OFC^W;W^\G
M_?-=-L3^XOY4;$_N+^5 ',_V[>_WD_[YH_MV]_O)_P!\UTVQ/[B_E1L3^XOY
M4 <S_;M[_>3_ +YH_MV]_O)_WS73;$_N+^5&Q/[B_E0!S/\ ;M[_ 'D_[YH_
MMV]_O)_WS73;$_N+^5&Q/[B_E0!S/]NWO]Y/^^:/[=O?[R?]\UTVQ/[B_E1L
M3^XOY4 <S_;M[_>3_OFC^W;W^\G_ 'S73;$_N+^5&Q/[B_E0!S/]NWO]Y/\
MOFC^W;W^\G_?-=-L3^XOY4;$_N+^5 ',_P!NWO\ >3_OFC^W;W^\G_?-=-L3
M^XOY4;$_N+^5 ',_V[>_WD_[YH_MV]_O)_WS73;$_N+^5&Q/[B_E0!S/]NWO
M]Y/^^:/[=O?[R?\ ?-=-L3^XOY4;$_N+^5 ',_V[>_WD_P"^:/[=O?[R?]\U
MTVQ/[B_E1L3^XOY4 <S_ &[>_P!Y/^^:/[=O?[R?]\UTVQ/[B_E1L3^XOY4
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M77*:S_R%9_\ @/\ Z"*ZN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=UW!$"].,98^O2M?2-#_ +*U76K[[3YO]IW*S[-FWR\1JF,Y.?NYSQUK+O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@
M-9^(YTOXCV7AI;)7L7,<5U>%C^YED#&-?3G:/SKO)I4@ADFD8+'&I9B>P')K
MYWEB\6>(?"GB#5[3PT)K?5;PZE#J/VU$>)83^[Q&1DX"GZYJ>:TKO9:O[[?Y
MOY TW&RW>B_/_)?,]?U_7[[3O'?AC2+=HQ::B+G[0&7).Q 5P>W-/^'VO7WB
M/PP;_4&1I_M4\647:-J2%1Q]!7)2ZU'XA\7?#/5HSQ=6UW(P]&\H;A^!S6U\
M(?\ D1C_ -?]U_Z-:K2:NGTO_P"E6_(ERORM=;?^DL[RBBBD4%%%% !1110!
MR'Q"\8W'@[1K>>QL1?7]S-Y4-L21N 4LQX] #3/$/BZ6/X5S^*=)9!*UFEQ"
M67< 3C@CVR17*^)[_6M5^+"+H>AQZU'H-H5EA>Z6!5EG')RW4[1C'O7/VMW=
M6WP9\9>&-1@^S7NCN5\CS ^R*1@ZC<.H&2,U";<&_FO2Z7_!'M42Z;/U:O\
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M\#^MI=VI>B_(LS:\EMXJMM#F@9#=6SSP3[OE=D(W)CL0"#4.E^(I-:TB^O\
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MUO\ \#^K)IJ.GG_P/^"7KOQK?_V_J>BZ5X:N=1NM/*-*PN8XHRC*&!#-_%U
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MIGAZ\NM-M?/GCB<_ZQ4\L!2=_P W!Q@<=ZV*JZE:?VAI=W9[]GVB%XMV,XW
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MMKH>@:DNI3M/'>:@2);-F W978?,&<D#(ZXKTC2;!=+TBSL%*E;:%8LJ@0'
MQD*.!]!41^'7?3_@_P!?F:/XM-OZL7****8PHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^?_ /AIK_J4?_*E
M_P#:J/\ AIK_ *E'_P J7_VJO0/^%)?#S_H7O_)VX_\ CE'_  I+X>?]"]_Y
M.W'_ ,<H \__ .&FO^I1_P#*E_\ :J/^&FO^I1_\J7_VJO0/^%)?#S_H7O\
MR=N/_CE'_"DOAY_T+W_D[<?_ !R@#S__ (::_P"I1_\ *E_]JH_X::_ZE'_R
MI?\ VJO0/^%)?#S_ *%[_P G;C_XY1_PI+X>?]"]_P"3MQ_\<H \_P#^&FO^
MI1_\J7_VJC_AIK_J4?\ RI?_ &JO0/\ A27P\_Z%[_R=N/\ XY1_PI+X>?\
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M7:$3!.Y>^?:O2(HD@A2*)0D:*%51T ' %/IM*[MMT^ZR_#\24FXZ[]?F[O\
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MKJ$FG7=C%=F-(8[Z\:XN&5 >9#O95Y)P >G6J2NVGY_I_P '[B;O2W];_P#
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_^-O_ "2'7?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#TS@?E5BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\_^-O_ "2'7?\ MW_]*(Z] KS_ .-O
M_)(==_[=_P#THCH \_\ V9?^9I_[=/\ VM7T!7S_ /LR_P#,T_\ ;I_[6KZ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>?\ QM_Y)#KO_;O_ .E$=>@5Y_\ &W_DD.N_]N__ *41T >?_LR_\S3_
M -NG_M:OH"OG_P#9E_YFG_MT_P#:U?0% !1110 5C>(O^/>'_>/\JV:QO$7_
M ![P_P"\?Y4 6=$_Y!<?U;^=:%9^B?\ (+C^K?SK0H **** "BBB@ HHHH *
M*** "BBB@ HHHH Y36?^0K/_ ,!_]!%=77*:S_R%9_\ @/\ Z"*ZN@ HHHH
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M"BOG_P#X6G\7_P#H0O\ RCW?_P 71_PM/XO_ /0A?^4>[_\ BZ /H"BOG_\
MX6G\7_\ H0O_ "CW?_Q='_"T_B__ -"%_P"4>[_^+H ^@**^?_\ A:?Q?_Z$
M+_RCW?\ \71_PM/XO_\ 0A?^4>[_ /BZ /H"BOG_ /X6G\7_ /H0O_*/=_\
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M6G\7_P#H0O\ RCW?_P 71_PM/XO_ /0A?^4>[_\ BZ /H"BOG_\ X6G\7_\
MH0O_ "CW?_Q='_"T_B__ -"%_P"4>[_^+H ^@**^?_\ A:?Q?_Z$+_RCW?\
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MWC$4EU"'=!T5NAQ[9!I_U^=G^ E*]OZ[?YFE>7EMI]G->7DZ06\*EY)9#A5
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6-XB_X]X?]X_R
MK9K&\1?\>\/^\?Y4 6=$_P"07']6_G6A6?HG_(+C^K?SK0H **** "BBB@ H
MHHH **** "BBB@ HHHH Y36?^0K/_P !_P#0175URFL_\A6?_@/_ *"*ZN@
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MW;'7T8<,I!!!IM?$OZTNOU%=/E=_Z>OZ&9\.+2YL?!=O!=V\UO,)[@F.9"C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGI/@7PWHFH17^GZ=Y5W$C1I,T\CL%;&5RS'CC@=!VQFK'_")Z)_8W]D?8O\
M0/M'VGRO-?\ UGF>9NSG/WN<9Q^%-:._]?'S?EI_P#/D?+R^7_MKC^>O_!.+
M\2^#_#VH_%?11>:1;3"^M;J6YW+_ *UU\L*3[@5T7CSP]I&H^"[[[9I\$_V"
MRF>UWKGRF$9P1^0K6USPUI/B..%-4M3,8&+1.DKQ.A/!PZ$,,]^:LG2K(Z,=
M(,)-B8/LYB+L?W>-N-V<].^<UG*-Z;@O/^OD;1=JBF_+^OF5/"?_ ")VB_\
M7C#_ .@"L/X8_P#(L7?_ &%;W_T>U==:6L-C9PVELFR""-8XUR3M4# &3STJ
M#2])L=&M7MM/@\F%Y7F9=[-EW8LQR2>I)K63O.4N_P#G<QC%J$8]O\K%VO$_
M&-M:ZG;^*=7M=$DU![1I4_MB]OQ%]D>-1\L"J"<*1Z#)/6O;*YF]^'WA;4;Z
MYO+O24DEN23,OFR".1L8W&,-MW?[6,^]92BWM_6QJFNIKZ'-)<>']-GE8O))
M:Q.['J25!)KG_B-9RZCX<ALX+JVCEFNX@MO<RM''><Y\DLO(W8_3TKJ;2UAL
MK.&TMU*PPH(XU+%L*!@#)Y/'K4&K:1I^N:>]CJ5LEQ;.02C9&"#D$$<@CU'-
M74]YMKO^MR*:<8I/M^ECRJ/R+/P+XZTA=(N=&NX;(RRZ:;E9[>(-&0&A8#@-
MM)(/>M^>1#XK^'BA@6^QW# 9[>2G-=7I7A;1=&L;FSL;%5ANL^?YKM*TO&/F
M9R6;CCDU4TOP%X9T:_@OK#3!%<V^X0R&>1R@(P5&YCA<?P]!V%'7[OP4E^J^
M[T$XZ:>?XN+_ $_K4XC2='T75_#5]XJUV\EMM7COIC)J*R-YMILF*K&H[
M;<<Y]ZU#H^F^+O'7B"W\0Q_:8M/AMQ90R.56-'0LTJ@$88MD9[;:Z6X\#>&K
MK5SJDVEQM=-()6/F.$=QT9HP=C-P.2":EUKP?H/B&XCN-3L/-G1=@D25XF*_
MW6*,"R^QR*FVB7];)7_#RWWOJ5;5_P!=;V_3Y=M#@/$<LMWI_@W1]-=O$&EW
M1F#_ &F[-N+WRU^57?:<]SC'S;:;96M_;^&O%^D//9>'H%\H6]NNH&=;-G'*
M%P 45^, =-QQ7I%_X:T;4](BTJ[T^)K*';Y,293RMO *%2"I'J"*CL_"FAV&
MCW&DP:=']BN<^?'(6D,I/4NS$LQ]R:;5^;SO^G^7G^=Q+;RM^O\ GY?E;C/
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M] /3MFNONG5OB;X14,"?[+NC@'L1'S6_IW@WP_I5M>V]GIJ)%?($NE=VD\X
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M>^%9=0-\VD)Y_GK< B60*LH;=O50VU3D<X SWS73U=]+;:_=HE^G]:A;6_\
M6[?ZA1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6\@N( J GYRY7)Z'"]JA\3>.IK#Q.^AV.HZ!ITEO;K/-/K,^Q7+$[410RDG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;Q%_Q[P_[Q_E6S6-X
MB_X]X?\ >/\ *@"SHG_(+C^K?SK0K/T3_D%Q_5OYUH4 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %8WB+_CWA_WC_*MFL;Q%_P >\/\ O'^5 %G1/^07']6_G6A6
M?HG_ ""X_JW\ZT* "BBB@ HHHH **** "BBB@ HHHH **** .4UG_D*S_P#
M?_0175URFL_\A6?_ (#_ .@BNKH **** "N;^($,MQ\/?$$4(+2-8RX ZGY3
M724C*&4JP!4C!![U,E>+2*B[-,\_UB6.]N/AV+1@Y>Z6==O_ #S6W;<?IR!^
M-6-5M+>T^*7A46T$<(DBOY'$:A=SL$)8XZDGO6YI'@WP_H5^][ING)!<,I4-
MYCL$4G)5 Q(0'T4 5H3Z397.JVFIS0;KRS5T@DWL-@< -P#@YP.HJV[M/S;^
M^YE&-H\ODE]QS?Q*9HO#EG<QDB>#5+-XB#@[O.4?R)%=C7/Z_I5SK.KZ- 8L
M:;:S_;+B0L/F=!^[3'7[QW9Z?+[UT%*.S]?T2*?Q?+]6SC_BD"?AIK8!P3",
M'T^9:G\.Z'XFT^\6?5?&#ZK:&+ M6TZ&'!.,'<G/%;NJ:79ZUIL^G:A#YUI.
M-LD>XKN&<]00>U6U4*H4= ,"B.E_/_*P/6W]=4>6^"?!ND:W;7VHZ@MS+=VN
ML7*VLHN'4VZI,2%3!X!.<^N:Q]5M=0U_Q'XKGN- M]2:PG,-O<SZL;9K!!&&
M#(NPXSDMNSST[5Z]IFDV.CP2PV$'DQRS/<.-[-F1SECR3U/;I69J_@GP[KM\
M;W4=-66X90CLLKQ^8HZ!PK ./9LU/+HEV5OG9*_X/L_,?=^?X7;M^/IY''1Q
M-XHUCPGI7B1X[RU?1WNW1')BNK@%!NXQNP"6'US7/.)M+\'W^F:2S7%K/XJ:
MTD+71BW1$CY#+@D D!,^]>N:OX9T?7;2"VU"R62.W.8/+=HFBXQ\K(05XXX-
M0V_@[P]:Z+<Z/#I<*Z=<N9);<DE68XYY/!X'3OS3>K;_ *?O)Z_+3_@:$*+2
M2_I:-?F[_P#!U.0\&6%YI7BR^TXZ19:+82V D;38-1^T_/NP) NU=H(R#ZX%
M1?#;P;I-YX:TC7;H7,NJ1R,T=R;E]R*KLJQCG&S ^[WKN-$\+Z-X=$W]F69B
M:?'FR/*\KN!T!=R6P/3.*N:7I5EHNG1:?I\/DVL6=D>XMC))/))/4FFM'?R7
MYM_K;_@#M=6Z7_2W]?YG$ZKH>EZ;\5_#5_9V,,-W>F\:YE0?-*1&,9I;S2;#
MQ7\2=5T[7XOM-K86,#V=K(Q"9<MOEP#RV0!GM7:W.E65WJ5GJ$\.^ZLM_P!G
MDW,-F\8;@'!R!WS5'6_">B>(I8IM3LO-FB4JDJ2O$X4]5W(02/8G%2E9)=K_
M ([?=_PQ3U;?>WX?YGGGB0W$6E^"8_"]\NJ7$6IRPVD]ZYVDB.1?F.,D+R,]
M]O>NK^&ZV3:#-,JR?VPT[+JS3G=,;D?>W'T_NXXVXQ6]_P (YI&S3$6Q1$TM
M]]FD9*K$=I7@ X/!/7/6I;?1K"UU>ZU2"#R[R[55G=7;$@7[I*YVY'3.,^]6
MM+^=_P!/SMK\B.7;Y?K^5]/F79'$4;2-G:H).!GI7G_C'5[/Q!X3\/7VG2^9
M%>:O9M"",,V)02,>HP<CVKT*N<LO 7A?3M=.M6FD117Y9G$@=RJLW4JA.U2?
M4 4E\2;VT?W.Y4M8M+S_ !5CHZ*HW^CV&IW-C<7D'F2V,WGVS;V&Q\$9X//!
M/!R*O4#.*^+"N_P]O%CD,;M/;!7 !VGSDYP>M:&@:)XDTZ\DEUGQ<^L6[1E5
M@;3XH-K9'S;DY/&1CWK8U72;+6[!K'4(/.MF97*;V7)5@R\@@]0*NTDK)^?^
M5@>MOZZW/+?A_P"#M)U;1XM8O1<RZA;ZA.+>?[0X:%(YF 1<'A3CD=\FKWB7
M0M+LOB1X3U2VL88K^[OY1<3J/FDQ V,G\!7;Z7I-CHME]DT^#R8/,>79O9OF
M=BS'))/))-%YI-C?WMC>7,'F3V,C26[[V&QBI4G .#P2.<TUHXVZ6_*S^\EJ
MZEYW_/0X?XF^'='U&[\/7=YIT$\\NJV]K)(ZY)B.XE#[9J_XNT?PGI/A&"VO
M=#@NK:V?9I]@ <O,W"H@SU)/Y9-=1J^C:?KVGO8:G;+<6SD,5)*D$'((((((
M/<'-8MS\/?#-Y86=E/8SO!9N\D'^G3AD9_O'>'W$GW)J;:./G?\ +\>WJ4_B
MYO+_ #_KY#/ /A"'PCH31>5%'>7<AN+I81A%<_P*.RJ.!^==763H?AK2_#B3
M)ID4\:S$%_-NI9LD=,>8S8_"M:K;N3%604444B@HHHH **** "BBB@ HHHH
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M3TL--M4M[923L4DDD\DDG))/J3FC6TK[N_XN_P"&WY:$N.JMT_R_4YSX7?\
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M:% !1110 4444 %%%% !1110 4444 %%%% '*:S_ ,A6?_@/_H(KJZY36?\
MD*S_ / ?_0175T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\1?\>\/^\?Y5
MLUC>(O\ CWA_WC_*@"SHG_(+C^K?SK0K/T3_ )!<?U;^=:% !1110 4444 %
M%%% !1110 4444 %%%% '*:S_P A6?\ X#_Z"*ZNN4UG_D*S_P# ?_0175T
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M6LCPU\0M,\2ZDVFK8:KIM\(O.2WU*U\EI$S@LO)!%4_C#G_A5VL;<9Q%C/\
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M8[PS\1-(\3:A_9R6NHZ=?F/S4MM2M_)>1/[R\D$?C6W-K<,/B*VT4VUTTUQ
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M8+FY*K/) 6X\P(2K'G!'0XYJ_)JNK>#O$'BRR75;[5(+;11J4 OI!(T<N6!
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MM;:YCEGM&59T0Y,9(R ??':N#TN+4O#7CV'PQ)K^IZK8ZE82SB2]E#S6\BD
ME7 'RG/ [$5E?#WPPT'COQ/*?$&MR_V??HA22Y4K=9B',PV_.1GCITIQU:[6
M?X.W]?\ #B<K>MU^*N>MT5XCJVO>)-5UKQ%<6 \3BXTV[:VL(]/\H6:E /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ^%7O#/C";7]>U?2+G2)-/N-,$7FAYA)N9P3Q@8QP"#GG/0=*IQO>+_JUO\
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MZWVU_P W]Z^\:M=+OI_P/N_ U]!\*V>@W-S=K<WM]?W*JDMY?2^9*RK]U<@
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M 'G/M7944I+FT947R['/:9X4L8/ UMX9O85GM1:B&="?OG'S'/KNR<U6\/\
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M/AQHNLZG<WDL^HP)>%3>VMM<F.&[*]/,7OT[8S76111P0I#$@2.-0JJHX '
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ML;62[O;CS95B((V*2, #/I]<U/\ \(/IG]F^'K'S[ORM"E26U.]=SE5*C?\
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MI7(F(SC9@';D$ G&<9Q7I%4TT)23V"L;Q%_Q[P_[Q_E6S6-XB_X]X?\ >/\
M*D,LZ)_R"X_JW\ZT*S]$_P"07']6_G6A0 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%9<\)LZG(YS6E10M$EV*ZM]_^!_D%%%% !1110 4444 %%%% !1110 4444
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M;Q%_Q[P_[Q_E6S6-XB_X]X?]X_RI%%G1/^07']6_G6A6?HG_ ""X_JW\ZT*
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M^@8C- &A12 A@"""#R"*6@ HJ&VO+6]1WM;F&=$=HV:)PP5E."IQT(/45-0
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M0P!!!!Y!%'F M%%% !139)(X8GEE=4C0%F=C@*!U)/85A#QUX0) 'BK0R3T
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MS6*W@/48-$\,-;'3)M6T:T^RR17:LUO.A4!AG&1RH(.W\*4=(I/R_P#;K_\
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M$[2'?(FT A@,<X8$'/M6O>>&/$EG?ZROA^[TU;'67,LQNP_F6TA4*S(%&'R
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MZ=1110 4444 %%%% 'F_Q1C2;7O L4BAXVUI<JPR#@>E>D5YQ\3B%\1>!"2
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M*** .4UG_D*S_P# ?_0175URFL_\A6?_ (#_ .@BNKH **** "BBB@ HHHH
M**** *]]?6NFV4U[>SI!;0J7DED.%4#N:RM%\8Z#XANY+33;UI+B-/,,4L$D
M+%,XW .HR,]QD55^(-V]CX-NYTLH;O#Q@B:$RI$-ZYD9!R0GWOPKB/#^IC4O
MBKI<Z^(9-=C.FW*K<BT6"'.Y"4CP!N/<Y)QQTI1=Y-?ULW^G],4G97_K=+]?
MZ1WMKXX\-WFL#2K?4U>[,C1*/*<([CJJR%=C$8/ )/%=#7B>E7Z6&LZ;8:-?
M2W(_M+]YX:U*S626RR[;I4DQE H)8'D8/6O;*:UBG_73^O\ @W07]YK^NO\
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M7H-"UC%^2_)%=6O,Q-9\7:%X?G\C5-02WF\L2B/8S,RDX^4*"6.>PR:#XOT
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MP&R!D9[5L6WB?1[K0I-;6[,6G1YWS7$3P[<=<AP#^G-<KXP%Y=_"BTN)M/\
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MYKVD6GA+1O"EUIIO=>MYXX9=,>,ATD63)F)(P%'+[NA]>:]7I6T[^??;^O\
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MN\$B1R>7(RD*^ =IQP<'K7!>!)/$UQKNNKK'B=]1MM-N6LUA:QABWG8C!\H
M1U(QS7>S31V\$DTK;8XU+,WH ,DUYK\-O%>AZMXC\56UCJ"3375^UW"JJPWQ
M".-=W(]>.>:S6[MV?Z?\$N7PKU7Z_P# ,;2_B-KEYX%UF6:[V:Q8ZC&D<IB3
MY[=YP@.W;CLZYQV]:ZZ]OO$'B+Q;J.D:)JZZ1:Z5''YTXM4G>:9QN"X?@*%Q
MG'/->6:MIMQ!X T36K-?DEOI+&]'K&;PNA_!UQ_P*O1#K5AX&\>>(9=<D>UL
M]7$-S:W!C9ED=4V-'D _-P"!WS27G_348_G>_J)MW=OZ7,_RM;T.TT!]6DT6
M#^W(H8]17*R^2<HV"0&'ID8..V:TZPK+Q(!X3;Q!K5J^EP(CS.C[G9(@3M9@
M!D$K@[<'&<5LP31W-O'/$VZ.10Z-C&01D&K>X*UM!969(G9$+N%)5 <;CZ5Y
MV^I>+]%31=7U?4D;^T;V*WGT;[-&! )"0 CCYBR\$Y)!P:]#N)X[6VEN)FVQ
M1(7=O0 9->/^'O'_ (7\3>++?5M:UJ);D2^3I&EB*0B#<=H=SMP9&^N%!Q4Q
MUFDOZ7_!V_'U<_@_KM^FYT6H:OXEU.\\1W>C:E':6NA-Y4=L;=)!>2*@=P['
ME1R%&W'K2^+_ !QJ5IX#BU;0-/EEGN[ W8N2!Y5JFT$LQ/5N>%QSCT%9T^LV
M_A2X\9:5?+(MYJ,[W.FQ!&)N_,B5=J8')# @CMUK2\0:;)H_P*N]-E_UEKHW
ME/\ [P0 _K4_8O\ X?OZ_P!?E<:_B6]?NTM^IJ>*_$%]H_@F"_M7C2ZG:WA-
MQ*N4A\QE4R$=.,Y]*B\+ZGJJ>*-5\/ZCJ8U=;6"&XCO?)2-EWY!C8( N>,CC
MH:J>-EE?P/I2NLSZ69;<:HL()8VN/FZ<XSC..V:I>!ETA?&5\?!R@>&VLE,Y
MA!\@W6[C9G^+9]['MWK3_EY)>;_+\-=N[T,DW[.+\E^?X^?EJ>DUY;9:OXR\
M0G4=6T;7;3S;.\DA'AXVT62B/MP\A(968#.>!R*]2/3BO$?%&L>%]2AO?MNF
MRZ7X_A9TM4M(I%GDE!Q&RNHPZGCKVSZ5%[2_KNNG7T[&K5U_79]>GJ=QXG^(
MEGX<U[2M,F20&>0_;#]EFD\I/++#:44ACD <9P,\5OWGB?1]/T6#5[N\\FSG
M"F)GB<.^X9 $>-Y/MC/M7*^+KE],N?!.KZPWE0V=R3?3[24B9H&7+8Z#<<9H
M\2:O8MK'A3Q7YWG^'X6N!)<HA9(F=-J2'C('##/;-5LK>;7]?H2GU\D_Z_4Z
M>'6?#_B+0;FZ\^VNM, 9;D7$>%4#EA(C@$8]&%0:3XQT#7'EM=)O@\\<1=8V
MA>(E!QN4.HW+[C(K@=0MY_$FE>.-4T2&2;3KUK4P!$(^V>5@RE >H8#;GOBN
MILO%.@>(];LH](M!?2V]K*9+M4*_800!Y;9'#,>-OM42;Y7Z?^VMW_#^G9-W
MU_KNM/Q_#UL_PCXNCG\(>'KC6[[S-3U,%4"PDO*P8Y.U%X  &3@ =Z[.O#_
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MN=%#2!())!$#T+E%(3_@1%9FF_\ )7]>_P"P5:?^AR5Q_B77'_M+Q7IYU/\
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M_P >\/\ O'^5 %G1/^07']6_G6A6?HG_ ""X_JW\ZT* "BBB@ HHHH ****
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M'9]_QO\ Y_B*-K)K:WX6_P OP)- \,VN@-=3)<W=[>7; SW=Y('EDVC"C(
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M_<;Z4-V7/Y?H_P"OF.R>@M8Z>&[.._UF\$D_F:LB)."PPH5"@V\<<'OFO//
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MU5[ZRMM2L9[*\B6:VG0QRQMT92,$5FZKKXTC5=%M)+;-OJ4S6_G^9CRI-I9
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MXZ^@JMI7@'69)K>WO[0P6SV>J6\T@E1MGGS9CX#9.5YXZ=\5ZI9S-<6-O.X
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M+61BJ32W2*C$'! 8G!(-6?[1L3;PW O+?R9R!%)YJ[9">FTYP?PIS]Z[??\
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M.0P]0:IZQK%AH6FRW^HW4%O!&#\TTJH&;'"@L0,G' ISEO)Z=11CIRK7^O\
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M+/R+?39+L7'ERE6#2#:6"@Y P#VJ.PTOQ9=:EX-BO= 2SM=$9EN)_MD<A?\
M<E ZJ#G;]>>1QC)KTZBA:._I^%_\W^'8.71KU_&W^2_IGB>M^!_$.IZ;JEO<
M>&([_6))GDCU>XU!65DWY411LWR-MPH!"@<\UZ#8Z1?Q_$&]U62W*V<NDP6Z
M2%U.9%=B5P#G@$<]/>NKHI)6CR_UM;\OQ&U=W_K>_P#7D>=P^$M7D^#A\//
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M% !1110 4444 %%%% !1110 5C>(O^/>'_>/\JV:QO$7_'O#_O'^5 %G1/\
MD%Q_5OYUH5GZ)_R"X_JW\ZT* "BBB@ HHHH **** "BBB@ HHHH **** .4U
MG_D*S_\  ?\ T$5U=<IK/_(5G_X#_P"@BNKH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]5Y8V[L>^>OO7J/48-9UKX?T6QG\^STBPMYMYD\R&V1&W$8)R!G)'4U*WO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%,DECA0O+(J(.K,<"@!]%5EU&Q=@J7MNS'H!*I)_6K- !
M1110 4444 %%%% !1159M1L48J][;JPZ@RJ"/UH LT4R.6.9 \4BNAZ,IR*?
M0 4444 %%%% !1110 45!->6MNVV:YAC;T=P#^M.ANK>YSY$\4N.NQPV/RH
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MP#<7&D12^&[[2M3AN5N[J7[2;5OL[(TC.I$OW>01QUS7$MX5N;6RO]!N=/\
M%=U>37<HB2WO)4T^>-Y"P=V!V*,'Y@><CH<T)W<?1?/:_P"O]7!Z)^K^6_\
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M;.T/EPV5\T,+$'JRKU//7/85Z#7,?$6UN+[X>ZY;6EO+<7$ELRI%$A=F/'
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M*G'H*KW^BZK=^%-;OSIEW'+JVN6UW%9>43*D2O$NYE&<$A2Q]!UJ[>]9=_\
MVY+\FW^.QGS.U_+[]&_S2^^QW>B^*[;6-4GTQK#4+"]AB6<0WL2H9(B<!UVL
M1C(Z'!'I6_7)_8[G_A;!O/L\WV7^QA%Y^P[-_G$[=W3..<5UE):I/^MV7K=K
M^MD<EJOQ!T_2[F]0:9JUY;V!VWEY:VX:&W( )#$L"< @G:#BIM1\<V-CJT&F
M06&HZC=W%H+R%+*)6WQDXSEF 'KSCKZ\5P/BF#7-33Q+97EEXHFO9&E6QM[
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M-I8P<%DPQ!P2,C.1D9%<3J?AG5-5T3QM;Q6ETLLFM1W=NG,1N$18B=C<==I
M([BK7A/2Q<>,;?4(;'Q1Y5I;2*]QK]S+E'? V1H_WNF2PXX'6G'7[E_Z3?\
M/3_@BDVOO_6WY?UN;=E\2=+U&>%;33-9E@>;[/)=)9DQ02[MNQR#G.<= 0,\
MD5V5<E\.+*YL/"C0W=M+;RF^NGV2QE&P9G(.#V(P0?2NMI]%_71#6[^?YLY+
MQ%\0])\,:J]A?6U^[1VZ7,LL$(=(XV?9N/S9X;'0'J,9J6+QYI,FA7&JM#>Q
M^1=?8VM7AS.9L@! H)R3D8Y[]JY#X@Z1J5[KVMR6NG7<\<FD6L:-% S!G%UN
M*@@<D#DCTYI9;?7]/TSQ UG9:C&DWB+S)GMH,W'V8JF7A5@=QR ,@'OCI41;
M:U_K4<M'I_6AU]AXV@OVOX/[&U>WU"R@%PUA/"BS2H<@%,.5.2"/O"LSP%XS
MU'Q$UW#?Z/J496[N%2Y:&-88T1L+&2')WCH>#SWK+\$V-S'\0[V_%EKZ6,VF
M)''<ZP7:21A(2?O?<Z\*<="<5I>"[BXT2^O] O=)U-9IM3N;A+I;5C;&-V+J
M?-^Z..,=<U<=]>J_&_\ EJ0W^#_3_/0AT_QYJ=QX^U#2I/#^L?8XXX%CC$$.
M82S,#(Y\S.PX&,9X!X'?H=:\76NCZBFG1V&HZE?&+SG@T^$2-%'G&YLL  2#
M@9R<<"L2>XN/#WQ)U/4)])U.ZM-2M+:*&6RM6G"NA<,'V_=^\#D\5D^*=$EM
M?'=YJUS%XF>QO;2)(Y-!FE#I(F04=8SG!!!!/ .>E3?W8_._KK_7](M_%+Y?
MH=9?^/-$T_0M/UF1KF2ROY!%$\4)9E<@D*R]0<J5QC.>*=:>-+&;2M2U"]L=
M3TN+3EWSK?VQC;;C(*X)#9QV.:Y)/#UY:^$O"ENFE7<;KKD=W- [M</$K,[%
MI&]>02>@)ZUWGB:&2Y\,ZC##IT>HN\#*+.1MJS<?=SVS3EHFU_6B_P W_5Q1
MU:7];M?DD4M#\86VM:@U@VG:EIUUY/VB.._A"&6/.-RE68=<<'!YZ5T5>:>!
MK?4+;Q&D6FIXCAT!;5OM%OK:L!#+D;%A+_,1][."1TYKTNJ?0F+;W_K0****
M184444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %8WB+_CWA_P!X_P JV:QO$7_'O#_O'^5
M%G1/^07']6_G6A6?HG_(+C^K?SK0H **** "BBB@ HHHH **** "BBB@ HHH
MH Y36?\ D*S_ / ?_0175URFL_\ (5G_ . _^@BNKH **** "BBB@ HHHH *
M*** *>K:K::)I=QJ-])Y=M NYV )/L !U)/ %9.B^,;36-3;39-/U+3;WRO/
MCAU"$1F6/."RX8@X)&1P1GI6OJ<-A-I\O]IQP/9H!+)YX!1=IW!CGT(SGVKB
M].^U>+-;F\6)$\&G6MG+;:6'7:\^_!:8CLIV@*/QJ'+EN^R;_!_F]/O!]+?U
MJOTU-6U\?Z5=:I%:+;:@MM/<&V@U!X,6TTHR-BMG/4$ D ''!I=7\>:?I-_=
M6HT_4[X62AKV:RMQ)':@C/SDL#G'.%!.*XHX_P"%&>&/*QYWVBQ\O'7S//7/
MXYS74>*;Z.WFN/#GAVTA;7M84O,RIA84(V&>4CT P!U)%7).-TM6G;U=D_DM
M[^5OG,97U>BW]-6OOV^?R-;5?&&GZ;#8-##=ZE/J"^9:VUC&'DE0 $L,D *
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M:EI?@RT9=8D&I:>;R].C%4N)2JKPK%EVC+9.#FNI^'U[JD\.J6NH0ZFD%M<
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MHHH **** .4UG_D*S_\  ?\ T$5U=<IK/_(5G_X#_P"@BNKH **** "BBB@
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MNGK-<6NGI>1LT^P2LS,H0_*=OW?O<]>E<]X!USQ1J6HZM'J>FQ&U74IT>?\
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M]Q66GD(0&!!&0>"#7(6GPWT>TOHI5NM2DL8)OM$&F2W.ZUBDSD%4QG@G(!)
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MI6C)XGV:KX>LOL>?[8BDEW^;_J=J!\8Q\V<X[4EOIUM^3M^%QNW7I?\ -?\
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M 8$=\#WJ;0/$NK:K,8[WP\;19+?[1;3PW0N()1G&TR!0%;IQSQWXI_Y?AO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "L;Q%_Q[P_[Q_E6S6-XB_X]X?]X_RH LZ)_P @N/ZM
M_.M"L_1/^07']6_G6A0 4444 %%%% !1110 4444 %%%% !1110!RFL_\A6?
M_@/_ *"*ZNN4UG_D*S_\!_\ 0175T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !6-XB_P"/>'_>/\JV:QO$7_'O#_O'^5 %G1/^07']6_G6A6?HG_(+
MC^K?SK0H **** "BBB@ HHHH **** "BBB@ HHHH Y36?^0K/_P'_P!!%=77
M*:S_ ,A6?_@/_H(KJZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\
M1?\ 'O#_ +Q_E6S6-XB_X]X?]X_RH LZ)_R"X_JW\ZT*S]$_Y!<?U;^=:% !
M1110 4444 %%%% !1110 4444 %%%% '*:S_ ,A6?_@/_H(KJZY36?\ D*S_
M / ?_0175T %%%% !5#6;N^L-(N+G3=..HWD:YCM!,(O,.>FX@@5?HI,$>;Z
M!\1?%&MZ]+IK> F@6UN%@OIO[5C?[-D9R1L&[@YX-=5X2\2?\)1IES>?9/LW
MDWDUKL\S?GRVV[LX'7TK \"_\CGX\_["47_HH5YJVB6T7PUUSQ,DMRNJV6M3
M-:RK.X$.)P"%4''.3GCFB+O:_5)_>TOU)U;LN[7W)L^AZ*\5\31W_B+Q[JUK
M=:3'J4%A80R6R2ZJUD+?<I+3+A3N.>,]L5Z3X&FO9_!.E/J-U#=W7D /<0RB
M59,$@-N'7C'/K36JO_6[7Z?UJ'-JDOZT3_4D\8^(SX3\+7FM"T^UFV"X@\SR
M]^6"_>P<=?2L?PWXZO\ 4M?31->\-S:)?3P-<6P:Z2=)D4C.&4#!&>E1_&$$
M_"[6 #@XBP?3]XM<C -9\+^/-*;4]:C\2WE]IUQ':O\ 9UA>TVKOX5200Q !
M)YXJ5*UV_P"O=;^_3T*FG96_K5+[M?4]GHKP2.RMK/P!I/CNTU"ZE\5W-U#Y
MDQNG8SNTN&A*9VX )XQQBM#Q_;V.LW/BF]MK*YO+W2;=0]U<Z@88K!PA;]RB
MC+-W.>">,TY/EWZ;_<GI]_\ 5T*+YG9==OO:_3^K,]KHKR3Q(+C5]+^&ZRWU
MW$][-''<2PS,C.KP'=R.Y&1GKR:D\7>&=/\ #&D:5HFFS7EKH^KZS#%>JUV[
M!(RIRBLQRH8@9Y[U333:\[?.Z7ZDJ::OY7_!O]#N8?$OF^.KGPU]DQY%BEY]
MH\S[VYBNW;CVSG/X5O5Y=X6TC3]#^-&KV&F,XMH]'BQ$TK2>22_W06)('?'O
M7J-2OA3_ *W?^0TWS-/^M$%8'B[Q,/"VEPW*V;WMS<W*6MM;K($\R1SP"QX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;Q%_Q[P_[Q_E6S6-
MXB_X]X?]X_RH LZ)_P @N/ZM_.M"L_1/^07']6_G6A0 4444 %%%% !1110
M4444 %%%% !1110!RFL_\A6?_@/_ *"*ZNN4UG_D*S_\!_\ 0175T %%%% !
M116'XPU/4=%\*:AJ>E0PS75I'YPCF4LK*IRPX(.=N<4FTE=C2N[(NV&BZ?IE
M[?WEG;^7/?R"6Y?>Q\Q@, X)P./3%46\&Z VA76B&P_XEUU,T\T/G2?,Y;<3
MNW9'(S@'%9R^+IK_ ,4:%IVF) ]K=V+:A=R."3'%@!-I! !+'OGI7.R_$/Q*
M^GW7BBST?3I/"EK,R-OF<7<D:MM:11C9CJ<'FGL[?UH[?GL0FGJO7[U?[['8
MZWX*\.>(Y()-6TJ*YD@78CEF5MO]TE2"1['(K;M[>&TMX[>WB2*&)0B1H,*H
M'0 5Y9XYU'Q7)XT\*?V-+I?V*ZE:2R6:651(WE9/G!1C SE<9KHO%_C&[\+Z
M?I%M(^E1:OJ+>69;N<QVD)5<NY8X.WL!P3D4D[1^;5O,>E].U_D=-K.BZ?XA
MTF?2]4M_M%E. )(][)NP01RI!'('>LCP[\/?"GA2[:ZT71XK:X92IE,CR, >
MH!=CC\*@\#>,&\41:C;W#V$EYI\PBEFT^;S;>4,,JZ-Z=01V(KK",@C)&>XI
MVY=5U"_,K/H<A9^%/ 4?B^6]M++2_P"WT/FNB2@R(3_%Y><*??%7M2\">&-7
MU&>_O](AFN9TV2N68"08P"P!P2.QQD=C7GVJ>'=*\->,O#%C96ES;W']I&YG
MUZZC'[_?N/D&4#YF/3! %>QTDDX+YK\OZ^7:P-^^UZ?U^'X][F!_8_AN2ZTO
M2SY+76CA9[.V^U,980!M#%=VXC'&6R*3Q!<^%-1TR]L->OM+>SC98[I+BY11
M$QY4,<@JW<=#Z5SOQ*27P_-IWCJRB,DVE$Q74:G!EMWX(_!L'\ZY/Q/HS:-\
M)+:ZU.W:[O\ 4=6@OK^-%WM*[OGRP.^!A0*5^9:]]?5M?IK\@^%Z=OP2?ZZ+
MU.^\*6/@*WU)Y/"UQI<EZ+?RI!9WHF;R]V<L QSR?O'GWKIX=2L;F]N+."]M
MY;JWQY\"2JSQ9Z;E!R,^]<3X&NM"DN;ZXL/ E]X:>&'+SW>FBV\Q<Y(!'7&,
MXKBO 5S<6OC^R\1W#OY'BTW:C=T&Q\Q?^.BKWDH^7^=OOLR6^6+?G_E?[M#N
MKS1_AIJGBW[5='0I]>23#1F[3S"XX^:,-@L,=P36]XDC\.2161\0W%I#'!<I
M/;&XN?) E7[I'S#/7IR/:O!;_P#LS4=0\4>'T\.2W7B+4-:F73]1\I$2(A@<
M>:2#D8)VCUKN/%^AWEAXFM]8U;PP_BK2AIB6KI&!));2*<LZH>N[U'-0G[D7
MM^6U_P ]+OJ7+XY+?\][?E=^ESUR.1)8UDC=71AE64Y!'J#575=*LM;TNXTW
M48?.L[A-DL>XKN'IE2"/P-8W@ Z-_P (5IXT"6X?30K"(7!S(GS'*GTP<C%6
M_%?B&+PMX;NM6DA:<Q +'"IP9'8A57/N2*JHDKIB@V]2#PYX&\->$GD?0])B
MM))!M:3<SN1Z;F)./;-:4NBZ?-KD&LR6^=0@A:".;>WRHQR1C.#TZXS7)Z7X
MJ\367B*PTGQ9IVFP?VHCM9RV$KL%=1N,<@;OCN..*P+?XD^*?^$<MO$<^F:4
M=*%_]CN C2"9@92@=!D@8XZDYYZ4[W:_KKR_F[?,FZ2;_K:_Y*_R/2QHNGC7
MFUL6_P#Q,6MQ;&;>W^K!W;=N<=>^,U'KGA[2?$EB+/5[*.Z@#;U#$@JWJK @
MJ?<&M,<BO.OC)=:]:>#9)-*DM8[0LB73O(Z3<R(%";1@@Y(;/8U#MHO-?G_P
M31:N_P#6QTQT3PQH7AM]*EMK"ST>4^6\4[!4=F.,$L>6)]3FG>'?!GAWPGYW
M]AZ7#9M-_K'4LS-[;F)./;I7$?$-]=3X80OK<5@VH+J-L5CL&?RV'F+M&7&<
M^M;>E>+M:@\67FA^);2PA*6']H0R63NP$8.&5MW4CU  JKV<F_Z25_Z]#-.Z
M2MIO][M_3\S:NO!/AV]\0)KL^F(=31E83K(ZY*_=)4$!B,#D@U'JG@'PKK.L
M)JVHZ);7%\A!\U@1NQTW '#?B#7%:1\6I[S4-,GN9= .FZG<BWBM+:\W7UMN
M)"-*F<8/&0 ,9KUBA*R3[?@5=-M?TS+U/2M(FN++5-0CC5]++203/*46'(P2
M>0,8]:9<VV@^,-&\N7['JNG2-D-'()$W#N&4\$>H-<3\:SK7_");+-;!M,DF
MA2Y$S.)2QE7:% &TJ>^:O7&KZOX0\-Z9IXTC1?[=U&[-O;6NG[H[4$Y.]L@'
M@#)XZU*LT[][?-Z_U]X-V:]/P_K_ ".ETO0M!\(V5S+900V,!&^XGEE).%'5
MY'). /4\5<TS6M*UJ.232M3L[](SM=K6=90I]"5)Q7->'M?U/4=8U#PKXLT_
M3UU&*V6?_1"SV]Q"Q*GAQG@\$&J/P\MH+/Q7XXM[:&.""/48@D<2A54>4. !
MP*I:NWE?[A-I+3O;[SH-'N/"D.O:E%I.HZ>^K7DOF7D$5Z))6=!M)*;B5P!@
M@ 5)KW@SP]XFFBFUC2XKJ6(;5<LRMM_NDJ1D>QXKE[^PL[+XV>'VM+2"W:>P
MNY)3%&$,C97EL#D^YJUJOBGQ->^)-1TGPGIVFSC2E0WDVH2NH=V&X1QA>^.Y
MXJ;KEBWY_*VGW#ZR7I^)TNI^&=$UC1ET>_TVWFT]  D!7:$QTVXP5Q[5'IWA
M+P_I.B2Z-9:5;1:=,")8"NX29Z[B<EOQKDK/XG_:;C2;N6WB@TJ[TVZN)@^3
M)%- ?G3=G&,9[5H6?BW5?$.J7]MX?73_ "DTNWNK:6Z5R/.E)(#E3]T*.@&<
M]Z;Z^>_R$FM/(N^'/"7@S3(M1A\/V5DHE+6]X8)C(P/\4;-N)7K]W(Q2M\.?
M"C6_V<Z5F+[-':[?M$O^JC?>B_>[-SGKZUE_#G4;JYL/$;7EEIMO>VVJ31S&
MPC=8YI HRY#,3DGZ5B:?\2/%,F@Z'XBOM+TH:3>W:VDPB>3SLLY4.H)("Y'0
MDD^U-:M=[1_';\=@=DFWW?X;_@=M_P (+X;\_P _^SOWGVJ2\SY\G^N==K-]
M[N.,=/:EN/ WAJ[T"TT.?2XY-/LQBWC,C[HO]U\[AU]:YS4/&WB&1_$EYHMC
MITFF:$7BD^T,_FSR*NYBN. %]#U]177^&=3FUGPOI>IW"QK/=VL<SK&"%#,H
M)QDDX_&DDG'RT_X'Y#>DO/7_ (/YD'_"'>'QI%II2Z9%'8V<ZW$$,;,@613D
M-D$$G/KG/>K?]A:;_;4VKFU!OI[<6LDA9B&B!R%VYV]2>V:QO'GB6^\+Z38W
M6GVT-Q-<7\-J8Y<X(<D'!!&#[\_0U7T;Q-KB^++GPYX@M-/2Z-I]LM);)W*.
MF=I5MW.X''/Z47O?Y_EK^'X TE;^NO\ F6;/X<>$;"ZBN;31(89H9Q<1NCN"
MCC.,?-P.3\O3VJ:[\!>%[_57U*YT>%[J1@\AW,%D88P70':QX'4&N<\,^+_&
MGB>"TU*TT324TS[0T%T)+EQ*Q#E6>/C&T#UY)!Z5!=>/_$\MOJ>OZ5H^G2^&
MM,FDBE\Z9Q=3B,X=X\#: .>#UQ1>UOZMM_P/Z6AO=?T]]/S_ *9Z:    , =
M *Y/X@6VM:GX;GT;1])CO3J,;6\LTMPL:VP(^^0>6[\#G(%9$OC/Q'JOBN?1
M_#5II<D/]FPW\5Q>LZA0^>#M)W9XP!C'.34:?$F_OM T@:=ID#>(=2NI;,6T
MTI$,4D6?,9B.=HQGCGFE)<RL_N[ZM?FF$9I:K^M$_P G<[/2]"L].\,VNA-#
M'+:0VRV[(RY5P!@Y!]>:IZ!X(\->%[B:XT72(+2:88>12S-CT!8G ]AQ7-IX
M^UC3-.\0V^NZ5;-KFC6RW/EV+L8;B-NC+D;@ <YS5SP9XMU7Q!?E)KCP_?V;
M0^9Y^E7)+0MG[CQL2W3OQ]*N_-)R6_?[_P#@_EY$Z1BH]O\ @?YK\R]-\-?!
M\]S<W#Z'!YMS()9&5W7YPP;(P?E.0,XQGO6Q-XAT2UU--,GUC3XK]B MK)=(
MLI)Z (3GGMQ7!:Y\0O$'A_5T:_MM#AL7OEMDL#=[KYHRV!* I*XYSC'UJU\2
M;"SCU?PE?):0+=R:[;H\XC D90&P"W4BICJHVV;2*EIS=TF_Z^X]%HJEJ[:D
MFDW3:0EN^HB,_9UN<^67[;L<XJQ;&<VL)N0@N"B^:(_NAL<X]LTQDM%%% !1
M110 4444 %%%% !1110!&]Q#'-'"\T:RR9V(6 9L=<#O4E>1:GH<^G?';PU?
MW6IW%[+?&[*K( %@C6/Y44#TR<GO7=>.M:U+PYX1O-8TN&">:TVR/',I(,>1
MOQ@CD#)_"DG[BD^O^=@^TXK^M_\ (Z.BN&U#Q\UOKFRVCADTJUT9M5O9-I+@
M'_5JI!P,X)Y!K%\,_$N_OM>TFUU*[\/7$.L!O*ATRYWSV;;=P64;CG(XR,<T
MUJ[?UU7Z/[B>96O_ %LG^J/4Z*\PU;Q_K&A^)X8+N^\-36DM\MJ=/MYV-[&C
M-M5SSC/0D8XK0T_Q9XFU;Q_JFB6=A8_V9I=VB7%RY8/Y3(" !GE\YYX&!THC
M[UK=?TM_FAR?+O\ U_5COZ***!ATJM;:C97KR):7EO.T9PZQ2JQ4^^#Q3KVS
MAU"QN+*Y4M!<1M%(H)!*L,'D<C@UY;IFBZ-I_P :K6T\*V4=I#I^GR?VIY!P
MA+8\M6]6[T+627];7_KU%)VC?^MTOZ]#UFBN5\8^);WPS<Z%-'% ^G7=^MI>
M.ZL6C#\*RD$ <]<@]:P]8^(]WIC>*+E;>T>QTN>"QM6<E/,N7QNWOG 1<C/
MZ'FE?^ON_P U8;T_KU_R9Z-17G7A?QW?ZCJFH:+=7F@:E?161O+>YTJXW0-S
M@H^6.T@XYST-1^&?'FIW?C.+0=1U#P[J(N8))4DT:5F\ADQE'R3G@\'CH:?6
MWS_/_)BOI?\ KI_FCTFBO)+/XD^+)?#&J^))='L#INGK/&-A8/+,L@52!DX0
M*>3UR#TKM/ ^K:IK6CM>ZEJ&BWRR$&*32BVU1CE6W$\@T+7\/QV!NSMZ_AN=
M/1110,JOJ=A'>+9O?6RW3=(#*H<_\!SFK5>)_%JT\/174]I'X=N(-8O989/^
M$@>(K;P,6 R90200%QC'<5ZMJ\VHV'A6ZGTWRKC4+>U+P^<"R2.JYY (/./7
MO4\R4'-] M[ZBNO^9K45P%IX_N=33P>+"&V+ZQ$]S>[E8B&*-?GVX;@[N!G-
M8%A\6[NXO;*_EN?#YTF]O!;)817.;^%&;:LC+NQUP2,< U=O>Y>O_!M^9/,N
M7F_K:_Y(]>HKS+QAX]UCPMJ\TC7_ (:-E#*@&FM.WVZ6,D L!G /)(&#P*NW
M/BWQ-=?$*Z\.:/86,EM;I;7$EQ.6!2)C^\'7ECQMX'?.:47S6MU_X?\ (<GR
MWO\ UT/0**\[\(>--9\4>)[V(W&B06-K<RP/IY+_ &U53(#GG')]NE>B4+5)
M]POJUV"D)"@DD #DDTM<A\3=6DTKP+>K;-MO+XK96^#@[Y3MX^@)/X5,FTM-
MRE:^IU4-U;W$'GP3QRQ<_/&P9>/<5#IFJ66L6$=]IURES:R9V2IT.#@_J#7G
M7PVA7PSJ'B+P5YI>*S"7EHQ;.Z.1!NQ]&!_.N6\'>*O$_A?X;Z5JJV&GMX=@
MN6@G#L_VAP\Q!D7^$ $XQSG%6K-V7E;YMK\]"+OENUU?Y7_(]YHKSJW\:ZSJ
MGQ%O=#M+C1+.UL9HT:WO"_VFZ0@%FCP0. >.#[UF^#[KQG+\5?$T5]-I4EM"
M81<QJ\QV*8V,8A!X'JV>^<5*=[>C?W#;6OE;\3U>JUGJ-EJ'G?8[J&X\B4PR
M^4X;8XZJ<="/2O.M+\?:NGC+3M'U.^\-7J7\CQ&'2IV>:T<*6 ?)((XP3@<U
M2_X3B^T?0=9OM-T?3%G3Q,UAY443()P6 +MAO]8?[W3VIK7^O-+]1MVOY?Y-
M_HSUNBN)\,^)/$,OC+4/#?B.WTX7$5JEY!+8%]NQFV[6W<D@]^*[:CHF)/5H
M****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5OO_ ,,%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M Z>^::6MB6]+GJ=%(K*Z*ZD%6&01W%+0,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;Q%_
MQ[P_[Q_E6S6-XB_X]X?]X_RH LZ)_P @N/ZM_.M"L_1/^07']6_G6A0 4444
M %%%% !1110 4444 %%%% !1110!RFL_\A6?_@/_ *"*ZNN4UG_D*S_\!_\
M0175T %%%% !6?KFL6N@:)>:K>MMM[6(R/ZG'0#W)XK0JO?6-IJ5G)9WUM%<
MVTHQ)%*@96'N#UJ9)M60U:^IXAX)O[*3XMV6K7>M6%QJ.K:=+).(KM'6.1G'
MEP#!^\$ &.IP:]WKBX/AGH-GXSM-?LK*PMHK:W,:VD5FJCS"V1+N!X8=.GXU
MT3V%^WB**_75&6P2W:)K#RAAW)R)-^<C XQBKTY8I>?RU=OZ^_J19\S;\O\
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M#VJ\&U7_ (31E$TAT@6 )B, "K-OX(?&6)7.1VP/6J[+U_K^OO)5U=OR-JN
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M .MB6W^7_!^[^M](M9_Y"L__  '_ -!%=77*:S_R%9_^ _\ H(KJZ"@HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV5Q=PQV\=G%+YA2-"Q!=P "Q+'IP!W--;_K_ %W(;=OZ_K0BUG_D*S_\!_\
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MFZV8DK9DRQGRU)_AYSC)QFM^5(;KXOSVTH61'T#9(A[@S'@_44+5Z?U[M_\
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M2%I,-&T>SH02FS/'X4XZNW];V_K_ #$Y65_ZVO\ U_D>^T5X_?\ A_3=4O\
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MTG3;OPE?16,*Z@FIV=J;D+\Y15("Y].!5=5;:Z7]?*S^9',]5U2?X?\ !O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *QO$7_'O#_O'^5;-8WB+_CW
MA_WC_*@"SHG_ ""X_JW\ZT*S]$_Y!<?U;^=:% !1110 4444 %%%% !1110
M5%<7$-I;2W-S*D4$2EY)'.%51U)-2UE>)-(;7?#M]IB2B)[B/:CL,@-U&1W&
M1R/2E*]M!HQ#\08)</9>&_$E];MG;<0:>0C#U&]E)!]A5WPY>:-K&H:AJVGF
MZ2^D$<-W;W*O&\14':#&WW>">0.:S_\ A)?%UH$@G\"SW$H #2V>H0F)CZC>
M58#V(J[X>T[5)-<U#Q!J]K#97%W#';QV<4OF%(T+$%W  +$L>G '<TUO^O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %8WB+_CWA_WC_*MFL;Q%_P >
M\/\ O'^5 %G1/^07']6_G6A6?HG_ ""X_JW\ZT* "BBB@ HHHH **** "BBB
M@ KG_',UQ!X(UB2U:59A;L T()< \$KCG.">E=!12DKJPT['AEWJ/@ZUU#3H
M] ;6=*L)0\>J"QL;B)ID"Y7)V9SN&-PYP3S7HO@>\\*307-OX8LI+98\-,9+
M.2%G)S@EI%!<]>YKKJ*I:7_K^EY$<O\ 7]=?,Y36?^0K/_P'_P!!%=77*:S_
M ,A6?_@/_H(KJZ104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8WB+_C
MWA_WC_*MFL;Q%_Q[P_[Q_E0!9T3_ )!<?U;^=:%9^B?\@N/ZM_.M"@ HHHH
M**** "BBB@ HHHH **** "BBB@#E-9_Y"L__  '_ -!%=77*:S_R%9_^ _\
MH(KJZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\1?\>\/^\?Y5LU
MC>(O^/>'_>/\J +.B?\ (+C^K?SK0K/T3_D%Q_5OYUH4 %%%% !1110 4444
M %%%% !115+5]+M];T>[TR[W^1=1&-]C;2 >X/K2=TM!HNT5Y_IOP@\*0Z?#
M'J.F1W%VHQ)-'/,@?G@[=_!QC..,UNZ3X=\->"B6TZU%E]MD2$DRR2;WR=H^
M8G'4U6A-]+E?6?\ D*S_ / ?_0175URFL_\ (5G_ . _^@BNKI#"BBB@ K#\
M9SS6O@C7+BWEDAFCL9GCDC8JR,$."".0:W*P_&<$UUX(URWMXI)II+&9(XXU
M+,[%#@ #DFLZM^1V-*7QQOW1P$=K>^%Y?"%_:^)];OKC5;B&*XL;^^,Z21R)
MEF56Y7;US6ZMI-I'Q9T^WAU35)K:^LKJ>6WN;V26(,'3&U"<*!N.,"KO@SP%
MX<\/V=CJ%IHD-MJ;6R>;*X8R*Q4;OO$[3G.0,5)J%G=/\4]$O$MIFM8]-ND>
M8(2BL6CP"W0$X/'M6\M*B7G+[K/3\#EC=T[^4?S6I:UGQE::3J3:=%IVI:E=
MQQB:>.P@$A@0YPSY8=<' &2<=*=>>,]+MM)T_4+=+G4!J/\ QYP6<6^6;C)P
M"0!@ YR1BN)\1:)+8>-]6U&ZB\526FH1Q/!)H,\HPZ+M,<BQGCH"&/')YJ2X
ML=8T3PMX:LDLM8M-/!E:_72R;F[A9LLB[L%L$D[BHS^%9)MQN_+\WI^"_IHU
M>DK+S_)?J_ZLSK+;QWI4VCZGJ-S#>V/]F-LN[:ZAQ-&Q *C:I(.<C&"<YJ?0
M_%MMK5]-8OI^HZ;>11"<P7\(1FC)P'&UF!&1CKGVK@M$TB^73?&ZOX=U.[AO
M&A>"UU65S+=1A,$^82?FX) SD' XK2\&6FI#5[NUL6\11>'FLRICUQ6#PSDX
M A+#<5"YSU'3!HN]=.E_G9_JOTW%?\_U7Z/]3>@^(>E7%Y$BV>I+833_ &:+
M4WM\6LDF=H ;.>2, D8)[UUM>&Z9X5N8M/T[P]<:;XKFOX+B-)5DO)ETT(CY
M\T-DIC R%'.>U>Y5>EOZ\OZ_X*87?-;^MW_7_ ,37O$]MH,UK;&SO;^]NMQA
MM+*,/(RKC<WS$  9'4]ZCA\5V]YX<_MG3].U&]7S#$UI#$HG5PVUE*LP *G.
M>?SK$^(5C%=W&F2W6DZI<6T1D_T[1V?[7:.0,;53DJ><]<8'%:?@/^V1X;QK
M+W;N)Y!;->J!<&#/R&4#^+'X^M0M4_ZZ_P!?FAMVDOZ_K^DP\$ZG;7GA+[>M
MSJ+PB>X+OJ; RIB1MRD@D87! YZ 54M?B3I=UJ&FVHTW5XX]3F\JRNI;8+#/
MP3N!W9V\=P"<\#%4_#&BWDWPPU32KB.6RN+F2_1?.4H5#R2;6Y[8(.?2L&36
M+J>Z\!Z/<:%J%E/9W\<<\D\&V+>D+KB-NC@\G(XP.:I:S2_P_BM?N$VU%O\
MQ?@]/O.HG^)>E027^=.U9[;3[IK6\NDMU,4# @9)W9*\Y^4$@=0*[-6#*&4Y
M!&0:\MO-)U%OAYX]MET^Z-Q=:A=/!$(6WS*2N"HQE@>Q%>FVBE;.!6!!$:@@
M]N*4=8W>^GXJ_P"8W\5NFOX.Q0U[Q!9^'K..>Z2>:2:00P6]NF^6:0]%5>YX
M/4@<52M/&-K>:7J5TFG:DESIR[KC3Y(56X QD87=M.1G!#8.*Q_B1HMUJ/\
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M@J9?L]PNTYR&C8X!^O2L+P#J-Q!X'O;J[FO=0:SO+Q09)3+,Z1R, H9SR<#
MR:Z;1=936[-[F.QU"T57V;+ZV:!SP#D*W..<9]C6'\.[*YL_#EU#>6TL#MJ5
MVX2:,J2K3,0<'L0<@]ZII^];33\;BO\ #Z_H7SXOTPZ?HEY$)IDUF1([58U!
M;+*6RW/  !SUQCO6_7E?@K2+J/Q[?:=.,Z=X;:461SD9N2' Q_LID?C7JE/1
MI2777Y=/U!7NT^G]?Y&%KGBFWT2[@LEL+_4;Z=#(MK8Q!W" @%CN95 R0.35
M0>/-);PVNM+%>E7N/LBV@A_T@S[MOE;,XW9'KCWK(\9RZF/$MK'*FOKHK6IQ
M)H49:5I]WW9&4;E7;C!&!GJ:Y[2]&ND^'E]::CX9U&X0ZW)-);/(_P!JCB+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOG=_E:_S13=FUZ_=;];V^3.[T'PW:Z!]JDCN;N\N[M@UQ=WD@>63 PH)
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MU:\W^;"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M EWL/DM<*6C#=MP!!(^AI/;4:W,"Q^'OA?3KJVNK;3"MQ:R"2"5[F5VC.",
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M>VL;QPR[V&U7QN&,X.<#J*:FC6$>IWFHK!B[O(DAGDWM\Z+G:,9P,;CT'>N
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ME6C0"90C*9Y)%"C. JLQ"CD\  5SD7CO4AX=8RV5J^N_VJVD)%&S"!Y@?O\
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MBI#?Q-"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/ )#8P.E=1IGC3P[K.K/IFGZI'/=J"VP(P#@=2C$;7QWVDUO52Z/[OOO^?\
MEL39--?UM;\OZN<IXAT/6I/$UAX@T%M/>ZM[:6UD@OG=$9'*MD,@)!!7ICO7
M3P>=]GC^T!!-M'F>7G;NQSC/.,U)10M%8KK<**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K&\1?\>\/^\?Y5LUC>(O^/>'_ 'C_ "H LZ)_R"X_JW\ZT*S]$_Y!<?U;
M^=:% !1110 4444 %%%% !1110 54U1+"32KJ/5#"+!XV6<SL%381@Y)Z"K=
M5=2M+._TRYM-02-[.:,I,LGW2IZYI2O;0:W,R/Q=X5BC2-/$>CA$ 51]NCX
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MQC:H&2>VW%>XUB^%] _X1K1CI_VG[3_I$TWF>7L_UDC/C&3TW8JV^:;D^O\
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M!(^M=/H>NVNOVMQ<6L<R)!=2VK"4 $M&VTD8)XR.*TZ4=+/^OALOPU):O?\
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MT$6@:4(X8U\NTC5,*/E!49 ].E:E%%:2?,VR(1Y8J/8****DH**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]$,9)'5410,<\=:G\,W-]:>(M4\/7.I2:I#9PQ3174P7S4WE@8W*@ D;00<
MX/-5'1V>^O\ P?Z_R,^EUMI_P/Z_S8NL_P#(5G_X#_Z"*ZNN4UG_ )"L_P#P
M'_T$5U=!84444 %9/BF:6W\):Q-!(\4L=E,R.C%64A"001T-:U9/BF&6X\):
MQ#!&\LLEE,J(BEF8E"  !U-9U;^SE;L:4_CC?NOS.(L?[1T%/!NH'6M0OY=7
MDCM[U+FX:2.0/$6W(IX0J5'3&1G.:P/$FM7D%IJFLV&I^)KR[M;IBEU;$PZ;
M&JR8\LHS . /E) 8DUVO@[P1;:?8:+?7=SJ<\]K:IY%I>2YCM'9 &VK@$'J/
MF)QD@8I+OX6Z1=VEU8OJ>LIIL[M(MBET!#$['=N4;<]3G#$C/:MIZ5/F_P#T
MI:?<G]]MCGIZP5^R_)_YK[NZ15U:VU#6_B0FDC7-2L=.DTA;F:*SG\MF<2%1
MM;JO7G')P*K_ !(\/&+X;,MQJ^J7,MEL42-<LGG!I4'[P+@.0.A(]^M=K'H-
MK'XA76_-G:Z6S%GM)&PH&W9QC.[/OCVJ?6-)M-=TBYTR^5FMKA-C[6VL.X(/
M8@X-9M>ZK?U[U_R+C>]WV_2S_$Y#Q?9W'AGX8ZBNF:MJ8N \;1W5Q=O+*A:1
M!PS'./;ZTRT-WX<\>Q:>NIZC?6MUI$MW+'>7!E_>HZC<F?NY#'@8'M6TW@N&
MX\.W6BWVLZO?0W+HQFN9D:1-I! 4A  /E';UK2DT&UE\1VVN,\WVFWM7M53(
MV%&8,21C.?E'>FT[NSW_ /D6OSM^8K:)=O\ -/\ *YY'I/B#Q%=V.G>((;?Q
M7+J%S<1R2&1X_P"SFB9\%%3?P IX.W=D<UUEQ87_ (@^(VN:4^OZK9:?;VMM
M.D5E<>4PD;<.&ZA?ESCH2>:U8OASI,5W$PO-3;3XI_M,>EM< VJR9W A<;L
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M!M-R%8,G1LY/)S[8KL98+SQ;XOURSDUC4M.MM)2%(([&X,):1TWF1B/O#D
M\<'BMEO ^F/X<OM#,]W]EO;I[N1]Z[P[2"0@';C&1Z'BEUCP79ZMJ+7\>H:E
MIUS)$(9WL)Q'Y\8SA7RIZ9/(P>>M19\J7E_[:E?[T_S';6_K_P"E-_E_D<;=
M:YK>K^!/"EU%JDUGJ%UJBV4]S!@>8N9(V;;T.=NX=LX-=I8^$S9Z??6#Z_K=
MS!=8VO->$S0'OLE&&&?KQVJ6;PEI<FG:1I\2R6]KI5Q'<6R1,/O)G ;(.1R<
M]_>MVM';7S?^7ZIL23T\O\W^C2.*\ ">33=>LI[Z^N5M]5N+:*6XN7DE5!@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *QO$7_'O#_O'^5;-8WB+_CWA_WC_*@"SHG_ ""X
M_JW\ZT*S]$_Y!<?U;^=:% !1110 4444 %%%% !1110 54U2]L].TNZO+]E6
MTAC+2EEW#;CD8[_2K=9^N:3%KFBW>F32/&EPFWS$^\AZAA[@@&IEMH-;GE\O
MA;[9*MQIWPYOH+1B65#K[6?'8B%&(7/IQ7:^"9]+AM[K2;/1)-$O+9@]S92X
M9SNSB3>"?,!P?FR>E8=WXI\3Z/<)8W.J^"9I5^7S+C46MI'QW,>&P?H371^&
MM*O!>76O:I?6EW?7L:1#[$#Y$<2%BJJ226Y8DL>OH*J/EM_5B'TOO_5R#6?^
M0K/_ ,!_]!%=77*:S_R%9_\ @/\ Z"*ZN@H**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "L;Q%_Q[P_[Q_E6S6-XB_P"/>'_>/\J +.B?\@N/ZM_.M"L_
M1/\ D%Q_5OYUH4 %%%% !1110 4444 %%%% !6-XLBU"?PIJ46E^9]L: B,1
M-M<^H4]F(R ?6MFLSQ#J_P#86@7FI^5YQMX]RQ[L!FS@ GL,D<U,_A&MSA[/
M7_A386L=L\>DV4@7#P7EELF4]]X=<D]>3UK3\#QV;:WJ]UH%L]MX<F2+R4\H
MQ1R3@MYCQH0,+C8,@ $CBI6\/>,;TI<7'B^WMI>ODVNE1/&GL&D)8X]>*O>'
MM3U4:S?:!K4MO<W=I%'<)=V\9C66-RP&Y,G:P*GH<'BK6]WOK_7R,^BMMH0Z
MS_R%9_\ @/\ Z"*ZNN4UG_D*S_\  ?\ T$5U=(L**** "BBB@#F[R\UZZ\57
M>EZ7>:;:06ME;W#-=63SL[2O,N!MF0  0CL>IJ3['XP_Z#NA_P#@FF_^2J+/
M_DH>L_\ 8*L/_1MW704 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_
M "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\
M8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P3
M3?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?
M]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_
M "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\
M8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P3
M3?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?
M]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_
M "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\
M8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P3
M3?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?
M]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_
M "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\
M8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P3
M3?\ R51]C\8?]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?
M]!W0_P#P33?_ "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_
M "57044 <_\ 8_&'_0=T/_P33?\ R51]C\8?]!W0_P#P33?_ "57044 <_\
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MZ"B@#G_L?C#_ *#NA_\ @FF_^2J/L?C#_H.Z'_X)IO\ Y*KH** .?^Q^,/\
MH.Z'_P"":;_Y*H^Q^,/^@[H?_@FF_P#DJN@HH Y_['XP_P"@[H?_ ()IO_DJ
MC['XP_Z#NA_^":;_ .2JZ"B@#G_L?C#_ *#NA_\ @FF_^2J/L?C#_H.Z'_X)
MIO\ Y*KH** .?^Q^,/\ H.Z'_P"":;_Y*JQX8U"\U/13/?F!KJ.[NK9V@C,:
M-Y4\D08*68C(0'&3UK8KG_!O_(#N?^PKJ7_I;-0!T%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %8WB+_CWA_WC_*MFL;Q%_Q[P_[Q_E0!9T3_ )!<?U;^=:%9^B?\@N/ZM_.M
M"@ HHHH **** "BBB@ HHHH *AN[2WO[.:TNH4FMYD*21N,AE/!!J:BDU?1A
ML<:? ,L15+'Q?XDL[9!A8$NDD"CT!=&;'U)K<T/P[9:"DQMWN)[BX8-/=74I
MEFE(Z;F/8=@, >E:U%,5D<IK/_(5G_X#_P"@BNKKE-9_Y"L__ ?_ $$5U= P
MHHHH **** .?L_\ DH>L_P#8*L/_ $;=UT%<_9_\E#UG_L%6'_HV[KH* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!S_CO_ ))YXE_[!5U_Z*:N@KG_ !W_ ,D\\2_]@JZ_]%-704 %
M%%% !1110 4444 %%%% !1110 5S_@W_ ) =S_V%=2_]+9JZ"N?\&_\ (#N?
M^PKJ7_I;-0!T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '/^'O\ D.>+/^PK'_Z16M=!
M7/\ A[_D.>+/^PK'_P"D5K704 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 <_XR_Y =M_V%=-_P#2V&N@KG_&
M7_(#MO\ L*Z;_P"EL-=!0 4444 %%%% !1110 4444 %%%% !7/^#?\ D!W/
M_85U+_TMFKH*Y_P;_P @.Y_["NI?^ELU '04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C>(O
M^/>'_>/\JV:QO$7_ ![P_P"\?Y4 6=$_Y!<?U;^=:%9^B?\ (+C^K?SK0H *
M*** "BBB@ HHHH **** "BBB@ HHHH Y36?^0K/_ ,!_]!%=77*:S_R%9_\
M@/\ Z"*ZN@ HHHH **** .?L_P#DH>L_]@JP_P#1MW705X_\0?B;_P *Y^(<
MO_$H_M#[?I5K_P O/E;-DMQ_L-G._P!NE<__ ,--?]2C_P"5+_[50!] 45\_
M_P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!] 45\_\ _#37_4H_^5+_ .U4
M?\--?]2C_P"5+_[50!] 45\__P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!
M] 45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5+_[50!] 45\__P##37_4H_\
ME2_^U4?\--?]2C_Y4O\ [50!] 45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5
M+_[50!] 45\__P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!] 45\_\ _#37
M_4H_^5+_ .U4?\--?]2C_P"5+_[50!] 45\__P##37_4H_\ E2_^U4?\--?]
M2C_Y4O\ [50!] 45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5+_[50!] 45\_
M_P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!] 45\_\ _#37_4H_^5+_ .U4
M?\--?]2C_P"5+_[50!] 45\__P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!
M] 45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5+_[50!] 45\__P##37_4H_\
ME2_^U4?\--?]2C_Y4O\ [50!] 45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5
M+_[50!] 45\__P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!] 45\_\ _#37
M_4H_^5+_ .U4?\--?]2C_P"5+_[50!] 45\__P##37_4H_\ E2_^U4?\--?]
M2C_Y4O\ [50!] 45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5+_[50!] 45\_
M_P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!] 45\_\ _#37_4H_^5+_ .U4
M?\--?]2C_P"5+_[50!] 45\__P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!
M] 45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5+_[50![!X[_Y)YXE_P"P5=?^
MBFKH*^<-=_:'_MOP]J>D_P#"+>3]NM);;S?[0W;-Z%=V/+&<9SC(J_\ \--?
M]2C_ .5+_P"U4 ?0%%?/_P#PTU_U*/\ Y4O_ +51_P --?\ 4H_^5+_[50!]
M 45\_P#_  TU_P!2C_Y4O_M5'_#37_4H_P#E2_\ M5 'T!17S_\ \--?]2C_
M .5+_P"U4?\ #37_ %*/_E2_^U4 ?0%%?/\ _P --?\ 4H_^5+_[51_PTU_U
M*/\ Y4O_ +50!] 45\__ /#37_4H_P#E2_\ M5'_  TU_P!2C_Y4O_M5 'T!
M7/\ @W_D!W/_ &%=2_\ 2V:O'_\ AIK_ *E'_P J7_VJO0/@_P")_P#A*O"%
MY>_8_LNW5;OY/-WY\R3S^N!T\[;[[<]\  ] HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M Y_P]_R'/%G_ &%8_P#TBM:Z"O#_ !-\8/\ A7_CWQ)I/]A?;_.NX;GS?M?E
M8S:P+MQL;^YG.>]9_P#PTU_U*/\ Y4O_ +50!] 45\__ /#37_4H_P#E2_\
MM5'_  TU_P!2C_Y4O_M5 'T!17S_ /\ #37_ %*/_E2_^U4?\--?]2C_ .5+
M_P"U4 ?0%%?/_P#PTU_U*/\ Y4O_ +51_P --?\ 4H_^5+_[50!] 45\_P#_
M  TU_P!2C_Y4O_M5'_#37_4H_P#E2_\ M5 'T!17S_\ \--?]2C_ .5+_P"U
M4?\ #37_ %*/_E2_^U4 ?0%%?/\ _P --?\ 4H_^5+_[51_PTU_U*/\ Y4O_
M +50!] 45\__ /#37_4H_P#E2_\ M5'_  TU_P!2C_Y4O_M5 'T!17S_ /\
M#37_ %*/_E2_^U4?\--?]2C_ .5+_P"U4 ?0%%?/_P#PTU_U*/\ Y4O_ +51
M_P --?\ 4H_^5+_[50!] 45\_P#_  TU_P!2C_Y4O_M5'_#37_4H_P#E2_\
MM5 'T!17S_\ \--?]2C_ .5+_P"U4?\ #37_ %*/_E2_^U4 ?0%%?/\ _P -
M-?\ 4H_^5+_[51_PTU_U*/\ Y4O_ +50!] 45\__ /#37_4H_P#E2_\ M5'_
M  TU_P!2C_Y4O_M5 'T!17S_ /\ #37_ %*/_E2_^U4?\--?]2C_ .5+_P"U
M4 ?0%%?/_P#PTU_U*/\ Y4O_ +51_P --?\ 4H_^5+_[50!] 45\_P#_  TU
M_P!2C_Y4O_M5'_#37_4H_P#E2_\ M5 'T!17S_\ \--?]2C_ .5+_P"U4?\
M#37_ %*/_E2_^U4 ?0%%?/\ _P --?\ 4H_^5+_[51_PTU_U*/\ Y4O_ +50
M!] 45\__ /#37_4H_P#E2_\ M5'_  TU_P!2C_Y4O_M5 'T!17S_ /\ #37_
M %*/_E2_^U4?\--?]2C_ .5+_P"U4 ?0%%?/_P#PTU_U*/\ Y4O_ +51_P -
M-?\ 4H_^5+_[50!] 45\_P#_  TU_P!2C_Y4O_M5'_#37_4H_P#E2_\ M5 '
MT!17S_\ \--?]2C_ .5+_P"U4?\ #37_ %*/_E2_^U4 ?0%%?/\ _P --?\
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M_P#X::_ZE'_RI?\ VJC_ (::_P"I1_\ *E_]JH ^@*Y_P;_R [G_ +"NI?\
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MOM<-JUHJ!AY91F#$D8SG(]:XSQC;!/%HO'T_Q+:DVRHFI^'P97F&3F*6,(V
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MS_\ 7I6V\O\ AOR'_7ZEWP[X;L_#=I-%;23W$]S*9KFZN7W2SR'^)C@#V
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M?E1=?#+1[C0+#28;S4[1;*Z-XEU;SJ)WF(.79V4Y)R3G J]_;UYZ1?\ ?/\
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MO L/A^['V/6M5;3$#"/2Y94:! V<C[NXCG@9X]ZHGX867E-IZZUJZZ"S[SI
ME7R>N=F=N\)G^'-:G]O7GI%_WS_]>C^WKSTB_P"^?_KT!8Z2.-(HUCC4*B *
MJ@< #H*=7,_V]>>D7_?/_P!>C^WKSTB_[Y_^O0/8Z:BN9_MZ\](O^^?_ *]'
M]O7GI%_WS_\ 7H Z:BN9_MZ\](O^^?\ Z]']O7GI%_WS_P#7H Z:BN9_MZ\]
M(O\ OG_Z]']O7GI%_P!\_P#UZ .FHKF?[>O/2+_OG_Z]']O7GI%_WS_]>@#I
MJ*YG^WKSTB_[Y_\ KT?V]>>D7_?/_P!>@#IJ*YG^WKSTB_[Y_P#KT?V]>>D7
M_?/_ ->@#IJ*YG^WKSTB_P"^?_KT?V]>>D7_ 'S_ /7H Z:BN9_MZ\](O^^?
M_KT?V]>>D7_?/_UZ .FHKF?[>O/2+_OG_P"O1_;UYZ1?]\__ %Z .FHKF?[>
MO/2+_OG_ .O1_;UYZ1?]\_\ UZ .FHKF?[>O/2+_ +Y_^O1_;UYZ1?\ ?/\
M]>@#IJ*YG^WKSTB_[Y_^O1_;UYZ1?]\__7H Z:BN9_MZ\](O^^?_ *]']O7G
MI%_WS_\ 7H Z:BN9_MZ\](O^^?\ Z]']O7GI%_WS_P#7H Z:BN9_MZ\](O\
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MZ1?]\_\ UZ/[>O/2+_OG_P"O0!TU%<S_ &]>>D7_ 'S_ /7H_MZ\](O^^?\
MZ] '345S/]O7GI%_WS_]>C^WKSTB_P"^?_KT =-17,_V]>>D7_?/_P!>C^WK
MSTB_[Y_^O0!TU%<S_;UYZ1?]\_\ UZ/[>O/2+_OG_P"O0!TU%<S_ &]>>D7_
M 'S_ /7H_MZ\](O^^?\ Z] '345S/]O7GI%_WS_]>C^WKSTB_P"^?_KT =-1
M7,_V]>>D7_?/_P!>C^WKSTB_[Y_^O0!TU%<S_;UYZ1?]\_\ UZ/[>O/2+_OG
M_P"O0!TU8GB)U\N!,_-DG'M53^WKSTB_[Y_^O4,-O=:K<[V).?O2$< ?Y[4
M;FB@C2X\]RW\ZT*9#$L$*1(,*HP*?0 4444 %%%% !1110 4444 %%%% !11
M10 4UXHY/OHK?49IU% $7V6W_P">$7_? H^RV_\ SPB_[X%2T4 1?9;?_GA%
M_P!\"C[+;_\ /"+_ +X%2T4 1?9;?_GA%_WP*/LMO_SPB_[X%2T4 1?9;?\
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M4 1?9;?_ )X1?]\"C[+;_P#/"+_O@5+10!%]EM_^>$7_ 'P*/LMO_P \(O\
MO@5+10!%]EM_^>$7_? H^RV__/"+_O@5+10!%]EM_P#GA%_WP*/LMO\ \\(O
M^^!4M% $7V6W_P">$7_? H^RV_\ SPB_[X%2T4 1?9;?_GA%_P!\"C[+;_\
M/"+_ +X%2T4 1?9;?_GA%_WP*/LMO_SPB_[X%2T4 1?9;?\ YX1?]\"C[+;_
M //"+_O@5+10!%]EM_\ GA%_WP*/LMO_ ,\(O^^!4M% $7V6W_YX1?\ ? H^
MRV__ #PB_P"^!4M% $7V6W_YX1?]\"C[+;_\\(O^^!4M% $7V6W_ .>$7_?
MH^RV_P#SPB_[X%2T4 1?9;?_ )X1?]\"C[+;_P#/"+_O@5+10!%]EM_^>$7_
M 'P*/LMO_P \(O\ O@5+10!%]EM_^>$7_? H^RV__/"+_O@5+10!%]EM_P#G
MA%_WP*/LMO\ \\(O^^!4M% $7V6W_P">$7_? H^RV_\ SPB_[X%2T4 1?9;?
M_GA%_P!\"C[+;_\ /"+_ +X%2T4 1?9;?_GA%_WP*/LMO_SPB_[X%2T4 1?9
M;?\ YX1?]\"C[+;_ //"+_O@5+10!%]EM_\ GA%_WP*/LMO_ ,\(O^^!4M%
M$7V6W_YX1?\ ? H^RV__ #PB_P"^!4M% $7V6W_YX1?]\"C[+;_\\(O^^!4M
M% $7V6W_ .>$7_? H^RV_P#SPB_[X%2T4 1?9;?_ )X1?]\"C[+;_P#/"+_O
M@5+10!%]EM_^>$7_ 'P*/LMO_P \(O\ O@5+10!%]EM_^>$7_? H^RV__/"+
M_O@5+10!%]EM_P#GA%_WP*/LMO\ \\(O^^!4M% $7V6W_P">$7_? H^RV_\
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M_P">$7_? H^RV_\ SPB_[X%2T4 1?9;?_GA%_P!\"C[+;_\ /"+_ +X%2T4
M1?9;?_GA%_WP*/LMO_SPB_[X%2T4 1?9;?\ YX1?]\"C[+;_ //"+_O@5+10
M!%]EM_\ GA%_WP*/LMO_ ,\(O^^!4M% $7V6W_YX1?\ ? H^RV__ #PB_P"^
M!4M% $7V6W_YX1?]\"C[+;_\\(O^^!4M% $7V6W_ .>$7_? H^RV_P#SPB_[
MX%2T4 1?9;?_ )X1?]\"C[+;_P#/"+_O@5+10!%]EM_^>$7_ 'P*/LMO_P \
M(O\ O@5+10!%]EM_^>$7_? H^RV__/"+_O@5+10!%]EM_P#GA%_WP*/LMO\
M\\(O^^!4M% $7V6W_P">$7_? H^RV_\ SPB_[X%2T4 1?9;?_GA%_P!\"C[+
M;_\ /"+_ +X%2T4 1?9;?_GA%_WP*/LMO_SPB_[X%2T4 1?9;?\ YX1?]\"C
M[+;_ //"+_O@5+10!%]EM_\ GA%_WP*/LMO_ ,\(O^^!4M% $7V6W_YX1?\
M? H^RV__ #PB_P"^!4M% $7V6W_YX1?]\"C[+;_\\(O^^!4M% $7V6W_ .>$
M7_? H^RV_P#SPB_[X%2T4 1?9;?_ )X1?]\"C[+;_P#/"+_O@5+10!%]EM_^
M>$7_ 'P*/LMO_P \(O\ O@5+10!%]EM_^>$7_? H^RV__/"+_O@5+10!%]EM
M_P#GA%_WP*/LMO\ \\(O^^!4M% $7V6W_P">$7_? H^RV_\ SPB_[X%2T4 1
M"VMP<B"('_<%2@ # &!110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
=10 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxy_002.jpg
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" A^!I(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** .7L_'FEWWCR\\'Q07@U"TB\V21D7RB,*>#NSGYAV
M]:ZBO%/#_P#R=!XA_P"O/_V2*L7PM'XW\;Z]XMTBT\8WNFV-K?.3,6>60?.X
M6-#N!1<*>A'04+6*]+_C8):2?JE^!]"T5\^^"IOB!X[T[4_#Q\62:?'I$QCD
MOT0O<3-D@)O# @#:3NSDYYS6GX,\7:]J7PD\8)J-_/)J.D1S1178<B48C.#N
M')((//6AZ)ORO\@6K2\[?,]OHKY]\*Z+\1/&O@2WUJ+QQ=V?V<.+2W5G+7!0
MG)EDW9.3D<[A@#BM;3/B_J*?!BZUVZ6.76[6X^P*S+A9)" 0Y _V221QDCMF
MG)6O?I^H1UMYGME%>$7/ASXEZ9X7;QJWCFYDOH[<7DNFNI,(3;N*XSLSCL$'
MU[U8\=^.]0U?X(:5XCTV[N=.O)[M(Y3:S-&0P#A@""#@D9Q]*3TO?I9/YA'W
MFK;/]-3VF[N[>QLYKNZF2&WA0R22.<*J@9)-5-"URP\1Z1#JNF2M+9S%O+=E
M*[MK%2<'GJ#7C>N>"?%MU\/=4U[5_'6HM+/9?:Y+"-66%5"$F+ ?&""!T XY
M!K0^#.A:Y9?#Z35[/7#<M>V[K96%V7%O:R*[#=D$\$\G"BG:W-?I_P $5[J+
M74]EHKYU\6:A=^&O#YU)_BC=W?B^.5?,L;._$EKG=@J(@H PO/S <CIR*U?B
M3XRUS_A6W@S7+*^N+.]O)$DF^SRM$)#LR00I&5)[4O\ -+[Q_P"3?W'NM9&N
M>)M)\._9%U*Z$4EY,L%O& 2TKD@8 'U&3T%>)>.&^('@ :9XJNO&,U\]U.L<
MUB$*01DC=M"Y*D8!&< T_P"->CWU[XL\*WT>M7,,6I2I#! -V+1\KF1?FZG<
M.@'W1S32>GK8._I<^@:XKQ'\4- \*^*K/P_J:7B3W2HXG5%,*!F*@L2P(Y'/
M!KH/#>E76B>'[33KW4YM3N8%(>\FSOE.2<G+,>^.IZ5X5\7M ?Q1\:=,T:*4
M12W.G (Y&0&'FL,^V0!2>DDM_P#AK@M8MO0]N\6>*;'P=X>FUO4(KB6VB9%*
MVZJSG<0!@$@=_6K^CZI!K>C66J6RR)!>0I/&L@ 8*PR,X)&>?6OG?4_%\^L?
M W5O#^K[H];T:>""5)/O,@D !^HQM/X>M=?K?C/4?"?P?\(6^BA?[6U.V@M[
M=V .SY!E@#P3DJ!GUJK:.VNJM\T)=+Z;W^1[-61KGB;2?#OV1=2NA%)>3+!;
MQ@$M*Y(& !]1D]!7C^O:3\0OAOI(\6-XUGU<1R(;VQN QC 9@,+N8C&3C@+C
M]*ROBO;W/B+5_!>NVNLW,-MK7E+;0#=BS<[,R+\P^;YAT ^Z.:FVJMWM_7J/
MH_1O[O\ (]TUS7_[#>R7^R=5U#[5+Y6;"V\T0]/FDY&U>>M;%>,>/SKGA'2O
M VF+XCU&XG_M$17-V)GC:Y4L#A_F)(P<8)-6O'.N^(_$'Q'M? 7AS53I*?9_
M/O+R,?O!D$X!!!&!CH0<GK1OMKJU]R3#S>FE_P ;'KM%>:^#]"\>>%=?N8-7
MUX:UX<6$N+BZ<^>&QGY0=QZ\$%L8Z5YU9^)-:^(%SJ&LS?$BU\*Q6\Q6QT\W
M2Q;P "-PWKD=.2&YSQCBC_AP/H^L#QAXNL/!.A'5]2AN9;<2+%MME5GRW3AF
M QQZUSGP@\:7GC+PI*^INDFH6,Q@FE0 "48RK<<<\CCTK/\ V@/^28O_ -?D
M/]:52\5]WXV'#WGKY_A<I?\ #1W@_P#Z!NN?]^(O_CM>C>&?%.D>+M*&I:-=
M>?!O*-E2K(P[,#R#TKQB+XU:MHOAS3=-O/ <\*26J6\$]Y<M'%-\H4-\T0!4
M]>N,=ZW/ .BZE\+?AMK^O:O'']JE7[4EFC@JF!A02,CDGMGC%6[+F;V77]"%
M=\O=GLE%?,Z:YXEO/#LGC)_BG:6^JJK31Z&+A "H)^7R]^-V.@*$].:Z_P 2
M?%35)_A=X?OM'"0ZSK<OV;>H_P!4ZG:Y4'/4XQZ9I6=O/1??L5=?+7\-SVFB
MOGSQQI?C[X?^!GG?QI>:E#=2QI,Y>1)K5\YRDF\L5."I''7I7HGB,>(+SP=H
MAL/$%GHUH\,3:GJ%S<%)A&57/EL5(W'DY)'0<TNEUWL'6WE<[^BO -,\5OH/
MQ:T?1M"\9:AXBT>^VQW(O;G[3L<DCY7QVX/'XU+J4OBWQ#\;/$'AC2O$][IE
MHT*LSAW<0($0GRUW#:22.00>3S0M;6ZW_ 'I>_2WXGO5<SXH\<Z9X2U+1["_
M@NY)=5F\F P(I56RH^;+# ^8=,]Z\\\9ZEXGM-6\,_#;1->G6^N;<-=ZK(3Y
MSCYN<Y)'"L>#GISUKEO&V@^)/#OB[P39:UX@?7+47RM;7,L1653YD>Y6)9B>
MQ!)/>JBKR79NWJ#T3OO:_P#D>]2:_P"7XHBT/^R-5;S(O-^WK;9M%Z_*9,\-
MQTQW%;%>5WNK:DG[1FGZ6NH7:Z>^FEVM!,PB+;7Y*9QG@<X[5S"W7C'7_C)X
MG\-Z3XFN=/M<;FD<M*+=!MXB0L I)8<C'?FI6J5NM_P8F[-^5OQ/>Z*\6^&^
MM>(]&^)>M>"M<UF;5X+2 S1W$[%G!&TYRQ)P0_().,<5G^'9/&WQ5U74]>L/
M%L^A:=97)BL[>%"R-QG#J& ;C!);=R3@4[7M;:U_T_,>U[]['O-0W=W;V-G-
M=W4R0V\*&221SA54#))KR7X1ZYK^J^-O&$&NWDTLMLZ)Y'G,T,3AF5O+4GY0
M<9XKJ/BWI=UJ?PYU/[+J4UC]FB:XD\K/[]%1LQ'!'#9YZCCH:F;M%2\KE15Y
M<K-8^-=(;P7/XLMVGN-+BC>3,<>'=58J<*Q'<=\5;\,>(K3Q9X>M=:L(YX[:
MY#%%G4!QABIR 2.H]:\.\+:%?V7P#US5YM;N;FSO=/D6'3WW>7;%9&!*Y8CG
MKP!5/0=$\:2_!V+7[+Q=-IMEIL4TUM86R%/,5&8L7<,,DG=P01P*N247*_2W
MXD*[M;K<^E**\:D^*6J6?P)L_$DACDUFX<V:2,HQO#,-Y'3.U<XZ9KD+O7_$
M/@_3[3Q-!\3K/7KJ61#>:/\ :EE50W)"KO/3H=JKBDU:33Z:#Z)]_P!#Z4JC
MK6KVN@Z+>:K>EA;6D32R;0"2 .@SW/05+IU]%J>F6M_!_JKF%)D^C $?SKRS
MX\:E++H^D>%;1O\ 2M9O$4J/[BD?^S%?R-*2DGRK>]AQ:?O/;<ZCP/\ $[0O
M'UQ=V^EQ7L$MJJNR7:(I922,KM9LX[_45VE>%ZYIUO\ #+XM^&-5M5,6EW]N
MNGW&!P"H5,G_ ,</_ 36]\4]3U7PIXJ\,>);>_NTTC[0+:_MEG80D'D,4S@G
M:6YQ_"*K1VMU=OG_ ,'3[R==;]K_ -?C]QZM17DOC76=3USXK^'/"6C:E=6E
MO&OVR_>UF:,NG7:Q4CC:O_CXJYXPMKV7Q+-)XB\=IX=\/K&/L4&G:A]GN9'X
MRSEEY')X!/;ZU/1/U_ ?6WI^/]7/32<*3@G Z"N9@\;6[^%M2U^ZT76M/M]/
M#M)!?6HBFD"@$E%+8(YP#D<@UP?P9\7ZEK5SXBTF[U6;5+2P8&RO)_\ 6-'E
M@"2>3D 'GGK6+X1U;4M8^!/C:;4]0N[V5&N$5[F9I&5?*7@%B<#D\42T3:[)
M_>RDN_>WX'M'AO7[7Q1X?M-:LHYH[:Z4LBS* X )'(!([>M:M>5^#TUV3X#:
M4GAV\LK*_:%@+F]8JD2^8V6X5N?3(Q7!^*/$[>"KS2+SP_\ $74->O7EQ?VL
MMZ+F C@G: -J@G( Z\\=#5M+VG*N]C.#;@I'M6J>.-,TCQEIGA>X@NVOM13?
M#)&BF-1D_>)8$?=/0&NFKPCXGIJEW\:?"::++'!J$MH!#+(NY8\L^6([X&3^
M%/O;CQC\+/&.BOJ7BB?7])U>X\F<7*D",D@':"S;<;LC! X(Q40U2OU;7XZ%
M2TU79/\ #4]<77]WBAM#_LG51MB\W[>;;_13_LB3/WO;%5-%\:Z;KOB;6- M
M8+M+O2B!.\J*$;)Q\I#$G\0*Y"'5M2/[14^EG4+HZ>-,#BT\YO*#8'.S.,^^
M*I_#K_DLWQ _ZZ+_ .A&E'6WHW]S"6E_5?B>AZ1XFBU2TO[J?3=3TJ&R=E=M
M3M_)W*!DNO)ROO5C0=?T[Q+I:ZEI4QFM&=D23:5#%3@D \XR*\3T!M;\5?#7
MQS%-XBU".2UO9'25YGD/E(I8Q#+#"L!C'3GH:@^'/A/7KGX3:EJFG>)M2C:X
MMI19V,$KQB"5)-V58/U;:0< ?>-%]&WT2?WC:ULN[7W'T-17CVF_$:8? ";6
MY;IVU6WB:Q,C,2YGSM5B3SG!#9^M=K\-;+4[+P%IG]L7MU=ZA/']HEDNIFD<
M;^0N6)/ P,?6K<;-KM;\?^!J3?1>=_P_X)UE%>8?%'Q9KMIK>B>$?#,R6VIZ
MLV7N6&3%'G'&?HQ)ZX7CK7+ZPWC3X/W&FZK>^*[CQ#H]S<"&ZANPQ9"1GY2S
M,1P#R".1TJ8Z_-V^8WI^9Z=XN\?:1X-EL[>]BO+J]O3BWL[&'S)9.0.!D#J?
M7GM6YI&H_P!K:5;W_P!BO++SEW?9[V+RYDYQAER<&O#/B)8:U<?&CPP8/$.Q
M[PA["7[$A^Q+GIC/[SG)^;UKW?3X;FVTZVAO;O[9=1QJLMQY8C\U@.6VCA<G
MG HCK&[[O\!-^]9=E^)P'BCXU>&_"7B&YT6_LM5DN;?;O:"*,H=RAA@F0'H?
M2I?"WQH\)^*]5CTRW:\L[N4[84O(E42'T!5F&?KBO.M8\8Z?X'_:&US5M3AN
MI8&M4A"VRJS9,<9'#,!CCUJ+5M9/Q>^(GAVY\,Z)>00Z?*K7-]/$%( 96^8J
M2!@#@9R=U.G[W+?KOY;E5/=YK=/QT1]&T5X=XSO/%-_\;X_#>AZ_=Z=#>6*J
MQ5V9(1AF9PF0-V%QG@\]15_Q?K'B3P5H_ASP9I.M3:AK^J3-&=3NQEPI8#/S
M%L?> R2<!326J3[[?>U^@GHVNV_W7/8J*\'UV#QU\)([/7YO%UQX@TZ2=8KR
MUN@W&<_=+,V!UY&.<<&MOXG7>NZ#<:/X]T/4;Z32XC']MT_[0_DNC=&V9V\@
MX/'!P:--'?K;T#7;ROZGKM%>1?#JYUWQ_K^J>+KZ_P!1L]%.ZVT^PCN72,\8
M+E0<$CU_O'_9%.^%?B6_L/\ A*M!\2ZA<W-UHD[S>?=REW,.#SECG'R@_P#
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M@?AY:7T,][+#XW3Q'H9.+99)!//$>OSR@]>2,$>G3I77:[:WUYHMU;Z;J/\
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ML+I%5BV >-K-QS735\Q_"CPWXJ\2^%M5@T?Q.^AV,=SN)@C)DFEVC@L&4JH
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MC*]Z61+J!HF9=BC(# 9%<[X \":IJG@+QIH>HV-WITM]<!K=KJ!XPS+\RD9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.>?>B/O6\VU^1$M+^E_S/6Z*\.\2:K;>(?'>N6/B'0/%&N:5ISI;VUGH\#M
MK;0S/*4=27R>/0"MWX;WMW;^*+S2K'0_$NG^&VM1+;QZU;NOV>52 4C9B?E*
MD$ GJ#1'WD-Z'H'B34IM'\,:IJ=NJ--:6DL\:R E2RJ2,X(../6N<^&?CX>.
M=":2ZA2VU:W(%S;H"!AAE'4$D[6%;'CG_D0?$/\ V#I__19KS==-N]!\'^%/
M'VBQ,]S8Z9!'J5NG_+S:[!G_ ($O4?\ UJ(VU;VT^6_]/[^A37NJV^OSVT_R
M.^3Q+>-\4)/#)B@^Q+I0O1)M/F;S)MQG.,8]L^]=37EUAJ]IJ'QD?5[*036L
MOA=9XV7^(>;G\ZJ>$/!6F_$'P[!XJ\5O=W^HWSO-#BZDC2T7<0JQ*I &-H/.
M>:=G9>FOWM?H1=7_ "^Y,]-US58]#T*_U66-I([.!YV1.K!1G _*J$&I:OK'
MAW1M3TF*QB>[\B>XCNV<A86&7"%>K\\9X]:\TN8&U+X;^./#VMS3:G_PCLLG
MV2YF<[R!'OC+$'YBOOUILV@Z;H?PV\#_ -FVWD?;=8TZZN/G9M\K*,M\Q..G
M08%$4G]\;?/^OP'_ /;?A_7]6/:Z*\QU>P3QW\4+[P]JLUP=#TJQCD>RBE:-
M;F60YRY4@D >_7\:LW6AS?#/P]XBU31-1E;3([(R6NEW :5;:4#[RNS$[3W7
M'XU%[1YF.VMD>BT5\\VL&B7-C%?WW@_XCW7B%XMYUF.VE#B0C.Y,2;0N2<#'
M2O8_ >H:MJG@O3KG7+6XMM2V%)TN(C&Y*L5W%2!C( /XU?+OY$WV.CHK@/B0
M=$\W3%\2^(Y;'26+B33+=9/,OV(  )C._:,\@#!SR:XG0)-$T7XI>';3P=9:
MUIFG7RSI>17<<R0SE4R-HE.2PP,GMD>]**YG8;T5SW6BO'O#_@W3O%GBWQNN
MM-<7&GIJF%LDN'BC9]H.]MA!8],9.!S3=(U2Z\%:+\1+"RN)IK70F4Z<L[%S
M#OCR%R?X0<<>U3?W;^5_R_S#K;SL>MW\[6NG75P@!>*)W4-T) )YK,\':Q<>
M(?!^E:O=I$EQ=VZRR+$"$!/H"2<?C7#K\,K"+PE)K*7U_P#\)/)8F6353=R%
MG<IN*LI.TIVQCI73_#'_ ))GX>_Z\DJK6YD^EOU%>Z376_Y(K>./$7B+2]8\
M/Z3X<CTMKK59)D+:BLA1=B!NJ$$=^Q[5GW.J_%'1+2;4M2T_PM?V=LADE@T^
M6XCF*CDE2X*\#/%0?$J[U"Q\:>"+C2],_M.]2:Z\NT\]8?,_= 'YVX&!D_A4
MU[JOQ'U^PN-+B\&6NB&YC,9OKG5HYUC!X)"(N2<$X[5.O+=;ZEM*ZOM9?J=S
MH^J6^MZ-9ZI:%OL]W"LT>X8(##.#[U=KQ_Q1X;2S\1_#GPS!=3QVRPW-K+)$
M^QWC$:[QD<C< >G/-6];T&UTS6?#7P_T)[C2M&OWN+N[^SSOYCJ@!V!R2P!/
M7FK:3?N]6[?+_@$:I>]VO_7S/5:*\F\0>%[#X9?V7KOA0W-C%]OBM[VR%P\D
M5U'(VTY5V/S#C!%.\?WS_#+67\6Z6L3PZJ#;WMB\@423A28YE'J,8;';\ZFZ
MW^7SZ?>.SO;YGJ]%>=:?X!6Y^'.I6US=)=:SK<7VJYOU.[=.1N0J1_"IQC''
M'O575_$=UKWPMTJUMR4U77733)%QS&^2LY]L!7IM.]NNGX_\$$T[/IK^&OY'
MI]<5K/BC7[OQ%=^'O"-A837EE$DEW=ZC*RP0E^53:@W,2 3VQ7765I#86,%G
M;($@@C6.-0, *!@"N*U;PO+J7B2ZUSPAXH33=67;;ZA&J)<12E1PLB9^5@#U
MZX_.D[7\@6WF.LO%7B71];T[2O&6G::@U)S%;7^ER.8?-QD1LKC<"1T.>U;8
M\3(WCP^%UMFWKI_VYIRW&-X0*!^9S]*YF#Q7XO\ #.J:?9^--/TV6RO[@6L.
MI:8[!4D;[HD1N>>>1@5BR>#M!NOV@IFFL-Q&FIJ0_?2#_21-@/PWH!QT]JJ.
MK5]M?P7Z">B?R_,]?J*ZN%M+2:X8%EBC9R!U( S7C^O6W@2^\2ZG#XKU2_\
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ME7<!E=2=N#Z  <46U^=OZ^\B^E_*YZ[7(>.?B!IO@S3ILL+K53$TD%C%\SD
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M7,:[E)8QY((Y'&<\=JX+P;=Y\+_$/3+;^TH]*LHG%E;:B&$L"-"WRX;D#@$
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M[E_)_DW^A[8.0#2UX[X_U@:AX]'A_4M+\0:GHEK8I-)8Z)"SF:1R1F4JRG8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ^8GZYKOZ*FVEOE\@ZW^9Y;H'@_XA>%?#5EHFD:WHC0;")GNXI'>V8G)\D@
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MZC5Z+25]$XI:]?A_73H@Y)=SQ;6O'7AR+Q')XC\+^*;*&_G@6"YMKZPN3!.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&<?!_P#T$M<_[_P__&J/^&<?!_\ T$M<_P"_\/\ \:KV"B@#Q_\ X9Q\'_\
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M/@__ *"6N?\ ?^'_ .-5[!10!X__ ,,X^#_^@EKG_?\ A_\ C5=)X*^$V@^
M]9FU32[O4IIY;=K=ENI$90I96R-J*<Y0=_6N\HH YOQKX*TWQYHT.EZI/=PP
M17"W"M:NJL6"LN#N5AC#GMZ5P?\ PSCX/_Z"6N?]_P"'_P"-5[!10!X__P ,
MX^#_ /H):Y_W_A_^-4?\,X^#_P#H):Y_W_A_^-5[!10!C^%O#=GX1\.6FAV$
MD\EK:[]CSL"YW.SG)  ZL>U<?XI^"GAOQ=XCN]<O[W58[JZV;T@EC"#:BH,
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ML;-V,;57^^>N>U'CKX<:/\0/L']K7-]#]A\SR_LCHN=^W.=RM_<'3'>NPHH
M\?\ ^&<?!_\ T$M<_P"_\/\ \:H_X9Q\'_\ 02US_O\ P_\ QJO8** /'_\
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M&$';UKI** .#\:_";0?'FLPZIJEWJ4,\5NMNJVLB*I4,S9.Y&.<N>_I7-_\
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M!QD>HKU2B@"GJVFPZSHU]I=PTBP7MO);R-&0&"NI4D9!&<'T->5_\,X^#_\
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MI\-V?B[PY=Z'?R3QVMULWO P#C:ZN,$@CJH[5L44 >/_ /#./@__ *"6N?\
M?^'_ .-4?\,X^#_^@EKG_?\ A_\ C5>P44 >/_\ #./@_P#Z"6N?]_X?_C5=
MYX*\%:;X#T:;2]+GNYH);AKAFNG5F#%57 VJHQA!V]:Z2B@#S?Q3\%/#?B[Q
M'=ZY?WNJQW5ULWI!+&$&U%08!C)Z*.]8_P#PSCX/_P"@EKG_ '_A_P#C5>P4
M4 >/_P##./@__H):Y_W_ (?_ (U5S2?@%X5T;6;'5+?4-9:>RN([B-9)HBI9
M&# '$8.,CU%>J44 8_BGPW9^+O#EWH=_)/':W6S>\# .-KJXP2".JCM7F_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH YOQKXUTKP-HAU'4V9F<[(+>/&^9\=!Z
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M_P !5KZH_L^R_P"?.W_[]+_A1_9]E_SYV_\ WZ7_  H ^5_^%^>.O^?JR_\
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M_P#A?GCK_GZLO_ 5:/\ A?GCK_GZLO\ P%6OJC^S[+_GSM_^_2_X4?V?9?\
M/G;_ /?I?\* /E?_ (7YXZ_Y^K+_ ,!5H_X7YXZ_Y^K+_P !5KZH_L^R_P"?
M.W_[]+_A1_9]E_SYV_\ WZ7_  H ^5_^%^>.O^?JR_\  5:/^%^>.O\ GZLO
M_ 5:^J/[/LO^?.W_ ._2_P"%']GV7_/G;_\ ?I?\* /E?_A?GCK_ )^K+_P%
M6C_A?GCK_GZLO_ 5:^J/[/LO^?.W_P"_2_X4?V?9?\^=O_WZ7_"@#Y7_ .%^
M>.O^?JR_\!5H_P"%^>.O^?JR_P# 5:^J/[/LO^?.W_[]+_A1_9]E_P ^=O\
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MM_\ OTO^%']GV7_/G;_]^E_PH ^5_P#A?GCK_GZLO_ 5:/\ A?GCK_GZLO\
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M_P"?JR_\!5KZH_L^R_Y\[?\ []+_ (4?V?9?\^=O_P!^E_PH ^5_^%^>.O\
MGZLO_ 5:/^%^>.O^?JR_\!5KZH_L^R_Y\[?_ +]+_A1_9]E_SYV__?I?\* /
ME?\ X7YXZ_Y^K+_P%6C_ (7YXZ_Y^K+_ ,!5KZH_L^R_Y\[?_OTO^%']GV7_
M #YV_P#WZ7_"@#Y7_P"%^>.O^?JR_P# 5:/^%^>.O^?JR_\  5:^J/[/LO\
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M%6OJC^S[+_GSM_\ OTO^%']GV7_/G;_]^E_PH ^5_P#A?GCK_GZLO_ 5:/\
MA?GCK_GZLO\ P%6OJC^S[+_GSM_^_2_X4?V?9?\ /G;_ /?I?\* /E?_ (7Y
MXZ_Y^K+_ ,!5H_X7YXZ_Y^K+_P !5KZH_L^R_P"?.W_[]+_A1_9]E_SYV_\
MWZ7_  H ^5_^%^>.O^?JR_\  5:/^%^>.O\ GZLO_ 5:^J/[/LO^?.W_ ._2
M_P"%']GV7_/G;_\ ?I?\* /E?_A?GCK_ )^K+_P%6C_A?GCK_GZLO_ 5:^J/
M[/LO^?.W_P"_2_X4?V?9?\^=O_WZ7_"@#Y7_ .%^>.O^?JR_\!5H_P"%^>.O
M^?JR_P# 5:^J/[/LO^?.W_[]+_A1_9]E_P ^=O\ ]^E_PH ^5_\ A?GCK_GZ
MLO\ P%6C_A?GCK_GZLO_  %6OJC^S[+_ )\[?_OTO^%']GV7_/G;_P#?I?\
M"@#Y7_X7YXZ_Y^K+_P !5H_X7YXZ_P"?JR_\!5KZH_L^R_Y\[?\ []+_ (4?
MV?9?\^=O_P!^E_PH ^5_^%^>.O\ GZLO_ 5:/^%^>.O^?JR_\!5KZH_L^R_Y
M\[?_ +]+_A1_9]E_SYV__?I?\* /E?\ X7YXZ_Y^K+_P%6C_ (7YXZ_Y^K+_
M ,!5KZH_L^R_Y\[?_OTO^%']GV7_ #YV_P#WZ7_"@#Y7_P"%^>.O^?JR_P#
M5:/^%^>.O^?JR_\  5:^J/[/LO\ GSM_^_2_X4?V?9?\^=O_ -^E_P * /E?
M_A?GCK_GZLO_  %6C_A?GCK_ )^K+_P%6OJC^S[+_GSM_P#OTO\ A1_9]E_S
MYV__ 'Z7_"@#Y7_X7YXZ_P"?JR_\!5H_X7YXZ_Y^K+_P%6OJC^S[+_GSM_\
MOTO^%']GV7_/G;_]^E_PH ^5_P#A?GCK_GZLO_ 5:/\ A?GCK_GZLO\ P%6O
MJC^S[+_GSM_^_2_X4?V?9?\ /G;_ /?I?\* /E?_ (7YXZ_Y^K+_ ,!5H_X7
MYXZ_Y^K+_P !5KZH_L^R_P"?.W_[]+_A1_9]E_SYV_\ WZ7_  H ^5_^%^>.
MO^?JR_\  5:/^%^>.O\ GZLO_ 5:^J/[/LO^?.W_ ._2_P"%']GV7_/G;_\
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M_OTO^%']GV7_ #YV_P#WZ7_"@#Y7_P"%^>.O^?JR_P# 5:/^%^>.O^?JR_\
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M\;?^2O:[_P!N_P#Z3QU]?T %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW\]Q!9W]K<36S;)XX9E=HF]& .5/!X->0^,&U3X7^*;O4_#]L);'Q(IA6W#
M"&^/W7 Z8.2?S]J]"\!>$T\(>&8K)V\V^F)GO9R<F69N6.?0=!]*2U5_ZO\
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M%+:2:1I(I]I /(/R\G)R3STXKN=2\1:5H^HZ=87]UY-UJ,ABM4\MF\QAC(R
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O#OVE?^0!H7_7U)_Z
M"*]QKP[]I7_D :%_U]2?^@B@#J?@3_R2C3O^NT__ *,:O2*\W^!/_)*-._Z[
M3_\ HQJ](H **** "BBB@ HHHH **** "BBB@ HHHH ^0/C;_P E>UW_ +=_
M_2>.OK^OD#XV_P#)7M=_[=__ $GCKZ_H **** "BBB@ HHHH **** "BBB@
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MH]'GFN/A)\29]-;S!+J4CAT/WHB5+$>VW-'V;^2?S]W\+/\ ,+>];SM\M?\
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M^,$U6T;X\^%M<UJRTJVL-82>[F6&-I88@H+' R1(3C\*L_ O_DE=E_UVG_\
M0S47P-_Y%'5/^PO<?^RUI9*;3Z:_D9M^ZFN]OS_R(=5^/OA72-7O--N-/UEI
MK29X7:.&(J64D'&9 <<>E=EX,\9:=XYT5M5TR&ZB@69H2MRJJV0 >BL1CGUK
MQ[PWI?Q$OM?\7/X.U[3M.M%UF<31W2!F9\]1F)^,8[BO:/"=KXAL_#\,/BB_
MM[[50S&2>W4!"N?E  5>WM4Q^&[[(J>DFEW8WQ5XNT?P;I#ZCJ]QL0<1PI@R
M2G^ZBDC)_3UJ:7Q+IMMX57Q'=RM;Z>;=;DM(/F56 (&!GGD# SS7%?%_PSI,
MOA/7/$<MJ)-3CL5@BE<Y\M=^?E'8G<>>M9'Q":0? C0@O^K(L1+Z;<#K^.*2
MU7G=+[P>C7:S_ [KPSX]TOQ/?2V$=IJ.GWR1B86NHVWDR21'@2*,G*U2N?BG
MX>M=:DL'CU V\4XM9M36V)LXILX\MI,\'..V/>LK7?,'QM\+_9^O]E7._;_=
MP<9]LXKA;1BW[,^MM-CSC>N9-W7?YZ=?>BZW_KXN7^O,$KNW>W_I-SZ%ZT53
MTKS/['L?-SYGV>/?GKG:,U<IM6;0HNZ3"BBBD,**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KP[]I7_ ) &A?\ 7U)_Z"*]QKP[]I7_ ) &A?\ 7U)_Z"* .I^!/_)*-._Z
M[3_^C&KTBO-_@3_R2C3O^NT__HQJ](H **** "BBB@ HHHH **** "BBB@ H
MHHH ^0/C;_R5[7?^W?\ ])XZ^OZ^0/C;_P E>UW_ +=__2>.OK^@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH X[7_AMI&OZV^KF]U73[N:,17+:?=F$7,8_
MAD&#D8XXQ5K5/ .@:IX8M?#[6\EM9V95K1K:0I) Z]'5N?FY/)SGO73U@Z'X
MLL/$&L:SIEI#<I-I,P@G:55"LQS]W!)(X[@4+LO7^OO!OJQGACP;IOA8W,UO
M->WM]=8^T7U_.9IY0.@+>@] !4NC>%;'0];UG5K>:YDN=6E66?SF4JI4$ +A
M00.>Y-;;,$4LQ 4#))["N3\&?$70_'4]_#I(N4>R8!Q<(J[P20&7#'(X[X[4
MT[O3M^ FM->_XG6GD5Y)<?L[^$KFYEG?4=;#2.7($\6,DY_YY5WNG^+;#4?%
MFJ>&XXKF.]TU$DE:15".K $%""2>HZ@51\*_$/1?&&J:KI^FI=++IK;96F50
MKC<5W(0QR,COCJ*FR>OE^!3;2M_5S'U?X->'=:T'1M'N;W5%M])1T@:.6,.P
M8@G<2A!Z=@*C\+_!3PWX2\0VVM6%[JLES;[MBSRQE#N4J<@1@]#ZU/>?&#P_
M9>&#X@>RU1K'[>UBA2)-SNH)+*"X&W@\YS[52T+X\>$-=U>WTU8]2LY+A@D<
MEU"@0L3@+E78C.>XQ[U4;MZ;_P"?_ ):LK/;_+_@G6>'?!FE^&]-U'3[9I[B
MWU"XDN)UN2K9+@!E&%'R\5!X0\ Z/X+TR]T[3VN9[6\E,DB73*_48VC"CC'K
MFLSQI\6M!\"ZQ'IFIVFI33R0B8-;1HR[22/XG4Y^4]J9X4^+WA_QA<7T.GV>
MIQ-9VK74AN(HU!5>H&'///M23NF_+\%_E8IW3L^_XLS;CX ^"+C5?MHCOXHB
MVXVD5P!$?S4L!]&%=5KO@/1]>\/6F@.;BSTJV=&%K:,J+(%Z*V5)QWX(/O2^
M%?'6D>,/#T^LZ8)UA@9EEAF51(A49Y )'(Y'-.T+QQHVN^$#XH5I;/3%WEVO
M JE IP2=I(_6F]%9]-?\A+5W7703Q)X'TGQ+:Z;#,9[-]-E66SGLBJ20E>@!
M*D8X'&.PK>N;5;JQEM)7<I+$8V88#8(P3TQG\*\YL/CQX*O]:73A+>P*[!$N
MYX L+$D <Y+#KU*@5L^./B=HO@&XLX=4MK^=KM&>,VD:, %(!SN=?6D]M=F"
MWTZ'+P_LZ>#8IDD>\UF95.3&]Q&%;V.V,'\B*[C6O ^CZUX2C\,LLMGIL9C\
MM;5@K*$.0 6!].>*YSPW\:?#WBK49;'3M.U?SX[>2XVR11#<$&2!B0\GM_.N
MN\->)M/\5>'8-<L/,2UF#'$P"NFTD$, 2 >/6GJE^/\ 7W"TO^!'XH\):9XN
MT/\ LK4A*(U97BFA8++$Z]&4D'!_#O4$O@RRG\1:+KMQ>7TU]I,#01,[IB4,
M,%I %Y//;'TK(B^+&AS:19:HMEJ?V2]U+^SK=S%'\[_WQ\_W/?K[5NVWBRPN
MO&=YX62&Y%]:6ZW,DC*OEE3C !SG/([4*]]/ZT_R8/:S_K7_ #15\5> =%\8
M:CI5]J?G^;ILOF1")E DY!VOD'*Y4=,5<\6^%;'QEX?ET749;B*VD=7+6[*K
M@J<C!8$?I5CQ%KUKX9T"\UF]CFDMK5-[K" 7(R!P"0._K5K3;^+5-+M-0@5U
MBNH4F0. & 8 C.,\\TK75NG]?Y#OK?\ K^M3RZV_9X\)6UU%<)J.MEXG#J&G
MBQD'//[NNTM?#/D_$>]\2CS%6:P2U(9P0Y#9RH R  .YY)]N>>\3_&SPWX3\
M0W6BW]EJLES;;=[011E#E0PP3(#T/I6UX&^(FD>/XKV32K>^A%H5$GVI$7.[
M.,;6;TIQ;>J\_P#(4DEH_+_,V?$/AW2_%.D2:7J]L)[5R&QD@JPZ$$<@UQOA
MOX(^$?#6KQ:G"+V\N(6#P_;)598V'0@*JY/UST%>CUR^@^/M'\0^)=6T"U%Q
M%?Z8Y659U4"3#;24PQ) ..H'44HZ/3<;U6NQ1\:?"OPWXYNX[S4EN;>\10IN
M+20*SJ.@;<"#^6?>M#PIX"T+P9I4]AI$,B_:!B>>5]TDG&!DXQW/  ')XJ;0
MO%^G^(-<UK2;2&Y2XTB58IVE50K$Y^Z0Q)'RGJ!3M<\66&@:SHVEW4-R\^KS
M&&!HE4JK#'WLD$#GL#0EI9=?QN#WN^GZ#_"GA:Q\'^'XM&T^6XEMHV9@UPRL
M^6.3R !^E-\*>$[#P?IT]CI\MS+%/<O<L;AE9@S8R!@#CBMN21(8GED<)&BE
MF9C@ #J37&Z+\3]"UO5X+"&#4K=;HLME=W5J8X+PCKY3]^G<"G=M^8GHO+^O
M\SG]5^ 7A75]7O-2N-0UE9KN9YG6.:(*&8DG&8R<<^M=AX+\%:;X$TB73-+G
MNYH9)C,6NG5FW$ ?PJHQP.U9^O\ Q.T3P_J\^FO:ZI?2VJ"2]>PM3*EFIY#2
MG(P,<\9K4U/QKH>E^';77);II;.[V"U$*%Y+AF^ZJ+U)/I^=):1TV*>KUW+G
MB+0;7Q-H%YHU[)-';72;':$@.!D'@D$=O2HYO#.F77A5?#EW$USIXMUMRLA^
M8JH !R,<\ Y&.:I>%O&^F>*YKNUM[>_L;^SQ]HLM0MS#-&#T)7)&#]:6_P#'
M&D:?XTT_PH_GR:G?(741J"D8 )&\D@C.TXP#1;IW%?KV(O#/@+2_#%]+?QW>
MHZA?/&(1=:E<^=)'$.1&IP,+5&X^%?AZYUJ2_>34%MI9Q=2Z8ET19R3 Y\QH
M\<G..^/:I_$7Q(T?P[J[Z6UIJ>H7<,8FN4TZU,WV:,_QR'(P._>NDTK5+/6]
M*MM3T^836ER@DBD (R#['D?2FFW[RZ?U_7GY@]-'U_K^O+R+G2BBBD 4444
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M5()K'5/1)-[B&8_^@'V(JG"6'[-NF;L_8_[6'VS!(S%YIST]\5[;8>!-'L/
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MDTU:\?*WX)Z?CN)WM+SO^-M?PV-CXB-*GPY\1-#G?]@EQCKC:<_I7FVJ;O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O#OVE?^0!H7_7U)_Z"*]QKP[]I7_D :%_U]2?^@B@#J?@3_P DHT[_
M *[3_P#HQJ](KS?X$_\ )*-._P"NT_\ Z,:O2* "BBB@ HHHH **** "BBB@
M HHHH **** /D#XV_P#)7M=_[=__ $GCKZ_KY ^-O_)7M=_[=_\ TGCKZ_H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O#OVE?^0!H7_7U)_Z"*]QK
MP[]I7_D :%_U]2?^@B@#J?@3_P DHT[_ *[3_P#HQJ](KS?X$_\ )*-._P"N
MT_\ Z,:O2* "BBB@ HHHH **** "BBB@ HHHH **** /D#XV_P#)7M=_[=__
M $GCKZ_KY ^-O_)7M=_[=_\ TGCKZ_H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O#OVE?^0!H7_7U)_Z"*]QKP[]I7_D :%_U]2?^@B@#J?@3_P D
MHT[_ *[3_P#HQJ](KS?X$_\ )*-._P"NT_\ Z,:O2* "BBB@ HHHH **** "
MBBB@ HHHH **** /D#XV_P#)7M=_[=__ $GCKZ_KY ^-O_)7M=_[=_\ TGCK
MZ_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O#OVE?^0!H7_7U)_Z"
M*]QKP[]I7_D :%_U]2?^@B@#J?@3_P DHT[_ *[3_P#HQJ](KS?X$_\ )*-.
M_P"NT_\ Z,:O2* "BBB@ HHHH **** "BBB@ HHHH **** /D#XV_P#)7M=_
M[=__ $GCKZ_KY ^-O_)7M=_[=_\ TGCKZ_H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O#OVE?^0!H7_7U)_Z"*]QKP[]I7_D :%_U]2?^@B@#J?@3
M_P DHT[_ *[3_P#HQJ](KS?X$_\ )*-._P"NT_\ Z,:O2* "BBB@ HHHH **
M** "BBB@ HHHH **** /D#XV_P#)7M=_[=__ $GCKZ_KY ^-O_)7M=_[=_\
MTGCKZ_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O#OVE?^0!H7_7U
M)_Z"*]QKP[]I7_D :%_U]2?^@B@#J?@3_P DHT[_ *[3_P#HQJ](KS?X$_\
M)*-._P"NT_\ Z,:O2* "BBB@ HHHH **** "BBB@ HHHH **** /D#XV_P#)
M7M=_[=__ $GCKZ_KY ^-O_)7M=_[=_\ TGCKZ_H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWCKQ]XMLVQH,440:X .R5XTRS#UZ'\QZUYB=4\0ZIX1U9?\ A!]:N+C5+_\
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M&, #:I)&#^6*S3M=[VMH:6ORKO?7YHZO7/&<>D:SX9L8;07<6NS&-)Q-M$8
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M?P6,=]IL!AEN7$:';@$;CQV/Y4_PMJ=EKGQP\2W^EW45W9QZ9#"9X6W(6R.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK+:W<$<]O*I62*50RL/0@]:FHH>NX+38Y'2_A?X*T;5/[2L= MX[L-N5W9Y
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M_P!?4G_H(H ZGX$_\DHT[_KM/_Z,:O2*\W^!/_)*-._Z[3_^C&KTB@ HHHH
M**** "BBB@ HHHH **** "BBB@#Y ^-O_)7M=_[=_P#TGCKZ_KY ^-O_ "5[
M7?\ MW_])XZ^OZ "BBB@ HHHH **** "BBB@ HHHH *X[Q;XJ\3>'99Y=/\
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MMST[UQD>@Z5XM\6>(KOQ#<7 N])NA'9JMX\(LXO+5A*H5@,DECN.1QCM6O\
M"78/AU8^7-YR>=<;9>/G'G/\W'KUHBKIM]E^+!_K^AVU9VKZS;:,EHUR)#]J
MNH[6,(,_.YP,^U>?_$CP[=:]X@@:/3K;Q'!!; MHCZHUI)&Q<_OEVD Y&1EO
M[O&>E8>I:;HOBCP?X;AO+/4':SUU=/EBU"Y+RQ!F_>1[T(##&T!NN!USFE'6
MWJOSL$M/N_2Y[;17F'_",:+XO\7ZYIWB S2P:1Y$5A8?:GC6*+R@?- 5@222
M1N.>F*R#?7%YH&FZ)/JMT^BR^(I=.:^\\AYK90Q1#(.<%ALSGG%-*^BZ_J[
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M]N[RHV?;G&<#.*Y3X58'PRT,*VX>2V&]?G;FM>^UK3KBVURRCND^T6$!%RC
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M9_LMY<VT;RMN;8DK*H)[X  H6J^7ZM ]'_79,[&BBBD 4444 %%%% !1110
M4444 %>'?M*_\@#0O^OJ3_T$5[C7AW[2O_( T+_KZD_]!% '4_ G_DE&G?\
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MSV5XS"*<856 YPAVJ,<8! XKJJ*'JK M#RKP)X%FL?$EMJS>$;3PQ;V<4J+
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M3_R2C3O^NT__ *,:O2* "BBB@ HHHH **** "BBB@ HHHH **** /D#XV_\
M)7M=_P"W?_TGCKZ_KY ^-O\ R5[7?^W?_P!)XZ^OZ "BBB@ HHHH **** "B
MBB@ HHHH *Y_Q'XNM/#EU96CV.I7]Y>EO*MM/M_-?:N-SGD *-PR<]ZZ"O-?
M$/AW[;\9-#N?[9U>#?9S3>5!=;47RVC^0#'"MGYAWP.E"UDD'1L]*[5DW/B&
MTM=;?27CG,Z637Q95&W8K;2,YSNS[8]ZXG3]5OV^$7B:^DO[DW4+ZB(IVF;>
MFUW"X;.1C QCI1:RR3>);.65VDD?PAN=W.2Q++DD]S2EHF_+_P!M;&M[>?\
M[<E^IWVC:K!KFBV6JVR2)!=PK-&LH 8*PR,@$C/XU>KFOAY_R3GP[_V#X?\
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MV#BET7R_&_\ D.VK_KHF>TT5YE\.=6U3^V[C2I+7Q>VE?9_-CN/$EKME20,
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ME6&9X)" <!U.&'/H>*M5XIH-O?>&/".L2Z=K>HO=7VNG3$EO9A,EOF<H9@I
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M9_UWT_S$FG^'W:_Y'J=%>;SZ5J?@K5-(N4\4ZQJL.I7R6=W;:C,) =X/SQ8
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M=*_6WXMK_():/3S_  2?^9[A17C/BWQ%J&I>,]4TUU\;I9::T:1+X8MP=SE
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M4[DSS;,YV G  SZ"NDHHOK</(R/^$9TL1ZS']G&W6&+7@_ODH$/Z#\R:2_\
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M@A@L)[PM:K(O23R^F[(SZ9YQ4NK_  [T_5=6EU"/5]=TTW#!KJ#3K]H8K@X
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MUG$6:.WB6)"YR2%&!GWXK$O?!EC>:[>:M]MU""2]M#:7,$,P$,JE2H9E(/S
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M&W'XUV=%"TV!ZJS.(?X7:/)>LYU+7/[.=R[:0-0869).2/+],\XSCVKM@
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M\5:S<>&=+UN\EBVVNH266J+%& DB!S%YHR,KAMK<'IFNCTO4KK4_%.KK'/\
M\2VP"6HCV#YI\;W;=C/ 9!CIG-.W]?=_FA7_ *^]?H;]%9/B26_MM$EN].D*
MSVS+.R! WFQJ073D=UR 1SG%9[^)F_X2JWM4\HZ2\(5[C=SY[+YB+]-BD_\
M EI?U^HS9N]7L;'4;&PN)]EU?,ZVR;&.\JNYN0,# ]<5->WD&GV,][=2>7;V
M\;2RO@G:JC).!R>!VKRS5[C6]6USP;?6US#%<WUW>261N(LK! 8L(2JX+';\
MV">K8R!6C;ZYXET>+Q9H^JZM%J-[IFF"^M=02U6%CN5\!D&5X*_XTGI%OKK^
M%BDKR2]/Q;1Z);7,5Y:PW,#[X9D$D;8(RI&0<'GI5?4-7L=+DLX[V?RFO)Q;
M6XV,V^0@D+P#C@'DX%<//K/B77[W2M T75H=,N7TF/4;S4)+59V^8@!40D+R
M0V?TJEXMA\30:?X4@U&ZTZYU9->18+I$98Y!L?:[IV/JH./0U;5I6\[?BU^A
MG%WC?RO^%SU*BN&\/7WB/3/&\WAS7M7@U=)[$WT%PEHMNT>'"E"JD@CD8.<U
MUFKPW-QH]Y#9W?V2Y>%EBN/+$GEMCAMIX./0U$M(\Q:U=B*YU_2[5+%Y;R,I
M?SBWMGC!=9)#G !4$?PGD\<5I5X1I]IK5O\ #[P&1J<-W<3:Q$UF)H!&ENOE
MN IV\N <G/!.<<5V=EKNO^&/$6HZ9XCU6+68$TN35(IXK1;=XPC8:/:"01Z'
MKZU325[]+_@DQ6;>G]:M?Y'HE%>!VWQADBDBU>?QK8W!<J9= 32)45%)&56X
M(R7 [GY2?:O>T8.BNIRK#(-%G:XKZV%HKE]'U>^NO'_B33)I]UG9Q6K01[%&
MPNK%N0,G.!U)KD?^$J\4W/A_27LK^'[?=^(9[ O/"I3RE:4 $ #H%!XP3CKS
M26MOE^+L/^OPN>K52U;5['0]/:^U&?R+965"^QFP68*O"@GJ17#V.N>(?"VO
MZCI?B/5XM;ACTJ35(KA+1;=T"-AHRJD@CT/6N>\4P>,KOP(=8U36;*XLKU[2
M9M-CM!']E4RHPV2YRYZ [AZXII7:^7XNW^8/2_S_ "O_ )'LU%>/>,OB2;;Q
M9>Z*GB^W\,Q:?Y8+MI;WDERY7<>Q54 ('KG/:K:?$#5=<\,:!=:->VJ7=WK!
MTV:<0$Q2?*^'",-P!^5MO![9I+570/1V?]:7/5JIW^J66F-:K>3>6;N=;>'Y
M2=\C D#@<=#R>*\R\8ZYXH\+C3['4/%<MC:+!OGUY-$6X$TI<C8R+\L8 *^I
M-;*>*M1GT#PM=PZK873WNJI:W%Q8+F.:,[^,.,H2 N1U!R,TUKMWL#T^X] H
MKS9KSQOXC.J:QH>N6.G6-E<3V]M8RV0E^TF(E2TCDY7+ XV]L9JG;^(/%VL6
MG@JVT_5H+>ZU?39IKNYFMD<!E"'>$ '(R< $#GG.*2U_KO=_H-JW]=K?YGJM
M%>8IXRUKPIIGBRWU^\AU:ZT2.&2&[6 0><)A\H=%X&&ZX[5@^'_BEL\0V$4_
MCBSUY-0N$@DL4TB2U^S%^ 8Y"/F ) .[G'O32N[+^KB>BNSVF65((7ED.U$4
MLQQG '6H--U*TUC3;?4;"7SK2Y0212;2NY3T." 1^-<"]SXP\3KJVJ:7J]E9
MZ7:S7%K%ILEIO^U"/*,7ESE"2#C:..,@UO\ PVX^&WAW_KQC_E0E=-^GX@]'
M;U_ W;C5+*UU.TTZ:;;=W@<P1[2=X0 MR!@8!'6KE<UK&JWUKXV\/:?!+BUN
MX[IIH]H^<HJE>2,C!)Z5Y[I/CO7#XK@M]7\4VEA>2SA)-!U#2VMXT0OM/EW'
M)9L#@GAB?R4=78'HKGL]%%>*^(OB@3XGU&T3QK:^'(M.N# EL^D27;717[Q=
M@,*I.0-O..:5];#MI<]JI"0H))  Y)->92^-=:\0:'X0N_#]U;6MQJUW);SE
MXM\7RH^X@'YL97<!D'H#WIT5QXJAN?$'A/4_$,5Y=#2A>6VIK8)&R EE*M&#
MM/3BG*\4_*_X"6K7R_%V.\EUS3(3I^Z[1AJ,GE6C1Y=96VEN"N1C"DY/%%[K
MNF:?8R7MS>1BWCF6!W3+[9"P4*0N3G) ]N]>;^%+K7-(\'> [8ZSYR:E.J?\
M>J+Y<!MV98^^=I4'=P36%9V&K6GP_P!>?4-:^WQ'7TC6/[*D6V1;Q=\F1UW'
M!V]!CBK<;2Y?/]4OU$G=7_K:3_0]UHKQ_P 9_$DVWBV]T5/%]OX9BT_8"[:6
M]Y)<N5W'L55 "!ZYSVK1LO'^I>)?#6DPZ+=6::KJ-]+8F^\EC$@C4LTJQM@Y
M*@$*W0MSTJ%JKH;T=F>A'5[%=:31S/\ Z>\!N5BV-S&&VELXQU(XSFKM>:Z+
M9:Y8_%FVAUS48-2E71)!'>1P"!I!YR9W("0",]1P?2N]U>&YN-'O(;.[^R7+
MPLL5QY8D\ML<-M/!QZ&B6D>;U_4%K*WH68+B&Z@6:WFCFB;[KQL&4_0BI*\>
M\)7OB/2OA[X9TRRU2">^UJ4I:2SVH"6,*H6884_O"-IQG'+>U=5HEYXDT3Q5
M;>'_ !#JT&LQWMM)/;7J6HMY%:,KN1D4E2,,,$>E4XZV%T_KO8[>BJ]_%<3:
M?<Q6<YM[EXF6*8*&V/CAL$$'!]:XV'Q1J.J:-X:@M9%AU74+CR[PA0?)$)/V
MC@@CJNP?[XJ5J[#>BN=U44ES!#+%%)-&DDQ*Q(S %R!D@#OP":X".X\:>*[F
M^U+1=>L])T^SNY;:WM'L1.;GRVVDR.2"H+ XV]JQ+N[UKQ9X@\!:O:ZLNF-.
M+A7@6U641R(")<%CDA@-H].O6A:M?UN$M+^7Z'K]%>(:S\56E\0:@J>-K/0(
M["Y>"*P?1Y+HW&PX)DD ^4$@X"\@>]>K>%->3Q/X6T[640)]JB#LJG(5NC >
MV0:%JK@]'9FS17(>*-1URYU^Q\->'[R#3[FYMY+J>^FA$QBC4JH"(2 6);OQ
MQ6!?^)/$_A_1?%&EZCJ-O=:IINFK>V>I0VZQF16++\\9RH8,O;@@T#MK8].H
MKS<7_C+0=:T&[UC7+2_L=8NDM9+"*R$0MBR%@4DSN;D<Y_*O2*;1*=PJE<:M
M8VNI6VG33[;NYCDDBCV,=RIC<<@8&,CK7D_BCQIX@AU74Y-,\2D"PDD4:?IN
MA/>1ML&=LL[8 ;'WMO"\\\5T!U)M9\3^"M3= C7>C74Y0=%+)$2/UJ?L\W];
M-_H5:SL_ZU7^9W6F:G9ZSIL&HV$WG6EPN^*3:5W#Z$ C\:MUR?PS_P"2;:#_
M ->P_F:C\7ZEKMOXA\.Z9HEW#;MJ#W"2M-$)% 6/(;'4XZX!&>YQ5R5I60EM
M<["BO,+&;QYJ-UK/AM/%%G%>:0\;MJO]G*7N%D3<J&+.Q,<@L,GIQWIU]XUU
M2?P!H.H+JMII5[J(*2RK:/=2EE!!\B!0=QR,_,< >M3TOZ?B'6QZ8[K&C.[!
M549+$X %0"_LS';.+J I=$"W;S!B7(R-O][@$\=J\CTWQ%XBUWP_XNT.YU>X
M>:TL%N(-1N=(%K)(C!BRF$G&"%*AN.Y[56;1O$K6'PW5?%>V21_W+_V=&?*S
M S#C/S80%.>N<]:I*[MZ?C?_ "$WI]_X6_S/;:*\5\0_%!CXFU&S7QK:^'8]
M-N# EL^D27;717[Q=@,*I.0 O.*VCXUUGQ)8^$6T*^M[&763<PS2F#S41HU.
M756P3@J2 2.HSZ5*U5U_7]6&]'9GJ%%>1>+_ !-XC\.:I;6.H^*VTBSA@BVZ
MF=$^T)?2D'?OV\1<@?*HSSG->E>'K^34_#]C>RW-E<RRQ O-9.6A=NY0GG&?
M7I3M=70/1V9IT45XKXB^*!/B?4;1/&MKX<BTZX,"6SZ1)=M=%?O%V PJDY V
M\XYJ;ZV';2Y[517G@\:7U[X'TOQM9SI]BM]QU.T51MEC#%'9"PW J1N49&1P
M1FEE\5:W:>!)O$CM%)<ZG/$NF6CA?+MTE8)'N9>6.#N;D^@Q5-/5?UY?>*_]
M?G]QZ%17%V:>+_#*WNH:_KUGK.F16LMQ(%LQ;RPLHR%3;D,N ?O8/2O-[;XP
MR121:O/XUL;@N5,N@)I$J*BDC*K<$9+@=S\I/M0M78.ESWRHI[F"V56GFCB5
MW$:EV"[F)P ,]R>U<%=7/B[7O%VNZ3HNO0:79VL=M)'.UFD[J70DJJG P<9)
M)..PKG?$EYXA\1Z)HJ'5HM/U&P\0+87+0VJR(\P;Y)E#'@ <[>AW8[4EK;Y?
MG8._]=+GLE%1P))';QI++YLBJ \FW;N..3CMGTKS;QSXDU>#Q"VFZ;XF_LSR
MHT?R=/T=]1N&+9_U@QMC!XP.2>M#T=@6JN>FT5Y.?''B6_\ AI8:M"'M+E[N
M2VO[Q-/,SVR(6'F>1GKD*""2 2:Z#X;>))?$&GW0D\2V.O+"R[+F&W-M, 0<
MB6$C"\C@C@BG;5KM_7ZBOM_7];'<45B>+K_5-,\+7UYHUM]HOHD!C387(&1N
M8*.6(&3COBN*\ >+KO5-2O+*;QC::X4A=FBFT\V-W!(I P(\;77KD]0:F^_D
M5;8]0HKR2PU?Q\_@>U\9RZY8O!;VQGFTTV:_Z3&I.YC*,%7(!P%  XZU%XQ^
M)JIX@;28/%</AB&&WBF-P^F/>2SM(N[:%P550",D\Y--Z.P6_K\#V"H+V\@T
M^QGO;J3R[>WC:65\$[549)P.3P.U>:6/Q)O-7\'VS:7/9W&K7&JKI,=WY+K"
MQ(W>=Y;88?)SM/?VK8,7C3PYH&N3ZIX@M-5CAL)9K:[%FL$T<JJ3@H,HR]#D
M\Y[4I>ZF^W^5_P!0BKM+O_G8V]7\;>'="L["ZU+4T@BO\?9?W;LTN0",*H+=
MQVXS6GINJV6L6SW%A-YL22O"S;&7#HQ5A@@="#7F,MIXAU/XB^$;]/$?DB?2
MC.8_L,;84"(RIG_;)Z_PXXJ\OB[7IM"MK:UN(#JVI:Y<Z?!<3Q I!&CO\VU<
M;B%3 ]3UJW&UUUU_.Q*=TGY+\KGIE%<;;#Q;X<T?5IM;U_2M2BAMS+;7MQ";
M78XSD2J@(V#CD<]>*XO1O''B"'Q5I$<^NW6L6&IW0MW630&LX8=RDJ8Y6P6]
M@0<@&DE=V0/17/3G\4Z-'#-,UYB.&]%A(?*?B<D )T]6'/3GK6Q7C]Y_R!M8
M_P"QTA_]&Q5U\WB6ZT.'Q)#J4OGW%CBXLSM ,L4O$2X  )#@I^ SUH^S?^MD
M_P!1];?UNU^AV-4VU2R36(]):;%]) UPL6T\Q@A2<XQU(XSFC2HKR'2;2/4+
MC[3>K"HGFV!=[X^8X' YKG]6UF_MO&PT^&XVVO\ 8T]UY>Q3^]5U"MDC/ )X
MZ4I>Z_O_  3?Z M5_7=?YG645Y!!KGCNR\(:1XSOO$%G/:2K;";3!8JOF)(R
MJ7\T'(?YLX "BNDN[OQ3XB\3ZE::#K-KI%EI$D<3^;9BX:ZD*!RK9(VIAE&1
MSUIN+3L).ZN=%%XKT6>WM[B.]W17%X;&)O*<;IP2"G3CE3R>..M;->2>%]3U
M/2O"VC(DB0377BB:VNU0!U93)*64$CID=>#6JEWXT\6:AJEYH.NV6E66G7DE
MI!:RV0F^U-'@,9')R@+9 VC.*7]?@O\ ,?\ 7XO_ "/1JCN+B"UA,UQ-'#$N
M,O(P4#)P.3[UYUXW\1ZS8W=EIL/B&WTBY:U$TRV.FR:C<,V<'";0%CST8\GT
M&*YC5=:U_P 5_"VY,^HR6MWI^LQ6LTLNGK&]P!(FQFC)_=L"RL0/[N.,TTK[
M?UK8/7^M&_T/<**\@\7^/+O0M6M_#-UXR@T>>VLXY+G57TDW$EU(W98E!1!@
M9.?48Z5<TOXDW>L>%"NFW=G>ZJVIQZ7#?>0\<,A<;A*8VPPPN[Y?5>.*2UV_
MK6P/3?\ KJ>C7&KV-KJUGI<T^V]O%=X(]C'>$ +<@8&,CJ:NUY?%I_B+3_B9
MX5BU[6(-7_<7ICNDM1;ODJN59%)&!Q@C'O7IY^Z?I0_AOZAUMZ%32]4L]9T^
M.^L)O.MI"P5]I7)4E3P0#U!JY7C?AX^,+#X?QZ[INKV4-AIXN9?[,>T#_:E6
M1RQ:7.5/!P%'IG-3^,OB:L.KV^F0>)H?#,+645VUW)IS7DDADY"*@!4 #J3Z
MC%#_ *^ZX?\ !_.QZCJ6JV6D6\<]]-Y4<DR0*VTMEW8*HX!ZDCGI5RO'6\8+
MXN\$PL;R&]ELM?LH&NX86B2<>:C!PC<J><$>H..*Z2XN/%OBC7=5BT+7+71;
M#2KD6WS62W#W,@4,V[<1M7Y@..>*=OZ\K+_,5_Z^;_R.^HKAM \3:M?G2[J_
M,<:&>XTR_BB4>6+E&.V12?F"G81C/\0IZ^,+Q]-UF0Q1BXWK_92J<^<DC>7$
MQ^K@D^Q%%NW];?YH?K_6_P#D=M14-I'-#9P1W$YGG2-5DE*@;VQR<  #)]*?
M,_EPR/E!M4G+MA?Q/84GH"U'U$+F!KE[99HS.BAVB##<JG(!(Z@'!_(UXC-\
M0O$=I<P:M'XA?4[5KB-);*VT%ULU1G"DK=-AB!T#=R1QBNLTBPU<?&O7;AM<
MW6:V=N[VOV1!O1O,")OSD;2"<]3G!Z4TK_C^"N)NW]>=CT>LVYU_2[5+%Y;R
M,I?SBWMGC!=9)#G !4$?PGD\<5+J\-S<:/>0V=W]DN7A98KCRQ)Y;8X;:>#C
MT->*Z?::U;_#[P&1J<-W<3:Q$UF)H!&ENOEN IV\N <G/!.<<4EJ[>GXLI[7
M]?P5SW>BO.[+7=?\,>(M1TSQ'JL6LP)I<FJ13Q6BV[QA&PT>T$@CT/7UKA[;
MXPR121:O/XUL;@N5,N@)I$J*BDC*K<$9+@=S\I/M32NTE_73\Q/17_KN>^51
MU?6-/T'2YM2U2Y6VLX #)*P)QDX' Y/)'2KJ,'174Y5AD&O-/B3XJ\/V/B/0
M]%\07RV^GC=?72F%I!)MRL:$*">6);I_!4OL-:ZGI4<B31)+&P='4,K Y!!Z
M&G5Y5X5\8QS_  GUYM'U#SIM"BGBMKDH<M&JDPN5<?W<#D=5-3#4_&VBOX?U
MK5=<L[RRU.YM[:;3([)4$/FCAEESN8@]<X'7 Z5=M;+R_'8GI=^?X;GI]%>:
MF;QOKVM>)(=+\26VF6FF7WEP[K!)GD_=(WEDG&%R<YY;GVJ6S\9:IJ6F^ KU
M72 ZO<M'>QH@*N!&Y(&02!N7/'-)*]OE^/\ PPWI^/X'HM%<A-KM_#\0]1TW
M[3$+&#15NTCFPB+)YC LSXW 8 SU ]*\_B\?^([74]/OO^$@EU:SN;N&&:VB
MT!X;2-9&"EDN&PQ]B<Y)Z8I1U:7?_.WZ ]$WV_RN>QVFJ65]>WMG;S;[BR=8
M[A-I&QF4,!DC!X(/&:35]7L="TJXU/4I_(L[==TLFQFVC..B@D]>PKG/"O\
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MXJ7Q?X974/,AEDCF>WDEA5E20J>'56^9000<'D9I+570/1V9U%%%% !1110
M4444 %%%% !1110 5X=^TK_R -"_Z^I/_017N->'?M*_\@#0O^OJ3_T$4 =3
M\"?^24:=_P!=I_\ T8U>D5YO\"?^24:=_P!=I_\ T8U>D4 %%%% !1110 44
M44 %%%% !1110 4444 ?('QM_P"2O:[_ -N__I/'7U_7R!\;?^2O:[_V[_\
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MX?\ )\9W?B'[5G[191VGD>7]W8S-NW9YSNZ8[5M44[_U_7H']?J>7>(_"_\
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M*%H#U#H,5QFI>"]6_M6YO/#GBNYT2*\E\V[MQ9Q7".^ "R;^4) YZ\\UV=%
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MVE_*9KRUCM8Y0SD ,T;-S&3CDC//-=Q12_K\O\D']?F_U9Q.I>!=3_M**_\
M#_BN\TJX-M':W3RP)=M<(F=I)DY#?,?FYZU7M?AH;;PKK.B?V[<S/J%X+Y+R
M6(-+'*"C9;G#_,F>@X./>N^HHO\ U\[_ )A_7Z'&:AX,UB=K?4-/\5S:?KHM
MDMKJ^CLHWCN@I)!:%N <DXP>,FK#^"C=^&GTW4M;U"\O7F6Y&HLP5XIEP5:-
M1\J 8^Z!CKG.375T4 <3I?@?58/$>F:YK'BF?5KNR2:/#VB0HRN  %5#A2,<
MGDGVQ7;'D8HHH>JL'6YYU#\,M0BTV/1QXPO1HKF3[99);(//#,20KG+1@@X(
M!.><8S6SKG@Z[N;U-1\.Z[-H.H"!;9Y([9)XY8U/RAHWXR,G!SWKK** .2E\
M%W%SH,-A>:]=WETM]#?37=RN[>T;JVU4!"QJ=N,#IG/)J'5O!.IR:U<ZEX=\
M4W.AF^96O85M8YTE8 +N4/\ <;  R/0<5V=%._\ 7]>@'-Q^#+&#P9+X;AN+
MA4D5B;MGS-YK'<9=W'S;OF[58?PM8-J6C7B[D_LJ)HH8U)"L" !N'?&,C/<U
MN447Z@9)&I_\):I%PYTK[$=T)A4*LV\88/U)*[OEZ# />K]Y:Q7UE/:3@F*>
M-HW .#M88/\ .IZ*EJZLQIV=T>97/PMUJ^TI-*O?'5W-IULT9L[86$2*FP@J
M)"I!D  '=>1FNK/AJZC\;CQ#:ZL889;9;>\LC;JPGV;MA#YRF"QZ9S71455W
M_7W$V7]?>(ZAT93T(P:X73_AY=V=AI%A-KYN;;2=26\M UFJLL2JP$1(;G[V
M=QY]J[NBDM'<>ZL8%UX8BO/%O]MS3AXCISV#VICR&#.&)W9]L8Q^-8EIX#UN
MTFBLT\<:D- AVB.P2"-)0HZ)]H'S[>W8X[UW5%"T!ZA6/I6@C3]8U?599Q<7
M6HRJ=WE[?+B1<)&.3G'S'/&2QXK8HH#R.5UWP9_:^H:E=P7_ -D_M'3'T^Y3
MR=X?KLD^\.5W,,=P>V*L:OX6_M72=&L?MGE?V;=6]QO\K=YGE=L9&,^O./>N
MBHIIV!Z_U\C%TGP__9=WKD_VKS?[4NOM.WR]OE?NU3;U.?NYSQUK /PZ9?!N
MC:-;:W+;:AH\GG6FHQ0+\K_-UC)((PQ!&>:[FBE_P/PV#^OO.)M/AZQOK^[U
M?6[C4YM0TS^S[IWB6,MDD[E"G:@P<!0/<DUF3?#/7;^WM;?4_'5U=VUC/%-9
MP?8(XT7RV! DVD&3@8SD8//M7I-%-.SO_7</+^NQCZ5H7]F:UK6H_:?-_M.:
M.7R]FWR]L83&<G.<9[4OB?0_^$C\.W>D_:/L_P!H"CS=F_;A@W3(ST]:UZ*7
M8#F[SPA!=^--/\1FY96M83&]N%^65AN".3GJH=\<?Q>U5CX$MIK77[>YO9&7
M5;X7R/$FQ[9P$VE3DY(* YQ^%=;11_7XW_,#D]$\+Z]::HEWK?C*]U:*'/D6
MZVZ6J#(Q^\V?ZSCUXSSBJ+^ M8MKEX-%\9WVF:+*[.]A':Q.R%B2PCE/S(,D
MXX..U=U10!S.K^%;B]U+0]0T[6);*XTO,9:6(7'GPMMWHQ8YR=H^;.>M58O
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MDZ8EK+?W=_*"6DN+J3<[L3D^P'H!@"M"BA:*P/4**** "BBB@ HHHH ****
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M=B/D?,!Z=Z]3I=+C>]@HKGO%?B"[T:*QM=+LX[S5=1G\BUBE?9&"%+,SGKM
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M'I_7S_([>BL:RU:XO_$^I6,2PFPL(XT>3!WF=LL5SG& FT].K5LT ,,T2SK
M94$K*66,L-Q QD@>@R/S%1S7EK;2P13W,,4EP^R%'D"F1L9PH/4X!.!Z5QD5
MQ?ZE8>+M7T]K<WR2RV5F9RWEHD(P<[>1ERYX]O2N)LIO$$7A3X;RRV]C=7GV
MO_0HX9&16C-NVWS6;HW4MC/L#36OX?C<'I^/X'N%%<'IOC/5],O-9L/&-MI\
M5QIUC_:(FTQG:-X<L",/R&!7\:P[#XJ:@+NVO=2NO"1TNY>-!9V6J"2^M]Y
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MRY8Q_P#33=_'G/3CI3M_7W_Y"O\ U\KG<T444AA1110 4444 %%%% !1110
M5X=^TK_R -"_Z^I/_017N->'?M*_\@#0O^OJ3_T$4 =3\"?^24:=_P!=I_\
MT8U>D5YO\"?^24:=_P!=I_\ T8U>D4 %%%% !1110 4444 %%%% !1110 44
M44 ?('QM_P"2O:[_ -N__I/'7U_7R!\;?^2O:[_V[_\ I/'7U_0 4444 %%%
M% !1110 4444 %%%% !7*>)/#NL3ZQ;Z_P"&K^UM=5A@:W>*\C+P7$9.X*VW
MYEPW.1ZFNKHH XW0_#_B.XU^'7?%E[IKW5K!)!;6NF1N(D#D;F+/\S$A1QT%
M9EIX%U^+P^NFMJ&GP7&EWYN]'NX4=C@EB5F4\<AV'RGH?:O1:*/Z_&X?U^%C
MB]&\/>);W7;;6?%]YI;RV<<D=K::9&XB4N &=F?DG QCH,UGV/A;QQH:+HFB
MZUI$/A]9&,5Q+;NUY A8ML4',;8S@%ORKT2BG?\ K\0. F^'LMTWB.:6>"*]
MO;Y+W3KR/F2!TC4*6X'<'(&003ZUK6NA:J_C2Q\07S6:[-)-G/'#(S?OBX8E
M<J,KP>3@^U=310G;^O*P?U^OZ'"3^!+N\3Q('O8K>6_U*+4+">(%S"\:IM+*
M0!]Y.0">#UI^G^'O%NJ:W87WBZ_TDP:9*TUM;Z9%(!+)M*AY&<\8!/ XR:[B
MBA.W]?('J<!_P@NJ1Z89+2^M;?6+;5[C4;*4JTD6V0M\D@X."K8..G;-+8^$
MO$6H>(VU3Q3>:;/'/I4MA+;V(=4CWN#\FX9(('))SGH*[ZBEY?UM;\AWUO\
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M6_\ 7J<?\,K%UT6YU65BXOIMMJS<G[)&/+A_-1N_X%7<4U$6-%1%"HHP%48
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M_P#2>.OK^OD#XV_\E>UW_MW_ /2>.OK^@ HHHH **** "BBB@ HHHH ****
M"BBLN/6/^)W?Z=<0"$6T"7$<Q?(EC.0QQC@J5((YZ@]\4 :E%<VOB^"Y\.66
MJV-J\LE[<+;06LI\IBY?:0<@D8 9CQT%#>+X+7PQ+K%_:R0O!.UO/;1DR,KA
M]A X&1_%G XYH_K^OO#^OZ^XZ2BN9\0^*Y-&N8X[33UOD2W-W>/Y^SR( P&X
M#:=Q.6('&0C<UHS:_9P^(++1SN::[A>9' ^48Z GU8;B/]PT6 U:*S-'U8ZN
M;YT@"6T%R]O%*'W>=LP&;&. &W+U/W:@M/$"3:OK.GW4'V5]-"2;R^X2PLN1
M)T&.0X(Y^[1_PX&U17$6VO6VKZUX3O;G1C'<WT-W+:2M<-F", <E< ,77:<'
M[OO6'JGQ!\1:IX*U74M'\+S16L=I-B_-^B&.16*L44C<VT9;/&2I ]:3T&E=
MV/4Z*XK0/%NHLWAC3-5T<VMWJ=K,[%KL2E!$%PQ('S;P0>HQ[UI#Q8!K7B#3
MSI\\@TB"*;-OF62?>K':J 9S\N.ISGM5-6=O7\"8NZOZ?B='17 6'Q&O_P#A
M(K+2]<\,MI,=_*8;64ZC#,[-@D!XU.Y/UP2!533/$<?AC3/$]\UK)=22>(I8
M(8$=4WR/L"@LQ 4>YI?U^*7ZC_K\_P#(]*HKAAXBU36O"NO0ZOX<N='N(]/D
MD4F=;B&12K#Y94^4GCD=1D5B^%O'%]I7AWPS#>>&+R'1);>VM%U5IT_UK */
MW7W@A/\ $?RII7=O3\;_ .0/:_K^!ZG17&^)?&6L:1?26^E^%)]1CA ,US<7
ML=E%R,X1I/OX'7' ]:AE^(\4FAZ#J>FZ5/?'697@BMTE576158[<\J?F7&<@
M <YI+74'IN=Q17%7OC76H?LUA9>$IK[7VMUN+JP2^C6.T4D@!IC\I)P< #G!
MK%\:^(TU?P&ET]E<VUU::O:1W5DX#RQ2+*AV_+D-D$$$=013MK_7>P?U^%ST
M^BN/T?QI?W7B1-%UKPW<Z-+<Q/-9/+<QS"=$QNSL^XV"#MR?K5&?XBZBSSWN
MG>$+^_\ #]LSK-J4=Q&K'82&:.$_,Z@CKQWI =]17")J=G-\28-52=39/X<-
MP)>WE^:&S^5<QXU\7ZGKO@Z9I?"M[9:1<SVK6>H23(WFCSD(+QCYHP1T)SVZ
M9IVU2_K>PK[O^MKGL5%<AK7C'4K?5YM+\.^&KC7;FU"&\9;J.WCAW#(7<_WG
MQ@[1V(YJ._\ B#%;:-I=_;:5=7,M]>FP:S+!)HI@&RA'(SN7'4#G.<4MQG9T
M5PL_CK6[>]MM+?P?,^LW%BUV+**^C8(1)MVM(0% Q@[L]\8-5'^)VH-H[ZA:
M>#KZX6Q=TU=3<1I]C9/OA2?]<0.?EXQCD=* /1:*Y/6O&D]O+:V?A_1)]<U*
MYMA=K!'.D"1PGHSR-PN><#G.#1'X[MH_#UYJ&HZ?=6=]92K;SZ:=KR^<V-B(
M0</NW#!'!SVYHM_7X?F!UE%<?I/C#59M1CL=>\+7&BRW6[["SW<<R3E06V$K
M]QR 3@^AYKCM,\2ZG?\ @GQ%/XJ\.R36D.I[55]1!W-]H"^4"@RHC.WGHU-*
M_P#7FE^H=+_ULW^A[#17$:IXXU:#Q#J.B:+X4GU>ZLDBD)6\2%-KC/S,XX/'
M &<\]*D/Q#MY/"UEJMII=W<7][.UI!IBD"4SJ6#(2> !M)+= !2W5P\CLZ*X
MOP_XWU/4_%(\/:OX8GT>]%FUVQDNDF0@.% 1E&&Z\GC!&,5L^)_$<7ANPAE^
MR3WMU=3+;VMI!C?-(<X&3P!@$DGH!0] 1MT5Q]EXVO(--U*Z\3^&[W0WL(A,
MP,BW$<JDD )(G#-G V]>15>Q\>:F-1M8M?\ "5YHUC?2K#9WCW,<P9V^Z)%7
MF,G@#.>3BG;6PKZ7.XHKS^\^(]_"VJO9^%+J]MM)NY(;VX2Z1%CC0 EP& +-
M@YV#/UYJU;^/[B;6]-CD\.W<&AZHXCLM5DF0>:Y4LN8OO(" <$\^U):[#>FY
MVU%<1KA_M"^\3W'RM'INDO:(0>1)(ADD!_X"(OSKC?%%A/?Z!\/1: F[M[-K
MNW'K)% LBC\2N/QH7GY?C?\ R!]O7]/\SVFBN!\;:A'XC\$6MG92X368/.8J
M>1;JGF.?QPJ?\#KE+W3[K5/!/PQM;&[:TO"4>"8?PNMLS+GV) !]B:=M6GWM
M^?\ D'1-=CVFBO-?$&OKXA\$Z=<-'Y%Y#K5G!>6Q/,,RSH&7Z=P>X(-9]_<W
MFA?%#Q'XE@>22RLX[2/4;9><P,AS(!_>0@'Z;J+:_P!=D_U#I_7=K]#UJBN+
M$J77Q6@FMY59)= +1R+\P(,PP1ZBN;\1> ].T'2DU:'4+Z;QG+*B6VH"YD$E
MS.6!V^7N*[.N5Q@*#SQ0EM?^M;!WM_6ESUBBO.=0\.V'COQSJMAXA26YL=*M
MK80VRSO&GFR!V:3"D9., 9I=!T>XUSPM>^')-7O8[;3M7EMI)@[>=/;JVX1[
M\Y'#!2?08[TNG]=[!I_7I<]%HKSK0/#EAX8\>G3/"K2V^G+8N^HVIF>:*.4E
M?*/S,<.1NR,]!]*YWQ!H-EX:UJPG)UD^(99HI;GQ._G"T5#+\T;X9E4$# 0C
M RN332NUY_\ #?U_F#T3\OZ_K_(]GHH!!&0<BL;Q)XAA\.:='</;3W<\\RP6
MUK  7FD;HHSP. 22>@!I M39HKD-$\9W]SJ0TOQ!X<GT/4)(GFMT:Y2XCG5<
M;@'3@,,C@CI3O!WB_4?%L<5Y_P (])9:7+;ATO)+I6WR9PR*F V!S\QQG'2G
M8#K:*P?$^OWNAP1#3M#N=6NI=VU$D6&) .IDE?Y4Z\=SV%<A??$+4M3\#>)W
MM-(:SUW2X<3V\=_%((0RDB195X.T G'!R,5-]&^PTKM+N>FT5B>$;W4=0\+:
M?<ZK8&RNVB&Z)IQ,2!T8L.NX8/MFL#Q%X]U;1KVX%KX2GN=/M2?/O;F^BLP0
M "QC63F0#GG@$CBJDN5V9,?>5T=U17$:A\1#&N@'2-$N=4?6[62XMHHY5C8%
M0I"MG@#YCEB>,=Z++Q]>3:3K$E[X=FL]5T?8]YI[7"R8B;G>CJ"'^4,<8ZC'
MO19_U]P^QV]%9%UKJQ:II%C:PBY;4-\FX2;?+A5<F3H<\E!CC[U3ZSJ;Z3ID
MEW'875]*I"I;VJ;G=B<#V YY)X Y-)Z M30HKAO#OQ N]1\1+H>N:"ND7DT+
MSP!-1AN@ZKUSLY4_4<X-<YXS\;7^M>!]=>W\+WO]@36LD<.K><AWG. WE?>"
M$_Q?B0!0_P"OR&E=V/7**XFRU72]/\1W$EQ:"&:UT&"XGOS,QS"&?Y-G08P3
MGJ<XJO;_ !%U%7@O=3\(7^GZ!<LBPZE)<1LPWD!3)$/F122.>>HIM:V_K=K]
M";Z7_K9/]3OJ*Q-)\0_VIK^NZ7]E\O\ LJ2)/-\S=YN] ^<8&W&<=37.CXD2
M2:'HU_!H4L\^J7<]I%:Q7 W!X]^.2H')3O@#.<G%+^OO&=[17!77CW78-3CT
M>'P9-<ZR]@EXUK'?Q[8LNRE6D("@#:.1G).,=Z>?B0B>$VUB71[B.Z@U!-/N
M[ R O#*753@@'?C<",#GVIV_KYV_,-OZ\K_D=U17!CX@:NM]<:7/X,OHM7:,
MSV%G]KB;[3&#@LT@.V+'&02>HQDU<L_'T#^%;O5]0TVYL[NSN#9SZ<")9/M&
M0!&A& VXLN#QUI =A17(Z-XOU2?58=/\0^&+C0WNRPLI'NHYTF(&[:2GW'P"
M<'T/-8C?%#5397.I6_@N\GTJQFFCO;M;R,",1N5+(I :3@9.,8Z9.* /2:*\
M[OO$NNO\4M#M=.TV2YT>YT]I=XO%161F3,I0]2@(&.IW''>NP\0Z[;>'-&EU
M*Z2614*HD4*[GE=B%5%'J20*=K*_];V!:NR_KJ:E%<;I/C74I-9MM-\1>%[K
M0WO69;*5KF.=)2!NVL4^XV 3@^AYJ3PUXPU'Q+?LL7AV2'38Y)X9;][I=HDC
M<J%5,!FR!G/ '3G%%A7L==17->*/%DGAV_TJSATJ?4)M1:5(HX' ;<B[@.1C
M![DD #FJ>F>/,VVICQ)I,VA7VFV_VJ>V>99P8><.CKPW3&.QXI=+C\CL:*X2
MT^(&I+=6LFM>$+[2M)O)4BMKZ2XCD^9^%\V->8\D@<YZT7OQ!U%=<O;/2?"E
MUJEGI\IBNYXKN)958 $[("=[]1Z9[9IV [NBO/=3\0>($^*^C6%GI,TNF36+
MNVZ[6(8+)NE:,C.4Z;3R=QQWIL?Q+U2XM9KZT\&7USIMI/-%>W,=R@\L1N5R
MB, TO R0.F<9)!I=+_UO8/Z_"YZ)17(:OXXDBEL[3PWHTVOW]U;"\2**=(8T
MA)X9Y&X&><#OBJMQ\1TM?"U_JEQHUS!?Z;/%;WFFR.-\;.R@%64$,,-D$=<=
MJ+?U^'Y@=S17&:5XWU&?Q);:1K?A>ZT87RNUA-)<QR^=M&2&"_<;'."3WJ&Y
M\>ZF][</HWA&]U31[25XKC4([F./YDX;RHV.9 #D<8Y!H [FBN-U/QX8+_3+
M31]'FUA]3L7O+7R)E3=@K@$MPH(;)8GC&,$FLX_$G59=-FGL_!E]<75A(R:M
M;_:HU%GM&2%<_P"M..0%'3KBAZ;@M=CT.BN1U/QNR6^FIH&CSZUJ.HVPNX+6
M.580L/'SN[<*.0!UR:@F^(#6GA35=3OM%FM-2TH)]KTV6925W$8*R*"&4Y."
M!S@CBFU:]_ZZ M;6.UHKB;#QUJ,FOV>GZOX5N]*MM1++874MS')YK!2VUT7F
M,D#@$FJ_PYUSQ#J]_P"(DUC2Y+:*+4)!'(]XLWEL H\D*.@48.>AS0E<3>ES
MOJ*X#Q+KOB*R^)_A[3M/TJ2YT^6&5I,7JQJ_*AF*G_GF#G'?=QTKGO#WBK5=
M L?$+V/A:\U2TM]:O);RX2=(EB3?D[0W,C #.!^=);7_ *WL4T_R_%'L%%<E
MJGC<QP:<F@:1/K>H:A;"[@M8Y5A"P\?.[MPHY '7)J"3Q^;7POJ>I7^CS6>H
MZ7L^V:=+*"5W$8*NH(92"<$#G!'%%K?U\A+6UCM**XR7QMJ=KIZ277A:ZCU&
M[N##INGK<QO)<J%W;V(^6( =<DXJ?2?&<DD5['XCTB70;ZSMS=R023I.C0C.
M721.&QCD8R,B@#K**X&W^(NHJ\%[J?A"_P!/T"Y9%AU*2XC9AO("F2(?,BDD
M<\]16))%?:[\<MFJ>&GFM=,AC>UG.I +;#<Y6<1C&XN0!M.2-N332;:7]: ]
MFSUFBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5X=^TK_ ,@#0O\ KZD_]!%>
MXUX=^TK_ ,@#0O\ KZD_]!% '4_ G_DE&G?]=I__ $8U>D5YO\"?^24:=_UV
MG_\ 1C5Z10 4444 %%%% !1110 4444 %%%% !1110!\@?&W_DKVN_\ ;O\
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MQBN=U3P'>Z[H7BFPN8(T:[U@7UHLLF$F55CP&*'<H;:R]B.M>E44NEOZWO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O#
MOVE?^0!H7_7U)_Z"*]QKP[]I7_D :%_U]2?^@B@#J?@3_P DHT[_ *[3_P#H
MQJ](KS?X$_\ )*-._P"NT_\ Z,:O2* "BBB@ HHHH **** "BBB@ HHHH **
M** /D#XV_P#)7M=_[=__ $GCKZ_KY ^-O_)7M=_[=_\ TGCKZ_H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "O#OVE?^0!H7_7U)_Z"*]QKP[]I7_D
M:%_U]2?^@B@#J?@3_P DHT[_ *[3_P#HQJ](KS?X$_\ )*-._P"NT_\ Z,:O
M2* "BBB@ HHHH **** "BBB@ HHHH **** /D#XV_P#)7M=_[=__ $GCKZ_K
MY ^-O_)7M=_[=_\ TGCKZ_H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "O#OVE?^0!H7_7U)_Z"*]QKP[]I7_D :%_U]2?^@B@#J?@3_P DHT[_ *[3
M_P#HQJ](KS?X$_\ )*-._P"NT_\ Z,:O2* "BBB@ HHHH **** "BBB@ HHH
MH **** /D#XV_P#)7M=_[=__ $GCKZ_KY ^-O_)7M=_[=_\ TGCKZ_H ****
M "BBB@ HHHH **** "BBB@ HHKR7XO?#;1M7T[5_%UQ<WZZA:6),<<<B"([
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MP0.G':E_7XV!:M>?^5SV&BO-?$_Q"N=)U6Q\/:/+H5I>M9+=2W.M71AMXU.
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M[@#DYQC&>WXU@:=XY\=ZQ:VOB'3?#=A<^'KF?RX[59'^VF/<5\PDX0#CI_\
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MC&KTBO-_@3_R2C3O^NT__HQJ](H **** "BBB@ HHHH **** "BBB@ HHHH
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M*/#.F6=]-967V"XTV-UM4:/J#&6X0 D\>@'6O2**E:)>7^5OR&]6_/\ SO\
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MI]%2M-5Y?@-Z[^?XGG.F:)XD\3>.=-\3^)=)@T:'289$M;);I;B1Y'&"[,O
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M?]?A]Q-O=:7:QMHBQQK&@"JH  '8"N!U#1_$%A\7K?Q%I^EQW^G7=@EC</\
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M->8\]LYJIH?C'Q5J'Q7UK1;C11_9EGLC)6[0?9D(8K*1C+E^.!]W\\JS_/\
M .E_ZU/3:*\DT/X@KH7PLF\1-;ZC?JFIM;E+_4/.EP7 R)/+' [+M_&NAL?B
M'<OXRL] U;PW=Z6FHHSZ?<33HYF"C)W(OW#[$D],@4)7V_K2_P"0/2]_/\'8
M[JBN N/B5.^M:I;Z5X9O=2TW26:.^OXID7RW R0J'E\=\<^QXST'@OQ+_P )
M?X3LM=^R?9/M08^3YGF;=K%?O8&>GI26JN@>CLS?HK"\4:_>:%9PMI^AWFKW
M<[[(X8/D1>,[I)#\L:^YKG]!^)7]KV/B'[5H[66IZ'"9KBT%VDR,-I8!94&/
MX<'CCWI7T;[#L[I=SO:*\M7XPW"Z1I.MW'A*\AT.]=8I;XW*$1.QQ\J8W,H.
M1N(4<<9K?\1>.Y]-\26_AW1-"FUO59(?M,L4=PD*PQ9QN+MQGT''UJFFOZ_K
MU)N=G17FOPPUZ^UWQ)XS>ZEOA%%>HL-K=R$FVX;* 9(7D=N.*[O6M3_L?2+B
M_%E=WK0KE;>TB,DLAZ *H_R*3T2?<:U;7G8OT5P&@_$BZO?%L'AO7/#K:/>W
M432VP6^CN=P4$D.$P4. >#Z&HM6^)]U!?:FNA^%[K6=/TF0QZA>1W*1B-A]X
M(I!,A'.<8Z?C1V ]$HKRSQ+XL>'Q_P"!KPW]WI^DW5K<W%U#,[0KM$>X>8G3
M(]_PK9M_B%<7'@C5_%G]A/%IUJK260EN-KWD:_QD;/W8/;[U-Z*[\_P=@W=D
M=U17F\7Q4N%N]"DOO"UY9Z1K+1Q6^H/<(?WKC@>6!G;_ +1QD<XK4UWQW=VN
MOS:#X<\/3Z]J=M&LMVB7*6\<"MT!=LY8^F*&FOZ[;@M3M**X&3XHV9\.6FLP
M:=*8CJ2:=?PSR>6]DY."6 !!P<>F<]:M1?$2TD^)MQX,^R@&"V\XW?G<%MH8
MILQ_=.<Y[=*7]?A?\M0_K\;?F=I17CGB/QS?Z]X;\+ZQ8?:-+ANO$:6RB&Z;
M,\(9ERV O#$?=Y''4UUNM>/;RVUZ[TCP_P"&[C7)]/5'OV2Y2%8 PR "WWVP
M,[11TN_ZT3_4+:_UW:_0[:BN'O\ XG:7!X-T[7[&VGO9-3D$%E9+A9))B2-A
M/.W!!!//XUST'BG7-0^,7AZPU"QO]%/V&9KG3FNA)"YPQ5P4.U^G4C((IV?-
M;^MK_P!>HF[1O_6]CUFBO-IOBM<-%J^HZ?X5O+S0M-\Q'U%;A%#RH.0$(W;,
M_P 8SCTK3N/B&L7A?0M1@TF6ZU37$4V6F13#+,5W$&0@ *!U;'X4NE_3\=BK
M?UZ;G;45Q.G?$6%K'6CKFEW&D:CHT/GWEDTBS?(1E61UX8'I]:@\._$#5]9N
MK![KP9?6NEZ@?]%OX+A+I<$9!E5!F,=.O0FG;6PMCO:**\_M/B+J>I^,-2\/
MZ;X5ENO[.NT@N+K[:B(D;'!D(*YR/[HSG!Y%):NP=+GH%%>=7GQ1FBDO;VR\
M,7E[X<T^9H;O54N$7:RG#%(C\SJ#W!'>M3Q#X]CTZ;3+'1--DUO5=3B\^UM8
MIEB!BQG>SMPHQT]:.E_Z[_EJ'6QV-%</9_$FW'A/4];UC2;W2Y--E,-Q:R#>
M6DSM"QOP'RW&:=HOCR\N-?M=&\0>'+C0[F_1Y+ R7*3+.JC)!*_<;'.TT[7=
MOZ[_ )!LKG;45Y=I_C/^R+7X@:IY6HWG]DWQ'D7>H;T/.,1?)^Z7_9^;ZU:@
M^*EPDFD76I^%KS3]#U0QQP:D]PC#S'' ,8Y"^C'&>N*4?>M;R_'8'I>_2_X;
MGH]%>:67C#Q5<_&"^T$Z(&TRWB4'%V@\J-FXG/&6S@?(.17I1(4$DX Y)H7P
MJ0=6NPM%>;R_%:X>.YU73_"M[?>&+1V2?54N$4_*<,R1'EU'KD=_2L'XH^)]
M?OK_ ,+V'AQ;T:;JV)(KC3]02VENR1GRPQ!,>!@Y/!W8QQ1V\Q][]/T/9J*J
M:7;O::39V\CSO)%"B,UQ+YDA( R6;^(^I[UX^WBW6=$^-FN27-[/+X;ADM[:
MYADF9DMO-1=DBJ>%&\8)']ZG;WN5$_9YCVNBO-O#^K7C_&GQ?9W&H7#:?;6<
M$D<#S,8HLJI)52<#OTI&^+$[6SZU!X4OYO"D;E'U99T#8#;2XA^\4SWS26J3
M[_YV&U9M=O\ )/\ 4]*HKR[Q5XY\26OCSPYI^@:2E_IU["]S&%NDC-Z-A/WF
M'R!00W/WN*T-'\100>/?&PO+C4([?388)9?M%[YD$:^7N)CCVCR_?DY/I3MI
M=^?X!Z>7XGH-%><Z=\4+^\O=-EF\':A!HFJ2B*SU!9EE9R>A:%1E5ZG.>@JY
MJ_Q!O;?6;^PT+PS<ZU'I>/[1GCN4A6'(W84-S(P'.!BD]-PW.ZHK/T+6K/Q%
MHEIJU@Y:UNHPZ$C!'J#[@Y'X5E^+?%\7AA+.WBLIM1U2_D,5E8PL%:5@,DEC
MPJCC)[4/1V8+571TE%<1I7CR]OY=1TF[\.36'B:TM3<QZ9)=(RW"]%V3#Y>N
M 21QGO7+?!BZ\0Z]=:EKVM7&JR1NSQ1F74%>VW;AE5@ RA7&-V<')P*:5W;R
MN#T5_.Q[!17$_%7Q)K'A;P/<ZCHMNKSAEC>=F4?9U8XW[3]XYP,>^>@KD_$_
MBOQ#:7/@"[N[*^T^>XNI%N--M;P2FX "A 2I"MNR#@],\TEK]Z7WC:LK^3?W
M'L5%<=X:\=3:OK^H:#K&B3:+J=G$+CRI+A)E>$G ;<O&?4<_6L?_ (6PWE#6
M#X:O!X3,WDC6?/3KOV;O)^]LSW_2FE>WG_7YZ>HCTFBD5@ZAE(*D9!'>O//B
MEJ.IS_V+X5T*_FLM5UBY_P"/B%V1HH4&YVRI!]._/-2QK74]$HKB?A;XAN=<
M\&)'J,C/JFFRO97F]B6+H<9)/4D8R?7-<_'\8[Z?PW+KUOX,NYK"UG:.]F6[
M0+"H;&5R SG&"0  ,]:IV3M_5A)-K\/G_2/5J*X?7?B-'I5_X;M[/29]2378
M7E@,,@5QA0R@*1@YW#DL .M2^%O'<VNZEJ^DZGHDND:MIBB22V>=9@R,,@AU
M&/3UZCDTGI>_2_X;AV\[?CL=G17 6_Q-\_X53^-_[(V^46'V/[3G.)-GW]GX
M_=K0UKQEJ5E9::^D^&+O5+F]MQ<$"98((5(!P\[C:#SP.IQVH>FG]=P_X/X:
M'7T5Y-KWQ D\2?![Q%JNG+<Z5J%C(+>417&3%('3.R5#\PP>HQFO2M#D>;P_
MILLKL\CVL3,S')8E!DD]S1;?RM^*N';Y_@[%^BO"_BMKGB#3OBAIZZ5JM[!;
M6NG"^FM8KAUCE6-G9@5!P<JN.12?&GQ1K#/9GP_JUW96UI:QW5RUK.T9?SGV
MQ@E2,\*3^-$=4O-V&U9V\KGNM%<;KGC6YTS4;30]%T2;7-:EM1<O;K<) L<6
M0-S2-P,GH*9%\2]*/@^[U^>VN89+2X-G/8$!IEN,A?+&."22,'IBC^OQM^>@
MET_KS_([6BN)T?QUJ%SK']BZYX:FT?5)X'GLH7NTF6Y51R-Z\*WL>E<CH'CC
MQ/K7A;QG=:SI<\%M:"ZVW-I?I&\#HH'D)A20P&3YF",]J.[\K_H"U=O.Q[)1
M7FL?Q"_L'PWX* TV_P!1;6H0J[[KS;@,%!&25 D8D@9.T=ZU_#'CN?6?$6I:
M!J^AS:-J=E&)Q%)<+,)(CC#;EXSR.!GZTVK-KM?\-Q7T3_K4[.BO,9?BY<'2
M]3UNR\)WMSH%GO2/4!<(HE=>/N8+!">-XSCN!S7?Z)J7]LZ#I^I^5Y/VNWCG
M\O=NV;E!QG SC/7%%M+C>CL7Z*YGQ5XGU+0Y8+;2?#=WK%S*I<D2+;P1*/[\
MSC:">PZU@P?%:"X^'^K>)DTIQ/I4OD7%D;A2-^5!VRJ"&'S=0.<5-]&^W_##
ML[I=ST2BO/8/B=<#7-%MM0\,7EAIFLD)9W\LZ'>Y P#&.5!R,$D'VJSJ/Q!N
ME\57>AZ'X;NM9_L]5;49X9TB$&1D!0WWVQVR/QIM6_'\-Q;_ -=SN:*\[^#>
MK7FM>$;V[O+RZNF.I3A&N9&=E3C"_,<@#/3M4OQ7\3Z[X8T"TET2S$AN;E(9
M9S*JF/)&% /=N1N_AZT/2U^MOQM_F).]_*_X7_R._HKR3Q%XHU^R^('@QI;"
M^@FNK2X,^BVUX'5Y,$*"<A&QP=QZ5TOA_P"(D6HPZZFMZ9+HM]H:^9?6[RK,
M%0@L&5U&&X'IZ=:.E_7\&/K;T_$[:BO/=.^)MQ+=Z:^J^&+O2](U:18M/U"2
MXC?S&894/&O,>>V<UZ%3LT%PHKP#6EO=:^)7BFUN/B?<>%[>SFB$$,EXR(X:
M,$[5,J 8([9ZUN^"O'>I:9X"\3WNH7@\0QZ#<>7;W8<K]J3C^,@Y]<\]>IZT
MD_=N^UP>]EWL>Q45P=G\2)%\+77B;6] GTK24@BEM7:X262Z+_PJ@^[S@#)Y
M!!XI=-^(=[_;5CI_B/PQ=:$NI,5L)Y+A)EE/4*^W_5L1C@YIV=[?U_P_D*^E
MSNZ*\WUCXMVWAV_U[3]9TLVU]IZJ]E$+C=_:"L<+L.P8.<9X..>N*V(?&EY#
MXAT#2-7T06+:Q:O*D@NO,\J91DQ$;!DXQSGKQCO26NW];_Y#>F_];?YG845S
M>E>*SJ_C+6=#M[$_9M*6,2WOF\-*PSL"X[#J<_A5CQC?ZCI?@_5K[28?-OX+
M9GA3;N^8=\=\=<>U)NT>8:5WRFY17SUH$OBN:*RUS0/B.GB'5I2DEQH,TZI\
MI(+J%DDP,9QD*OM7<>,O&/BO2OB)H&C:5H@NK:XCDE\H7:1FZ(4[EW'[@3.?
M]KBKY=4NKT)OHV>FT5P?BGX@:IH%U="T\(W5Y8V2;[J]N+I+2,<9/E;Q^]P,
M_=[\5B>+_B-K7]E>$=0\,Z8TMKK-S'DR3)&[G/\ J.<[=V""_08]ZE:_U_78
M;T/5Z*XC5/'>IVU];:/I?A:;4]>-HEW>62WD<:6JGC!E(PQSD  <XS574_BK
M:6?@1?$]KIDUP5NQ9SV3R".2*3.&4G!!(_7-']?C;\] _K\+_D>@T5YN?BEJ
M$/B$Z%=>"]1AU"XA$VG0?:8F:X7G[Y!VQ8P2<DXP?;.GH/Q%M-2\/:SJ6J6,
MNE3:+(\=_;.XE,;*,_*P W9Z?6CI</([6BN"TKXC7<^IZ=!K?ABZT>RU9@NF
MW<ERDHF)&0'5>8R1C .:ANOB5J)UCQ!I>D^$KC4KG1Y%#>7=JB,A7)8EAP?1
M1N)H>F_]6W^X%KM_5]CT.BO)O%7Q-U.X^'>D^(/#.GL$U"X$$SR2JK0-NV[
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M[0J7Q)XBL?"N@W.L:BSBW@ ^5!EG8G 51ZD\4/0%KL:U%<)IOQ#O?[:L=/\
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MA?L[?O4DD>7$?'S<XZ9["O?:*FVEO7\;?Y?B-O6_I^%_\SPOQ#X*N;OP_P"
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MO5D:-]PC&1@$YSGTKEM$\,W,/B_2YO!_AWQ3X;E2Z0ZI'>MBR,0SN"L23+W
M]N<#K7T!10G:2D3;1H*\^\!:;>VGC3QU<75E<00W5^C022Q,JRKM;E21\P^E
M>@T4NM_)K[[?Y#>JMYW_ #_S/G2V\ V>BW5_I>L_#G5-?U-[IVLKVVN)([:6
M(G(\R17"QD<]5KM];T:_\)>+_#_B?3=#N[[3K33/[-N+&P)GF@7JI3=@R $X
MSUXS7JE%"NDDNG^5OR&]6V^O^=_S/*/$EMXH^)'PZUF"7P^^F.)TET^"Y?9-
M<(K9PZG[C$<=>OI5+P-X9T,^*+&YT_X:ZIH\EHI:>_U"[EC$4N,8C0LWF@Y/
M/ Q7LE%-:.Z_K2Q+U5F>%ZEIU]8^$?BO+=V5Q;QW-Z9('EB9!*N?O*2/F'N*
MFNFU[QGX5\,>$U\-:A:F,VL]UJ,BK]E$**,,C@G<Q&/E(!%>M^(=#MO$N@7F
MCWDDT=O=IL=H2 X&<\$@CMZ5:T^RCTW3;6QA9VBMHEA0N06(4 #.._%*'N_+
ME_!?YA+5W[W_ !L<"J7^C?&RZO)-'U&XL=5L8;>*[MH=\43*>?-;/R"O0YXA
M/;RPDX$B%21VR,5)12M[O*_ZW_S&M'=?UM_D>(Z<OB3PYX!O/AX?">J7=_(L
M]O;7T"*;1TD+8=I,_)C)X//3IFM34/"FHZ3>?#"PAM[B[72YF6ZGAC9TC^5<
MECCY1G.,UZU157=[O>Z?W ]FNFOXA7F.E>&I-1^(OQ!AU33[@:9J4%O$DLD3
M*DH\O!V-C!(/IT->G44O\FOO'?3[OP/$_A[X9\10^-?%MMKUO<JLE@MC'?M"
MRQSJH"*RL>&.T G'?-,M_P#A)['X<R_#EO".IR:FT4EJE\BK]B,;,?WAESQP
M?NXS_*O;Z*-U9_\ #ZM_J+9W7>_X)?H>2:UHVH>$M=\ WT.EZCJUGH]I)9W'
M]GP^;(&:,*#MR.,YYZ#%*OA?4M7\7_$NV:UN+:'5;.&&UN98F6-V\K'#8P<'
MKCI7K5%-OFO?S_'7\P6FWE^!Y3X8\3>*].TS0O"\/@K41>V02WO;FZ79:B)1
MC>DH)#'H<8]1S7,ZYX(L].\;Z]<Z[X&U3Q'#J4_VC3Y]/>3",WWDDV.NP9/W
MB#7OE%#=WS/?7\06BMT_K_,P_"&EQ:-X5L;*'2AI2JA8V0N6N/)+$L5\QN6Y
M-<SX_P!)U.'Q/X;\6Z;I\VI+I#2K<VEOCS6C=<;D!^\1Z=3Q7H5%#;<N8$K*
MQYIX?M-3\4?$IO&5QI%]I&GV^G_8K>&_3RYYF+$EBF3M R>O7BK?P<TZ^TOP
M1);ZA9W%I,;^=Q'<1-&VTMP<$ X->@44EIMVM^-P>N_?]+''?%/2+[7/AQJU
MAIT#3W3JC)$OWGVNK$#U. >*YC5CJ'B+6/ASJ4&A:O;1VUY)]ICNK1D>  *N
MYP,[0<'!/45ZQ10M'\T_N&W=6\FOOM_D>;_V-?7'QJUBX:TN$L;C01;K=&)O
M++EA\H;&">^*\ZT3P#9:?!'H>K?#+4M4UU)RIOUNY8;.2/<<.95;"D#^';GC
MUKZ-HH6EO+_-O]1/6_\ 72PR&)88(XD7:B*%49)P ,=37C6L^#?$OC[XDZKJ
M,.JZCX;MM+1+2RN5MY%:<')<H=R<9SR"01BO:**-W=@M%9'D'@?PUX@\ _$6
M[TV[N+_6M.U>U\]]3-N^U9U)X=LM@D9Y)YR*BT;0]4A^ .NZ<^EWB7\QNBML
MUNPE?+\83&3D=.*]DHI-75GVM^-_^ -.SOYW_"QY-'HVI'Q#\+)&TV[\NQL)
M%NF,#8MV\A0 YQ\IR,<XYK4TG2[\?&7Q7>/9W$=G<:?!'%<O$PC=@HR V,$C
MVKT6BJF^9W?][_R8E:*WI^!\]"W\2V7P>U3P./".LR7\$C;KA8,P.AE#9C(.
M7/LH/J<5O>)M(OSXA\+W&L>&]3UWP_%I:1"PM8R_E76/O2(2!C'&6X%>ST47
MUN_ZTL/_ (/XNYX#9^'M:B^%GC[36\.7MG=7&H>=;V,=N6RC,A"Q[1AP "/E
MR!BO;]#C>'P_IL4J,DB6L2LK#!4A!D$=C5^BB_Z?@K ]7?U_%IGF&O>'KK5?
MC7:SR6$SZ:VA2V\EP86,09BXV[L8SANF:\_C\(^)9OA-XB-_I=[+JK7=K:P0
M_9G\QX8-JJ57&2N">?8FOH^BB+Y?Z\[_ / &W=W_ *VM_P $\5\>>#HG\<VO
MB#5_"^H>(=%ET];>2#3]YG@E4\-M5E)!''7U]J34?A\^I_"JXMM%\)-HTYOD
MO4TR:^>5[A%X^8L?D8J3\H/&.N:]KHI=+?UO?YB6C7]=+'D/@+PWH7_"4V]_
MI?PXU31!:QL6OM2NI8V60C!5(F9MX()^8X'XU5TNSU>Q\,?$+PU/H.JBYN)+
MV[M[A;8M!.K@!51A]YSUP!^O%>T44/56\K?C<%H[^=SQ^#1-3V?"@/IEY_H*
MG[7F!O\ 1SY:X\SCY>1WQ6U'I-[+\;]5NWL[E;";0U@6Z\IO++[Q\H;&,X[5
MZ-00""#R#3D[MO\ Q?\ DRL'2WI^#N>""37?#'PDUWP9=^&[_P RS@N/^)B0
MHM6A9BVX/GEL$X4 ]LXKUWP3_P B)X?_ .P=!_Z+%<RWP:\/>;-'%J&N0:9/
M)YLNE17Q6T<]\IC/8=^U>@PPQV\$<$*!(HU"(BCA0!@ 4^:Z=]W;\%837O:;
M:_BSRKXA:;=S?$'2;S4_#VH^(/#BVQC2SLD\P1W))^=TR!C! RW%<U9^'M:B
M^%OCW36\.7MG=7&H":WL8[<ME&9"%CVC#@ $?+D#%>^T5%M+?UNG^GW%\VJ?
M:WX)K]3S+QKI-_<CX>K:V%S*+34K=YQ%"S>2H49+X'R@>IJ"V;6O!'Q \1NO
MAS4M6M-=D2XM)[% RHX!!64D@(,GJ?U[>J453=[^=_QM_D0DK)=K?A?_ #/.
M_@WI^I:=X1O8]5L9[*ZDU*>0Q2QLG!QR,@9'7!JU\6M-O]2\&)_9UG->36U[
M!<M! NZ1D1LG:.Y]J[JBD];>5OPM_D"6]^M_QO\ YGF-ZM]K?Q1\$:Y%H^IV
M]F+.Y,WVFV*FW)4@+)C(4GT)JA+X5U36/%?Q,MA:SP1ZG:016EQ+$RQ2,(^S
M$8.#P<=*]=HH=K6]?QU&FUKZ?@>!^$O!NE"]T>RG^%^J1:O:NAOM0N;R6&V1
MEY\R-@Y$A)&=H 'X5[Y113;N)*QY#9_#?2O$_P 2?&-WXFT*XFM_.@-E-(TT
M*./+PVTJ5#<@>N*Z/QKX9MM/^$VL:+X=TK8IM\16MK$69VR.PR6/OR:[NBI:
MO'E*3M+F/./%/A;4]>^$&G:;8P8U*U@M9DMY?D+/&!E#GH>HYQS6;J+ZQ\1]
M<\.VW_"-:MH]KI-\MY>W&H1B(%DZ)%R=X)S\PKUFBKYO><O._P R%&T5'RM\
MCQ#Q?HGB?QCXJO/$MCIDD$7ALH--M[NV*M?NK!G(##)7CCUXQWKHOB'/<:K\
M.;#Q9;65Q9ZCI,T6HI;W4;12(5.'1@0#C!/UQ7IM<WXK\%6/C$6L6HWVI1VL
M))DM+:X\N*XY!Q(N/FQCCIC)J->517]=W\R]&[O^EV,GX3:?-;^#%U2\7%]K
M4\FHSG_KH<J/IMQ^==%XIAUJX\-7J>';I;75MFZVD9%8;@<X(8$<C(R1QFM6
M**."%(HD"1HH55 X '04^JG9[:"C=:O<^=-;3Q+XNMSI3?"D6/B!F3S-<5/*
M 92,N'" =O[Y[XS7>>+K;5M(\8^"M=.F:AJ\.GP36]V=/A\V3>Z!0VW(X)R<
MUZ?10G:WK?\ "WRT8FK_ '6_K[CPG7=#U*?Q9XL75?!NHZ]?WL;#1KO:&MK>
M,J0!N9@J$'!]<CWR9YM+UB#X8> ;E=$U*:;1=0CGN[*.V;[0%5F!Q&<$]OSS
MTKV^BE'W4K>7X7_SU&]7KY_BDOTT/#?%_A>WNO'!\4:UX-U?6]'U.QBQ;VBN
M+FTF"CAXT<'H.>2 :FUWPI+#\)X+72/"-UI<LVJQ7#:=%/)>2*H.-['DKP!D
M#@5[9136FW?\G<3UW_K2QY[J.FWTGQST34%LKAK*+29(WN1$QC1R6PI;& >>
ME<[;>$-6UC2_B;IIM)[:34=0,EF\\919L'<"I(P02 ,CCFO9**CETMZ_B[_H
M4G9W]/P37ZGA?@WPEH[:QI$0^&&J6>HVC(][J%Y=RQ012)SOB^<B7+#H !SZ
M5V7A'3+RV\8^/[F>RN(H[JYC,$CQ,JS*(S]TD?,,GM7H5%7)WOZ/\;?Y$I6M
M\OP/"+7P[KB_ /3K4:/?&^L]2%U)9F%EF*+,2<(<$G!R!WKVO2M0_M32[>^^
MQW=GYR;OL]W'Y<L?LRY.#5RBAN]_/_*WZ!;6_P#6]_U//M2TZ^D^.FC:@EE<
M-8QZ3+&]R(F,:L6;"EL8!]JP]!T74H/A/XVM)-,NX[NZN;]H86@822AAA2JX
MRV>V.M>NT5-O=<?ZU=RK^\I>GX*QSO@*VGL_ &@VUU!)!/%91+)%*A5D(7D$
M'D&N<\<V&J:;XW\/^,;#3+G5+:PBEM[NUM%#3!'!PR+_ !=>GTKT6BJDVY<W
M]?UJ2DE'E/,]37Q'\2? _B*PGT&71XI0O]FB\/ES2E2&Q(G.SE<9SW_&L?5V
MU_Q[HVC^$V\*ZKI<EM<0/J-Y=H$@18QSY3@_O">V/_KU[)10M']S^:&]5;U_
M$X'0=,NX?C'XIOY;.X2UFL[9(;AXV"2$*,A6Q@D8YQ7%0Z#K ^#OC:Q.DWXN
M[G5I9(+<VS^9*IDC(95QEA@'D>E>YT5-M+>5OQN-.TK^=_PL>9>-=)O[D?#U
M;6PN91::E;O.(H6;R5"C)? ^4#U-<CKG@BST[QOK]SKO@;5/$<.I3_:-.GT]
MY,(S?>238Z[!D_>(->]T53=W?S?XV_R)2LK>2_"_^9Y'K'A2^TC2O!NM:-X=
MDB_L*9YKC1H+DW$BI)RX1VY=AZ>_'2NCTW7M?\76^N0OX9N]+TU[5H[234!Y
M,\DA4@@Q\X&<\Y].M=S12E[R:?6_XC3LT^UOP/!KRTUG4/@1#H"^'-9BU'3;
MB"&2*2T;,N')+1@9+*!WQBNLUB#5?"?Q)E\61:)?ZOIE[IR6LR:?&))X9%(P
M=F02#@=/?\?3:*;;O?\ K:Q*BK6_K>YXQ)X;UN]\+_$'Q!<:5=6]WK\0%KIN
MW?,$1<+N5<_,<].HJ_XNT;49_!WP_MK73;N22TO[)IXXX&9H55,,6 'R@=\]
M*]8HH3M:W2WX7_S&U?5^?XA7G(2_T?XV7=Y)H^HW%CJUE#;Q7=M#OBB93SYC
M9^05Z-12ZW_K4;U5CQ[P[HNJP?"SQW9RZ9>1W5S=WS00O P>4,@VE5QE@>V.
MM9.M^";JZ\-^ ]2U#P[>:K9Z;8^1J.F1!DN "HP54%6)!'3.>GO7N]%'_ _!
M6#_@_B>-67ABUC^'WB^70_ U_H9O+)H;>*>XEEN;H8/6$EMAR>!DDUM:CX4U
M'7O@+::#%"T.HC3K<B"8;&WIM;80<8)QCGO7I=%-ZIKT_ %HT_7\3Q/P3X6T
M5O$6F/;?#+5-,NK/#W6H7UW-%'#*HZQ LPF!(/H*FOO!^JW'QG:T:RF?PS<S
M#5993$QC$PB:/;NZ9W'..O2O9J*&[M/U_$5M&O3\#R'X1>&]:L=8U:[UVUGB
M.GPKI5@TL3)OA5V8LN>H/R\C@UBP>&-=F^ FI:<NDW@OQJ;7 M7A9)702JV5
M4C)X!QZ]J]XHHN[W\E^#O?[QZ?C?\+6^X\MU0W_B'QU\/=:AT35;:VC^U>>M
MU:LC6_RA1YF,A,XXR>:T=#TZ^A^-GB>_DLKA+*:QMTBN&B81R, N0K8P2/:O
M0:*+ZKY_B*VEO3\#%\7V4NI>#-:LH?\ 6SV4T:?4H<5YG=V=WXE_9NTV+2;:
M2ZN(X(#Y,0R[>5( P [GY3Q7LU9.@>'K/PW:W-K8/-]GFN9+D1R,"(BYR53
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MQH=K>6\UO<16^V2*9"CH<G@@\BNKHI;;>7X7_P QO75^?XI+] HHHH ****
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MW#J163??$&\TGXHW6G7*W]QIW]DI<0:;:68EG:8D9QM&<XSU;:*=M;?UM?\
M(/Z_&WYGI]%<!JGQ L=3^&>J>(M'OKS3VM2(Y'^QI)/;2!E!4Q.P4GGUQS6E
MJ?CK3O#VD:2UVM]J-_?PJT%K9VP>XG^4%F$8.!UR><>F:7]??J'_  ?P.MHK
MS;Q!\1XM0^&.N:YX;GGM-0L"L<D=S !+;R;U!#(V1G!/J.OI5S0_B?I5[=:1
MIEU#J<<]_"@AOI[,QVUS+M&51CC)SW Q[T)7=OZU5P>BOZ_@=[117 W7Q>\/
MVMU(#9:Q)IT4WD2ZM%9%K-'!P09,^O' /6CK8.ESOJ*X[Q!\2=(\/:_!HLUE
MJEY>W%K]I@2QMO.\T9("J <[OE)Z8QWI^L_$/3=&:S@.FZO>ZC<VXN?[/L;3
MS;B*,_Q2*#A<'CKUH#R.NHK-T+7=/\1Z3%J6F3>;;R9'*E65@<%6!Y!![5A>
M+-<FTOQ1X5LH]2N+5+^Z>-X8K2.5;@ #Y6=F!C'/5031U2#HV=?17#:A\5-&
ML-0U>P&G:Q=W>EN%GBM+3S201DN,-@*.Y;;^-:9\?>'QX.B\4F[;^S9L",A"
M9&<G&P+U+9!&/:CI<.MCIJ*Y+PU\0M*\2ZG-I@L]2TS48H_.-IJ=MY,C1_WP
M,G(Y]:H2_%SPY'>,OD:H^FI+Y+ZNEFQLD?.,&3Z]\8YZT[:V [RBN1\1_$72
M/#.KV.F7%KJ-W<WT#36PL8!-YF.B@ Y)/;C'J15:_P#BAI&F:C9:==:;K"WU
MY8K>0VRVH>4YR!'L#$^9P>,8'<T@.WHKFO#WCG1O$>FWMY$T]D; D7MO?1^5
M+;8&?G&3C@'O658?%CP_?:A;P&VU6UM+J01VFHW5FT=K<,>@1SZ^X%.VM@Z7
M.ZHKB]:^)FE:+XDN/#[:9K%[J,,*S"*QM1-YBM_=PW8<G.![T[7?B3I>AZE)
MIR:9K.IW4$8ENH]-M/.^RJ1D>8<@+QSWI=+CMT.RHKS;Q=\5(M+\/Z'J>A6-
MUJ,&K3JB3QP%@B[L,N./WIY"J>X/ISM:I\1-.TNWT_?I>LSZC?0>?'I=O9E[
MM$[ETS\N.^3V-%O\A?\ #G7T5S<7COP_+X3G\2F\,>GP$K-YB%9(W!P49.H;
M.!CWKBM2^*$^H:]X2M=*BU/2A?7X2YM]1L1&T\!QAE+ @J?53FG;7E$W:/-_
M6AZS139"5B<CJ%)%>/>#OC"L?A**[\1IJE_.MQ(EU>VMAF&U7=A?,90%''8
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M%OJFF3B:TN%W(^"#UP00>A!XH6JN@>CLS0HHHH **** "BBB@ HHHH ****
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M ?('QM_Y*]KO_;O_ .D\=?7]?('QM_Y*]KO_ &[_ /I/'7U_0 4444 %%%%
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M46W\@-FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^8KM)OKH_G_D==HVF0Z+HMEIEN (;6%(5_X",9KP_P 2:=(WQ'OO /EL-/\
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M?C<\*T[6K*VO/BOJ^CV5K?VFR%XXGBWPR@[@S%>C+DEO0BJL5Y:W'C+X=/\
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MG)PHX')JQ0[7T&K]0HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP[]I7_D :%_U]2?^@BO
M<:\._:5_Y &A?]?4G_H(H ZGX$_\DHT[_KM/_P"C&KTBO-_@3_R2C3O^NT__
M *,:O2* "BBB@ HHHH **** "BBB@ HHHH **** /D#XV_\ )7M=_P"W?_TG
MCKZ_KY ^-O\ R5[7?^W?_P!)XZ^OZ "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KP[]I7_D :%_U]2?^@BO<:\._:5_Y &A?]?4G_H(H ZGX$_\DHT[
M_KM/_P"C&KTBO-_@3_R2C3O^NT__ *,:O2* "BBB@ HHHH **** "BBB@ HH
MHH **** /D#XV_\ )7M=_P"W?_TGCKZ_KY ^-O\ R5[7?^W?_P!)XZ^OZ "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]SI@N9[J9=AN+MU9U7KM&U0 ,CTS6QK7A6QUW6-&U.ZEN$GTF9IH%B90K,0
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M1VOV4.S#S-FW;G.,9Q[4ZGO0DEU_R[BI^[)-]/\ ,Y[X0?\ )*M!_P"N+?\
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MD+)U9EV; 0<XVYW<>N/:FW??^]^*_P VR;6V\OP:_1'+? S_ ))G!_U]3_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7AW[2O_( T+_KZD_]!%>XUX=^TK_R
M -"_Z^I/_010!U/P)_Y)1IW_ %VG_P#1C5Z17F_P)_Y)1IW_ %VG_P#1C5Z1
M0 4444 %%%% !1110 4444 %%%% !1110!\@?&W_ )*]KO\ V[_^D\=?7]?(
M'QM_Y*]KO_;O_P"D\=?7] !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5X=^TK_R -"_Z^I/_017N->'?M*_\@#0O^OJ3_T$4 =3\"?^24:=_P!=I_\
MT8U>D5YO\"?^24:=_P!=I_\ T8U>D4 %%%% !1110 4444 %%%% !1110 44
M44 ?('QM_P"2O:[_ -N__I/'7U_7R!\;?^2O:[_V[_\ I/'7U_0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>'?M*_\@#0O^OJ3_T$5[C7AW[2O_(
MT+_KZD_]!% '4_ G_DE&G?\ 7:?_ -&-7I%>;_ G_DE&G?\ 7:?_ -&-7I%
M!1110 4444 %%%% !1110 4444 %%%% 'R!\;?\ DKVN_P#;O_Z3QU]?U\@?
M&W_DKVN_]N__ *3QU]?T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_)7M=_[=_P#TGCKZ_KY ^-O_ "5[7?\ MW_])XZ^OZ0PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *\._:5_Y &A?]?4G_H(KW&O#OVE?^0!H7_7U)_Z
M"* .I^!/_)*-._Z[3_\ HQJ](KS?X$_\DHT[_KM/_P"C&KTB@ HHHH ****
M"BBB@ HHHH **** "BBB@#Y ^-O_ "5[7?\ MW_])XZ^OZ^0/C;_ ,E>UW_M
MW_\ 2>.OK^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO:[_ -N__I/'7U_2&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MX=^TK_R -"_Z^I/_ $$5[C7AW[2O_( T+_KZD_\ 010!U/P)_P"24:=_UVG_
M /1C5Z17F_P)_P"24:=_UVG_ /1C5Z10 4444 %%%% !1110 4444 %5M12R
METZXCU'R?L3QE9O.("%3P<D]JLU6U&TM+_3KBTOXXY+2:,I*DGW2IX.:3VT&
MMRDGB+P_&BHNM::%4  ?:TZ?G4&BV7AM=6U'4]%:R:\O GVQ[68-NQG:2 <
M\GG'-5XO#OAG0-&C&HP:9Y,"[6N[R&),CMN8@#.._?%:NE6VCQP?:-'@L5AF
M _>VB(%<#IRO6JZW)Z'RA\;?^2O:[_V[_P#I/'7U_7R!\;?^2O:[_P!N_P#Z
M3QU]?TAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X=^TK_ ,@#0O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_KY ^-O_ "5[7?\ MW_])XZ^OZ0PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\._:5_Y &A?]?4G_H(KW&O#OVE?^0!H7_7U)_Z"* .I^!/_)*-._Z[
M3_\ HQJ](KS?X$_\DHT[_KM/_P"C&KTB@ HHHH **** "BBB@ HHHH *Q_%4
M5_-X6U*/2_,^V- 1&(FVN?4*>S$9 /KBMBLWQ!JPT/0;S4O*\TP1[ECW8W-T
M )[#)'/:D]AHXZRU_P"&&GV:VQ_LBP./WEM>6PBE![[U==Q/N>M7O!4=H=8U
M:YT*U>U\.RI%Y">28HWG!;S'C0@84C8,@ $CBK']A>++K9/<^+(K>7KY-KIL
M9C'ME]S''KD5;T#4M4&KWVAZS);W%W:Q1SI=6\9C66-RP&Y"3M8%#WP>*M;L
MGIIL?,7QM_Y*]KO_ &[_ /I/'7U_7R!\;?\ DKVN_P#;O_Z3QU]?U(PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\._:5_Y &A?]?4G_H(KW&O#OVE?
M^0!H7_7U)_Z"* .I^!/_ "2C3O\ KM/_ .C&KTBO-_@3_P DHT[_ *[3_P#H
MQJ](H **** "BBB@ HHHH **** "H;NU@OK2:TNHDFMYD*21N,AE(P0:FHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>'?M*_\ ( T+_KZD_P#017N->'?M*_\ ( T+_KZD_P#010!U
M/P)_Y)1IW_7:?_T8U>D5YO\  G_DE&G?]=I__1C5Z10 4444 %%%% !1110
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MYO=+=H4=ACSF(79NQWRP!^E;/PY_Y(1:_P#7C<?S>O/_ (7^'I?%7P0\4:/
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ML= ^'NL+%!(LB:C)<R;(74Y^8>:5X.WC))ST]??JI_"K[D=78****DH****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KP[]I7_D :%_U]2?\ H(KW&O#OVE?^
M0!H7_7U)_P"@B@#J?@3_ ,DHT[_KM/\ ^C&KTBO-_@3_ ,DHT[_KM/\ ^C&K
MTB@ HHHH **** "BBB@ HHHH **** "BBB@#Y ^-O_)7M=_[=_\ TGCKZ_KY
M ^-O_)7M=_[=_P#TGCKZ_H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\
MGGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\
M%4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_
M ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI
M7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_P
MT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7
M_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?
M5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"
M^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,
MW_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU
M_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W
M_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?
M*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^
M>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5
M'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">
M>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 5
M0!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\
MPT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?
M^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0
MOC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^
M S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]4
M45\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+X
MU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?
M_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_
M )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_
M !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K
M_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YY
MZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?
M\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ
M5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5
M'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##
M0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X
M#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^
M-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#
M-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U11
M7RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7
M_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\
M51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\
MGGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\
M%4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_
M ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI
M7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_P
MT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7
M_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?
M5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"
M^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,
MW_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU
M_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W
M_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?
M*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^
M>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5
M'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">
M>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 5
M0!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\
MPT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?
M^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0
MOC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^
M S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]4
M45\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+X
MU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?
M_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_
M )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_
M !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K
M_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YY
MZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?
M\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ
M5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5
M'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##
M0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X
M#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^
M-?\ GGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#
M-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U11
M7RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]445\K_P##0OC7
M_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\ %4 ?5%%?*_\ PT+XU_YYZ5_X#-_\
M51_PT+XU_P">>E?^ S?_ !5 'U117RO_ ,-"^-?^>>E?^ S?_%4?\-"^-?\
MGGI7_@,W_P 50!]445\K_P##0OC7_GGI7_@,W_Q5'_#0OC7_ )YZ5_X#-_\
M%4 ?5%%?*_\ PT+XU_YYZ5_X#-_\51_PT+XU_P">>E?^ S?_ !5 'U117RO_
M ,-"^-?^>>E?^ S?_%4?\-"^-?\ GGI7_@,W_P 50!]45X/^TK=P#3] LMX,
MYEEEV#J%  R?Q/Z&N./[0GC8J0$TL$CJ+9N/_'JQ-%\.^+OBYXH-W<233!V
MN-0F7$4*#L,8'T5?TY- 'OWP+C=/A/IA92 \D[+GN/,8?TKT:J.C:3::#HMG
MI5BFRVM(EBC!ZD =3[GJ3ZFKU !1110 4444 %%%% !1110 4444 %%%% !5
M2]TK3M1Q]NL+6ZP-H\^%7X].15NB@#&_X1'PS_T+ND_^ 4?_ ,31_P (CX9_
MZ%W2?_ */_XFMFB@#&_X1'PS_P!"[I/_ (!1_P#Q-'_"(^&?^A=TG_P"C_\
MB:V:* ,;_A$?#/\ T+ND_P#@%'_\31_PB/AG_H7=)_\  */_ .)K9HH QO\
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M$?#/_0NZ3_X!1_\ Q-'_  B/AG_H7=)_\ H__B:V:* ,;_A$?#/_ $+ND_\
M@%'_ /$T?\(CX9_Z%W2?_ */_P")K9HH QO^$1\,_P#0NZ3_ . 4?_Q-'_"(
M^&?^A=TG_P  H_\ XFMFB@#&_P"$1\,_]"[I/_@%'_\ $T?\(CX9_P"A=TG_
M , H_P#XFMFB@#&_X1'PS_T+ND_^ 4?_ ,31_P (CX9_Z%W2?_ */_XFMFB@
M#&_X1'PS_P!"[I/_ (!1_P#Q-'_"(^&?^A=TG_P"C_\ B:V:* ,;_A$?#/\
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M+ND_^ 4?_P 31_PB/AG_ *%W2?\ P"C_ /B:V:* ,;_A$?#/_0NZ3_X!1_\
MQ-'_  B/AG_H7=)_\ H__B:V:* ,;_A$?#/_ $+ND_\ @%'_ /$T?\(CX9_Z
M%W2?_ */_P")K9HH QO^$1\,_P#0NZ3_ . 4?_Q-'_"(^&?^A=TG_P  H_\
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M)_\  */_ .)K9HH QO\ A$?#/_0NZ3_X!1__ !-'_"(^&?\ H7=)_P# */\
M^)K9HH QO^$1\,_]"[I/_@%'_P#$T?\ "(^&?^A=TG_P"C_^)K9HH QO^$1\
M,_\ 0NZ3_P" 4?\ \31_PB/AG_H7=)_\ H__ (FMFB@#&_X1'PS_ -"[I/\
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MC_\ B:V:* ,;_A$?#/\ T+ND_P#@%'_\31_PB/AG_H7=)_\  */_ .)K9HH
MQO\ A$?#/_0NZ3_X!1__ !-'_"(^&?\ H7=)_P# */\ ^)K9HH QO^$1\,_]
M"[I/_@%'_P#$T?\ "(^&?^A=TG_P"C_^)K9HH QO^$1\,_\ 0NZ3_P" 4?\
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,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
